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Figure 1.31 Different mediolateral levels experience different phases of 
longitudinal growth in the murine frontal bone  
Figure 1.32 Deposition of mineral in the samle mediolateral level at the same age 
van vary in size considerably 
 
Table 1.1 :Temporal sequence of matrix labelling dye injections into pregnant 
dam 
 
Chapter 2 
Figure 2.1 The intercalary patterns of growth in the frontal bone cannot be 
explained by the traditional model of dermal bone growth 
Figure 2.2 Application of lipophilic DiO/DiI to skull explant allows tracking of 
cells in the frontal bone 
Figure  2.3 Cells labelled with lipophilic dye in L1 or L3  can be found in L2 in 
the prenatal mouse frontal bone 
Figure 2.4 Cellular invasion of L2 persists into early postnatal stages and extends 
to full invasion of the bone 
Figure 2.5 Some invading cells are of the osteocyte lineage 
Figure 2.6: Cells are likely to originate from a different layer from the one they 
are observed in 
Figure 2.7 In the thicker more developed frontal bone (50 microns +) cells 
originating from either L1 or L2 are most likely to be observed in L2, whilst in 
thinner bone cells are equally likely to be found in L2 or L1/3 
Figure 2.8Cells are more likely to be retained in L2 in thicker regions rather than 
thinner regions 
Figure 2.9 RUNX2+HAND2+  double labelled cells carrying lipophilic dye can 
be found in L2 and L1/L3 of the murine frontal bone 
Figure 2.10:  Downward and upward invading populations have different 
abundances of  RUNX2+ and HAND+ cells 
Figure 2.11 Beta distribution of RUNX2 single positive cell populations shows a 
difference in L2 retention depending on a cell’s direction of invasion 
Figure 2.12: Beta distribution of HAND2 single positive cell populations shows 
no significant difference in L2 retention depending on a cell’s layer of origin 
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Figure 2.13: Beta distribution of RUNX2+HAND2+ double positive cell 
populations shows no difference in L2 retention depending on a cell’s layer of 
origin\ 
Figure 2.14 Beta distribution of RUNX2/HAND2 negative cell populations 
shows a difference in L2 retention depending on a cell’s layer of origin 
Figure 2.15Downward migrating cell types show distinct invading behaviour 
 
Figure 2.16 Ablation of HAND2 in the NC lineage leads to a lack of thickness 
growth and elaboration of the frontal bone biomineral   
Figure 2.17: The Confetti construct recombines in the presence of Cre 
recombinase to express one of four colours 
Figure 2.18 : Experimental set up of live imaging of Wnt1CrexConfetti frontal 
bone allows tracking of cells over many hours  
Figure 2.19:Visualisation of XY dimension of  cell tracks in cultured murine 
frontal bone reveals a prevailing direction of migration within a bone 
Figure 2.20:Visualisation of XZ plane cell tracks in cultured murine frontal bone 
reveals that some cells that move great distance in Z , and do so in large steps 
reveals that some cells that move great distance in Z , and do so in large steps 
Figure 2.21: Cells make large movements in both upward and downward 
direction 
Figure 2.22: The median pathlength of a cell is between 19-26 µm 
Figure 2.23 : Net displacement is shorter than pathlength 
Figure 2.24:Largest displacements in XY and Z plane when cells are moving into 
regions of low cell density 
Figure 2.25 Cells in bone with thinner L2 is skewed towards bigger movement in 
XY axis than Z 
Figure 2.26: The max velocity of a cell does not correlate positively with its 
pathlength  
Figure 2.27: Max velocity and  total net displacement correlate positively, which 
suggests that the majority of a cells path is achieved in a short burst of fast 
movement 
Figure 2.28 Cells make bigger speed changes in the Z direction than the XY 
direction 
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Table 2.1: Samples numbers used in analysis of behaviour of invading cells 
Table 2.2 Layer distribution of invading cells DiI labelled in L1, assessed for 
RUNX2 and HAND2 positivity 
Table 2.3 Layer distribution of invading cells DiI labelled in L3, assessed for 
RUNX2 and HAND2 positivity 
Table 2.4 Details of live imaged frontal bone samples A-D 
Table 2.5 Pathlength and displacement of cells in samples A-D 
Table 2.6 Velocity of cells in Samples A-D 
 
Chapter 3 
Figure 3.1 Neural crest derived endothelial cells in the frontal bone 
Figure 3.2 Neural crest cell population in the murine frontal bone includes NC 
derived endothelial cells whose proportion of total NC derived cells increases 
progressively through layers 1 to and 3 
Figure 3.3 VEGFA+ VEGFR2+ double positive cells labelled with lipophilic dye 
can be observed in the murine frontal bone along the walls of a blood vessel 
Figure 3.4 Upward and downward invading cell populations have different 
abundances of VEGFR2+VEGFA+ double positive cells 
Figur Figure 3.5 Beta distributions of VEGFR2 single positive cells shows very 
high probability of L2 retention 
Figure 3.6 Beta distributions of VEGFR2+VEGFA+ double positive cells shows 
high probability of L2 retention 
Figure 3.7 Beta distributions of VEGFA single  positive cells shows a potential 
difference in upward and downward migrating populations 
Figure 3.8 Beta distributions of VEGFR2VEGFA double negative cells show no 
significant difference between upward and downward migrating populations 
Figure 3.9 VEGFA single positive cells invade upward fully into L2 unlike any 
other invading cell type 
Figure 3.10 Invading population of frontal bone includes RUNX2+VEGFA+ 
double positive cell type 
Figure 3.11 The upward and downward invading cells have different population 
profiles in a RUNX2/VEGFA double stain 
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Figure 3.12 Beta distributions of RUNX2 single positive cells show strong 
probability of L2 retention 
Figure 3.13 Beta distributions of RUNX2VEGFA double positive cells show 
even probability of half or full invasion of the frontal bone 
Figure 3.14 Beta distributions of VEGFA single positive cells show a potential 
difference in migration behavior depending on the layer of origin 
Figure 3.15 Beta distributions of  RUNX2VEGFA double negative cell 
populations are equally likely to half and fully invade the frontal bone 
independent of layer of origin 
Figure 3.16 Downward invading RUNX2 positive cells show increased 
likelihood of L2 retention compared to the other downward invading cell types 
Hypoplasia of the frontal bone in the Wnt1-Cre;Vegfafl/fl  mouse  
Figure 3.18: Wnt1Cre:Vegfafl/fl KO mouse frontal bone lacks NC derived cells 
in L2 in contrast to the WT specimen 
Figure 3.19: Neural crest derived cells with endothelial morphology in the frontal 
bone in timelapse imaging 
Figure 3.20: NC derived endothelial cells can form lumen by a change in cell 
morphology  
Figure 3.21 Lumen space can be  increased by cells at the lumen margin forming 
a ‘doughnut’ before  dividing into two separate cells  
Figure 3.22: Endothelial cells change morphology and work as a pair to enclose 
and line a lumen, creating three enclosed compartments from two 
Figure 3.23:The  lumen of vessels can be  enlarged by the  elongation of an 
endothelial cell 
 
 
Table 3.1: Layer distribution of invading cells DiI labelled in L1, assessed for 
VEGFR2 and VEGFA positivity 
Table 3.2: Layer distribution of invading cells DiI labelled in L3, assessed for 
VEGFR2 and VEGFA positivity 
Table 3.3: Layer distribution of invading cells DiI labelled in L1, assessed for 
VEGFR2 and VEGFA positivity 
Table 3.4: Layer distribution of invading cells DiI labelled in L3, assessed for 
VEGFR2 and VEGFA positivity 
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Chapter 4 
Figure 4.1: The NC clone lineages of the frontal bone produce more than one cell 
type 
Figure 4.2:Architectural structure of biomineralisation defines different regions 
in the frontal bone 
Distinct cell morphology allows identification of three cell lineages in the frontal 
bone from the DAPI and brightfield channels  
Figure 4.4: The relationship of the architectural structure of biomineralisation 
and cell lineage distribution is complex 
Figure 4.5: Different architectural features of biomineralisation and cell topology 
emerge at different times 
Figure 4.6: The Global distribution of osteoblast, endothelial and osteocyte cell 
lineages varies in different regions of the frontal bone 
Figure 4.7 Groups of osteoblasts can be found at the termini of branches of 
intercalary biomineral 
Figure 4.8 Osteoblasts are found largely ventral to intercalary biomineral and 
aligned with the direction of branch growth 
Figure 4.9 Endothelial cells are found most commonly in trabeculae in the 
intercalary region  
Figure 4.10 Endothelial cells like osteoblasts, are found most commonly ventral 
to deposits of intercalary biomineral 
Figure 4.11 Osteocytes are common in the appositional biomineral surrounding 
the intercalary biomineral 
Figure 4.12 Osteocytes are rare within intercalary biomineral, but common in 
appositionally deposited e16-e17 biomineral 
Figure 4.13 :Endothelial cells and osteoblasts are at the  centre of system of e16-
e17 trabeculae at P1 
Figure 4.14: e16/17  ridges of biomineral extend mediolaterally from the 
supraorbital ridge to the midline in the frontal bone 
Figure 4.15 All three cell lineages are found associated with e16/e17 biomineral 
‘ridges’ 
Figure 4.16:Osteoblasts and osteocytes are found at the most medial point of  the 
biomineral ridges, whilst endothelial cells are found at medial and lateral levels. 
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Figure 4.17 There is a region of bone that is mineralised but not trabeculated 
posterior to the supraorbital ridge. 
Figure 4.18 Osteoblasts surround osteocytes and biomineral in a ‘fringe’  
Figure 4.19 At the ventral level of the frontal bone matrix, groups of osteocytes 
and osteoblasts expand and coalesce 
Figure 4.20: Characteristic cell distributions in relation to biomineral architecture 
 
Chapter 5 
Figure 5.1 Anatomy and tissue origins of the cranial base 
Figure 5.2: Studies on tissue growth of the cranial base are limited by the genetic 
approach  
Figure 5.3 Whole mount analysis shows appositional and symmetrical growth of 
bone either side of the SOS and MSS 
Figure 5.4: The e18 Wnt1xLacZ cranial base shows cells anterior to the pituitary 
are NC derived 
Figure 5.5: Confetti labeling reveals directionality of growth in SES and ethmoid 
chondrocytes clones 
Figure 5.6:Confetti labeling reveals anisotropic  growth in the MSS in the dorsal-
ventral axis 
Figure 5.7: The neural crest chondrocyte clones at the neural crest: mesoderm 
boundary expand anisotropically like the clones of the MSS 
Figure 5.8: NC derived cells in the e14.5 cranial base consist of a very large 
number of small clones 
Figure 5.9: SES clonal expansion appears relatively chaotic at early stage to but 
becomes anisotropic at a later stage of development 
Figure 5.10: Anisotropic clonal expansion is established early in the MSS 
Figure 5.11: NC clone contribution to the SOS is lost after birth 
Figure 5.12: MSS chondrocyte clones show more defined anisotropy of growth 
than SES 
Figure 5.13: Number of clones in the synchondroses rises from e14.5 to P1 and 
declines after birth 
Figure 5.14: Cranial base length is dominated by different regions at different 
ages  
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Figure 5.15: The rate of longitudinal growth in the cranial base constituents 
changes between the prenatal and postnatal stages 
Figure 5.16: Clone length continuously increases with age in the MSS and SES 
Figure 5.17: Expansion of the SES at clonal resolution 
Figure 5.18: Ontogenetic expansion and contraction of the MSS at clonal 
resolution 
Figure 5.19: Continuous growth in synchondrotic thickness between e14 and P26 
Figure 5.20 Thickness growth in the SOS is biphasic 
Figure 5.21: Clone height and cellular numerosity does not continuously increase 
with age 
Figure 5.22: Thickness growth of the SES is explained by both cell shape and 
cell proliferation 
Figure 5.23: Thickness growth of the MSS is explained by cell proliferation 
alone 
Figure 5.24:There is correlation and disjunction of growth in length and 
thickness within the cranial base synchondroses 
Figure 5.25 Prenatal synchondrotic  growth is length skewed, whilst postnatal 
synchondrotic growth is thickness skewed 
Figure 5.26: The coordination of synchondrotic clone growth in the AP and DV 
axes is different in the MSS and SES 
Figure  5.27 The evolutionary emergence of bone 
Figure 5.28: There is preferential biomineralisation on the basisphenoid at the 
midline in the cranial base 
Figure 5.29: Mineralisation is not continuous in anterior posterior axis 
Figure 5.30: Both the basisphenoid and basisocciput are extensively mineralised 
between e14 and e17 at certain mediolaeral levels  
Figure 5.31: Intercalary patterns of mineralisation found in the frontal bone can 
also be observed in the endochondral bone of the skull, 
Figure 5.32 The oldest biomineral is found closest to the margins of the cranial 
base synchondroses 
Figure 5.33 Evidence of  intercalary mineralisation in medaka vertebral bodies 
Figure 5.34 Intercalary biomineral growth a mechanism of mineral growth 
shared by endochondral ossification and dermal ossification, which emerge at 
separate points of phylogeny 
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Table 5.1 Total numbers of neural crest derived chondrocyte clones 
 
7 Materials and Methods 
 
Figure 7.1: DNA Ladders used for running Cre and Confetti samples on 2 % 
agarose gel 
 
Table 7.1: PCR Master Mix component concentrations 
Table 7.2: PCR primer sequence and fragment size 
Table 7.3: PCR programs for genotyping 
Table 7.4- Primary antibodies 
Table 7.5- Secondary Antibodies 
Table 7.6: Details of Lipophilic dye (DiI/DiO) labelling experiments 
Table 7.7- Matrix labeling Agent Dosage 
Table 7.8- Administration regimes of matrix labelling agents 
Table 7.9: Live Imaging of Wnt1CrexConfetti frontal bone explants 
 
8 Technical Appendix 
 
Figure 8.1 Landmarks for measurements of cranial base length dimension 
 
Table 8.1 P values for differences in the absolute thickness of labelled biomineral 
layers 
Table 8.2 P values for differences in the rate of radial biomineralisation 
Table 8.3RUNX2 / HAND2 antibody labeled bone sections 
Table 8.4VEGFR2 / VEGFA antibody labeled bone sections 
Table 8.5 RUNX2 / VEGFA antibody labeled bone sections 
Table 8.6 Alpha and beta values used for beta distribution input for downward 
(L1 labelled) invading RUNX2 /HAND2 stained cells 
Table 8.7:Alpha and beta values used for beta distribution input for upward (L3 
labelled) invading RUNX2 /HAND2 stained cells 
Table 8.8:Alpha and beta values used for beta distribution input for downward 
(L1 labelled) invading VEGFR2 /VEGFA stained cells 
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Table 8.9: Alpha and beta values used for beta distribution input for upward (L3 
labelled) invading VEGFR2 /VEGFA stained cells 
Table 8.10 Alpha and beta values used for beta distribution input for downward 
(L1 labelled) invading RUNX2/VEGFA stained cells 
Table 8.11:Alpha and beta values used for beta distribution input for upward (L3 
labelled) invading RUNX2 /VEGFA stained cells 
Table 8.12: Percentage overlap between beta distributions of downward invading 
cell populations assessed for RUNX2/HAND2 expression 
Table 8.13: Percentage overlap between beta distributions of upward invading 
cell populations assessed for RUNX2/HAND2 expression 
Table 8.14: Percentage overlap between beta distributions of upward invading 
cell populations assessed for VEGFR2/VEGFA expression 
Table 8.15 Percentage overlap between beta distributions of downward invading 
cell populations assessed for RUNX2/VEGFA expression 
Table 8.16 Percentage overlap between beta distributions of upward invading 
cell populations assessed for RUNX2/VEGFA expression 
Tables 8.17-8.19 Percentage overlap between beta distributions of upward and 
downward invading populations of the same cell type 
Table 8.20 Cranial base length measurements in Wnt1CrexConfetti specimens 
Table 8.21 Height measurements of cranial base synchondroses in 
Wnt1CrexConfetti specimens 
Table 8.22: Number of clones used in analysis of clone height, length and 
orientation in in Wnt1CrexConfetti specimens 		
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iv) Abstract  
The mammalian skull is a complex ossified structure of multiple embryological 
tissue origins. It is formed from two distinct forms of ossification: 
intramembranous ossification that produces the flat dermal bones of the calvaria 
craniofacial region and the mandible, and endochondral ossification that forms 
the cranial base. 
I investigated the patterns of mineralisation in both bone types, in the dermally 
ossifying frontal bone and the endochondrally ossifying cranial base. I also 
investigated the cell behaviour within the frontal bone and expansion of 
chondrocytes clones in the cranial base synchondroses. 
 
I find that the intramembranously ossified frontal bone displays complex and 
novel forms of biomineralisation, including a system of intercalary biomineral 
thickness growth that cannot be explained by the current accepted model of 
dermal ossification. 
 
I discover that the cells associated with the specialised biomineralised 
architecture of the dermal bone, contribute to its growth via a novel mechanism 
of bi-directional cellular invasion from the outer layers of the bone to the 
intervening mineralising layer. Cell behaviour is found to depend upon the 
directionof invasion for preosteoblasts, which also show a distinct invasive 
pattern compared to other cell types. 
 
I discover a number of previously unknown cell types that possess invasive 
behaviour, including a double positive RUNX2+HAND+ population and neural 
crest derived endothelial cells in the dermal bone, which co-express the 
endothelial growth factor VEGFA. Ablation of VEGFA and of HAND2 in the 
neural crest lineage prevents invasion of the frontal bone and a loss of thickness 
growth of biomineral respectively. 
 
My analysis of the cranial base reveals a cryptic modularity of growth of its 
separate bones and cartilages that varies with time. I also find the synchondroses 
of the cranial base not to be the origin of biomineral growth as expected but 
discover a system of radial and longitudinal intercalary biomineral growth 
similar to that observed in the frontal bone. 
 
My findings suggest that the timing of growth and ossification of bone is crucial 
for proper development, and this may inform the pathophysiology of cranial base 
syndromes than have complex timing of the onset symptoms. It suggests hints 
that the ancient mechanisms of biomineral growth in dermal bone are co-opted 
for use by tissues that ossify in an endochondral fashion. 
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v) Abbreviations 
 
A-P- Anterior-posterior 
Ab-Antibody 
BA-Branchial Arch 
B.occ-basisocciput 
B.Sph-basisphenoid 
BSP- Bone sialoprotein 
CD31- cluster of differentiation 31(Platelet endothelial cell adhesion molecule) 
Col 1- Collagen Type 1 
Col 2- Collagen Type 2 
Col 4- Collagen type 4 
Col 10- Collagen type 10 
CRE- cre recombinase 
DABCO- 1,4-diazabicyclo-2.2.2-octane) 
DAPI- (4',6-diamidino-2-phenylindole) 
dH20- Dionied waster 
DiI- 1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine Perchlorate ('DiI'; 
DiIC18(3))) 
DiO- 3,3′-dioctadecyloxacarbocyanine perchlorate (‘DiO′; DiOC 
DMEM- Dulbecco's Modified Eagle Medium 
DNA- Deoxyribose nucleic acid 
dNTP- nucleoside triphosphate 
dpc- days post coitum 
D-V- Dorsal-ventral 
EDTA- Ethylenediaminetetraacetic acid 
EtBr- Ethidium bromide 
EtOH- Ethanol 
FCS-Foetal Calf Serum 
FGF- fibroblast growth factor  
FGFR- fibroblast growth factor receptor 
Fiji- Fiji is ImageJ 
FLK- Fetal Liver Kinase 1 
GFP- green fluorescent protein  
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HAND2- heart and neural crest derivatives expressed 2 
IHC- immunohistochemistry 
Ihh- Indian hedgehog 
KDR- Kinase insert domain receptor 
KO-Knock out 
MgCl2- Magnesium Chloride 
ML- Mediolateral 
MSS- Mid sphenoidal synchondrosis 
NC- neural crest 
OPN- osteopontin 
PBS- Phosphate buffer solution 
PCR- Polymerase chain reaction 
PFA- Paraformaldehyde 
RUNX2- runt-related transcription factor 2 
SES- Spheno-ethmoidal synchondrosis 
Shh- Sonic hedgehog 
SOS spheno-occipital synchondrosis 
TAE-Tris-acetate-EDTA 
Taq- Taq polymerase 
TRAF-6-TNF receptor-associated factor 6 
VEGFA- vascular endothelial growth factor A 
VEGFR2-vascular endothelial growth receptor 2 
Wnt1-Wingless-Type MMTV Integration Site Family, Member 1 		
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vi. General Introduction 
Ossification in vertebrates 
 
The mammalian skeleton is a phenomenally complex structure, comprising 
bones in a wide variety of shapes and sizes, derived from different embryological 
tissues. 
These bones form via one of two distinct mechanisms: dermal 
(intramembranous) and endochondral ossification. 
 
Dermal (intramembranous) ossification is confined to the skull in mammals, the 
exception being the lateral portion of the clavicle (Hall, 2001, Morriss‐Kay, 
2001). Dermal ossification is responsible for the formation of the flat bones of 
the craniofacial region and skull vault, as well as the mandible. 
 
Endochondral ossification is responsible for the formation of the cranial base, 
spine, thoracic and appendicular skeleton. 
 
Dermal bone is believed to arise from osteogenic condensations of mesenchymal 
tissue. In these condensations precursor cells differentiate into osteoblasts that 
are capable of depositing collagenous matrix that is subsequently mineralised 
(Hall and Miyake, 2000). This typically results in flat bones such as the frontal 
bone, unless there is a structure present for the condensations to form around. An 
example of this is the mandible, a dermally ossified 3D structure that forms 
around Meckel’s cartilage. 
 
In contrast, endochondral ossification involves the replacement of an initial 
cartilaginous template by mineralised boney tissue	(Mackie et al., 2008).  
Cartilage was the first internal structural tissue to arise phylogenetically. It took 
the form of the pharyngeal rings (potentially as early as the Cambrian) in 
Haikouella, proposed to be in a sister group to craniates (Mallatt and Chen, 2003, 
Meulemans and Bronner-Fraser, 2007). 
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Dermal bone however is the phylogenetically older of the two bone tissues, being 
the first cellular bone to emerge. It originated as hard armour on the bodies of 
osteostracans (vertebrate fish) in the Ordovician and Silurian (Qu et al., 2013) 
(Donoghue et al., 2006, Donoghue and Sansom, 2002). 
Endochondral bone emerged later, firstly as ‘perichondral’ ossification on the 
surface of cartilage and then as the true invasion and replacement of cartilage 
with bone in the ossified cranial base of placoderms in the Devonian era (Rücklin 
et al., 2012, Janvier, 1996, Eames et al., 2007). 
 
These two bone types come together to help form the complex mammalian body 
structure and protect vital organs. Aberrant ossification of either type can of 
course cause pathology in an organism. 
 
Pathologies of bone formation and growth 
 
The aberrant ossification of dermal bone is most frequently exemplified by 
craniosynostosis of the cranial sutures, where the early closure (ossification) of 
the suture restricts the growth of the developing brain in young children (Wilkie, 
1997). 
 
The Arnold- Chiari malformation is an example of aberrant endochondral 
ossification in the skull. In this disease the cartilaginous posterior cranial base 
ossifies prematurely and excessively, impacting on the developing brain and 
causing herniation of the cerebellar tonsils into the spinal cord (Milhorat et al., 
1999, Speer et al., 2003). Of especial interest in Chiari is that the onset of 
symptoms is likely to happen either early in life or in an individual’s thirties and 
forties (Albert et al., 2010, Fernández et al., 2009). 
 
A number of syndromes that display craniosynostosis are associated with 
shortening of the cranial base, thought to be due to over ossification of the 
cranial base synchondroses, such as Apert, Crouzon and Muenke syndromes 
(Nah et al., 2012, Liu et al., 2013, Nagata et al., 2011). Both Crouzon and 
Muenke syndromes are due to mutations in the fibroblast growth factor receptor 
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3 (FGFR3) gene, whilst Apert syndrome is caused by a mutation in the FGFR2 
gene.  
Thus problems with the mechanisms of dermal and endochondral ossification 
can occur both independantly and together. 
 
Of the two types of ossification, endochondral is by far the better studied in 
terms of the mechanisms of formation, perhaps due to its greater relative 
abundance in the human skeleton and the relative ease of manipulating discrete 
bones compare to the flat membranous dermal bones. As such many mechanisms 
of endochondral ossification are assumed to be true of dermal ossification, as 
many genes and cell types are shared. This however is not intuitive based on 
their phylogenetic emergence. 
In recent years there has been an increasing amount of research devoted to the 
mechanism of dermal ossification, as the calvaria of the skull has proved a 
popular research tool as a whole explant and a source of cells. 
 
In this thesis I consider the formation of a dermal bone and an endochondral 
structure of the skull, the frontal bone and cranial base respectively. 
I am particularly interested in the timing of mineralisation of these bones and the 
behaviour of the cells involved in their development. 
 
The major cells types involved in ossification 
 
There are three major bone cell types involved in the formation, maintenance and 
remodeling of bone that are common to both dermal and endochondral 
ossification: osteoblasts, osteocytes and osteoclasts. A fourth cell type intimately 
involved in bone formation are endothelial cells, which can make a very large 
proportion (40%) of cells in the bone (Ortega et al., 2003). 
 
Osteoblasts are of mesenchymal origin and osteocytes are thought to be the 
terminally differentiated cell of the osteoblast lineage. Osteoblasts also share a 
common progenitor cell with chondrocytes (Akiyama et al., 2005). 
Cells committed to the osteoblast lineage highly express the Runt related 
transcription factor 2 (RUNX2). RUNX2 induces expression of both collagen 1 
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(Col1) subunits (alpha 1 and alpha 2) in osteoblasts, as well as many of the non-
collagenous components of the bone extracellular matrix such as osteopontin, 
osteocalcin and bone sialoprotein (Roca et al., 2005, Harada et al., 1999, Ducy et 
al., 1997). RUNX2 expression is maintained in immature osteoblasts but declines 
in mature osteoblasts (Komori and Choi, 2010). 
Mice null for Runx2 are completely devoid of mineralised bone, though cartilage 
forms as normal (Otto et al., 1997).  Human mutations in the Runx2 locus have 
been identified, for example in Cleidocranial dysplasia (CCD)(Lee et al., 1997, 
Mundlos et al., 1997). This syndrome is characterised by abnormal or missing 
clavicles, open sutures and fontanelles and short stature. These mutations are 
various, and chromosomal translocations (Zhang et al., 2000), nonsense 
mutations (Tsai et al., 2000), insertions (Mundlos et al., 1997), missense (Quack 
et al., 1999) and splice site mutations (Zhou et al., 1999) at the human Runx2 
locus (Ch6p21) have all been described. This variation at the gene level is 
reflected in the wide array and severity of symptoms displayed by patients, even 
within the same family (Otto et al., 2002). 
 
Between 50-70% of osteoblasts in bone undergo apoptosis (Karsdal et al., 2002).  
The remaining cells either become incorporated into the periosteum as ‘bone 
lining cells’, or can undergo the differentiation process to become osteocytes, the 
second major bone cell. This differentiation is characterised by a change in 
expression of molecular markers and morphology of the cell, which reflects the 
change of function. 
Osteocytes reside in distinct pits or ‘lacunae’ and have many dendritic processes 
that extend throughout the bone in channels known as canaliculi. These 
processes allow communication between osteocytes in other lacunae hence 
forming the ‘lacunacanalicular system’. The dendrites allow the cell to respond 
to mechanical stain, which cause microcracks that require repair and remodeling 
to ensure the integrity of the bone (Hazenberg et al., 2009). 
The earliest molecular marker of the osteoblast to osteocyte transition is 
expression of the E11 protein by mature osteoblasts, which is located on the 
developing dendrites. E11 has a role in allowing the osteocyte to respond to 
mechanical strain by lengthening of the dendrites (Zhang et al., 2006). DMP-1, 
another marker of osteocytes, is also thought to aid in the sensing of mechanical 
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stress by the osteocyte and allow it to stimulate repair of the bone (Kalajzic et al., 
2004). 
An osteocyte can also communicate with osteoblasts that the dendritic processes 
contact, in particular exerting control through the secreted factor sclerostin, 
which suppresses differentiation of osteoblasts (Poole et al., 2005, Van 
Bezooijen et al., 2004). Osteocytes are also capable of inducing angiogenesis by 
secretion of vascular endothelial growth factor A (VEGFA), which induces 
proliferation of endothelial cells (Prasadam et al., 2014). 
Osteocytes are traditionally thought of as immobilised osteoblasts, but in the last 
decade a great deal of evidence has emerged suggested that this cell type 
transformation is far from passive, and that these cells, as well as osteoblasts, are 
motile and can travel significant distances across the surface of bones (Dallas et 
al., 2008, Veno et al., 2007). It is not yet clear if all osteoblasts have the potential 
to differentiate into osteocytes, or if there is a predetermined population.  
 
The third major cell directly involved in ossification is the osteoclast. These large 
multinucleated tartrate-resistant acid phosphatase (TRAP)-positive cells are of a 
haemopoetic cell lineage, unlike mesenchymal osteoblasts and osteocytes (Boyle 
et al., 2003). Osteoclasts achieve resorption of bone by forming a sealed pod 
between the cell and the bone- the resorption lacunae- that the osteoclast fills 
with Cathespin K and mineral metalloproteases (MMPs), proteins that are 
capable of degrading collagen. Prior to the proteases however HCL is secreted 
into the resorption lacunae to maintain an acidic pH to degrade the inorganic 
calcium phosphate crystals (Novack and Faccio, 2011) (Bossard et al., 1996, 
Rice et al., 1997). Resorption of both dermal and endochondral bone is an 
important part of bone turnover and calcium and phosphate homeostasis in the 
body, though differences in the mechanism of action of osteoclasts in dermal vs. 
endochondral bone have been demonstrated (Everts et al., 2006). The ability to 
degrade the inorganic component of bone matrix is considered unique to 
osteoclasts. 
 
Bone of both types is highly vascularised, and the development of the 
vasculature is intimately linked with proper bone formation. Hence, endothelial 
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cells are another major cell type in the mammalian bone architecture, and of 
interest in this thesis. 
Endothelial cells are elongated cells of mesodermal lineage that line the blood 
vessel walls. Both endothelial cell progenitors and mature endothelial cells can 
be identified by expression of Vascular endothelial growth factor receptor 2 
(VEGFR2) (Yamaguchi et al., 1993, Millauer et al., 1993). Proliferation and 
organisation of these cells extends the vascular network of the bone in a process 
known as angiogenesis (distinct from de novo ‘vasculogenesis’ directly from 
pools of angioblasts).  
Endothelial cells can provide differentiation signals to osteoprogenitors 
(Ramasamy et al., 2014). As well as aiding the synergistic invasion of 
endochondral bone with osteoclasts, there is some evidence endothelial cells can 
directly inhibit osteoclast differentiation (Enoki et al., 2014) . 
 
I will now discuss the specific types of ossification in more detail. 
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Dermal (intramembranous) Ossification 
Overview 
 
In the traditional model of dermal ossification, the osteoblast precursors and 
osteoblasts are thought be arranged in a continuous layer and deposit a collagen 1 
(Col I) rich matrix in a single direction (Lieberman and Friedlaender, 2005) 
(figure 1).  
 
 
 
 
In the frontal bone this means a layer of cells on the ectocranial (dorsal) surface 
of skull depositing matrix ventrally and osteoblasts in a layer on the endocranial 
(ventral) surface of the bone depositing matrix in a dorsal direction. The 
thickness of the bone is therefore built up in layers in the manner of a tree trunk, 
with older layers on the inside and the youngest layers on the outside (Cleall et 
al., 1968). The matrix over time will become mineralised by the addition of 
calcium phosphate crystals forming hydroxyapatite. This is done around existing 
A B C D 
Figure 1: The traditional model of dermal ossification  
figure adapted from (Lieberman and Friedlaender, 2005)  
A) A layer of osteoblasts (white cells) secrete collagenous matrix ventral to the cell layer 
(black stippling). This matrix becomes mineralised with hydroxyapatite to form the 
bone (green). 
B) The osteoblasts continue to deposit matrix downwards, and matrix is deposited 
outwards by osteoblasts lining the blood vessels. 
C) Over time the mineralised matrix builds up. New osteoblasts are supplied from the 
periosteum as preosteoblasts (cyan) differentiate, and overlay the previously 
deposited matrix. This results in matrix building up in layers of the same age over 
time. 
D) Osteoblasts that become trapped in the mineralised matrix (black arrows) mature into 
osteocytes, which can survive for many years in the bone coordinating remodeling 
and repair. 
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vasculature to form the vascularised dermal bone (Lieberman and Friedlaender, 
2005). 
 
Dermal ossification in the frontal bone 
The dermally ossifying frontal bones of the vertebrate skull vault are typically 
flat, and the cells that form it are supplied from the ‘frontal bone primordia’, a 
condensation of neural crest derived mesenchyme in the orbital region (figure 2, 
dotted outline). 
In the mouse it has been shown that the cells that instigate the initial growth of 
the frontal bone all originate from this primordia (Yoshida et al., 2008). A 
lipophilic cell label (DiI) was injected into the frontal primordia mesenchyme at 
e13.5 and the embryo returned to the uterus and allowed to develop until e18.5. 
By e18.5 cells labelled with DiI were widespread in the frontal bone with high 
levels of labelling in the bone itself, and some connective tissue also labelled. By 
contrast, DiI injection into the lateral mesenchyme and midline mesenchyme of 
the frontal bone at e13.5, resulted in labelling of connective tissue and meningeal 
tissue only by e18.5, showing no contribution to the developing bone.  
 
After the mesenchymal condensations have initiated ossification, the frontal 
bones grow towards each other and to the parietal bones, and where the bones 
meet the cranial sutures form sometime between late prenatal and early postnatal 
life rats and mice (Opperman et al., 1993).They are fibrous and remain 
unossified in the human in normal conditions until the bone is fully formed. In 
mice, with the exception of the posterior half of the frontal suture, sutures remain 
patent throughout life. 
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The interfrontal (metopic suture) and the frontoparietal (coronal) sutures from 
their time of formation are thought to be the source of osteoprogenitors for the 
growing bones (figure 2). 
Zhao et al. 2015 have demonstrated in a lineage tracing experiment beginning in 
1 month old mice, that all the cells of the frontal bone are derived from a 
population of  Gli1+ stem cells. The expression of Gli1 by cells was claimed by 
the authors to be restricted to the periosteum, dura mater and suture mesenchyme 
at P0, gradually becoming more restricted by 1 month of age to the suture 
mesenchyme. However, in the frontal bone sections from both the Gli1 lineage 
tracing and expression mapping, there appears to be labelled cells in the frontal 
bone itself, which are presumed, but not demonstrated unequivocally, to be 
derived from the suture. 
 
Figure 2: Embryological origins of the bones of the murine calvaria 
Diagram of a postnatal mouse skull. The nasal and frontal bones of the murine 
skull are of neural crest origin, whilst the parietal is of mesodermal 
origin(Couly et al., 1993, Morriss‐Kay, 2001). The interparietal has a medial 
neural crest contribution(Yoshida et al., 2008). The dotted outlines mark 
approximately the position of the frontal bone primordial. FN=frontonasal 
suture, FP=frontoparietal (coronal) suture, IF=interfrontal suture, S=sagittal 
suture. 
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The growth mode of the bones of the cranial vault is of great medical 
significance, as the fusion of these bones along the sutures too early in 
development leads to the relatively common birth defect of craniosynostosis, the 
prevalence of which is between 0.45 and 7.2 in 1000 live births (Sharma et al., 
2013, Heller et al., 2008, Inverso et al., 2016). In craniosynostosis the calvarial 
bones fuse along the sutures, preventing further growth of the skull vault, which 
prevents proper expansion of the brain (Aldridge et al., 2005a). 
It is known that the dura mater has an influence over the patency/closure of the 
sutures. The contact between the posterior frontal suture and the directly 
underlying dura mater inhibits its closure. If contact is prevented between the 
bone and the dura mater the posterior frontal suture will close (Roth et al., 1996). 
In fact if the dura mater under the interfrontal suture is reversed surgically, i.e. 
anterior dura mater underlying the posterior interfrontal suture, the anterior 
suture fuses whilst the posterior interfrontal suture will remain patent (Levine et 
al., 1998) .While it is expected that brain growth has some influence over the 
bone growth, through the signalling from the dura mater, the brain growth 
trajectory for human patients with surgically corrected synostosis is unchanged 
from those with uncorrected synostosis, suggesting there is some independence 
of growth between the brain and cranial vault (Aldridge et al., 2005b) 
As well as the brain, the overlying dermis might be expected to provide growth 
signals to the developing frontal bone. It has been demonstrated in the mandible 
(a dermal bone) that interaction of cells in mesenchymal condensations with the 
mandibular epithelium is required for differentiation of preosteoblasts and 
osteoblasts in the chick (Dunlop and Hall, 2002). 
 
A complicating issue of studying the growth of the cranial vault is that the bones 
are of different embryological tissue origins (see figure 2), and the interactions of 
these cells are a factor on top of any gene interactions.  
In mammalian phylogeny the neural crest derived frontal bones are believed to 
have developed prior to the mesodermally derived parietal bones that they share 
the coronal suture with (Koyabu et al., 2014). 
There is evidence that these cell populations from the frontal and parietal 
contribute differently to the growth of the bones and sutures. For example 
(Holmes and Basilico, 2012) demonstrated that the introduction of the FGFR2 
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mutation (Apert mouse model) in the mesodermal line only was necessary and 
sufficient to induce coronal synostosis. Mutation of FGFR2 in the neural crest 
line, whilst inducing other features of Apert syndrome, did not result in 
craniosyntosis. This is an indication that growth of the frontal and parietal either 
side of their shared suture is not necessarily symmetrical. 
The growth of the bones of the cranial vault is clearly a complex process, 
demonstrated by the great genetic heterogeneity in the population afflicted with 
craniosynostosis, thus their development merits further investigation. 
 
New cell types and behaviour in the frontal bone 
 
Initially established in the Koentges lab is the presence of three distinct 
generative layers within the frontal bone. 
Jordan et al. 2011 observed that first to develop in embryonic life are Layers 1 
and 3. Layer 1 (L1) is nearest the dermis and is formed of mostly large rounded 
blast-like cells. Layer 3 (L3) is nearest the brain and displays a tightly layered 
‘plywood’ of collagen and cells, histologically distinct from L1. Layer 2 (L2) is 
an intervening middle layer which develops after L1 and L3. It is the layer that 
becomes mineralised, and hence considered the only layer to contain osteocytes. 
 
RUNX2 labelled preosteoblasts in L1 were observed in this study to be 
‘reaching’ down into L2 making contact with cells ‘reaching’ up from L3. 
This population of RUNX2 positive cells in the frontal bone was also found to 
express CD31, and endothelial cell marker, and TRAF6, a protein required for 
the differentiation of osteoclasts. This evidence hints at a more complicated 
arrangement and array of cell types than that presented in figure 1 of this 
Introduction. 
 
What is not clear in the study by Jordan et al. is whether the cells in are reaching 
into the matrix via a morphological change in the cell membrane, or whether new 
cells are actively entering the intervening L2 as a result of division or active 
invasion. 
These results merit further investigation of the cell types and behavior in the 
frontal bone and their contribution to its development and mineralisation. 
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Endochondral Ossification 
Overview 
 
In contrast to dermal ossification, endochondral bones are preceded in situ by a 
cartilaginous template. 
The template consists of chondrocytes that secrete and are embedded in an extra 
cellular matrix made up principally of type II collagen (Col2). The Col2 in 
cartilage is mineralised, but not to the extent that bone is, and this forms the 
cartilage proper.  (George and Veis, 2008).  
In all cartilaginous bones, there is a strict organisation of chondrocytes into 
regions based on the maturation stage of the cells. 
Typically there is a zone of  ‘resting’ chondrocytes that merges into a zone of 
chondrocytes actively proliferating. Both types of cell secrete Col2.  
The proliferative chondrocytes mature into prehypertrophic and hypertrophic 
chondrocytes, which switch to secretion of Collagen X (ColX). 
The hypertrophic chondrocytes abut the ossified tissue, and this region is known 
as the growth plate. The mature cartilage in the region of the hypertrophic 
chondrocytes has long thought to the be invaded by vasculature and osteoblasts 
supplied from the periosteum (Nakahara et al., 1990), whilst the hypertrophic 
chondrocytes undergo apoptosis (Vu et al., 1998, Ahmed et al., 2007). 
Authors in the past have suggested that some of these hypertrophic chondrocytes 
could differentiate further into osteoblasts and contribute to ossification (Roach 
et al., 1995, Galotto et al., 1994). However, it is only with lineage tracing studies 
in recent years that it has been demonstrated that a large proportion (in the order 
of 60%) of osteoblasts found in newly formed endochondral bones (the ‘primary 
spongiosa’) are in fact derived from a population of hypertrophic chondrocytes 
that ‘transdifferentiate’ into osteoblasts (Zhou et al., 2014, Yang et al., 2014b, 
Yang et al., 2014a, Park et al., 2015). 
Therefore, not only do osteoblasts and chondrocytes arise from a common 
progenitor, but the lineages can converge to produce the same cell type. 
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Growth and ossification in the cranial base 
 
The regions that gives rise to new chondrocytes, and hence elongate the cranial 
base, are the so-called synchondroses, which are analogous to the growth plates 
of long bones. Unlike the growth plates of long bones however, they are ‘double 
ended’ and appear to be able to extend from two sides. 
 
At the centre of cranial base synchondroses are the ‘resting’ chondrocytes (figure 
3, blue cells). These cells are comparatively small and round and divide slowly in 
all directions. They express SOX9, which commits cells to the chondrocyte 
lineage from a common osteochondroprogenitor cell (Mori-Akiyama et al., 
2003), as well as secreting Col2 to contribute to the ECM. 
 
 
Adjacent and flanking the resting region are the proliferative chondrocytes, 
which are larger and more elongated that the resting chondrocytes, with 
distinctive ‘discoid’ morphology. In the long bone the proliferative cells align 
into columns that extend in the direction of longitudinal bone growth. In the 
1 
1 
2 
1 
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Figure 3: Cellular organisation in a typical cranial base synchondrosis 
At the centre of the synchondrosis is an area of ‘resting’ chondrocytes (blue). This 
population matures in the anterior and posterior direction into proliferative chondrocytes 
(green) which have distinct coin like morphology and stack into organised column. These 
mature into the prehypertrophic (orange) and then hypertrophic (red) stage. Many of these 
hypertrophic chondrocytes undergo apoptosis, and the hypertophic region is first invaded 
by endothelial cells (red lines) and osteoclasts (yellow), before being infiltrate by 
osteoblasts originating from the perichondrium (arrow 1 pink cells).There is recent 
evidence that some hypertrophic chondrocytes can transdifferentiate into to osteoblasts 
(pink cell- arrow2). 
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synchondroses the columns of cells extend in the dorsal-ventral direction, at 90° 
to the direction of length growth of the cranial base (figure 3, green cells).  
 
The proliferative region expresses and secretes high levels of Col2 (Young et al., 
2006). These proliferative cells mature in to prehypertrophic and then 
hypertrophic chondrocytes.  
Hypertrophic chondrocytes are characterised by expression of ColX and are very 
large and are surrounded by a large amount of extracellular matrix. The 
hypertrophic regions are adjacent to the boney regions, and ossification of the 
hypertrophic region begins by the infiltration of endothelial cells and osteoclasts. 
This begins the process of degradation of ColX and Col2 rich ECM, after which 
osteoblasts either invade from the perichondrium (figure 3, arrow 1) or are 
supplied by transdifferentiation of hypertrophic chondrocytes (figure 3, arrow 2). 
These osteoblasts will deposit the Col1 rich ECM of bone. 
 
This ColI is associated with sialoproteins and other molecules that can attract 
more calcium than type II collagen. This means an ordered system of 
hydroxyapatite crystals form, creating a stronger but more rigid structure. 
The proliferation and differentiation of chondrocytes is controlled by indian 
hedgehog (Ihh) signaling .When chondrocytes reach the prehypertrophic stage 
(figure 3,orange cells) they begin express Ihh. Patched (PTC), the receptor for 
Ihh is expressed by proliferative chondrocytes (figure 3,green cells). Thus 
prehypertrophic chondrocytes can induce proliferation in the neighbouring 
region, and differentiation of osteoblasts in the perichondral tissue (St-Jacques et 
al., 1999). In Ihh -/- mice the synchondrosis cartilage is disordered and there is 
very little proliferation of chondrocytes, resulting in a cranial base reduced in 
length and width (Young et al., 2006). 
 
The mammalian cranial base is the major endochondral element of the skull. It is 
constitutes three major bones from anterior to posterior: the ethmoid, the 
sphenoid and the occipital bone (figure 4). 
 
The two anterior elements of the cranial base (ethmoid and sphenoid bone) are 
neural crest in origin, with the boundary between NC and mesodermal tissue in 
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the mouse embryo being at the point of the cranial base that lies ventral to the 
pituitary gland (figure 4, green vs. grey shading) (Khonsari et al., 2013). The 
pituitary gland itself is at the boundary between endodermal, mesoderm and 
neural crest derived tissue, hence this region is influenced by a large number of 
signaling pathways. 
This boundary between NC and mesodermal tissue appears to shift anteriorly 
with age from e16 to at least P10 within the cranial base, moving to the midpoint 
of the basisphenoid (McBratney-Owen et al., 2008).  
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Figure 4: Anatomy and tissue origins of the cranial base 
The anterior half of the spheno-occipital synchondrosis is the boundary between 
neural crest and mesodermal tissue in the embryonic cranial base. Dark green= 
neural crest derived bone, light green= neural crest derived cartilage, dark grey= 
mesoderm derived bone, dark grey=mesoderm derived cartilage. 
 B.occ=basisocciput, B.sph=basisphenoid Eth=ethmoid, MSS= midsphenoidal 
synchrondrosis, bs=basisphenoid,P.sph=presphenoid, SOS= spheno-occipital 
synchondrosis, IOS=intra occipital synchondroses 
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In most mouse lines the synchondroses never fully close, though they do become 
narrower throughout development (exception in the DBA/2J mouse line, Adams 
2013). In humans however these synchondroses eventually become ossified and 
disappear, though not at the same time in development.  
The mid sphenoidal synchondrosis (MSS) closes by birth in most humans, whilst 
the spheno-ethmoid synchondrosis (SES) can close at any point  between birth 
and the mid teens (Lingawi, 2012). The spheno-occipital synchondrosis (SOS) 
closes last of all in late adolescence or potentially at the beginning of the third 
decade of life (Bassed et al., 2010). 
 
There are various developmental diseases and pathways associated with 
malformation of the cranial base, many of which are associated with its 
shortening by premature ossification or ‘closure’ of the synchondroses. This can 
occur to one synchondroses or multiple. 
For example in Apert syndrome and the Apert mouse model both the MSS and 
SOS close prematurely (Laurita et al., 2011), and the same is reported in the Six2 
mouse mutantn(He et al., 2010). In contrast in Chiari syndrome and mice 
overexposed to Vitamin A, it is the occipital bone alone and the SOS that appear 
to be affected (Yasuhara et al., 2011, Kessel, 1992). 
Failure of the skull base to extend has an impact on the developing brain. Chiari 
sufferers experience ataxia, dysphagia and debilitating occipital headaches as a 
result of cerebellar herniation due to shortening and thickening of the occipital 
bone. 
As well as over ossification, the inability of chondrocytes to proliferate and align 
properly can result in the improper formation of the synchondrosis and 
shortening of endochondral bone (Li and Dudley, 2009)  
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Angiogenesis and ossification 
 
Angiogenesis accompanies both types of ossification, though better studied in 
endochondral bone. Angiogenesis is the process in which an existing network of 
blood vessels is extended and elaborated in situations of growth and repair. 
Angiogenesis traditionally meant a system of sprouting of a new blood vessel 
from an existing one, but other mechanisms have more recently been described. 
Intussusceptive angiogenesis involves the splitting or dividing of a blood vessel, 
so one lumen will become two separate lumen, this being first described in the 
vasculature of the lung (Patan, 2000). 
Endothelial cells form the walls of capillaries and it is the proliferation and 
behaviour of these cells on which angiogenesis depends. As previously 
mentioned endothelial cells express VEGFR2, and binding of its ligand VEGFA 
encourages survival and proliferation of endothelial cells (Gerber et al., 1998), 
but has also been shown to be necessary for chondrocyte survival (Zelzer et al., 
2004). 
In addition, hypertrophic chondrocytes highly express VEGFA, the most 
important ligand of VEGFR2, and abolishing VEGFA signalling in the bone 
causes an increase in the area of hypertrophic cartilage, loss of vascular invasion 
of the hypertrophic region and a loss of trabecular bone (Gerber et al., 1999) 
(Haigh et al., 2000). 
There is also evidence of a more direct coupling of angiogenesis and 
osteogenesis. 
In endochondral bone there is a small population of endothelial cells identified 
by very high coexpression of CD31 and Endomucin, and they can have a 
profound influence on the osteoprogenitor population. Decline in the numbers of 
these endothelial cells results in a decline of osteoprogenitors and a decrease in 
long bone ossification (Kusumbe et al., 2014).  
I wish to extend what is known about the presence and behaviour of endothelial 
cells in the dermal bone. 
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Thesis structure 
 
I aim to extend the findings of my lab, and investigate the spatial and temporal 
distribution of biomineralisation in the frontal bone as well as the cell types 
associated with it, and characterise the behaviour of these cells. 
I want to investigate further the ‘reaching’ RUNX2+ cells of the frontal, and 
establish if there is true migration occurring or not. 
  
In Chapter 1 I investigate the pattern of mineralisation as the skull develops 
through embryonic life and into the first week of postnatal life in the mouse. A 
regime of injections of calcium binding agents into a pregnant dam was used to 
analyse various phases of growth of the pup’s skull and to observe changes that 
occur subsequent to initial calcification. 
I find that there is a very complex developmental pattern of radial, longitudinal 
and mediolateral growth. Intercalary mineralisation is used alongside a branching 
pattern of appositional mineral growth to contribute to an elaborated architecture 
in the biomineral of the frontal bone. 
I finally quantify the rates of radial and longitudinal biomineralisation in the 
frontal bone and find that rate vary widely in the mediolateral axis of the frontal 
bone and that a single continuous layer of biomineral may be a composite of 
different ages. 
 
In Chapter 2 I explore the cellular mechanism that produces the observed 
patterns and rates of mineralisation in chapter 1.  
In Part 1 of Chapter 2 I use an ex vivo culturing technique to label the cells of the 
generative layers 1 and 3 of the frontal bone with a lipophilic dye, and track the 
cells through 24-48 hours of growth. This was combined with antibody staining 
to identify different cell types. I find invasion of cells from both L1 and L3 into 
the developing L2. These invasive populations are express both RUNX2 and 
HAND2 single positive cells, as well as a novel RUNX2HAND2 double positive 
cell type. I find that ablation of HAND2 in the neural crest lineage prevents 
proper formation of the L2 biomineral layer, suggesting an important role for 
HAND2 in invasive growth of the bone. 
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In Chapter 2 Part 2 I further explore the behaviour of cells using time-lapse 
confocal imaging combined with a genetic labelling strategy to directly observe 
the cells in a growing frontal bone. I observe migration of cells laterally along 
the layers of the frontal bone, travelling at velocities comparable to previously 
reported studies on the motility of osteoblasts and osteoclasts. I also observe true 
invasion into the middle L2. 
 
In Chapter 3 I examine the role of endothelial cells in the process of angiogenesis 
in the frontal bone.  I find a novel VEGFR2+VEGFA+ cell population that 
invades L2 from both L1 and L3. I also find neural crest derived cells invading 
the frontal bone by time-lapse imaging of the growing frontal bone where the 
neural crest lineage is genetically labeled. These neural crest derived cells 
display behaviour reminiscent of that of endothelial cells during intusussceptive 
angiogenesis and I propose that this is a possible mechanism by which the 
vascular network of the frontal bone. 
 
In Chapter 4 I explore spatial distribution of the different cell lineages of the 
frontal bone and the complex biomineral architecture described in chapter 1. I 
find that osteoblasts and endothelial cells have particularly specific cell 
distributions in relation to intercalary branches of biomineral, biomineral ridges 
and non-trabeculated regions. 
 
In Chapter 5 Part 1 I make a study of the growth of the cranial base in a time 
course. I uncover a cryptic modularity in the growth sequence of the elements of 
the cranial base, and a polyclonal nature of expansion of the synchondroses. 
Shape of chondrocyte clones emerges as a factor in synchondrotic growth, as 
does the coordinated loss of discrete clones. 
In Chapter 5 Part 2 I demonstrate with a regime of embryonic mineral birth 
dating that the cranial base ossifies in an intercalary fashion, a mechanism seen 
in the frontal bone. 
In Chapter 6 I summarise the findings of my thesis and discuss the implications 
of my results and compare them to the findings of others. 
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1:Complex and novel patterns of biomineralisation are established in the calvaria 
at different ages 
Introduction 
 
The vault of the skull, craniofacial bones, mandible and part of the clavicle of the 
mammal are formed by intramembranous ossification, and as such are composed 
of dermal bone (Matsuoka et al., 2005, Le Douarin and Kalcheim, 1999). Dermal 
bone, though more ancient than endochondral bone (Janvier, 1996), is by far the 
least studied, in some part due to it being less convenient to handle  thin 
membranous structures compare to well defined and large endochondral bones 
such as the femur  (Bilezikian et al., 2008). 
 
As such, there is a poor understanding of the mechanisms that govern 
biomineralisation in the frontal bone. In this chapter I address the following 
questions: 
 
1) How does biomineralisation of the calvaria contribute to its thickness, 
longitudinal and mediolateral development?  
2) What are the characteristic patterns and architectural features of 
biomineralisation in the calvaria? 
3) When do these features establish during development of the mouse 
embryo? 
 
Frontal bone embryonic development 
 
The primordia of the murine frontal bone is visible from e12 in the mouse 
embryo, but the earliest mineralisation is not apparent until around e14.5 (Jordan, 
2011). After initial mineralisation of mesenchymal condensations in the earliest 
bone, it is thought that the cranial sutures provide an osteogenic growth front for 
further ossification of the skull, by providing osteoprogenitors that mature into 
osteoblasts that secrete collagenous matrix (Percival and Richtsmeier, 2013, 
Opperman, 2000, Lana-Elola et al., 2007).  
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Before the growth fronts of the developing bone meet the position of the sutures 
is delineated by the expression of FGFR2, from as early as e16 (Iseki et al., 
1997). 
 
In the traditional model of dermal bone thickness growth, a continuous layer of t 
osteoblasts secretes collagenous matrix in one direction. This matrix then 
becomes mineralised and the osteoblast layer deposits another layer of 
collagenous matrix directly on top in an‘appositional’ fashion. Thus the thickness 
of the bone increases in the manner of sedimentary rock, with layers of 
biomineral ‘strata’ of one age (Lieberman and Friedlaender, 2005). 
To extend the mineralised bone in mediolateral and anterior posterior directions, 
it is thought that mineral is laid down in discrete ‘spicules’ that are later joined 
by subsequent mineralisation to form trabeculae (Midura et al., 2004, Gorski et 
al., 2004). This is distinct from observations of a continuum of biomineral foci 
that has been observed in ossifying endochondral bone (Sela et al., 1992), and 
demonstrates that in different types of bone different mechanisms of 
mineralisation are apparent. 
 
The existence of a unique mechanism of biomineralisation has been indicated by 
the previous (unpublished) work of Jordan 2011 from our lab. The most striking 
feature of this study was the ‘intercalary’ growth of the dermal bone. This 
described regions of new biomineral deposition within deposits of older, 
previously deposited biomineral. This produced a pattern of mineralisation where 
the bone appeared to be growing from the inside out, younger bone on the inside, 
oldest on the outside. 
This work did not consider however the global patterns of biomineralisation 
throughout the whole frontal bone with time, where this new mechanism of 
biomineralisation is found, or how it is coordinated with thickness growth of the 
frontal bone as a whole. 
 
In the literature to my knowledge there has been no comprehensive study of the 
biomineralisation of the calvaria that considers the difference between the 
embryonic stage and the juvenile or adult in any organism. Data that is available 
on human skull vault mineralisation is improving, with older studies on 
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preserved specimens being superceded by MRI studies on larger subject cohorts 
(Cotton et al., 2005). However, the growth is rarely considered in all dimensions 
(thickness, longitudinal and mediolateral growth), and attention is focused on the 
calvarial sutures. 
 
In this chapter I wish to resolve the temporal sequence and spatial (3D) pattern of 
mineralisation in the mammalian dermal frontal bone, in both the embryo and in 
the first stages after birth, by using fluorescent dyes for biomineral layer birth 
dating purposes. I will test for the occurrence of appositional biomineral growth 
and will ask whether other forms of biomineral growth also occur and where this 
happens in the growing bone. I will relate these biomineralisation patterns to 
their position in the bone and their relation to the frontoparietal suture. I will ask 
how and where thickness growth occurs and whether there are underlying 
spatiotemporal patterns visible that might shed light onto earlier cell behaviour in 
the frontal bone. 
 
Biomineral birth dating approach 
 
In this study the mouse is used as the system to study dermal bone 
mineralisation, by injecting fluorescent matrix labelling dyes (e.g. calcein, 
alizarin red, doxycycline). These dyes when injected into the animal become 
incorporated into the bones as they mineralise. Crucially it is possible to inject a 
pregnant dam and observe the dye labelled mineralised matrix in the progeny 
upon culling and fixing. It is also possible to use multiple dyes of distinct 
excitation/emission spectra for more complicated analysis (van Gaalen et al., 
2010). 
This type of labelling regime has been performed extensively in the long bones 
of the appendicular skeleton (Wealthall and Herring, 2006), and more rarely in 
the dermal bones such as the jaw (Kariyama et al., 1969, Nakamura et al., 2000). 
In endochondral bone the distance between two different fluorescent dyes has 
been successfully used as a way to assess the rate of mineralisation in many 
species, such as mice (Ylönen et al., 2005), rats (Fischer et al., 2011) and pigs 
(Funk et al., 2009). 
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The most extensive study available in the literature for the mineralisation pattern 
of the frontal bone is by (Cleall et al., 1968, Cleall et al., 1971). In this 
experiment 4-5 matrix labelling agents with distinct fluorescent spectra were 
injected into juvenile rats at varying time intervals, and the pattern of these dyes 
observed upon sacrifice and sectioning of the animals in the sagittal and coronal 
planes. In their 1968 paper the authors illustrated the pattern of labeled 
biomineral layers in a parasagittal section taken relatively near the midline. In 
figure 1.1 I have adapted this figure with the addition of colour to aid 
understanding of the pattern of biomineralisation. 
 
The first injection was of terramycin when the rats achieve 90 grams in weight at 
approximately 4-5 weeks of age (River, 2012). This initial matrix dye labels the 
+ 4 days 
Frontal 
Parietal 
B 
B
A 
Initial injection 
+ 15 days 
+ 36 days 
+ 66 days Cull 
Terramycin plus alizarin 
Trypan Blue 
Alizarin Red S 
Terramycin 
Figure 1.1: The traditional model of mineralisation in the calvaria is one of 
appositional deposition 
(Adapted from Cleall et al.1968, colours an addition to the original figure to aid 
understanding) 
The first matrix labelling agent, terramycin, was injected when juvenile rat reached 
90 grams in weight, between 4 and 5 weeks of age. 3 days after the initial injection 
alizarin red S was injected, trypan blue 15 days after initial injection, and a mixture 
of terramycin and alizarin red 36 days after initial injection. Animals were culled 
after 66 days after initial injection. 
A) Authors recorded the pattern left by staggered injections of matrix labelling 
agents in the parietal and frontal bones. Half arrows indicate surfaces the authors 
identified as regions of active apposition (+) or resorption (black half arrow).   
B) Inset of detail showing a recorded reversal in the order of mineral layers from 
agent injections 21 days apart. The younger yellow matrix is found on the inside of 
the older blue matrix in this region. Resorption is apparent on the outer biomineral 
layer of this ‘intercalary region’ (half arrow and uneven line) and not in adjacent 
regions. 
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inner most biomineral in the frontal bone at the border of cancellous spaces 
(figure 1a, green line). Interestingly this label at 4-5 weeks of age is not visible at 
all in the parietal bone suggesting it was not actively mineralising at this time, at 
least in this mediolateral plane. The second injection 4 days after the first one is 
of alizarin red (figure 1.1a, red line), and biomineral layers are apparent in both 
the frontal and parietal bones. However, the two bones show differences.  
 
In the parietal two layers of red biomineral have formed, whilst in the frontal 
there is only one red layer, overlying the previously deposited green labelled 
layers. 15 days after the initial injection trypan blue was injected and both the 
frontal and parietal show a ring of trypan blue labelled biomineral surrounding 
the previous layers. 36 days after the initial injection a mixture of terramycin and 
alizarin was injected (figure 1.1a, yellow line) and this dye also labels a ring of 
biomineral that surrounds the previously formed biomineral (figure 1.1, yellow 
line encompasses blue line). 
The only exception to these appositional rings of biomineral is in the anterior 
region of the frontal bone (figure 1.1b). In this region the order of biomineral 
deposited at 15 days and 36 days after the initial injection is reversed compared 
to the rest of the bone, the younger yellow biomineral is found on the inside of a 
layer of older blue biomineral. The authors note an area of bone resorption on the 
endocranial surface of the frontal bone (1.1b, half arrow). The authors make no 
mention of an apparent inversion of the appositional growth pattern, where the 
younger matrix is found within the older matrix deposited 21 days previously, 
which is very curious. 
 
From this data I can extrapolate that in the postnatal rat, mineralisation is not 
continuous and synchronised throughout the calvaria, as seen by the lack of 
fluorescent biomineral from the initial injection in the parietal, implying that 
there is some independence of growth of the frontal and parietal. There is also 
evidence in the anterior frontal bone of a reversal of traditional growth in a 
certain time window, and as this unusual pattern of mineralisation was in an area 
of resorption it may be that this area is one subject to remodelling in the postnatal 
animal. 
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This study is limited of course as we must rely on diagrams rather than the 
original photographs, and the authors include only one mediolateral plane. It is 
also limited in that the rats used in the study were already between 4 and 5 weeks 
old at the time of the first label injection, and so provides no information of how 
the initial mineralisation of L2 of the frontal bone takes place, or if it differs 
between the adult and the embryonic stage. 
 
The embryonic stage is a time of very rapid mineralisation, with the ratio of 
mineral to matrix increasing over threefold from 0.75-3.5 between the ages of 
e14 (onset of mineralisation) and e18. This ratio does not significantly change 
again until 6 months of age in the mouse, by which time it doubles to 7 
(Tarnowski et al., 2002).Therefore this period is one of especial interest when 
studying biomineralisation of the skull. 
 
To study this period of mineralisation I examined specimens that had undergone 
a regime of matrix labelling in the mouse at embryonic stages e14, e16 and e18, 
sacrificing the animals at either P1 or P8. The optimal timing of the injections for 
the purposes of labelling the prenatal frontal bone was designed and carried out 
in the lab by Dr.K.Jordan, details of labelling regime for specimens used in this 
chapter can be found in Table 1.1. After injecting matrix labelling agent at e14 
(e.g. calcein), the dye circulates in the blood stream of the pregnant dam for 48 
hours, and in this time will become incorporated into any actively 
biomineralising tissue as the agent binds to calcium. The result is that any 
mineralised matrix formed in that time will be visible under the appropriate 
uv/vis laser. By injecting different dyes at different time points, a multi-coloured 
record of the spatial and temporal patterns of biomineralisation can be created. 
The two-day gap between injections enabled clear recognition and distinction of 
the matrix labels, as the agents consolidate (see Technical Appendix) and clears 
from the bloodstream.  
If the time between the final injection and culling is more than 48 hours, the 
matrix forming after the 48 hours will remain unlabelled. Likewise if the interval 
between matrix labelling injections is greater than 48 hours (e.g. injections at e14 
and e18) there will be unlabelled matrix that represents the biomineralisation 
occurring between e16 and e17. 
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The matrix labelled frontal bones were examined as both flat mount specimens 
and sagittal sections to understand the form of biomineralisation in all 
dimensions. 
 
Details of the labelling regimes carried out can be referred to in Table 1.1. The 
details of the protocols for labelling, sample preparation and imaging can be 
found in Chapter 7 (Materials and Methods). 
 
 
Table 1.1: Temporal sequence of matrix labelling dye injections  
Injections into pregnant dams were undertaken at e14, e16 and e18. Pups were 
culled at either P1 or P8 age that the pups were culled. For concentrations of dye 
used please see Materials and Methods.  
 
Experiment e14 e16 e18 Cull Age n 
1 calcein xylenol 
orange 
X P1 2 
2 xylenol 
orange 
X calcein P8 1 
3 calcein xylenol 
orange 
doxycycline P1 2 
 
 
 
In section 1 of this chapter I describe the global pattern of biomineralisation in 
the frontal and parietal bone in a spatial and temporal fashion. 
In section 2 of this chapter I by analysing a time course of biomineralisation in 
the frontal bone I find that the complex trabeculation patterns of the frontal bone 
are established very early on in bone development. I find the early trabeculae are 
closely associated with osteoblast precursors, osteoblasts and endothelial cells. 
In section 3 I examine the pattern of thickness growth of biomineral at different 
mediolateral levels and anterior-posterior positions. I find that in the orbital 
region of the frontal bone there is a trend for ‘intercalary’ biomineral growth, 
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whilst in more posterior positions of the bone biomineralisation proceeds in 
traditional appositional manner. 
In section 4 I measure the rate of biomineralisation in the radial axis (thickness 
growth) and the longitudinal axis (length growth), and compare them. 
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1.1 Mineral birth dating injections reveal complex global patterns of 
biomineralisation that differ between the frontal and parietal bones 
1.1.1 Introduction 
 
In was found by Jordan et al. 2011 that onset of mineralisation occurs between 
e14 and e15 in the frontal bone, as pups from pregnant dams injected at e13 with 
matrix labelling agent displayed no mineralisation in the skull vault when culled 
at P1. Pups from dams injected at e14 do display mineralisation in the frontal 
bone, thus the very first stages of biomineralisation can be visualised and 
recorded. 
To understand the mediolateral and anterior posterior variation in mineralisation, 
a P1 mouse skull exposed to calcein and e14 and xylenol orange at e16 was flat 
mounted and imaged, allow examination of the mineralisation pattern at these 
stages. 
 
1.1.2 Results 
1.1.2.1 The global biomineralisation pattern of the frontal and parietal are 
different. 
 
The frontal and parietal both contain biomineral labelled with an injection of 
matrix dye e14 and an injection at e16, and show key differences in their 
respective mineralisation architectures. 
Figure 1.2 shows P1 WT calvaria from labeling experiment 1 (see Table 1.1), flat  
mounted with the dorsal (ectocranial) surface facing up. The labelling regime of 
calcein at e14 (green), xylenol orange (XO) at e16 (red) allows a record of the 
embryonic mineralisation pattern in the frontal bone (Fr) and the parietal (P). 
Both the frontal and parietal contain the e14 to e15 (green) forming mineralised 
matrix (figure 1.2a).  
In the frontal bone the e14 to e15 forming biomineral is centred on the 
supraorbital ridge (SR), the deposition of matrix is roughly symmetrical to the 
anterior and posterior of the ridge. This region is the origin of the frontal bone 
primordia from which the cells of the frontal bone initially migrate out of 
(Yoshida et al., 2008). 
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At e16 to e17 in the frontal bone (Figure 1.2b, red labeled matrix) the 
mineralisation is also centered on the supraorbital ridge, but extends further 
posteriorly, anteriorly, medially and laterally compared to the e14 and e15-
mineralised matrix (figure 1.2c, overlay of green and red channels). This is a 
form of concentric appositional matrix deposition in the mediolateral and A-P 
dimensions. There is also evidence of more extensive mineralisation along the 
margin of the frontoparietal (FP) suture at e16 to e17 than e14 to15, with a 
margin of red matrix parallel to the FP suture from a lateral level, to midway in 
the frontal bone (fig 1.2b and c yellow asterisk). 
There is a large amount of overlap between the older green and younger red 
matrix in the supraorbital region. The spatial pattern of mineralisation is also the 
most complex of in this region. 
 
In the parietal bone the e14 to e15 forming biomineral is found in the centre of 
the bone, slightly offset to the lateral side of the parietal. The e16 to e17 forming 
biomineral in the parietal surrounds the older matrix in an appositional fashion 
on the anterior, posterior and medial sides, but not the lateral side (figure 1.2c, 
overlay of green and red channels). This is a form of concentric appositional 
matrix deposition in the mediolateral and anterior posterior dimensions.  
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There are similarities and differences to the biomineralisation pattern of the 
frontal and parietal bones. 
Figure 1.2:Mineral layer birth dating reveal complex branching and overlapping patterns 
of mineralisation that differ in the frontal and parietal 
Specimen from Experiment 1 labelling regime, e14=calcein, e16=xylenol orange (see 
Table 1) 
A-D) Dorsal view of flat mount calvaria of postnatal day 1 (P1) WT mouse taken on an 
epiflourescent microscope. Dotted outline indicates supraorbital ridge (SR) of frontal 
bone. 
A) Calcein labelled matrix (green) only. Red asterisks indicate ‘branches’ of green 
biomineral. 
B) Xylenol orange labelled matrix (red) only. Yellow asterisk indicates extent of 
biomineralisation along the FP suture 
C) Calcein and xylenol orange labelled matrix overlaid. Pink asterisk indicates red 
biomineral surrounding older green biomineral. 
D) Superposition of brightfield, calcein (green) and xylenol orange (red) labelled 
matrix. 
F=frontal bone, FP=frontal parietal suture, O=orbital region of frontal, P=parietal 
S=sagittal suture SR=Supraorbital ridge 
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The frontal and parietal both display areas of trabecular mineralisation, which 
resembles ‘Swiss cheese’ in appearance. Both bones display a branching of the 
biomineral, though the branches of biomineral in the frontal bone are longer than 
those in the parietal. They both display forms of concentric appositional 
biomineralisation, with e16 to e17 biomineralised matrix (red) surrounding older 
e14 to e15 matrix (green). 
 
A key difference however in that the frontal displays extensive evidence of 
overlay between the green and red matrix, seen as large areas of yellow in figure 
1.2c and d, this yellow overlay is not apparent in the parietal. This suggests that 
in the e16-e17 time window there is growth of the frontal bone in thickness as 
well as laterally and longitudinally, whilst in the parietal there is no increase in 
biomineral thickness at this stage. 
Another key difference is that whilst the parietal mineralises from the centre 
outwards in a radial fashion, the frontal mineralisation is initiated at an anterior 
position then radiates out, and then proceeds to mineralise at the margins of the 
bone and well as regions posterior to the orbital region. Hence there is e16 to17-
aged biomineral along the FP sutures on the frontal side (yellow asterisk 1.2 b 
and c), but no evidence of biomineralisation between e14 to e17 on the parietal 
side of the suture. 
 
The difference in the mineralisation pattern in the frontal and parietal could be 
the result of a number of factors. One possibility for these differences is the 
different embryonic tissue origins of the frontal and parietal. The frontal is a 
neural crest derived bone, whilst the parietal is mesodermal in origin (Couly et 
al., 1993, Yoshida et al., 2008). Tissues of different embryonic origin are often 
attributed different properties, and this could provide a basis for different 
mechanisms of biomineral formation. In phylogeny also the frontal bone is 
thought to arise prior to the parietal, this could be recapitulated in the ontogeny 
of bone development (Koyabu et al., 2014). 
The parietal at maturity is a thin bone with very little elaboration in thickness. 
The frontal bone in contrast becomes very thickened and elaborated especially in 
the cancellous orbital region, where the frontal sinus is housed in many mammals 
and where most of the calvarial bone marrow is found. Hence, the mechanism for 
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the development of thick dermal bone early in the ontogeny of development may 
be specific to the frontal.  
The frontal bone and parietal bone also overlay different regions of the brain, 
which themselves have independent growth trajectories. An example is in the 
first weeks of human life the growth of the parietal cortex is significantly faster 
than that of the prefrontal cortex (which underlies the frontal bone in humans) 
(Gilmore et al., 2007). Furthermore, in a study of human subjects between 4 to 
21 years of age it was found that frontal, parietal and occipital cortex have 
different trajectories of maturation. Even within the cortices different regions 
achieved maturation before others, for example the frontal cortex matures in a 
posterior to anterior fashion (Gogtay et al., 2004). Being exposed to growth 
signals at different times that could result in differential thickness growth, even 
within a bone. 
 
1.1.2.2 Finer architectural features of the frontal bone 
 
When examined the frontal bone revealed further complexities in the pattern of 
biomineralisation. 
Figure 1.3 shows the right orbital from the calvaria in figure 1.3 enlarged, to 
make the patterns of mineralisation are more obvious. 
The pink arrows indicate some of the small ‘spicules’ of mineralisation, which 
appear as mostly red or yellow biomineral. 
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Along the length of the supraorbital ridge (figure 1.3, magenta outline), which is 
the centre of the area of symmetrical growth, the biomineral is of different ages. 
The dark blue outline delineates an area of unlabelled biomineral, deposited after 
e18, which is enclosed by older green, red and yellow matrix. This area is 
enlarged in figure 1.4a and described further. 
Figure 1.3: There is a complex spatial and temporal pattern of 
mineralisation in the P1 murine orbital region 
 
Epifluorescent image of the right frontal bone, showing e14 to e15 birth 
dated mineral (calcein green) and e16 to e17 birth dated biomineral (XO-
red). 
Various patterns of mineralisation are visible, such as intercalary (yellow 
matrix within green matrix), appositional with red matrix found on the 
outside of the older green matrix and branching morphogenesis of matrix 
of all ages (white arrows). Pink arrows show isolated ‘spicules’ of 
biomineral. Pink dotted outline indicates supraorbital ridge and blue 
dotted outline and area of no biomineralisation at all between e14 and 
e17. 
Scale bar 1mm 
	 64	
 
The black asterisks highlight deposits of yellow matrix within the green matrix. 
This type of deposition, where older matrix surrounds younger matrix in an 
intercalary manner, is unexpected based on the traditional model of 
mineralisation. 
The biomineral does not extend as a smooth front, but is a ragged edge of many 
‘branches’ of green, red and yellow biomineral (white arrows figure 1.3 and 
figure 1.4b). These patterns are reminiscent of the branching morphogenesis seen 
Figure 1.4:Examples of forms of mineralisation include intercalary, branching 
morphogenesis, trabeculation and parallel ridges 
 
Epifluorescent image of anterior P1 frontal bone with e14 to 15 forming biomineral 
labelled with calcein (green), and e16 to e17 biomineral labelled with xylenol orange 
(red). 
A) Intercalary growth, examples of yellow matrix within older green matrix 
indicated by black asterisks.  
B) Branching morphogenesis 
C)  Trabeculation in the e16/17matrix (red). 
D) Blocks of e16/17 matrix forming parallel ‘ridges’ of biomineral, orientated 
mediolaterally. 
Scale bar 500 µm. 
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in capillary networks in the skull. Branches of biomineral split from one another 
and from these branches there are further subdivisions, akin to the divide of a 
tree trunk, to it’s branches, and then twigs. 
The parietal also displays the branching pattern of biomineral, especially in the 
e16 to e17-aged matrix, but in a strictly appositional fashion, there is no evidence 
of overlapping matrix (yellow coloured) or intercalary mineral growth. 
The clearest trabeculation patterns can be seen in the e16 to e17 forming matrix 
extending posteriorly from the orbital region (1.4c). This region has a lace-like 
pattern of biomineral deposition, which borders and surrounds the older e14 to 
e15-aged matrix deposits. 
The mineralised matrix extending towards the midline also has a specific 
morphology (1.4d). This e16-aged matrix is arranged in discrete blocks, which 
arrange in parallel lines that are mediolaterally orientated. 
 
1.1.3 Conclusions 
 
The mineralisation pattern of the frontal and parietal differs in spatial and 
temporal distribution. 
The frontal bone is heavily elaborated by P1 and the structure of the biomineral 
is multipartite, extensive branching of biomineral, ‘Swiss cheese’-like 
trabeculation and biomineral ridges. There are large regions where biomineral of 
different ages overlap, as well as younger biomineral surrounding older. This 
suggests there is extensive thickness growth of the frontal bone between e16 and 
e17. 
The parietal in contrast is simpler in its biomineral composition, and though it 
displays branching and trabeculation, these form in a purely appositional fashion 
in the mediolateral and anterior posterior dimensions. 
There appears to be little to no thickness growth of the parietal in the e16 to e17 
time window, as there is no overlap of the two colours of biomineral representing 
two different ages. 
The frontal bone begins to mineralise at the periphery before the parietal, the FP 
suture is bordered by e16 to e17 forming biomineral on the frontal side only. 
Biomineralisation is confined to the centre of the parietal bone between e14-e17. 
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To understand this development further I conducted a time course to ascertain if 
there are differences in the onset of mineralisation in the frontal compared to the  
parietal, and examine the radial structure of early biomineral formation. 
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1.2 Time course of mineralisation in the murine calvaria 
1.2.1:Introduction 
 
The patterns I described in Section 1 were from observationa made at P1, a few 
days after the biomineral had formed. 
The branching patterns could arise via a continuous extension of branches of 
biomineral or could be the result of fragmenting early homogeneous sheets of 
biomineral, as might be expected from the traditional model of dermal 
ossification. 
To test between these two options and to establish the initial pattern of 
mineralisation in dermal bone, flat mounts of WT e15, e18 and P1 frontal bones 
were stained with calcein to reveal the extending pattern of biomineralisation 
(figure 1.5a, b and c respectively).  
 
1.2.2:Results 
1.2.2.1:Mineralisation commences in the frontal before the parietal 
Mineralisation in the frontal bone commences at the centre of the orbital region 
between e14 and e15 (figure 1.5a), as well as a small amount of mineralisation 
the temporal bone (red asterisk). From e15 to e18 the mineralised matrix radiates 
out medially, anteriorly and posteriorly out from the supraorbital ridge in visible 
branches of mineralisation (figure 1.5b). Between e18 and P1 the margins of the 
frontal bone along the temporofrontal, frontoparietal and interfrontal sutures all 
begin mineralising, gradually enclosing a non-mineralised core of bone (figure 
1.5c). 
In contrast, there is no evidence of mineralisation of the parietal bone at e15. By 
e18 there is deposition of calcified material in the central and lateral portions of 
the parietal bones. Between e18 and P1 the margins on every side of the parietal 
begin to mineralise, and like the frontal bone by P1 a non-mineralised region is 
enclosed in the parietal close to the midline. 
 
Between e18 and P1 the supraoccipital bone also starts to show evidence of 
mineralisation. The margin on every side of the interparietal is mineralised as 
well as a horizontal line of mineralisation in the centre of the bone. This 
corresponds to the attachment point of the trapezius muscle, where Sharpey 
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fibers and tendons become mineralised to provided support for the attaching 
muscle (Zelzer et al., 2014). 
The oldest mineralised region of the skull vault is the orbital region of the frontal 
bone. Globally speaking, mineralisation proceeds medially and posteriorly from 
this point, enclosing a region in the medial and posterior part of the frontal that is 
unmineralised at P1. There is an asynchrony of biomineral deposition in the 
frontal versus the parietal bones, which do not show signs of biomineralisation 
until e18. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Mineralisation of the frontal bone 
initiates from the orbital region at with the 
centre of the bone the last unmineralised region 
of the frontal bone by P1 
Brightfield photograph of mouse skulls taken at 
e15, e18 and P1 stained with calcein to indicate 
the extent of mineralisation. Percentage 
mineralised area of bone 2-10% at e15 (A), 42-
46% at e18 (B) and 50-55% at P1 (C).  
in= interfrontal suture, fp=frontoparietal, 
tf=temporofrontal suture, F=frontal bone, 
IP=interparietal bone, P=Parietal bone 
Scale bar 1mm. 
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1.2.2.2 Trabeculation in the orbital region commences from at least e15 
 
I wished to examine this early biomineral to establish how early trabeculae are 
formed and how early branching is observed. 
To examine the earliest mineralisation in detail, the orbital region of an e15 
embryo was flat mounted and scanned on a confocal microscope. 
Figure 1.6 shows a confocal scan of the right orbital region in Figure 1.5a. 
At this stage there has been a maximum of 24 hours of mineralisation. In the 
magnified B panel, it can be seen that there is already an extensive lace-like 
network of mineralised trabeculae in the orbital region. The centre of the 
trabeculae is very heavily mineralised, as it stains heavily for calcein. The edges 
of the trabecular network are ragged, with branches of more weakly mineralised 
matrix (figure 1.6, yellow asterisks) extending out radially. At this stage there 
little evidence of the spicules/nodules of mineralisation which could be observed 
in figure 1.3 (pink arrows).  
The branching pattern and trabecular network of the frontal bone is established at 
an early stage of development. 
Whilst the flat mount scan is ideal for examining mediolateral differences in 
mineralisation patterns, it cannot be used to examine how the bone is developing 
in thickness at this early stage in frontal bone development. 
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To investigate the structure of the mineralisation at greater resolution and to 
examine the pattern of thickness growth, and compare the initial deposition to its 
state at P1, it was necessary to section e15 skulls and stain with calcein to 
observe the mineralisation pattern in side view, in the sagittal plane and relate 
this pattern to three cell types; preosteoblasts, osteoblasts and endothelial cells. 
 
 
 
 
 
 
Figure 1.6: Mineralised trabeculae form in the orbital region at the initial stages of 
mineralisation 
 
Confocal image of flat mount of e15 WT mouse skull, stained with DAPI(blue) to label 
nuclei and calcein (green) to visualize biomineral. 
A) x40 collapsed confocal z-stack of mineralisation in orbital region in e15 skull  
B) Enlargement of the region of biomineral in A showing extensive trabecular network 
and branching morphogenesis (yellow asterisk).  
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1.2.2.3 Earliest stage of biomineralisation contains structural complexity 
 
Figure 1.7 shows a lateral sagittal section from an e15 embryo stained with DAPI 
and calcein. Already at this stage there are two layers of biomineral (yellow 
arrows), the layer closest to the dermis showing more signs of trabeculation than 
the thinner layer of mineral nearest the brain. This region in the older animal will 
be highly cancellous and contain the cavities where the bone marrow is found. 
The presence of two simultaneously developing layers is evidence against a 
single layer of osteoblasts in the developing frontal bone. 
 
 
Figure 1.7: At e15 mineralisation can initiate as a double layer rather than a 
single layer 
 
Sagittal section of e15 WT mouse head stained with DAPI(blue) to label 
nuclei and calcein (green) to visualize biomineral 
A) X20 magnification confocal tile scan of sagittal section of the anterior 
skull of an e15 mouse. 
 B) Enlarged orbital region of frontal, where a double layer of mineralisation 
can be observed (yellow arrows). 
Scale bar 40µm 
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Figure 1.8 shows a sagittal section of an e15 skull also in the orbital region, more 
medial than the section in figure 1.7. The red arrows indicate trabeculae that have 
either ‘branched off ‘ from a central layer of matrix or that have developed in 
isolation from each other. The mineral deposits are surrounded by cells on both 
the outer and inner surfaces (yellow asterisks). Mineral is being deposited in 
many directions. 
 
 
 
 
 
 
Figure 1.8:Mineralisation occurs towards the dermis and towards the brain at discrete 
points rather than in a uniform layer in early mineralisation  
 
Sagittal section of e15 WT mouse head stained with DAPI (blue) to label nuclei and 
calcein (green) to visualize biomineral 
 
A) Projection of confocal z-stack of mineralised bone in the e15 orbital region x 20 
magnification. 
B) Max project and magnification of mineral, including brightfield channel. Red 
arrows indicate the mineral’ branches’ extending or joining the ‘trunk’ from both the 
dermis side and brain side surfaces. 
C) As B, but without brightfield channel. Yellow asterisk indicate cell son the inner 
surface of mineralised structures 
Scale bar 120 µm 
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Figure 1.9a is a sagittal section of an e15 skull stained with calcein. An isolated 
loop (trabeculae) of biomineral is indicated by the yellow box. Enlarging this 
square (figure 1.9b) allows us to see that the outer surface and inner surface of 
the mineral ring has cells associated, which are most likely, the osteoid 
producing osteoblasts. These cells are not in the form of a single layer in this 
situation but are in a complex 3D arrangement. A 3D project of this trabeculae 
(1.9c) shows that four of the cells appear partly embedded in the matrix (arrows). 
The ‘arms’ of the mineralised structure can be added to by these cells and extend 
the network of trabeculae as the bone develops. 
 
 
Figure 1.9: Cells surround mineralised trabeculae from all sides 
 
Sagittal section of e15 WT mouse head stained with DAPI (blue) to label nuclei 
and calcein (green) to visualize biomineral. 
A) Projection of confocal z-stack of mineralised bone in the e15 orbital region. 
Yellow square defines an isolated trabeculae in this plane 
B) Max project and magnification of isolated trabeculae. Arrows indicate the 
closest associated cell, which are found on both ‘external’ (yellow arrows) and 
‘internal’ (red arrows) mineral surfaces. Scale bar 20 µm 
C) 3D projection of the mineralised trabeculae. Cells with red arrows appear to be 
slightly embedded within the matrix. Blue=DAPI, green=calcein 
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1.2.3:Conclusions 
 
Biomineralisation begins the frontal bone in the anterior orbital region prior to 
mineralisation in the parietal. This initial biomineral in the frontal is already 
structurally complex by e15, showing trabeculation and desposition of 
biomineral in double layers. 
I went on to investigate the cells types associated with this young biomineral 
architecture. 
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1.3: Biomineral in relation to surrounding cell types 
1.3.1:Introduction 
 
To clarify the cell types in the bone at this age and which are associated with the 
developing biomineral, I used antibody staining to identify the presence of three 
markers: RUNX2, CD31 and Osteopontin. 
RUNX2 is expressed in pre-osteoblasts and immature osteoblasts, and ablation of 
this transcription factor results in complete loss of bone in the mouse (Otto et al., 
1997). Runx2 mRNA is first detected in the skull in the mandible at e11.5 
(Shibata and Yokohama­Tamaki, 2008). The first Runx2 mRNA is detected in 
the frontal bone at e13 and by e15 Runx2 mRNA is very highly expressed 
(Maeno et al., 2011, Bialek et al., 2004) . 
CD31 is a marker of endothelial cells (Pusztaszeri et al., 2006). The proper 
formation of vasculature is essential for the developing bone, and interference 
with the vascularisation of bone can cause aberrant ossification or even loss of 
entire bones (Wiszniak et al., 2015). 
Osteopontin (OPN) is secreted by mature osteoblasts into the ECM, can act in 
cell signaling and but also has a structural role to play. OPN expression is 
induced by RUNX2 (Sato et al., 1998), and is expressed in the e14 frontal and 
parietal bones at relatively low levels, but this rapidly increases by e16 (Nomura 
et al., 1988, Iseki et al., 1997). OPN can play many roles in the bone. OPN 
inhibits apoptosis in endothelial cells and promotes their survival (Khan et al., 
2002, Scatena et al., 1998). OPN also aids the adherence of osteoclasts to the 
collagenous ECM by upregulation expression of essential adherence proteins and 
aids motility of these cells across the bone (Chellaiah and Hruska, 2003, 
Chellaiah et al., 2003). OPN is known to be involved in capping and organisation 
hydroxyapatite (HA) crystals (George and Veis, 2008) and essential in the 
directional growth of these crystals upon the collagen I rich matrix network. 
OPN is a very effective inhibitor of HA growth, hence its presence can force the 
growth of bone mineral in one direction (Steitz et al., 2002). 
Therefore cells expressing OPN can be thought of as actively laying down matrix 
that is being actively mineralised.  
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1.3.2:Results 
RUNX2+ cells are more abundant and less layer restricted than OPN+ 
expression in the frontal bone at e15 
 
I first assessed the distribution of preosteblasts in relation to the initial 
biomineralisation in the frontal bone (figure 1.10). Mineral deposits in the 
anterior e15 frontal bone stained with calcein and an anti-RUNX2 antibody show 
that RUNX2+  cells are abundant at this stage in all three layers of the bone. 
They surround the biomineral deposits on all surfaces, and are very closely 
associated with the matrix.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10: RUNX2 positive immature osteoblasts form a network around 
areas of mineralisation in the early stages of frontal bone growth 
 
Sagittal section of the anterior frontal bone in an e15 WT mouse embryo 
stained for RUNX2 (red) pre-osteoblastic marker and calcein (green) to 
label biomineral DAPI (blue) counterstain labels cell nuclei. Yellow line 
denlineated L1/L2 boundary, white line L2/L3 boundary. 
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I next examined the presence of OPN, the expression of which is induced by 
RUNX2 and a marker of more mature osteoblasts. I find in the e15 frontal bone 
OPN positive cells are found primarily in L1, in a single layer, with some 
staining in L2 and very little in L3 (figure 1.11). This is more restricted than the 
expression of RUNX2 seen in figure 1.10. There is some weak OPN staining in 
L2 that could be extracellular OPN, as this molecule is secreted by osteoblasts. 
The red box highlights a trabecular space with OPN positive cells on the inner 
surface. This potentially gives the mineralised matrix the ability to grow from the 
inside out in an intercalary manner. 
 
 
 
 
 
Figure 1.11: OPN labelled cells are largely restricted to L1 of the frontal bone at e15 
 
Sagittal section of e15 orbital region of the frontal bone, stained with calcein (green) 
to show mineralized matrix and antibody stained for OPN (red), a marker for mature 
osteoblasts. DAPI (blue) labels nuclei. 
Scale bar 50 µm 
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The final cell type I examined is the endothelial cell. I find that CD31+ cells are 
abundant in all three layers of the frontal bone at e15. 
Figure 1.12 shows a calcein stained e15 frontal bone that was stained with anti-
CD31. At e15 all three layers of the bone are CD31 positive. CD31 positive cells 
line the trabeculae of L2, and are closely associated with the mineral deposits, 
though they do not surround them as the RUNX2 positive cells do. The close 
proximity of vasculature to the osteoblasts would enable both the fast growth of 
the frontal bone and the linking of vasculature growth to biomineral growth. 
Figure 1.12: Mineralised islands are supported by an extensive system 
of endothelial cells. 
 
Sagittal section of e15 orbital region of the frontal bone. Mineralised 
matrix stained with calcein (green) and developing vasculature stained 
with CD31 (red), an endothelial cell marker. DAPI (blue) labels cell 
nuclei. 
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1.3.3 Conclusion 
 
Trabeculation and branching are established very early in frontal bone 
mineralisation and the network of biomineral grows continuously in the embryo. 
Biomineral can be laid down in two layers from e15, and in elaborate loops that 
could join to form trabeculae. 
At this early stage RUNX2+ preosteoblasts surround the developing mineralised 
matrix, and all three layers of bone stain extensively for RUNX2. 
All three layers of the bone at e15 show signs of vascularisation from endothelial 
cell staining, though these cells do not surround the bone as completely as the 
RUNX2+ preosteoblasts. 
Only the presence of more mature osteoblasts appears more restricted. OPN 
staining was strongest in L1 of the frontal bone, but there is only sporadic 
staining in L2 and L3. 
Hence, the presence of commited preosteoblasts at this stage is more widespread 
than that of mature osteoblasts. 
The presence of these cells at this stage of development of the frontal bone has 
been reported previously (Iseki et al., 1997, Nomura et al., 1988, Maeno et al., 
2011), but not in relation to the biomineralisation contributing to thickness 
growth of the bone. 
 
Now that I have established the biomineral pattern at the earliest stage of frontal 
bone development I go on to examine the radial pattern of mineralisation as the 
embryo develops. 
 
 
 
 
 
 
 
 
 
	 80	
1.4: There is variation in the form of biomineralisation depending on anterior-
posterior and mediolateral position in the frontal bone 
1.4.1: Introduction 
 
I have described novel patterns of matrix deposition in the mediolateral and 
anterior-posterior axes of the frontal bone. The supraorbital region of the frontal 
bone contains the thickest part of the frontal bone and its most cancellous region. 
After sagittal sectioning of skulls from various injection experiments, it was 
found that this region also displays the most complex mineralisation patterns 
found in the frontal bone. 
Figure 1.13 compares the e15 mineralisation pattern with that of the P1 pattern. 
The original network of trabeculae has become expanded and thickened, as 
indicated by the very strong fluorescent signal nearest the supraorbital ridge. 
There is also a large amount of yellow matrix, from overlay between green and 
red matrix. Previous evidence from our lab suggests that this could be the result 
of intercalary mineralisation. 
I wish to understand the mediolateral and anterior-posterior pattern of radial 
biomineralisation. I am interested to understand especially the mechanism in 
areas of overlay in the flat mount: where green and red biomineral of different 
ages overlap, as this pattern is unique to the frontal bone. 
In this section I will examine the radial thickness growth of biomineral, to 
determine the areas in which intercalary mineralisation is prevalent and areas 
where appositional growth is prevalent. 
 
I examined sagittal sections of frontal bone from pups exposed to two or three 
matrix labelling agents at different embryonic stages. This system allows the 
spatial deposition of younger matrix to be compared to the older mineral 
deposits. 
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1.4.2: Results 
1.4.2.1: Intercalary growth at anterior regions is in contrast to appositional 
growth at the posterior levels of the frontal bone 
 
Skulls from each of the experiments 1-3 (Table 1.1) were sectioned sagitally. 
This allowed a very accurate view onto the layering of biomineral in layer 2, at a 
resolution good enough to quantify biomineral growth. Such measurements 
allow us to assess biomineral deposition quantitatively and relate this to the 
overall spatial and cellular patterns that we see. 
Figure 1.13:Comparison of P1 and e15 mineralised matrix 
pattern 
A) e15 dorsal view of orbital region blue=DAPI, 
green=calcein 
B)  P1 dorsal view of orbital with birth dated biomineral 
shown, green =e14 calcein, red=e16 xylenol orange 
Scale bar 500 µm 
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Figure 1.14 shows a section from a specimen from Experiment 3 (Table1.1) 
labelled at three embryonic time points, calcein at e14, XO at e16 and 
doxycycline at e18. In the frontal bone of this specimen there is a concentric 
appositional form of mineralisation, in a nested ‘Russian doll’ fashion. Some 
time points display the deposition of several layers in one time window. The e18 
injection of doxycycline (cyan) has been deposited in 3 distinct layers (number in 
1.14c). The second layer of doxycycline is effectively increasing the thickness of 
bone in an intercalary fashion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Concentric appositional growth between e14 and P1 in the orbital 
region of the frontal bone  
X63 magnification confocal scan of P1 frontal bone showing birth-dated layers 
from matrix labelling injections at e14 (calcein , green), e16 (XO, red) and e18 
(doxycycline, cyan) 
A) Sagital section of anterior frontal bone showing the three birth dated mineral 
layers, as well as DAPI stained nuclei (blue) and brightfield channel (grey). 
The brighfield channel will show any unlabelled mineral matrix formed 
between P0 and P1 
B) as in A) with no DAPI 
C) e14 (green), e16 (red) and e18 (cyan) forming biomineral, showing 3 layers 
of e18 birth dated biomineral (red numbers). 
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Figure 1.15 shows frontal bone sagittal sections from two different mice exposed 
to calcein at e14 (figure 1.15, green) and XO (figure 1.15, red) at e16 
(Experiment 1, Table 1.1), which both show a distinct form of mineralisation 
compared to the pattern in 1.14. The circles outlines highlight regions where the 
older green matrix is surrounding the younger red matrix, in a reversal of the 
appositional pattern. Sometimes the section has revealed separate red matrix 
within the older green matrix, and in other instances the green and red matrix 
have become ‘mixed’ and appear yellow (figure 1.15b, red circle). Also, in 1.15a 
the majority of the red matrix (e16/17) has notably been deposited on the inside 
of the bone, hence for two days in the embryo there was preferential growth on 
biomineral towards the brain.  
 
 
Figure 1.15: Intercalary mineralisation occur in the  orbital region of the frontal bone 
 
x40 magnification confocal scans of P1 sagittal sections of the orbital region of the frontal 
bone, nuclei DAPI counterstained  
A) e16 (red) forming biomineral is found within e14 (green) biominerals in some deposits 
(yellow dotted circles) 
B) Not only is e16 (red) biomineral found with e14 (green) matrix (yellow dotted circles), but 
there is ‘yellow’ matrix (red outline) within green matrix which suggests a physical mixing of 
biomineral of different ages. 
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In figure 1.16 evidence of both appositional and intercalary growth can be 
observed in the same section at different anterior-posterior positions. At the 
thicker, anterior end of the frontal bone associated with cavities, 
biomineralisation is nearly exclusively intercalary, with older green matrix 
surrounding younger red or yellow matrix. 
At the most posterior end nearest the frontoparietal suture, mineralisation 
changes to become appositional, the red matrix surrounding and extending past 
the older green matrix.  
 
After observing evidence of local preferential deposition of e16 matrix on the 
ventral edge of L2 in figure 1.16, I examined sections at different mediolateral 
levels to establish if this is a widespread phenomenon. 
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1.4.2.2 Preferential deposition on the endocranial surface of L2 at some 
mediolateral levels 
 
Figure 1.17 is a section from an Experiment 3 specimen (Table 1.1), in which the 
biomineral was labelled at e14 with calcein, e16 with XO and e18 with 
doxycycline. The e14 to e15 and e16 to e17 mineral matrix (green and red 
respectively) is deposited on the same radial level. The e18 to e19 forming 
mineral matrix (cyan) however is deposited overwhelmingly on the inner 
(endocranial) surface of the bone, in a thick layer ventral to the older biomineral. 
 
 
 
 
This phenomenon is not restricted to embryonic stages. In figure 1.18 the 
specimen shown was matrix labelled at e14 with XO (note green in figure 1.18) 
and e18 with calcein (red in figure 1.18) then culled at P8 (Experiment 2, Table 
1.1). On the endocranial surface of the frontal bone in this section there is a layer 
of mineral matrix 100µm thick in places, deposited after P0. 
 
 
 
Figure 1.17 Preferential endocranial deposition of biomineral 
 x20 magnification of P1sagittal section orbital region of the frontal bone from labelling 
Experiment 3, with e14 matrix labeled with calcein (green), e16 with XO (red) red, e18 with 
doxycyline (cyan). Section counterstained with DAPI (blue) to visualize nuclei.  
Asterisk indicate mineral deposition between e18 and e19 (cyan) on the ventral side of L2, the 
endocranial surface of the bone.  
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1.4.2.3.Preferential deposition of biomineral on ectocranial side of L2 in 
attachment regions 
 
There were also regions where the matrix was preferentially deposited on the 
ectocranial (dorsal) surface of the bone (figures 1.19 and 1.20). 
Both these regions appear to be attachment points for facial musculature (solid 
arrow figure 1.20). The need for ‘reinforcing’ of the bone for attachment could 
be a reason why these dorsal surfaces experience preferential deposition. 
It is less clear why preferential deposition on the endocranial surface of the 
frontal bone would be desirable/biologically useful. 
 
Another feature observed in the frontal bone was the discontinuity of 
mineralisation at certain mediolateral levels. 
 
Figure 1.18 Preferential endocranial deposition of biomineral in postnatal specimen 
 x20 magnification of P8 sagittal section orbital region off the frontal bone from specimen1, 
Labelling Experiment 2, with e14 matrix labeled with XO (green), e18 with calcein (red) and P0-P8 
biomineral unlabeled (brightfield channel). 
White arrows indicate mineral deposition between P0 and P8 in the order of 100µm on the ventral 
side of L2, the endocranial surface of the frontal bone. 
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Figure 1.20: 
Mineral deposition occurs preferentially 
on the dermis side in attachment regions 
 
x20 magnification of sagittal section 
orbital region of the frontal bone from 
specimen1, Labelling Experiment 2.  
Section is a more lateral plane of the 
specimen in figure 1.20. 
White arrows indicate mineral deposition 
between P0 and P8 in the order of 80-200 
microns on the dorsal side of L2, where 
muscle fibres are attaching.  
Figure 1.19 Preferential dermis side 
deposition of biomineral in a 
postnatal specimen 
 x20 magnification of sagittal section 
orbital region of the frontal bone from 
specimen1, Labelling Experiment 2. 
Section is a more lateral plane of the 
specimen in figure 1.18. 
White arrows indicate mineral 
deposition between P0 and P8 in the 
order of 80-150 microns on the dorsal 
side of L2.  
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Figure 1.21: There is a lack of mineralisation between e16 and e18 in the medial frontal bone  
x40 confocal scan of a sagittal section of the frontal near the midline of a specimen from 
experiment1 (P1 cull, e14 calcein (green) injection and e16 XO (red) injection). Though e14 
calcein deposits are present, there is no evidence of xylenol orange, only grey biomineral 
deposited after e18 at the earliest. Yellow line L1/L2 boundary, white line L3/L3 boundary, red 
line shows mineral /collagen matrix boundary within L2. 
Scale bar 100µm 
 
 
Figure 1.21 is a confocal optical section from a very medial section of the frontal 
bone. There is clear evidence of mineralisation at e14 to e15 (figure 1.21, green), 
but then none between e16 to e17 (figue 1.21, absence of red). Biomineralisation 
seems to ‘stall’ for at least two days.  
 
The most medial levels of the frontal bone remain thinner at maturity than the 
thicker and more cancellous orbital regions. Addition of biomineral 
inconsistently could be a mechanism to restrict the thickness growth of this 
region. What inhibits cells from depositing matrix in the region is unclear, but 
could be similar to the signals secreted by the dura mater that keep the 
interfrontal suture patent. 
Also notable in this section (figure 1.21) is the large amount of collagen in L2 
that overlays the mineralised matrix. This volume of non-mineralised material 
has not been recorded before, and is a novelty in dermal ossification. 
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1.5 Biomineralisation pattern in relation to the sutures of the murine calvaria 
1.5.1 Introduction 
 
The frontoparietal (coronal) suture is the boundary between the neural crest 
derived frontal and the mesodermally derived parietal (Morriss‐Kay, 2001, 
Jiang et al., 2002). It is an overlapping suture, the frontal bone being ventral to 
the parietal at the boundary (Johansen and Hall, 1982).  
The FGFR2 domains which mark the suture boundaries even before 
mineralisation has extended the bone to the suture boundary (e16) orginiate at 
the most lateral portions of the frontal and parietal, as does expression of OPN 
indicating mature osteoblast activity (Iseki et al., 1997). 
The patterns of mineral growth described thus far in the chapter have not been 
analysed in relation to the suture, but to what appears to be the start point of 
mineralisation. In this section I examine and discuss the pattern of 
biomineralisation along the frontoparietal suture of the calvaria. 
 
1.5.2 Results 
1.5.2.1:The frontoparietal suture is not a uniform front of growth along its length  
 
The pattern surrounding the frontoparietal suture is complex, shown in figure 
1.22. 
Along the length of the suture on the frontal side there appear to be two zones, a 
lateral zone of e16/17 mineralisation and a medial zone of unlabelled or 
unmineralised matrix (figure 1.22b). 
As well as this there is no symmetry of biomineralisation if one takes the 
frontoparietal suture as an axis; the lateral e16 to e17 labelled frontal zone of 
mineralisation is not mirrored by matrix of that age on the corresponding parietal 
side at the same mediolateral level (Fig.1.22a, plane of black double headed 
arrow). 
This is evidence that in the e14-P1 time period, the suture does not constitute a  
uniform or symmetrical front of mineralisation. 
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Flat mounts can be misleading however, as the frontal parietal suture is an 
overlapping one, and the frontal bone goes under the parietal at parts of the 
suture. So to examine this finding more thoroughly, I examined the frontoparietal 
suture in sections with the layers of biomineral birth dated with fluorescent dyes 
at various mediolateral levels. 
 
 
 
 
 
Figure 1.22: Age differential of biomineral along the length of the 
frontoparietal suture 
Dorsal view of frontoparietal suture in flat mount skull from labelling 
experiment 1 (table 1.1).  
A) Left hand frontoparietal suture showing e14/15 labelled matrix (green) 
e16/17 labelled matrix (red) and brightfield channel which will include 
biomineral formed between e18 and P1 as well as unmineralised collagen 
(grey). Double-headed arrow indicates a plane where biomineral on the 
frontal side is older than parietal side of suture. 
B) As in (A) with brightfield removed. Arrows indicates that along the 
mediolateral axis of the suture the age of biomineral changes. 
FP=frontoparietal suture, dotted line indicates centre of the suture. 
Scale bar 0.5 mm 
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1.5.2.2 Bones either side of the suture are of different mineral ages 
Figure 1.23 is a sagittal section through the frontal parietal suture at a very lateral 
plane.  
On the frontal side of the suture the e14 to e15 mineralised matrix (green) 
extends nearly to the very end of the suture. On the parietal side of the suture 
however, there is 300µm of unlabelled matrix deposited (figure 1.23, white 
dotted line), displaying non-symmetrical matrix deposition.  
 
 
 
 
Figure 1.23: Non-symmetrical mineralisation either side of the frontoparietal suture in the 
lateral frontal bone 
x20 confocal scan of  P1 sagittal section of lateral frontal bone from labelling experiment 
1, calcein (green) injected at e14 and XO at e16, no XO at this mediolateral level. Nuclei 
stained with DAPI (blue) and brightfield included (grey). 
Parietal has 300 µm of e18-P1 mineralisation at its anterior end (white dotted line); the 
frontal bone has only 10-20 µm of e18-P1 growth at its posterior end. FP= fronto parietal 
suture. 
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Figure 1.24 is a section from a more medial plane in the same animal. On the 
frontal side the matrix is e14 in age, whilst on the parietal edge there is 100 µm 
of unlabelled (hence deposited at e18 to P1) mineralised matrix. Furthermore the 
e16 mineralisation that takes place in this region does not do so as a longitudinal 
extension of the earlier bone, but is laid down within the older matrix (red 
asterisks), 100-300 µm away from the suture. This could not be the case if the 
newest matrix was being laid down next to the suture as a result of new 
osteoblasts being supplied. 
 
 
 
 
 
 
 
 
 
Figure 1.24:  Asymmetry of mineral deposition either side of the frontoparietal suture  
 
A) x20 confocal scan of sagittal section of the frontal parietal suture from an 
Experiment1 specimen culled  at P1, calcein injected at e14 (green), XO at e16 (red), 
and the channel brightfield contains any e18 to P1 mineralisation. 
B) As in A with DAPI nuclear counterstain (blue). 
The parietal has approximately 100 µm  of e18-P1 mineralisation (grey matrix) whilst 
the frontal shows very little growth in this period. Also, the parietal shows evidence of 
e16-e17 growth only within 300 µm of the suture, whilst the frontal has e16-17 growth 
within 120 µm of the suture (red asterisks). F= frontal, P=parietal 
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Figure 1.25 is a very medial section, taken from the same specimen as in 1.23 
and 1.24, and the frontal portion of the FP suture is seen, as well as the frontal 
nasal suture. 
There is a 200µm portion of unlabelled matrix at the posterior end of the frontal 
bone, differing from the more lateral planes in the same specimen, where the 
posterior edge of the frontal bone was e14 to e15 in age, confirming the suture is 
not a unified front of biomineral growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.25: Differential in age along the mediolateral plane of the frontoparietal suture 
x20 confocal scan of P1 medial sagittal section of the frontal bone from an Experiment1 specimen, 
calcein injected at e14 (green) and XO injected at e16 (red). Brightfield channel (grey) contains any 
biomineral formed between e18 and P1. 
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1.5.3: Conclusion 
 
The frontoparietal suture is not a site of symmetrical biomineralisation for the 
bones either side of it as may be expected, which suggests it is not a site of 
symmetrical osteogenesis or a signalling centre that synchronises biomineral 
deposition on either side. The FP suture is also not a uniform front of 
biomineralisation along its length within the frontal bone (figure 1.26).  In the 
summary of this chapter (section 1.7) these findings are discussed in more detail 
in the context of current literature. 
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Figure 1.26:The pattern and rate of mineralisation varies along the length of the bone margin 
(frontoparietal suture)  
 
The expected pattern of biomineralisation was not seen along the frontoparietal suture. It was 
expected that older biomineral would be found at the lateral edge where osteoblast activity is 
reported in the literature and then extend medially and eventually (certainly at postnatal 
stages) originate from the suture. Instead I observe a variety of biomineral deposit patterns 
along the length of the suture. Along the mediolateral axis the nearest biomineral to the suture 
was found to be variously e14 (green), e16 (red) and e18-P1 (grey) in age. 
	 96	
1.6 Differential biomineral growth in the mediolateral axis in time 
1.6.1:Introduction 
 
After having examined the global patterns of biomineral growth I wanted to 
know in how much the different definable time periods of mineralisation 
contribute in terms of thickness (radial) growth and longitudinal (length 
extension in anterior posterior axis). Information about this can give us hints 
about inductive interactions from the overlying skin or underlying brain that have 
been posited but never examined experimentally. 
The quality and resolution of sagittal sections allows accurate thickness 
measurements of the layers of mineral matrix that were deposited at particular 
times and places, and so I may be in a position to assess the rate of thickness 
growth of the frontal bone and its rate of elongation in a comprehensive fashion. 
 
I wish to establish: 
1) How much biomineralisation is achieved in a day during the embryonic 
period? 
2) Is there a period of particularly fast growth? 
3) Is the rate of embryonic growth significantly different from the week 
following birth? 
 
To answer these questions I sagitally sectioned the heads of mice from all three 
labelling experiments in order to measure the thickness and length of the layers 
of mineral accurately. 
 
As large range of mediolateral levels was chosen, quality of the anatomy and 
mineral layers was the biggest restriction for selecting sections for quantative 
analysis. 
Sections included had complete frontal bones with no tears, and were free of 
artifacts (like bubbles in mounting media) that could prevent accurate 
measurement of biomineral layers. This was especially important for the 
brightfield channel which must be clear and sharp, as there is no coloured label 
to define the edge of mineralised material and quality of this channel is very 
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sensitive to factors like the variation thickness of mounting media when confocal 
imaging. 
 
1.6.2 Results  
 
Figure 1.27 shows the mediolateral levels of sections used from three different 
biomineral birth dating experiments to calculate rate of mineralisation. Sections 
used were those considered of very good quality, with very clearly defined layers 
of mineral whose margins were well defined hence could be measured 
accurately. The dimensions measured are defined in figure 1.28a (radial growth) 
and 1.28b (longitudinal growth).  
Thickness measurements were taken from experiments all three experiments (see 
Table 1.1, whilst length measurements were only taken from Experiments 1 and 
2, due to the insufficient quality of the PMT channel throughout the sections of 
experiment 3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.27: Approximate mediolateral level of sections used for mineral layer growth 
measurements 
Experiments 1, 2 and 3 refer to the mineral birth dating experiments referred to in Table 1.1. The 
biomineral layers in these experiments were measured for thickness growth and length growth 
(experiments 1 and 3 only). Mediolateral positions from different samples were judges by the 
surrounding anatomy, e.g. appearance of brain, presence of the eye, presence of inner ear, nasal bone 
and the appearance of the cranial base. Slide numbers for each sample are included. 
L=lamboid suture, S=sagittal suture, FP=frontoparietal suture, IF=interfrontal suture, 
FN=frontonasal suture. 
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1.6.2.1 e14/15 biomineral deposition contributes half the radial thickness that 
other embryonic time points do 
 
Due to depositing mostly in one layer, the e14 to e15 total biomineral is not as 
thick as deposits laid down later in embryonic life. 
Figure 1.29a represents the mean absolute growth for each age of mineral layer, 
and as I know how long the matrix labelling agents circulate in the blood stream 
(48 hours), I was able to calculate the rate of radial biomineral thickness growth 
(figure 1.29b). 
At e14 to e15 (1.29a, yellow column) (the first layer of mineralised matrix to 
form) 10 .7 ± 1.0 µm of mineral is deposited. This mineral is deposited in a 
single layer, unlike the later stages, which have two layers at some points along 
the anterior-posterior axis if not everywhere. 
 
Figure 1.28:Defining measurements of single age mineral layers in the frontal bone A) Radial (Thickness) growth measurements were made of all layers, when there 
are two layers for one matrix label; both layers were measured and included in 
the average.	B)  Length measurements used in the data in this chapter reflect the increase in 
length on the previous labelled layer of mineralised matrix.	
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At e16 to e17 (cyan column), and e18 to e19 (pink column), which both 
represent embryonic stages of mineralisation; the total thickness of the mineral 
deposits are 20.8 ± 2.9 µm and 16.4 ± 2.0 µm respectively, and are not 
significantly different. These stages lay down mineralised matrix either side of 
the original e14 to e15 layer in the sections measured, though only the e16 to e17 
deposit is significantly thicker than at e14. The e16 to e17 growth is significantly 
faster then at e14 to roughly triples the bone in thickness compared to its e14 to 
e15 thickness, and by the end of the e18 to e19 mineralisation the frontal bone 
has increased in radial thickness by approximately 5 times its e14 to e15 
thickness. 
 
The e18-P1 mineral layer (blue column) is 27.9 ± 7.9 µm thick and the P0-P1 
layer (green column) is 33.6 ± 10.0 µm thick. It is surprising that these two 
Figure 1.29: Rate of radial mineral deposition in the embryo is consistent, but 
increases 2-3 fold after birth in the mouse  
A) Column graph showing the mean absolute thickness in microns of each 
of the defined mineral deposits visualised by matrix labelling agent at 
different ages. Error bars show standard error of the mean. N value 
represents the number of sections measurements were made in, from 
the 3 mice used. 
B) Column graph showing the rate of radial growth of biomineral per 48 
hours at different ages. Error bars show standard error of the mean. N 
values as for A. 
Horizontal bars indicate level of significant difference between columns using 
conventional limits, see Technical Appendix for detail. Columns with no lines 
between showed no significant difference. 
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layers were not significantly different, as one bar represent 4 days growth and the 
other 1-2 days growth. 
 It suggests that mineralisation between P0 and P1 is especially rapid and then 
the rate decreases later in postnatal development. 
 
The P0-P8 mineral layer (orange columns) was as expected the thickest layer of 
mineral as it represents more days of growth than any other time period being 
103.4 ± 10.2 µm in thickness. 
 
1.6.2.2 Postnatal radial biomineralisation is faster than embryonic radial 
biomineralisation 
 
Mineralisation rates were calculated as the rate of formation of a single layer at 
any given time point. If two layers were formed in the same time window the 
thickness was averaged, not totaled as with absolute growth. The mean layer 
thickness was calculated and plotted with the standard error of the mean (figure 
1.29b). A parametric t-test was used to find and significant differences in the rate 
of mineralisation (See Technical Appendix for tables of all p values). 
I find that the rate of biomineralisation varied in the embryonic growth stage 
increases rapidly after birth. 
The rate of growth between P0-P8 was in the same range as P0-P1, 25.9 ± 2.5 
µm per 48 hours and 16.8 ± 6.1 µm respectively (figure 1.29b), and there is no 
significant difference in the rates (p = 0.1498). However the P0-P8 rate of 
mineralisation was significantly faster than all other time periods. 
The embryonic mineralisation rate does not vary significantly between e14- 
to e19, (figure 1.29 b, yellow, cyan and pink columns).  
The e18 to P1 time period, which will encompass around 24 hours of postnatal 
growth, did show a small but significant difference from e14 mineralisation, 
mineralisation is slower at e18-P1 than at e14, 6.7± 1.9 µm compared to 9.8± 1.0 
µm (p=0.0156). Though this is initially surprising, as the P0 to P1 rate of 
mineralisation is very fast though variable (large standard error), it may be that 
the gap in mineral availability between birth and feeding causes a slight decrease 
in mineralisation rate. 
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1.6.3 Conclusions 
 
The rate of radial growth of the murine frontal bone approximately triples in the 
week after birth compared to radial mineralisation in the embryo. 
The above data takes a generic view of the thickness of mineral throughout the 
frontal bone, not taking into account the position in the bone. 
There could be factors affecting thickness in one region vs. another, e.g. if the 
region is an attachment point or not.  
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1.7 Longitudinal growth of biomineral layers in the frontal bone vary over the 
mediolateral axis 
1.7.1 Introduction 
 
I have shown that the rate of radial mineralisation changes over time. I wish to 
compare this to the rate of longitudinal mineralisation in the frontal bone, and 
answer the following questions: 
 
1) How does the rate of longitudinal bone growth vary in frontal over time? 
2) How can we relate the radial biomineral deposition to the longitudinal growth 
of bones?  
3) How are these rates distributed along the mediolateral axes?  
 
I measured the length of biomineral layers of different ages in the sagittal 
sections of frontal bones. I first examined the absolute longitudinal growth 
within each skull.  
 
1.7.2 Results 
1.7.2.1: The length of biomineral layers varies along the mediolateral axis 
 
Figure 1.30 shows the absolute longitudinal growth at different time points of 
biomineral layers at five different mediolateral positions from Experiment 2. 
This range covers a mediolateral distance of approximately 100µm of the frontal 
bone. 
As was noted in the images of radial growth of the skull that at some 
mediolateral levels there is no mineralisation at all at certain time points. When 
measured, it can be seen that at some lateral positions there is no longitudinal 
growth before e18 (Figure 1.30, column 23 and 33). Also when mineralisation 
does occur during an injection period, there is more labelled matrix at some 
mediolateral levels than others, e.g. slide 37 gained 650 µm in length between 
e18 to e19 (pink segments), double the length of the other four positions 
sampled. 
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e14 growth is found mostly in more medial regions, not lateral ones, as was 
expected from the analysis of the flat mount mineralsied skulls images in section 
1 of this chapter. 
To compare growth at different mediolateral levels and different time points to 
each other, I calculated the rate of mineral addition in the anterior-posterior plane 
per 48 hours (figure 1.31a-c). e14 measurements were excluded from rate 
calculations, but were used as a landmark to measure the longitudinal growth of 
later layers. 
  
1.7.2.2. Longitudinal mineralization rate increased with age and varies with 
mediolateral level 
 
The rate of mineralisation varied widely between mediolateral levels, but the 
average rate of addition did increase with age. From 142µm per 48 hours at e16 
to e17 the rate nearly doubles at e18 to e19 to 333 µm per 48 hours. It increases 
modestly to 395 µm per 48 hours at P0-P8. 
At the individual mediolateral levels there is a large amount of variation. 
Figure 1.30 There is a large variation in the size of mineral deposits in the 
anterior-posterior axis 
Absolute growth observed in specimen from labelling regime 2 (see Table 
1.1) in A-P plane. X axis numbers refer to slide numbers of sections. No 
e14 to e15 or e16 to e17 labelling was observed in the lateral two slides 23 
and 33.  	
	 104	
 
At e16 to e17 the rate of longitudinal mineral addition is between 83 and 240 µm 
per 48 hours. This highest rate was observed at section 39, which was from the 
midpoint of the frontal bone in the mediolateral plane (figure 1.32a). 
Between e18 and e19 the range of mineral addition was between 124 and 650 µm 
per 48 hours (figure 1.31b). There is no obvious mediolateral trend. Between P0-
P8 the rate of mineral addition is from 175-500 µm per 48 hours (figure 1.31c). 
At this time point there appears to be a mediolateral trend, with the growth rate at 
the lateral regions outstripping the more medial regions. 
 
1.7.2.3 A single biomineral ‘strata’ maybe made up of different ages of 
biomineral 
 
The e14 injection label can often be observed as small islands interspersed by the 
e16 injection label colour, or by unlabelled matrix in the case of Experiment 2 
(see Table 1). The e14 mineral was laid down in small islands the next matrix 
labelling agent label in filled the gaps with labelled matrix. 
This produces long layers of biomineral that is not of one age. 
I wish to ascertain if there was any pattern to these islands over the mediolateral 
and anterior-posterior axes 
Figure 1.31:Different mediolateral levels experience different phases of 
longitudinal growth in the murine frontal bone  
A)Rate of growth in the AP axis of biomineral deposited at e16 to e17 
B)Rate of growth in the AP axis of biomineral deposited at e18 to e19 
C) Rate of growth in the AP axis of biomineral deposited at P0 to P8 
All measurements taken from a single skull from experiment 2 (see 
table 1.1). 
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I measured the length of the e14 to e15-aged mineral islands and the intervening 
e16 to e17-aged matrix in slides of known relative mediolateral level. Sections 
were only used if there was an area of islands uninterrupted by blood vessels or 
other elaborations/ confounding features in the bone. 
 
The length of the islands can be seen in Figure 1.32. There is no obvious 
anterior- posterior pattern, islands size and e16 block size varies within a given 
section’s anterior posterior axis. The range of e14 island size was from 4.6-150 
µm, with the most common size range between 30-40 µm, whilst the e16 blocks 
varied from 2.7-73.1 µm in size, the most common size range being between 10-
20 µm in length.  
It may be noted that the most lateral section has the most islands and the most 
medial has the least, however there is no gradient across the intervening slides, 
and this is likely an artifact due to the more medial regions of the frontal bone 
being shorter than the more lateral regions. 
 
 
 
 
 
 
 
 
 
 
Figure 1.32: Deposition of mineral in the sample mediolateral level at the same age 
van vary in size considerably, with the early mineral deposition become among the 
largest deposits contributing the length along the anterior-posterior axis 
  
Lengths of e14 mineral islands (yellow) and e16 intervening mineral deposits (cyan), 
arranged in mediolateral (y axis) and anterior posterior (x axis) sequence. 
Measurements taken from three skulls. 
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1.7.3:Conclusion 
 
The average rate of radial biomineral growth across all mediolateral levels in the 
murine frontal bone does not vary significantly from e14 to e19, being within the 
range of 6.9-10.6 µm per 48 hours. 
After birth, the rate of radial mineralisation nearly triples to between 25.9- 33.6 
µm per 48 hours. 
The variation in thickness in the A-P and M-L axes of the frontal bone is 
achieved by non-continuous mineralization. In the orbital region labeled matrix 
could be found from every injection time point, which was not the case in the 
more posterior parts of the frontal bone, as well as the most anterior medial and 
lateral regions of the frontal bone 
 
Longitudinal growth was quantified and mediolateral patterns were observed that 
corroborate with the patterns seen in figures 1.2. 
 
After mineralisation initiates in the supraorbital region, the biomineral growth is 
more continuous in the mid-mediolateral regions of the frontal bone but the 
highest rates of mineralisation are found at the medial or lateral margins at the 
late embryonic and early postnatal stages. 
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1.8 Summary of findings 
  
In this chapter I have described for the first time the distribution of novel forms 
of biomineralisation in the calvaria. 
 
The initial stages of mineralisation in the frontal bone centres around the 
supraorbital ridge, which is the site of the frontal bone primordia (Yoshida et al., 
2008). From the earliest biomineralisation at e14 to e15 in the frontal bone, a 
network of calcified trabeculae is extended by ‘branches’ of biomineralisation 
that radiate out of the orbital region posteriorly and laterally; and the extension of 
ridges of biomineral towards the midline.  The branching style of 
biomineralisation is continuous throughout the development of the mineralised 
architecture, as these ‘branches’ of biomineral join together to form a ‘Swiss 
cheese’ pattern of trabeculae. 
 
Differences in mineralisation in the frontal and parietal bones 
 
The frontal and parietal have independant trajectories of biomineral growth. 
The onset of mineralisation in the parietal slightly lags that of the frontal, after 
which mineralisation proceeds in a different fashion. 
As mineralisation progresses at e16 to e17 the frontal begins to increase its 
thickness through appositional and intercalary growth. In contrast the parietal 
between e16 and e17 only extends the biomineral network laterally and 
longitudinally with no thickness growth in addition to the e14 to e15 
mineralisation at this time. 
This difference in mineralisation and hence growth rate made it not altogether 
surprising therefore that at the frontoparietal suture the margins of the two bones 
did not show the same pattern of mineralisation.  
As discussed in the Introduction, the frontal is thought to have arisen first in 
evolutionary history, pre-dating the parietal (Koyabu et al., 2014). This in itself 
could be a basis for a different timing of development in ontogeny. Differences 
in the pattern and rate of maturation of grey matter in onotogeny have been 
found in the cortical regions of the human brain based on their emergence in 
phylogeny (Gogtay et al., 2004).The frontal and parietal are also of different 
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tissue origins, the frontal being of neural crest origin whilst the parietal is of 
mesodermal origin (Jiang et al., 2002, Morriss‐Kay, 2001). The phenotype of 
coronal craniosynostosis has been demonstrated to only involve the mesodermal 
tissue lineage, not the neural crest, in the Apert syndrome mutation again 
suggests that the frontoparietal suture is not a symmetrical growth boundary 
(Holmes and Basilico, 2012), and I can confirm that it does not mineralise 
symmetrically. 
It would be interesting to further investigate this asymmetry, and what along the 
boundary allows the suture to contribute more to one bone or be influenced more 
by one bone.  
 
The mineralisation along the frontoparietal suture within the frontal bone was 
also asynchronous. The first regions to biomineralise appear to be the most 
lateral ones, mineralisation extend then toward the midline, with the most medial 
parts of the frontal bone unmineralised at birth. This is in agreement with the 
progressive extension of the OPN expressing domains of the developing skull 
(Iseki et al., 1997). The proliferation and differentiation of osteoprogenitors in 
the cranial sutures is maintained by FGFR2 and FGFR1 expression (Iseki et al., 
1999) and the closure of the sutures is regulated by the BMP 2 and 4 genes 
(Warren et al., 2003). 
Ossification at a different rate along the suture is presumably due to different 
levels of expression of these signalling molecules along the length of the suture. 
 
An area that was neglected in this study was the mineralisation across the 
interfrontal suture. This boundary is an abutting boundary, not overlapping like 
the frontoparietal suture, and as the two bones are symmetrical and overlie a 
symmetrical brain structure, the mineralisation pattern would be expected to be 
symmetrical either side of the interfrontal suture. Small sample numbers 
precluded the coronal sectioning of the skulls in addition to sagittal sectioning. 
This could be interesting extension of this study, as it would allow the pattern of 
thickness growth in the orbital region to be seen from another angle, building up 
the appreciation of the 3D formation of the frontal bone. In addition the posterior 
part of the interfrontal suture is the only cranial suture in the mouse to fuse, 
	 109	
making it more similar to the human condition where all sutures fuse at maturity 
(Opperman et al., 1993). Hence this region has biology more comparable to the 
human state. 
 
Distribution of intercalary biomineral deposists in the frontal bone 
 
An observation from this study is the frontal bone mineralising in both an 
intercalary and appositional fashion, and for the first time I describe a ‘mixing’ 
of older and younger matrix. 
Where the intercalary and/or appositional growth take place appears dependent 
on the stage of development, with evidence for intercalary growth between e14-
e17 but none in the early postnatal stages in the mouse.  
The only other evidence of this phenomenon I could find was in Cleall et al. 
1968 in the juvenile rat. I can confirm that this type of mineralisation occurs also 
in the mouse, and indeed appears to be confined to the same region of the same 
bone, the orbital region of the frontal. This is incidentally the thickest part of the 
frontal bone, and hence may be involved with mechanisms specific to increasing 
radial growth.  
 
In contrast to the 1968 study I find that intercalary growth is restricted to a small 
time window in the embryonic time period in all mouse specimens examined, 
e16 to e17 matrix was found within e14 to e15 deposited matrix. As this does not 
appear to be restricted to pre or postnatal animals, I suggest there is an unknown 
signaling event in the region of the orbital that prompts this behaviour.  
 
In the orbital region at e15 there appeared to be a difference in expression pattern 
between different proteins in different layers of the bone. 
Whilst RUNX2 and CD31 were widely expressed in all three layers of the bone, 
OPN, and marker of mature osteoblasts, was found to more strongly and widely 
stain Layer 1 than either of the other two layers. That there is differential 
expression of genes on either side of the frontal bone surface has been reported 
before, and future work would involve understanding exactly what these 
differences are and how they change in the apparently important time of e14-e18 
in the orbital region of the mouse. This should not be restricted to proteins 
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involved in osteoblast development, but also osteoclasts. Lacking in this analysis 
has been a study of the cells that are chiefly responsible for destruction of old 
bone. If cells have to invade previously deposited matrix then this necessitates 
the removal of HA crystals, and ability to do this is considered a unique property 
of osteoclasts. 
 
The frontal bone orbital regions is known to be a site of remodeling in as the 
cancellous spaces in this region houses most of the bone marrow of the skull of 
the mouse. 
This region of the frontal bone in many species is subject to intense resorption 
and remodeling to form the frontal sinus postnatally. These sinuses increase in 
size with age and hence influence the overall shape of the skull  
 
The presence of the frontal sinus is very plastic between species, and has been 
suggested as a kind of ‘buffer’ in anatomy; allowing changes in skull shape to 
suit animal lifestyle without increasing skull weight and allowing dispersing of 
pressure, especially in carnivores (Curtis and Van Valkenburgh, 2014). 
Recent work has found that certain types of bone are preferentially resorbed 
compared to others, especially bone of lower mineral quality (Pernelle et al., 
2017). Resorbing and re-laying bone could be a way of creating heterogeneity in 
the biomineral compared to surrounding regions that marks it for later 
remodeling. The mouse has either very little or no frontal sinus (Bomer et al., 
1998, Hall, 1993), however the orbital region is the most cancellous of the 
frontal bone and these cancellous spaces are areas of remodeling. 
 
The apparent intercalary growth was in small deposits and localised to a few 
mediolateral layers in the mouse; it would be interesting to examine the mode of 
biomineralisation in species that do have a highly developed frontal sinus, such 
as rabbits and dogs. 
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Rate of biomineral growth is variable at different positions in the frontal bone 
 
In the study of the rate of biomineralisation, I found that the first week of 
postnatal life the bone increases in thickness at a greater rate than in the 
embryonic time period. 
The fastest rate of radial (thickness) growth of the frontal bone during the 
labelling experiment was between P0-P8, with mineral forming at approximately 
three times the rate of the e14-P0 range.  
Thickness growth per 48 hours is stable in the embryonic time period. 
In comparison to the adult mouse, the rate of embryonic and early postnatal 
mineralisation is very fast, as would be expected for a developing animal vs. a 
fully-grown organism. In the 8 month old C57/B mouse (the same strain as was 
used for this matrix labelling study) in 5 days the frontal bone is reported to 
increase in thickness by 6.5µm (Wu et al., 2003), which is less than slowest rate 
of mineralisation in 2 days in my study. 
The rate of longitudinal biomineral growth is many times faster than radial 
growth at the same age. For example the radial growth rate between P0-P8 is 
25.9 ± 2.5 µm per 48 hours whilst the longitudinal growth of this layer was 
between 175-500 µm per 48 hours depending on mediolateral level. 
The rate of longitudinal growth in the murine frontal bone varies along the 
mediolateral axis, with the rate of mineral addition in the youngest stages being 
higher in the more medial regions, but in later stages being higher in the lateral 
regions of the bone. Islands of biomineral show that even at the same radial level 
the age of the biomineral ‘strata’ is not the same. Gaps left by older biomineral 
are ‘filled in’ by younger biomineral in a process that occurs along the whole 
anterior posterior and mediolateral axes.  
 
Further works and concluding remarks 
 
The complex biomineral patterns provide a challenge for analysis. 
One possibility that should be considered is that the intercalary pattern described 
may not require the excavation of previously deposited biomineral in the style of 
osteoclasts, but the invasion of osteoblasts from a ‘gap’ in the mineral matrix. 
What appears in sagittal sections as enclosed spaces could in fact be tunnels of 
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biomineral, as I have shown that even at an early stage of development (e15) 
biomineral can be deposited in two layers. Osteoblasts could ‘invade’ the centre 
of the tunnel without the need to degrade HA crystals and deposit younger matrix 
within older matrix. 
What is less readily explainable if this were true is the presence of ‘yellow’ 
matrix in single optical sections of the frontal bone biomineral. This biomineral 
is formed from a mixing of the calcein and xylenol orange labelled inorganic 
material. The presence of this type of tissue would seem to require proper 
degradation of older matrix to achieve this. Currently the only bone cells that are 
believed to have this ability are the osteoclasts as these cells, using a vacuolar 
ATP-dependant pump to secrete protons, can create the very acidic conditions 
necessary to degrade HA (Väänänen et al., 1990, Blair et al., 1989). 
Further work to confirm a truly intercalary process of biomineralisation would 
need to either identify osteoclasts in the orbital region of the frontal bone at e16 
to e17, or show that osteoblasts can create these conditions themselves. The first 
tartrate resistant alkaline phosphatase (TRAP) staining and presence of MMP-9 
mRNA (indications of osteoclast activity) has indeed been reported in the murine 
frontal and parietal bones at e16 (Rice et al., 1997). Examination of the 
biomineral in species with a highly developed frontal sinus could provide insight 
as to the role and evolution of this novel mechanism of biomineraliation. 
 
Taken together the intercalary growth, biomineral mixing, branching biomineral 
and the anterior-posterior and mediolateral variation in the pattern and rate of 
biomineral formation tell against the traditional appositional model of a single 
layer of osteoblasts depositing matrix appositionally. 
 
My aim is to discover the cellular behaviour than can produce these complex and 
novel biomineralisation patterns. I go on in Chapter 2 to investigate the 
behaviour of the key cell types associated with the biomineralised architecture of 
the frontal bone, in particular their migratory potential. 
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Chapter 2: Invading capabilities and identity of cells in the frontal bone 
Introduction 
 
In Chapter 1 I described the temporal sequence and spatial pattern of 
mineralisation of the murine frontal bone in the embryo and early postnatal life. 
The basis of the current model of dermal bone growth (as outlined in the 
introduction of Chapter 1) is the arrangement of osteoblasts in continuous layers 
in L1 and L3 of the developing bone, depositing matrix in a continuous layer of a 
single age (Lieberman and Friedlaender, 2005). There are indications from bone 
cell cultures and observations in murine long bone that the vast majority of 
mineralisation is achieved by osteocytes in the process of maturing and 
becoming incoporated into the bone, not by surface osteoblasts (Barragan-
Adjemian et al., 2006). However this has not been demonstrated in dermal bone. 
The intercalary and concentric pattern of mineral deposition, as well as the 
localised variation in the pattern of mineralisation suggests a far more complex 
arrangement and behaviour of the matrix depositing osteoblasts (figure 2.1). 
Cells arranged in a single continuous layer would not be able to produce an 
intercalary pattern of biomineral (2.1b and c white cells). 
The pattern of mineralisation of the sutures and the non-mineralisation of the 
centre of the frontal bone as well as mineralisation of its periphery at e16 would 
also suggest against the suture being the main source of new osteoblasts in the 
e14-P1 time window. 
To understand how the complex patterns of mineralisation are achieved by the 
osteoblasts of this dermal bone, I undertook a study of the organisation and 
behavior of the cells of the frontal bone.  
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Motility and behaviour of osteoblasts in the calvaria 
 
It has been demonstrated that there is a population of motile cells that can 
migrate across the surface of the calvaria; this was done in live imaging 
experiments of calvarial explants from the neonatal stage up to P12 (Dallas and 
Bonewald, 2010, Veno et al., 2007).  
The majority of motile cells in these studies expressed Col1 (marker of mature 
osteoblasts), and a small subset expressed DMP1 (mature osteocyte marker) as 
well as a small population that expressed both. The average velocity of these 
cells was 5.3 µm/hr and their path of motion was described as continuous and 
random. The authors did not assess whether cells were moving in and out of the 
Figure 2.1: The intercalary patterns of growth in the frontal bone cannot be explained by 
the traditional model of dermal bone growth 
A) In chapter 1 a complex pattern of intercalary biomineralisation was described in the 
frontal bone 
B) Adapted from Liebermann and Friedlaender 2005, showing the initial arrangement 
of cells in the traditional model of dermal ossification. Osteoblasts (white) are 
arranged in a continuous layer that deposits matrix (green) beneath it. 
C) Over time this creates the thick L2 mineral matrix by appositional deposition alone, 
with embedded osteoblasts becoming osteocytes. Pre-osteoblasts (cyan) mature 
gradually from a single superpositioned layer. This rigid arrangement of cells could 
not produce the pattern seen in A) 
A B
C
e14e16DAPI 
Brain 
A 
L2 
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bone, but it was noted that the osteocytic cells could move out of their lacunae 
into areas of resorption. 
 
I am interested in the possibility that these osteoblasts could also be moving into 
the bone itself, rather than along its surface. Unpublished evidence from the 
Koentges lab suggest that RUNX2+ cells in L1 ‘reach’ into L2 to make contact 
with cells ‘reaching’ up from L3 (Jordan, 2011).  
These could be examples of specialised cell morphology, with the cell membrane 
developing a ‘limb’ to make contact between layers, and thereby forming the 
‘struts’ that are visible in sagittal sections in the collagen fibres. It could also be 
the result of cells in the peripheral layers dividing, and the daughter cells 
entering L2 parallel to the mother cell. The third possibility is that an active cell 
invasion takes place from the outer layers into L2, developing the middle layer.  
 
These RUNX2+ cells ‘reaching’ into the bone often expressed TRAF6, an 
essential signaling component in the RANK/RANKL signaling pathway, which 
is required for proliferation and differentiation of osteoclasts (Izawa et al., 2012).  
Osteoclasts are essentially macrophages with specialised morphology that have 
the ability to degrade mineralised matrix, using protons and MMP molecules to 
‘chew’ through calcified bone (Teitelbaum, 2000). It is known that osteoblasts 
have the ability to modulate the behaviour and differentiation of osteoclasts 
through expression of RANKL among other molecules (Fuller et al., 1998, Glass 
et al., 2005, Yasuda et al., 1998). 
 
Cells of osteoblastic lineage have also been shown to resorb organic bone matrix 
directly in vitro after the bone has been exposed to osteoclasts that remove 
inorganic molecules (Mulari et al., 2004). These cells have been observed in the 
calvaria of 5-day old mice and by their morphology inferred to be of osteoblastic 
lineage (Everts et al., 2002). More convincingly in cortical bone of the iliac crest 
a population of ColI digesting and resorbing cells (known as Reversal cells), 
have recently been demonstrated to be of the osteoblast lineage from their 
RUNX2 expression (Abdelgawad 2016). These cells produce MMP1 and 
MMP13, enzymes that degrade collagen 1 and 2 respectively, collagen I being 
the primary component of the collagenous matrix deposited by osteoblasts. 
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Reversal cells are thought to act on resorbed surfaces after osteoclasts have 
demineralised them to further clear up collagenous ‘debris’ before mature 
osteoblasts deposit new matrix. 
The implication of osteoblasts expressing these molecular markers is that it 
would confer the ability of mineral degradation to the osteoblast, allowing it to 
move through older, previously deposited matrix and deposit new matrix 
(Jordan, 2011).  
 
This is a possible mechanism that would result in the intercalary pattern of 
matrix deposition observed. 
 
Chapter structure 
From this starting point, I wish to investigate the following questions: 
 
1) Are cells reaching between layers the result of cell migration, a change in 
cell morphology or a directional cell division? 
2) Is this process multi- directional? Do cells only reach up or down, or can 
they also move/reach sideways? 
 
To answer these questions I have adopted two methods. Firstly an ex vivo 
experimental design, dissecting out and culturing frontal bones of prenatal and 
young postnatal mice, and applying lipophilic cell labelling dyes to the outer 
surfaces of the bone so as to be able to track cells in time. These labelled cells 
were then antibody stained to identify them. 
Secondly, I tracked the movement of cells in real time by imaging the cells of the 
frontal bone that have been genetically labelled with fluorescent proteins. I find 
that cells can actively migrate upwards and downwards into the frontal bone, as 
well as moving laterally within the bone considerable distances. 
 
In Part I of this chapter I track the movement of labelled cells for two days in the 
cultured explants of mouse frontal bone. I demonstrate that cells invade the 
frontal bone from L1 and L3, and that HAND2 has a role in this process. 
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In section 1 of Part I I demonstrate that cells invade the L2 of the frontal bone 
from both L1 and L3. These invading cells can invade the bone fully, i.e. the 
cells travel from L1 to L3, or from L3 to L1. Invading cells can also partially 
invade; defined as being retained in the L2 of the frontal bone. One of the cell 
types resulting from this invasion are osteocytes. 
 
In section 2 of Part I I quantify the cellular invasion of the bone. I find that in 
thinner regions partial and full invasion of the frontal bone are equally likely. In 
thicker regions invading cells are most likely to be retained in L2. 
 
In section 3 of Part I I characterise the identity of cells in the invading 
population. I find that up to one third of the invading cell population is RUNX2+ 
and up to two thirds of the invading population are HAND2+. 
 
In section 4 of Part I, I analyse the mineralisation pattern of the frontal bone in a 
mouse where HAND2 is ablated in the neural crest lineage. I find that thickness 
growth in impaired in this frontal bone, as a result of the lack of invasion of 
HAND2+ cells. 
 
In Part II of this chapter I track the invasion and movement of cells in the frontal 
bone in vivo, by genetic labelling of cells with several fluorescent proteins. 
In section I I establish that cells can travel distances of up to 100µm in 22 hours. 
I show that some cells have direct path profiles, and other cells travel in circles. 
Cells tend to ‘oscillate’ when moving in the z axis.  
 
In section 2 of Part II I analyse the speed of the cells. I find that the cells that 
travel furthest do not travel at a steady speed, but instead move very slowly for 
most of their lifetime, and have a short period of very fast movement. Changes in 
speed are favoured in the Z direction rather than the XY dimension. 
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2.1 A RUNX2+ /HAND2+ single and double population of cells invade the 
frontal bone from L1 and L3 
 
2.1.1.1: Partial and full invasion of the frontal bone by cells from L1 and L3 
Introduction 
 
To track the potential movement of cells in to the centre of the bone from the 
dorsal and /or ventral surfaces, I permanently labelled them with the lipophilic 
markers DiI and DiO. 
These dyes are incorporated into the cell membrane with no significant cell to 
cell transfer, and contain a unique terminal ring group which gives them a 
distinct fluorescent spectra (Hofmann and Bleckmann, 1999). This was 
exceptionally useful for confocal microscopy where we are able to visualise this 
fluorescence and penetrate 3D tissue (see Technical Appendix). 
The schematic in figure 2.2 indicates where dye was applied on specimens. The 
suture regions were avoided so as to have an impression only of movement 
within bone, not affected by any potential supply of new cells. The nasal bones 
and part of the parietal was left attached in prenatal samples to aid with 
identification of frontal bone orientation. The dye was applied on either the L1 of 
the bone or the L3 side as in figure 2.1 The explant was incubated at 37°C for 
between 24- 48 hours then washed with PBS, fixed and sectioned to observe the 
fate of the labelled cells (see Materials and Methods for full details).  
I find labelled cells are present all three layers of the frontal bone after DiI or 
DiO is applied to either the L1 or L3 of the frontal bone after 24-48 hours 
incubation in growth media. 
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Figure 2.2 : Application of lipophilic DiO/DiI to skull explant allows tracking of 
cells in the frontal bone 
DiO or DiI (red) was applied to discrete regions of a dissected frontal bone using 
a bent sterile needle tip. 3 to 4 applications were made on each frontal bone care 
being taken to avoid suture regions. The nasal bones were retained to aid in 
orientation of the sample. 
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2.1.1.2 Results 
2.1.1.2 .1 Dio and DiI labelled cells invade the embryonic L2 from both L1 and 
L3 
 
In embryonic frontal bone in which cells were labeled in L1 or L3, after 24 hours 
of growth labelled cells could be observed in L2. 
Figure 2.3a shows a sagittal section taken from an e17 mouse frontal bone 
explant to which a lipophilic dye (DiI, pink) was applied to L1. Pink labelled 
cells can be seen infiltrating L2 (white asterisk). 
In figure 2.3b the result of lipophilic dye (DiO, orange) applied to L3 of the 
frontal bone is shown. Just as in the dermis side label, dye labelled cells can be 
seen in L2, and also in L3 (white asterisks). 
These results indicate that both the L1 and L3 of the murine frontal bone contain 
cells capable of invading the developing L2. 
I wished to ascertain if this cell behaviour was also seen in postnatal frontal 
bone. The labelling experiment was repeated in a P6 frontal bone explants. 
 
 
 
 
 
 
 
Figure 2.3: Cells labelled with lipophilic dye in L1 or L3  can be found in L2 in the 
prenatal mouse frontal bone 
 
A) Sagittal section of an e17 frontal bone explant labelled with DiI (pink) on the 
dermis side and the nuclei counterstained with DAPI (blue). Cells carrying the 
label can be seen in L2 (white asterisks). 	
B)  Sagittal section of an e17 frontal bone explant labelled with DiO (orange) on the 
brain side and the nuclei counterstained with DAPI (blue). Cells in L2 and L1 are 
labelled with the DiO (white asterisks).	
Scale bars 50 µm	
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2.1.1.2 .2 The invasion of L2 by L1 and L3 cells persists in the postnatal frontal 
bone 
 
At P6, there is very extensive movement of cells from L1 of the frontal bone into 
L2 and L3, and from L3 into L2 and L1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4a shows a sagittal section from a P6 frontal bone explant labelled with 
DiO on L1, cultured for two days then fixed and DAPI counterstained to reveal 
the cell nuclei. There is a continuous ‘stream’ of labelled cells from L1, 
downward through L2 and then extending laterally in L3 (green dotted line). 
There are also cells in L2 labelled with DiI that are not in contact with L1, which 
could occur by cells entering L2 then moving laterally within L2 (yellow 
asterisks). 
L1 
L2 
L3 
* * 
* L1 L2 
L3 
L1 
L2 
L3 
L1 
L2 
L3 
A 
B 
DAPI DiI 
DAPI DiO 
Figure 2.4: Cellular invasion of L2 persists into early postnatal stages and 
extends to full invasion of the bone 
 
A) Sagittal section of DiI (pink) L1 labelled P6 frontal bone explant, 
nuclei labeled with DAPI (blue). There is extensive transfer of dye 
from L1 to L2 and L3. As well as vertical transfer of the label (green 
dotted line), there is apparent lateral transfer of the dye in L2 (yellow 
asterisks). 
B) Sagittal section of DiO (orange) L3 labelled P6 frontal bone explant, 
nuclei labeled with DAPI (blue). There is extensive DiO labelling in 
L2 and L1. 
Scale bar 50µm 
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Figure 2.4b shows a sagittal section from a DiO labelled P6 frontal bone explant, 
with extensive DiO cell labelling in L2 and L3 (orange). 
I conclude from this that cells are capable of invasion of the bone from both L1 
and L3. 
2.1.1.2 .3 Some invading cells are of the osteocyte lineage 
 
At least some of the cells that invade L2 from L1 matured into osteocytes. 
Figure 2.5 is a sagittal section of a DiI L1 labelled P6 frontal bone that has 
experienced mineralisation within L2 (2.5b-brightfield channel).  
 
 
 
 
 
 
 
 
 
 
 
 
 
There are DiI labelled cells embedded within the mineralised matrix (osteocytes-
red arrows figure 2.5a,b), and also a small number of unlabelled nuclei 
embedded (figure 2.5c, yellow arrows). The presence of labelled nuclei 
throughout the L2 thickness indicates that osteocytes have only become 
L1 
L2 
L3 B
A
C DAPI DiI 
DAPIBrightfield 
DAPDiIBrightfield 
Figure 2.5 : Some invading cells are of the osteocyte lineage 
Sagittal section of P6 DiI dermis labelled frontal bone. Red arrows indicate embedded 
osteocytes carrying DiI indicating they are L1 in origin. Yellow arrows indicate 
embedded cells carrying no lipophilic label. 
A) DAPI nuclear counterstain(blue), DiI(green), brightfield(grey) which shows 
the mineralised matrix of L2. 
B) DAPI(blue), brightfield(grey) 
C) DAPI(blue), DiI(green). 
Scale bar 50 µm 
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incorporated within the last 48 hours, and the same for the unlabelled cells. The 
bone in this region is of uniform thickness, so it would be expected that the rate 
of osteoid deposition was also uniform. In this situation, according to the current 
accepted model, all  the matrix embedded cells should carry the DiI, as the entire 
superposing cell layer is DiI labelled. 
 The presence of the unlabelled cells in the same ‘strata’ suggest that they have 
originated from a different region of the bone, having had to actively move 
laterally from another position, or originated from L3 which was initially 
unlabelled. 
 
2.1.1.3 Conclusions 
 
These results establish that the ‘reaching’ of cells between layers is not a simple 
change in morphology, but cells can actively invade the frontal bone, whether by 
directed division or cell migration. 
This cell behaviour occurs in the embryo and in early postnatal life. 
At least one cell type resulting from the invading cells is the osteocyte cell 
lineage. 
The next stage of this analysis was to investigate whether there were differences 
in the pattern of cell invasion based on the maturity of the bone, the cell type and 
the direction of invasion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 124	
2.1.2 In thicker frontal bone there is preferential retention of invading cells in L2 
2.1.2.1Introduction 
In thicker frontal bone there is preferential retention of invading cells in L2 
 
I have described the phenomena of cell invasion of the frontal bone by cells 
originating in L1 and L3.  
I want to understand the dynamics of this process further. How many cells ‘fully 
invade’ the bone, and how many are retained in L2? Does this behaviour depend 
upon the layer of origin of a cell? Does the maturity of the bone influence this 
invasion process? 
To answer these questions I quantified the number of labelled cells in regions 
where DiI/DiO had been applied to L1 or L3. Samples numbers are detailed in 
Table 2.1 
 
n Dermis side 
label 
Brain side label Total 
Number of 
mouse skulls 
7 7 14 
Number of 
sections used 
9 9 18 
Number of cells 1305 488 1793 
 
Table 2.1 Samples numbers used in analysis of behaviour of invading cells 
7 frontal bones were labeled with DiI or DiO on L1 and incubated in growth 
media for between 24-48 hours. From these frontal bone 9 sections were 
identified as showing both half and full invasion of labeled cells. The number of 
invading cells from these 9 sections were counted, totaling 1305 cells. The same 
procedure was applied to the L3 labelled frontal bones. 
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2.1.2.2 Results 
2.1.2.2.1 The layer a cell is observed in is most likely not the cell’s layer of 
origin 
 
In the layers of bone adjacent to the labeled layer, a very high proportion of cells 
are labelled, suggesting that over the last 48 hours most cells in the bone have 
originated from either L1 or L3. 
 
The percentage of the all the cells in each layer that were DiI or DiO labelled 
was calculated, colour coded depending if the label was applied to L1 (red) or L3 
(green),  (figure 2.6).  
Between 95% and 100% of cells in L3 and L1 are DiI/DiO positive when the 
fluorescent label was applied to L1 or L3 respectively.  L2 showed a similarly 
high fraction of labelled cells. When the label was applied to L1, 92-100% of 
cells in the underlying L2 are DiO labelled. When the cells of L3 are DiI/DiO 
labelled, 70-95% of the overlying L2 was labelled, showing slightly more 
variation. 
Firstly these results indicate that invasion is a very extensive event in the region 
of the bone it occurs in, with the majority of cells in layers adjacent to the 
labelled layer also being DiI/DiO labelled. 
Secondly, downward invading cells from L1 are likely to spread laterally in L2 
and L3, as these regions were consistently populated with labelled cells. 
Cells invading from L3 appear to take a more direct path upward and efficiently 
label L1, in preference to L2. 
This is the first evidence that there may be a difference in behaviour between 
cells that invade the bone upwards from L3 and cells that invade downwards 
from L1. 
One factor that may affect the invasive behaviour of cells is thickness, as proxy 
of maturity, of the bone, and so I tested this. 
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2.1.2.2.2 Cells are more likely to be retained in L2 in thicker regions rather than 
thinner regions 
 
In thinner regions of frontal bone (19-40 µm L2 thickness), cells invading 
upwards and downwards have no preference between L2 retention or ‘full 
invasion’ i.e. upwards invading cells ending in L1 and downwards invading cells 
ending in L3. 
 
Figure 2.7 shows the likelihood of all invading cells observed to be retained in 
L2 from sections taken from 12 P6 skull explants incubated for 24-48 hours with 
lipophilic dye. Numbers of animals, sections and cells are detailed in Table 1. 
Red markers represent downward-invading cells (labelled in L1, number of 
cells= 1305) and green represents upward-invading cells (labelled in L3, number 
of cells= 488.  The 50% line is used as a discriminator of likelihood of a cell to 
‘fully invade ’ or be retained in L2. 
Between the bone thickness of 19 and 40 µm (blue box) there is an even 
distribution of cells that are retained in L2 and that fully invaded for both 
upwards and downwards invading cells. 
Figure 2.6 Cells are likely to originate from a different layer from the one they 
are observed in 
In regions where dye is applied, L2 and L1/L3 contain a very high proportion 
of labelled cells, indicating that cells are not always observed in the layer of the 
bone that gives rise to them. n=10 DiI/DiO labelled skulls. 
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Above 50 µm and up to 100 µm (orange box) in bone thickness cells invading 
upwards and downwards into the bone are more likely to be retained in L2. This 
indicates that thickness of the bone can change the invasive behaviour of cell 
populations. 
 
 
 
 
 
 
 
Fig 2.7 In the thicker more developed frontal bone (50 µm +) cells originating from 
either L1 or L2 are most likely to be observed in L2, whilst in thinner bone cells are 
equally likely to be found in L2 or L1/3 
Proportion of invading cells labelled in Layer 1 (red), and Layer 3 (green) that are 
retained in middle Layer 2 of P6 mouse frontal bone of varying thickness after 48 hr 
incubation with lipophilic dye. Number of frontal bone explants=18, downward n = 1397 
cells upwards n= 660 cells. 50% used as a discriminator for likelihood to fully or 
partially invade. The thickness of frontal bone ranged from 19-97µm. 
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Figure 2.8 shows a schematic of cell behaviour. The thickness of the bone affects 
the behaviour of cells, with thicker bone (50 µm plus) cells are more likely than 
in thinner bone to invade and remain in L2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.2.3 Conclusion 
 
Cells in L1 and L3 of the frontal bone are very mobile, and supply the vast 
majority of cells in the under/overlying L2 respectively. 
In thicker bone invading cells have less mobility in the radial direction (thickness 
of the bone), favouring retention in L2 over full invasion of the bone. 
 
I go on to investigate the cell identities of the invading populations.  
 
 
 
Figure 2.8:  
Cells are more likely to be retained in L2 in thicker regions rather than thinner 
regions 
Upwards and downwards invading populations in the thinner (20-40 micron) and 
thicker (50-100 µm) regions of the developing frontal bone. There are behavioural 
differences between thick and thin regions. 
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2.1.3: A  RUNX2+HAND2+  cell population invades the murine frontal bone 
2.1.3.1 Introduction 
 
I have demonstrated that layers 1 and 3 of the murine frontal bone are capable of 
supplying cells to other layers, and this behaviour is potentially dependant on the 
thickness of the bone. I now wish to investigate the following points: 
 
1)  What are the cell types that are leaving these peripheral layers? 
2) Are cells more likely to be retained in L2 or fully invade into the opposite 
layer, is there a factor that makes this behavior predictable? 
3) Is there a difference between the behaviour or cell type of upwards and 
downwards invading cells? 
4)  Is there a difference between thick (more developed) and thin (less 
developed) regions of bone in the direction of invasion or the type of cells 
invading?  
 
To address these questions I used antibody staining on fixed sections of the 
cultured skull explants to identify the different cell types of the frontal bone and 
quantify the cells types invading the bone.  
 
RUNX2+ is a transcription factor that is necessary for the induction of bone 
formation (Otto et al., 1997). I used it in this investigation to identify pre-
osteoblasts in the layers of the frontal bone.  
HAND2+ is involved in the development of tissue neural crest tissue and in the 
organisation of tissues (Firulli, 2003).  In the pre-otic cranial neural crest 
migratory stream in the chick, HAND2 is very highly expressed in the population 
of cells that are found at the most distal region of the migratory stream. These 
cells were termed ‘trailblazers’ as they had the highest migratory potential of all 
neural crest cells. HAND2 expression was found at all in the proximal regions of 
the migratory stream, and the authors demonstrate that both ablation and 
overexpression of HAND2 in migratory cells alters the migration pattern 
(McLennan et al., 2015). Thus HAND2 is very important in the early embryo for 
migration of neural crest cells. 
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HAND2 is also confirmed to interact with RUNX2+ directly in vitro and is 
thought to do so in vivo (Funato et al., 2009). Jordan et al. demonstrated that in 
Hand2fl/flWnt1Cre mice, where HAND2 expression is ablated in neural crest 
cells only, the frontal bone has disrupted layer morphogenesis, trabeculae fail to 
form in what would be the most cancellous regions in the WT. Also only a very 
few cells in the mutant frontal bone are neural crest derived, whilst the WT 
frontal bone is almost exclusively neural crest derived. In addition, RUNX2 
expression is vastly reduced and displays a different distribution to the WT. Thus 
HAND2 may not only be involved in early neural crest migration in the embryo 
but later, more tissue specific migration. 
 
 I am therefore interested in the behaviour of RUNX2+ and HAND2+ cells in the 
developing murine frontal bone, especially in regard to layer formation. 
 
 
 
2.1.3.2.Results 
2.1.3.2.1: RUNX2+HAND2+ double labelled cells carrying lipophilic dye invade 
the murine frontal bone 
 
Explants with either L1 or L3 applied lipophilic dye were sectioned and antibody 
stained for RUNX2 and HAND2. Cells were quantified if they carried the 
lipophilic dye, and then assessed for RUNX2+ and HAND2+ positivity. 
 RUNX2+ preosteoblasts were identified in the upwards and downwards 
invading cell populations, as well as HAND2+ invading cells. In addition there 
was a population of invading cells that expressed both HAND2 and RUNX2. 
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Figure 2.9 shows a sagittal section of the L2 of a P6 WT frontal bone that was 
labelled with DiI on L1, and then antibody stained for RUNX2 and HAND2. 
Indicated with white asterisks are examples of invading cells that are positive for 
both HAND2 and RUNX2. 
HAND2+ and RUNX2+ cells are found in close enough proximity to interact and 
are co-expressed in the same cell. I quantified this cell population to analyse the 
invasive behaviour of the different cell types. 
 
Figure 2.9: RUNX2+HAND2+  double labelled cells carrying lipophilic dye can be 
found in L2 and L1/L3 of the murine frontal bone 
Example of RUNX2+HAND2+ double labelled cells carrying DiI lipophilic dye in 
cultured frontal bone explant.  
A-D) Sagittal section through L2 of cultured frontal bone explant of postnatal day 6 (P6) 
WT mouse. DiI was applied to L1 side of the sample. A) Superposition of nuclear counter stain DAPI (blue), DiI (pink), RUNX2 (red) 
HAND2 (green). Cells carrying DiO and positive for both markers are denoted 
with a white asterisks.	B) DiI and DAPI, triple labelled cells indicated with white asterisk	C) RUNX2 and DAPI, triple labelled cells indicated with white asterisk	D) HAND2 and DAPI, triple labelled cells indicated with white asterisk	
Scale bar 20µm	
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2.1.3.2.2Upwards and downwards migrating populations have different cell type 
profiles 
 
I calculated the percentage of each cell type in the upwards and downwards 
invading populations (figure 2.10). The proportion of the four cell types changes 
significantly depending of the direction of invasion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HAND2+ single positive cells (green fraction figure 2.10a) were the largest 
single cell type of the downward invading population. In total 70% of downward 
invading cells express HAND2 (i.e. HAND2+ single positive green fraction plus 
the RUNX2+HAND2+ double positive yellow fraction). In the upward invading 
population, HAND2 is less significant, with 32% of all cells expressing HAND2, 
meaning the downward migrating population of cells are twice as likely to be 
HAND2+ as the upwards migrating population. 
 
Figure 2.10: Downward and upward invading populations have different abundances of  
RUNX2+ and HAND+ cells 
A) The percentage of each cell type found in the downward invading cell population. 
HAND2+ (single or double) cells make up 70% of invading population. 
B) The percentage of each cell type found in the upward invading cell population  
 
n= 812 n= 211 
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Somewhat surprisingly, RUNX2+ single positive cells were rare in the 
downward and upward invading populations, making up 5% and 10% 
respectively of the total invading populations. RUNX2 is a marker of 
preosteoblasts, a very abundant cell type in developing bone, and it is interesting 
in the invading population that it is rarely expressed alone. 
 
The percentage of RUNX2+HAND2+ double positive cells is doubled in the 
downward invading population (27%) compared to the upward invading 
population (13%) (yellow fractions of 2.10a and b). 
 
In both populations there are a number of invading cells that are negative for 
both RUNX2 and HAND2. 
This RUNX2-HAND2- population is 25% of all downward invading cells and 
58% of all upward invading cells. 
This double negative population could be made up of a number of cell types, 
including endothelial cells, osteocytes, mature osteoblasts and osteoclasts. 
 
 
2.1.3.3:Conclusion 
 
Cell populations invading in different directions have different expression 
profiles of RUNX2 and HAND2. 
This indicates that the cell composition of the populations is different. 
I wish to investigate whether these populations invading in different directions 
exhibit different behaviour. For example, do RUNX2+HAND2+ double positive 
cells invade L2 or invade into the layer on the opposite surface of the bone, or 
both? Is this behaviour the same when this cell type is moving in different 
directions? 
Do different cells types invade L2 to cell types that fully invade into L1 or L3? 
I now go on to investigate this invasive behaviour in RUNX2+ and HAND2+ 
invading cell populations. 
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2.1.4 Different extents of invasive behaviour are seen in cells that express 
different molecular markers and originate from different layers 
 
2.1.4.1Introduction 
 
In the previous section I demonstrated the existence of RUNX2 single positive 
and HAND2 single positive invading cells in the frontal bone, as well as a double 
positive RUNX2+HAND2+ cell type. 
These cell types were observed invading from both L1, the dorsal surface of the 
frontal bone, and L3 that is on the ventral side of the frontal bone. 
 
I wish to establish whether invasive behaviour is affected by: 
1) The direction of invasion and/or: 
2) The cell type as defined as molecular markers. 
 
To achieve this all cells invading the frontal bone (i.e. all DiI or DiO positive 
cells) were counted, and then catergorised into the following cells types: RUNX2 
single positive, RUNX2+HAND2+ double positive, HAND2 single positive and 
RUNX2/HAND2 negative. 
These invading cell types were also categorised based on the layer they were 
observed in; either they moved into and were retained in L2 (‘half invasion’) or 
they moved into L3 (dorsal side label) or L1 (ventral side label) and this was 
termed ‘full invasion’. This was felt to be a meaningful way of categorising cells, 
as those cells that ‘fully’ invade and line the opposite surface of the bone have 
the potential to allow one surface of the bone to communicate with another. 
Those cells that ‘half’ invade have less invading potential and could be more 
directly involved with the process of ossification of the frontal bone. 
 
Sections from frontal boned DiI labelled and cultured as described in section 1 of 
this chapter were used in this analysis, and antibody labeled as described 
previously. 5 sections from 5 separate P6 WT skulls DiI labeled on L1 were used 
for assessment of ‘downward’ invading behavior and 5 sections from 5 separate 
P6 WT skulls DiI labeled on L3 were used to assess ‘upward’ invading 
behaviour. 
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All invading cells were counted using the ImageJ Cell Counter plugin. 
These 4 categories of cells were then split into a ‘half’ invading population 
(found in L2) and a ‘full’ invading population. The cell numbers from these 
counts are listed in Tables 2.2 and 2.3 overleaf. 
 
To investigate whether cells with different molecular markers and different 
layers of origin exhibited different invasive behaviour, I plotted a beta 
distribution of the probability of L2 retention of each cell type in each sample. 
 
The beta distribution is a continuous probability distribution, where there are 
only two possible outcomes (binomial data), a positive event (probability, p=1) 
and negative event (p=0), and can be used when the underlying distribution of 
data is unknown. The beta distribution is uniform, and it assumes that either 
event (positive or negative) is equally likely.  However, the distribution can be 
revised if there are observations for positive and negative events, hence taking 
account of observed outcomes. In this case a positive event (probability=1) 
would be L2 retention of a cell, whilst a negative event (p=0) would be full 
invasion i.e. the cell is not observed in L1 (upward invading) or L3 (downward 
invading). A conditional probability distribution of the outcomes of the binomial 
is then produced (see Appendix for formulas and positive negative input tables). 
If two peaks overlap significantly (5% or more) then there is no real difference in 
the distributions, thus the overlap between curves can be used to find the ‘p’ 
value (see Appendix for p value tables). 
 
The following results show the beta distributions of each of the four cells types, 
with upwards and downwards migrating beta distributions plotted on the same 
graph for a single cells type. The aim is to find whether the layer of origin of a 
given cell type will influence the type or extent of invasion of that cell. Any 
differences would indicate that differential signaling from the overlying dermis 
and the underlying dura mater produces different types of invasion. 
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Table 2.2 Layer distribution of invading cells DiI labelled in L1, assessed for 
RUNX2 and HAND2 positivity 
Each section was taken from a different frontal bone explant, n=5. The L2 and 
L3 distribution of cells were used to construct beta distribution curves. 
Section L2 
Thickness/µm 
No. of Dio only 
(double 
negative) cells 
No. of 
RUNX2 
single 
positive cells 
No. of 
RUNX2HAND2 
(double positive) 
cells 
No. of 
HAND2 
single positive 
cells 
Total 
cells 
 L2 L3 L2 L3 L2 L3 L2 L3  
1 19.1 12 1 1 1 5 15 35 14 84 
2 29.9 42 1 2 0 6 8 68 26 153 
3 57.2 48 7 0 0 10 5 57 37 164 
4 60.2 12 0 6 0 26 28 29 4 105 
5 68.9 73 3 28 2 83 37 78 2 306 
Total 187 12 37 3 130 93 267 83 812 
 
Table 2.3 Layer distribution of invading cells DiI labelled in L3, assessed for 
RUNX2 and HAND2 positivity 
Each section was taken from a different frontal bone explant, n=5. The L2 and 
L1 distribution of cells were used to construct beta distribution curves. 
Section L2 
Thickness/µm 
No. of Dio only 
(double 
negative) cells 
No. of RUNX2 
single positive 
cells 
No. of 
RUNX2HAND2 
double positive 
cells 
No. of HAND2 
single positive 
cells 
Total 
 L2 L1 L2 L1 L2 L1 L2 L1  
1 22.7 1 3 4 11 1 2 0 1 23 
2 22.7 0 14 0 1 2 1 6 10 34 
3 29.7 0 7 3 1 5 4 5 3 28 
4 31.3 0 10 6 9 2 8 13 5 53 
5 82.6 16 0 5 0 15 8 24 5 73 
Total 17 34 18 22 25 23 48 24 211 
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2.1.4.2:Results 
2.1.4.2.1: Extent of invasion of RUNX2+ single positive cells is direction 
sensitive 
 
In the following section I will discuss the invading behaviours of cells migrating 
in the L1>>L3 and L3>>L1 direction in four cell categories; RUNX2 single 
positive, RUNX2/HAND2 double positive, HAND2 single positive and 
RUNX2/HAND2 double negative. 
The beta distributions of RUNX2 single positive cells is shown in figure 2.11, 
with cells invading downward represented by red lines and cells invading upward 
by green lines. The solid lines represent individual replicates 1-5 (see tables 2.2 
and 2.3), whilst the dotted lines represent the total cell populations achieved by 
summing the replicates. If a replicate had no RUNX2 single positive cells then it 
was not included in the beta distribution. 
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Figure 2.11 Beta distribution of RUNX2 single positive cell populations shows a 
difference in L2 retention depending on a cell’s direction of invasion 
The 4 solid red lines represent the probability distribution of L2 retention of 
RUNX2 single positive cells invading downward in the L1 >>L3 (downward) 
direction from 4 separate skulls. Dotted red line represents the total cell population 
from summing these 4 replicates. The 5 solid green lines represent the probability 
distribution of L2 retention of RUNX2 single positive cells invading upward in the 
L3 >>L1 (upward) direction from 5 separate skulls. Dotted green line represents 
the total cell population from summing these 5 replicates. 
The total cell population distributions (red dotted vs. green dotted line) show very 
little overlap (<5%), suggesting that RUNX2 single positive cells change invasion 
behaviour depending on direction of invasion. Black arrow indicates an outlier in 
the downward invading population. 
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The distribution of the total downward invading cell population (dark red dotted 
line) shows that RUNX2 single positive cells are very likely to be retained in the 
L2 of the frontal bone, the peak of the distribution being at 0.92. Three of the 
four replicates included show this trend, the three solid red curves at the right of 
the plot displaying a high degree of overlap. The replicate that shows least 
likelihood of L2 retention (arrow) was also the one with the least cells (2) hence 
it has little influence on the total population trend. 
 
The upwards migrating population shows a different trend, with the total cell 
population distribution (green dotted line) centred at 0.44, indicating that this 
upwards invading population is nearly evenly split between full and half 
invasion. The replicates for this cell population do show more variation than the 
downward travelling populations. The total cell population distributions (green 
dotted line vs. red dotted line) overlap by only 0.086%, meaning there is a 
significant difference in the probability of L2 retention between the RUNX2 
single positive cells moving in different directions. I can conclude that 
downward invading RUNX2 single positive cells are more than twice as likely as 
upward invading cells to be L2 retained. 
 
The conclusion must include the caveat that the low number of cells in some 
replicates has skewed the beta distributions in favour of replicates with a higher 
cells number, hence may not be fully representative of the RUNX2 single 
positive population across the frontal bone. A larger number of replicates would 
improve the reliability of the results.  
 
The second cell population I considered in this study were cells that stained for 
HAND2 only. A relatively large number of HAND2 single positive cells were 
found in the upward and downward migrating populations (72 and 350 
respectively), their beta distributions are shown in figure 2.12. 
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There is a high degree of overlap between the upward and downward migrating 
replicates, with cells most likely to be retained in L2 in nearly all sections 
examined. 
The overlap between the upward and downward invading total cell populations 
(dotted lines) is greater that 5%, hence there is no significant difference in L2 
retention for HAND2 cells invading the bone in different directions. 
 
As mentioned previously, there was also a population of cells that expressed both 
RUNX2 and HAND2, hence were termed ‘double positive’. The beta 
distributions for these cells are shown in figure 2.13.  
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Figure 2.12 Beta distribution of HAND2 single positive cell populations shows no 
significant difference in L2 retention depending on a cell’s layer of origin 
The 5 solid red lines represent the probability distribution of L2 retention of 
HAND2 single positive cells migrating in the L1 >>L3 (downward)  direction from 
5 separate skulls. The dotted red line represents the pooled data from these 5 
replicates, which are represented by the solid line. 
The 5 solid green lines represent the probability distribution of L2 retention of 
HAND2 single positive cells migrating in the L3 >>L1 (upward) direction from 5 
separate skulls. Dotted green line represents the pooled data from these 5 replicates. 
The pooled data curves (red dotted vs. green dotted line) significant overlap (>5%), 
suggesting that for HAND2 single positive cells there is no significant difference in 
migration pattern depending on direction of invasion. 
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The downward replicates (red curves) do not show a consistent trend, with some 
replicates showing high retention in L2 (arrow) and some showing low 
probability of L2 retention (arrow head). This is also true of the upward (green 
curves) migrating cells. The upward invading total cell population distribution 
peaks at 0.51(green dotted line), and the downward at 0.57 (red dotted line). 
Due to the variation in replicates there is a very high degree of overlap between 
the peaks representing the total cell population data (dotted lines), meaning the 
difference between the L2 retention probabilities is non-significant. 
 
 
 
 
 
 
 
 
 
 
 
I conclude that there is no definite preference for full or half invasion in the 
RUNX2+HAND2 + population moving either upwards or downwards, and there 
Figure 2.13 Beta distribution of RUNX2+HAND2+ double positive cell populations 
shows no difference in L2 retention depending on a cell’s layer of origin 
The 5 solid red lines represent the probability distribution of L2 retention of 
RUNX2+HAND2+ double positive cells migrating in the L1 >>L3 (downward) 
direction from 5 separate skulls. Dotted red line represents the pooled data from these 5 
replicates. The 5 solid green lines represent the probability distribution of L2 retention 
of RUNX2+HAND2+ double positive cells migrating in the L3 >>L1 (upward)  
direction from 5 separate skulls. Dotted green line represents the pooled data from these 
5 replicates. The pooled data curves (red dotted vs. green dotted line) show a large 
degree of overlap (>5%). This suggests that the direction of invasion of a 
RUNX2+HAND2+ double positive cell does not greatly influence probability of L2 
retention. Arrow and arrowhead highlight significant differences between replicates in 
the downward invading double positive population. 
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is no significant difference in invasive behaviour in populations travelling 
upward and downward. 
 
The final population of cells were DiI labeled cells that were found outside of the 
layer of labelling that stained for neither marker, hence were termed 
RUNX2/HAND2 negative. 
These cells could be mature osteoblasts, osteocytes, osteoclasts or endothelial 
cells. 
 The beta distributions of this population showed significant difference based on 
layer of origin and the beta distributions are shown in figure 2.14 
 
 
 
 
 
 
 
Figure 2.14 Beta distribution of RUNX2/HAND2 negative cell populations 
shows a difference in L2 retention depending on a cell’s layer of origin 
The 5 solid red lines represent the probability distribution of L2 retention of 
RUNX2/HAND2 double negative cells migrating in the L1 >>L3 (downward) 
direction from 5 separate skulls. Dotted red line represents the pooled data from 
these 5 replicates. The 5 solid green lines represent the probability distribution 
of L2 retention of RUNX2/HAND2 negative cells migrating in the L3 >>L1 
(upward) direction from 5 separate skulls. Dotted green line represents the 
pooled data from these 5 replicates. The pooled data curves (red dotted vs. 
green dotted line) show no overlap, suggesting that for RUNX2/HAND2 
negative cells there is a difference in migration pattern depending on direction 
of invasion. Arrow indicates an outlier in the upward invading population. This 
frontal bone was signifcantly thicker than all other replicates. 
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The downward migrating double negative cells were very likely to be retained in 
L2 (red dotted line, peak at 0.94), the 5 replicates showing highly overlapping 
peaks. 
The upward migrating population in contrast shows a very strong probability of 
migration into L1, ‘full’ invasion of the bone (green dotted line, peak at 0.32). 
The total cell populations (dotted lines) overlap to a non-significant degree  
(1.74x10-8 %), suggesting that the differences seen between the populations are 
indeed significant. 
 
The outlier in the upward invading population (arrow) that shows a high 
likelihood of L2 retention was from a sample with significantly thicker L2 than 
the next nearest replicate (82 µm vs. 31 µm). 
This could indicate that maturity of the bone has some influence over migration, 
or even simply that migration is slower or more difficult in thicker, more 
mineralised bone. 
 
2.1.4.2.2: Expression of HAND2 alters the invasion pattern of RUNX2+ 
preosteoblasts 
 
I wished to ascertain if cell type had an influence on the invasive behaviour of a 
cell as well as layer of origin. 
To do this I plotted the total cell population data beta distributions for the four 
cells types originating in L1 (fig 2.15a) and L3 (fig 2.15b). 
 
In the downward direction there is evidence that the molecular markers 
expressed by a cell can influence its probability to fully or partially migrate.  
RUNX2+HAND2+ double positive cells are likely to equally distribute between 
L2 and L3 (pink line, peak 0.58), whilst RUNX2 single positive cells are highly 
likely to be L2 retained (peak at 0.92).  The overlap between these distributions 
is 0.0558% hence the difference observed is statistically significant. 
The HAND2 single positive distribution (peak at 0.76) is also significantly 
different from the RUNX2HAND2 population, with an overlap of 4.02% (green 
vs. pink line). The RUNX2HAND2 population is therefore more likely than 
either single positive population to fully invade. 
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The RUNX2+HAND2+ double positivity could represent a type of progenitor, in 
the same way as RUNX/SOX9 co-expression is a marker of 
osteochondroprogenitors (Akiyama et al., 2005, Loebel et al., 2014). This cell 
could be needed in all three layers, whilst more differentiated single positive 
cells are required in L2 to contribute directly to the developing bone.  
The double negative population (blue line) also displays a very high probability 
of cells being retained in L2, and shows no difference to the RUNX2 single 
positive population. However it does show a significantly different distribution 
to both the HAND2 single positive and RUNX2+HAND2 +double positive 
populations (0.00286% and 1.15x10-7 % overlap respectively). 
This unlabelled population is likely to be made up of endothelial cells, 
osteoclasts and mature osteoblasts transitioning to osteocytes. 
 
The upward invading cell populations do not display such significant differences 
between probability distributions (figure 2.15b). Only the double negative and 
HAND2 single positive populations have a non-significant degree of overlap 
(0.716%). In this case the double negative cells are nearly twice as likely (peak 
=0.33) to fully invade the bone than the HAND2 single positive cells (peak 
=0.65). All other beta distributions overlap significantly, hence there is no 
difference in invasion pattern. This suggests that cell type is not a strong factor in 
migration behaviour for cells invading upward from L3, a difference from the 
cells travelling downward. 
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Figure 2.15 Downward migrating cell types show distinct invading behaviour 
 
A) Beta distributions of cell populations labeled with DiI in L1. Whilst the 
RUNX2 single positive (red line) and double negative(blue line) population 
overlap significantly, the RUNX2+HAND2+ double positive(pink) and 
HAND2 single positive(green) show significantly different distributions 
from the RUNX2 single positive population, with non-significant. 
B) Beta distributions of cell populations labeled with DiI in L3. There is 
significant overlap between most populations, though HAND2 single 
positive (green) and double negative (blue) populations show a significant 
difference. 
The number of cells observed used in distribution are indicated above 
corresponding curve. 
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2.1.4.3:Conclusions 
Direction dictates invasive behaviour 
I find that in at least two cell types that the direction of invasion of a cell alters 
its invasive behaviour. RUNX2 single positive cells when invading downward 
are very likely to be L2 retained, whilst upward invading cells are equally likely 
to fully invade as half invade. 
This could mean that osteoblasts are supplied to the developing bone in L2 from 
the dorsal surface by preference, whilst the L3 cells have a role in 
communicating a signal from the growing brain to the developing bone. 
(Shah et al., 2011) 
There could be a signal in the dermis side of the bone or in the dermis itself 
attracting these cells, or a ‘repulsive’ signal from the dura mater overlying the 
brain. 
The upward and downward invading RUNX2 cells would have to express a 
discriminating marker that allow one population to be sensitive to such a signal 
and one to be resistant. 
The double negative invading cells showed a similar split in behaviour, with 
upward invading double negative cells highly likely to fully invade into L1, 
whilst downward cells very likely to be L2 retained. This population could be 
made up of a number of cell types, including mature osteoblasts, endothlelial 
cells, osteoclasts and osteocytes, all cells found in the bone at this developmental 
age with previously demonstrated migratory potential (Dallas et al., 2008, Veno 
et al., 2007, Ek-Rylander and Andersson, 2010, Shah et al., 2011). 
In Chapter 3 I go on the test for the presence of endothelial cells in this invading 
population. 
 
Cell type dictates invasive behaviour 
 
In the downward invading population cell type certainly influenced invasion 
behavior, with RUNX2 single positive cells highly likely to be L2 retained and 
RUNX2+HAND2+ double positive cells equally likely to fully and half invade. 
As the double positive cells showed distinct behaviour from both the single 
positive cell populations, I suggest that it is this combined expression that 
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confers the change in invasion behaviour. As I hypothesise that this invasive 
behaviour is linked to the novel patterns of biomineral development that 
contribute to thickness growth frontal bone, I investigated the effect Hand2 
ablation in the cells of the frontal bone has on the bones formation in the 
following section of this chapter. 
 
The different explants used in quantification were of varying thickness, a proxy 
of maturity. This in itself may have been a cause of difference in the pattern of 
migrating cells seen.  
 
To extend this study and test for differences based on maturity, the experiment 
could be repeated with a greater number of samples, catergorised based on 
thickness of L2. Categories could include a range of thicknesses (e.g. 10-20 µm, 
20-30 µm, 30-40 µm etc), and three replicates of each category set as a minimum 
inclusion criteria. 
This would have given the robustness needed to make a comment on the effect of 
thickness on the invading behavior of the different cell types of the frontal bone. 
Another confounding factor in this experiment is the known differences in 
signalling depending on the anterior –posterior position of the dura mater. 
Certainly along the suture there is evidence that the dura provides signalling that 
keeps the posterior interfrontal suture open and the anterior frontal suture closed 
(Opperman et al., 1993, Roth et al., 1996). 
Pooling data may have obscured differences based on anatomical position, but 
this study was too restricted by the low number of samples to be able to 
statistically analyse these differences. 
It would be interesting in the future to examine this invasive behaviour in the 
anterior frontal bone regions where intercalary biomineralisation is seen, and 
regions more posterior where only appositional biomineralisation is observed. I 
would predict that different cell migratory behaviour would be required to 
produce the different patterns of biomineral observed. 
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2.1.5 Hand2 ablation in the NC lineage disturbs thickness growth of biomineral 
in the frontal bone 
2.1.5.1Introduction 
 
Mice with a homozygous deletion of Hand2 are unviable, and die between e9.5 
and e10.5 of major heart defects (Yamagishi et al., 2000), too early to study 
frontal bone biomienralisation which does not commence until between e14 and 
15 (Chapter 1 of this thesis). 
However, it is possible to delete Hand2 conditionally in the neural crest (NC) 
lineage (Hendershot et al., 2008, Hendershot et al., 2007), from which the frontal 
bone is derived. These mice survive variably until between e12 and birth, hence 
allowing the observation of the effect that neural crest Hand2 ablation has on the 
early stages of dermal bone mineralisation. 
 
2.1.5.2 Results 
 
P0 Wnt1CrexHand2fl/fl; R26RLacZ   were a kind gift from the Clouthier lab. 
Sections from a P0 Wnt1CrexHand2fl/fl; R26RLacZ   mouse were stained with calcein 
(by K.Jordan) to visualise the pattern of biomineral formation in L2 (figure 
2.13a), and compared to biomineral deposition in a WT frontal bone of the same 
age and mediolateral level (Figure 2.13b) 
The gross phenotype of this mouse has been described previously by Hendershot 
et al. 2008. Mutant mice are smaller than WT littermates and have significantly 
shorter mandibles. 
The Hand2 ablation in the region of the frontal bone causes a loss of thickness 
growth and elaboration of the L2 biomineral layer (figure 2.13a).  The 
biomineral in the Hand2KO has a single layer of biomineral 10-15µm in 
thickness, and only in one layer. In the WT (figure 1.13b), there is a double layer 
of biomineral, with large cancellous regions in the anterior regions of the frontal 
bone and single layers of mineral are up to 50 µm in thickness. There are no 
cancellous elaborations of the mutant frontal bone.  
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2.1.5.3 Conclusion 
 
Hand2 is involved in the migration and invasion of cells in the frontal bone, 
expression of Hand2 affects the behaviour of immature osteoblasts, and ablation 
of Hand2 in the neural crest lineage disrupts the normal pattern of 
biomineralisation in the frontal bone. The result a very thin, unelaborate single 
sheet of biomineral, in place of a thick multiple layered system. Jordan, 2011 
demonstrated that Wnt1xCre ablation of Hand2 results in an absence or very thin 
L2 compared to WT controls. Taken together with the abberant mineralisation 
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Figure 2.16 Ablation of HAND2 in the NC lineage leads to a lack of thickness 
growth and elaboration of the frontal bone biomineral   
A) Sagittal section of frontal bone from P0 Hand2fl/fl; Wnt1- Cre+/- x 
Rosa26LacZ-/- specimen, stained with calcein to show biomineral and 
DAPI to show nuclei. Hand2 ablation in the NC lineage causes loss of 
thickness growth in the orbital region. White dotted outline indicate regions 
devoid of cells, result of imaging artifact. 
B) Sagittal section of frontal bone from P0 WT mouse shows normal 
biomineral morphology, layer formation and thickness. 
Slides matched for mediolateral level. Scale bars 200µm 
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phenotype it suggests that Hand2 has an important role to play specifically in 
frontal bone thickness growth.  
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2.1.6: Section1 Summary of findings 
 
The complex intercalary growth patterns observed in Chapter 1 could not be 
explained by the traditional model of dermal bone growth: to wit a continuous 
layer of osteoblasts depositing matrix onto the ecto- and endocranial surfaces of 
the bone in a purely appositional fashion. Previous unpublished evidence from 
our lab suggested that cells can ‘reach’ in to the middle L2 from the outer L1 and 
L3 layers. The aim of Part 1 of this chapter was to investigate this invasive cell 
behaviour. 
 
By culturing the frontal bone and labelling the cells in both L1 and L3, I have 
shown that this behaviour is not just a change in cell morphology, but that cells 
can invade the middle L2 layer from both the ectocranial side (L1) and the 
endocranial side (L3) of the frontal bone. The thickness and hence maturity of 
the bone has an influence on this invasive behaviour. The thicker the bone the 
more likely a cell population is to half invade. In less mature regions, cells are 
more likely to ‘fully’ invade, from L1 to L3 and from L3 to L1. 
 
There are differences between upward and downward invading population of 
preosteoblasts and other cells types 
 
I investigated the identity of these invading cells, and found the upward and 
downward invading populations had different cell type profiles. The downwards 
migrating population was enriched for RUNX2+HAND2+ double positive cells 
(32%), as it was for total HAND2 positive cells (70%), compared to the upward 
invading population where only 32% of the upward migrating cells expressed 
HAND2, and only 13% were RUNX2+HAND2+ double positive. Hence there is 
a difference in the cellular composition of upwards and downwards migrating 
cells. 
The different cell types showed differences and similarities in their invasion 
patterns. 
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The cell markers expressed by the invading cells and direction of invasion can in 
some cases dictate invading behaviour. 
RUNX2 single positive populations and HAND2/RUNX2 double negative 
populations display different behavior depending on the direction of movement. 
For both these cells populations the downward invading cells are highly likely to 
be L2 retained, whilst their upward invading counterparts are more likely to fully 
invade into L1. 
One obvious basis for the split behaviour would be differential signaling from 
the ecto and endocranial sides of the bone. The dura mater is documented to 
exert control over the overlying bone, for example the closure of the posterior 
frontal suture, which ossifies from the endocranial surface to the ectocranial 
surface (Warren et al., 2003). A repulsive signal from the dura on cells could 
push L3 cells to full invasion, whilst a weaker signal from the dermis would not 
repel cells sufficiently. 
The cells that fully invade vs. partial invasion could also potentially have some 
intrinsic difference in expression pattern, and heterogeneity of gene expression in 
osteoblasts in L1 vs. L3 has been demonstrated in the past (Candeliere et al., 
2001). 
If this were the case it would be of interest to characterise what makes a cell 
invade ‘fully’ rather than be retained in L2. 
The collagenous extracellular matrix of the bone is full of proteins that can alter 
the structure of biomineral and act as signaling molecules (George and Veis, 
2008, Khan et al., 2002, Rangaswami et al., 2006) and the local differences in 
this matrix composition could be yet another way that control of invasion is 
exerted. This would be a way for cells that have previously invaded to exert 
control on the behaviour of their successors. 
 
Expression of HAND2 alters the invasion pattern of preosteoblasts 
 
One characteristic noted in the downward invading population was that 
expression of HAND2 with RUNX2 increased the likelihood of full invasion of a 
cell. Also, the total HAND2 expressing fraction of cells was very significant, 
making up a third in the upward invading population and 70% of the downward 
invading population. When Hand2 was ablated from the NC lineage, from which 
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the frontal bone is derived, biomineralisation is disrupted, with only a single 
layer of thin L2 mineralising, rather than a thick L2 with multiple layers of 
biomineral and a cancellous morphology. 
 
From this data I conclude that cellular invasion of the frontal bone is a normal 
and crucial behaviour for the development of a thickened and elaborated 
biomineral layer. Also, that the direction of migration can affect the invasive 
behaviour of a cell. I propose that HAND2 plays a significant role in cellular 
invasion of the frontal bone, as it does in neural crest cells earlier in embryonic 
life (McLennan et al., 2015), and therefore its radial thickness growth and 
elaboration. 
 
The analysis of these cells is complicated by the fact that though a cell may have 
been labelled in L1 and invaded downward, it is impossible to know whether the 
cell originated from L1 or not. Potentially cells could ‘originate’ from L2 if the 
initial invading cells proliferate. 
 
In Part II of this chapter I go on to investigate the cellular invasion of the frontal 
bone in real time. 
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2.2: Active migration and invasion of cells in the frontal bone is visualised by 
live cell imaging 
Introduction 
 
In Part I of this chapter I presented evidence that the frontal bone is capable of 
transferring cells from one layer to another. 
One limitation of the DiI labelling technique is that only the resulting pattern of 
cell invasion could be observed, not the process itself. There are several 
important points arising from Part I that the data could not clearly answer: 
 
1) Do cells invade by active migration or an active cell division? 
2) How far can cells move? 
3) How fast can cell move, and do all cells move at the same speed? 
4) Can a single cell move up and down, or is movement unidirectional? 
5) Is there a difference between cell behaviour in the three layers of the 
bone? 
6) Are cells more likely to move up or down, or is there no preference? 
7) Does cell density affect cell movement? 
 
Point 1 is especially crucial to understand, as the two possibilities imply very 
different mechanism of growth. 
To achieve this aim with cellular resolution, it was decided to image 
fluorescently labelled frontal bone cells with confocal microscopy, which is 
capable of scanning bone depth, for a period of several hours. 
The frontal bone as explained in the introduction, is neural crest derived, with a 
small contribution by cells that are traditionally thought of being part of the 
mesodermal lineage, such and endothelial cells and osteoclasts which derived 
from the heamopoetic compartment. 
By lineage labelling the cells of the frontal bone with fluorescent proteins under 
the control of a neural crest promoter, Wnt1, all the cells of the osteoblast lineage 
will be labeled, and able to be traced as they invade the bone. 
 
To this end, I live imaged calvaria from Wnt1CrexConfetti mice to trace the 
invasion of cells in the frontal bone in real time. 
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The confetti reporter (Snippert et al., 2010) contains two pairs of floxed, 
spectrally distinct fluorescent proteins, GFP with YFP, and dsRED with CFP. 
The loxP sites flanking the pairs of reporter proteins face one another.  
In front of the reporter sequences is a floxed neomycin resistance cassette (neo 
cassette), and at the very front a CAGG ubiquitous promoter (Figure 2.17). 
 
 
Due to the arrangement and directionality of the loxP sequences, a number of 
excision/recombination events are possible in the presence of Cre recombinase. 
In this study I used the Wnt1Cre promoter (Danielian et al., 1998) to label all 
cells derived from the neural crest lineage. With the length of time Wnt1 is 
expressed, one excision/recombination event is expected. 
 
The recombination event is autonomous in every cell expressing the Wnt1Cre 
promoter; hence in each cell will independently express a stochastically chosen 
A B 
Figure 2.17: The Confetti construct recombines in the presence of Cre recombinase to express 
one of four colours 
Adapted  from (Snippert et.al, 2010) 
A) Knock in strategy for confetti construct in Rosa26 locus. Two pairs of floxed 
fluorescent proteins, the reporters, are under the control of the CAGG promoter. A 
floxed Neomycin roadblock casette sits between the promoter and the reporter 
sequences. 
B)  On exposure to Cre recombinase, the Neo casette is excised, after which there are 4 
possible recombination outcomes, which dictate which one of the four fluorescent 
proteins will be expresses I) nGFP II) YFP III) dsRED or IV) mCFP. 
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fluorescent protein. This system permanently labels cell lineages, so the neural 
crest population descendants will express the fluorescent protein of the ancestor 
cell.  
 
The advantage over a single reporter system is that it is easier to trace cells 
through time and space, as it is less likely that a neighbouring cell will be of the 
same clonal colour. 
 
In theory the four colours should be present in a 1:1:1:1 ratio in any tissue that 
Wnt1Cre promoter is expressed in. In practice I found that the GFP is far less 
common in the skull vault that the other three colours, and CFP somewhat less 
common than dsRed and YFP. One possibility for this is that the physical 
arrangement of the reporter proteins in the construct means that some of the 
recombination events are more likely than others. 
 
The protocol for incubating the dissected frontal bones of mice in Chapter 2 was 
adapted for use in an incubation chamber on a confocal microscope (see 
Materials and Methods for full experimental details.) 
 
A z-stack scan of the frontal bone explants of four Wnt1xConfetti mice between 
the ages of P0-P2 was time-lapsed imaged (see Table 2.4). This allowed 
visualization of the neural crest derived cells of the front bone, and hence the 
vast majority of the cells of the frontal bone. An estimate from the observation of 
Wnt1xConfetti frontal bone samples (see Appendix) puts the non-neural crest 
component of the frontal bone at 8-15%, which is mostly composed of 
endothelial cells and potentially osteoclasts, a cell lineage that is non-neural crest 
in origin. 
 
The frontal bone was imaged at x63 to give good cellular resolution, and gave a 
field of view of 243µm by 243µm. Scanning was done at the posterior and 
central region of the frontal bone. 
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Due number of time points and number of cells involved in this study, a 
collective cell tracking exercise was undertaken by a cohort of 60 undergraduate 
students (Module BS273, SLS University of Warwick), utilizing the ImageJ 
plugin MTrackJ (Meijering et al., 2012) and adaptions of this program developed 
by Dr. JML Lapage. This was arranged in such a way that the cells were sampled 
many times and could be curated by the cohort.  
 
As well as tracking the movement of cells through the bone through time, the 
tracks could be annotated to indicate any cell divisions taking place, at what time 
point and the subsequent fate of the daughter cells. 
 
In the four frontal bone samples between P0 and P2 in age, 224-557 cells were 
tracked over 15-22 hours, giving 1335 tracks to analyse. The L2 in all samples 
was between 10-20 µm. 
Figure 2.18 : Experimental set up of live imaging of Wnt1CrexConfetti frontal bone 
allows tracking of cells over many hours  
 
A) Set up on a confocal stage for the live imaging of a Wnt1xConfetti frontal bone 
explant. The x40 objective allowed a good working distance and cellular resolution. 
B) The area of frontal bone imaged was in a posterior region, to allow the z-stack 
imaging of all three layers of the bone. Practically this limit was in the order of 80-
100µm. This was severally reduced in anterior heavily mineralised regions. 
Old media out 
Coverslip 
 
x40 objective 
Fresh media in  
Laser line 
Frontal bone explant 
NB 
FB 
INF 
FP  
243µm 243
µm 
NB 
FB 
FP  
A B
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Table 2.4 Details of live imaged frontal bone samples A-D 
 
 
 
After the cell tracks had been manually traced onto the stack file in ImageJ, a 
table of the data for each of the four samples was produced as an output.  
Data processing was undertaken to remove any duplications, then correcting for 
sample drift during imaging that may give the false impression of movement. 
The data sets were then analysed for various properties. 
 
In section 1 of this chapter I analyse the pattern of the paths that cells take in the 
frontal bone and how far they can move. 
 
In section 2 of this chapter I analyse the distribution of speeds of cells in the 
frontal bone. 
 
 
 
 
 
 
 
 
Sample Age No. of 
Slices 
Slice 
Interval 
(µm) 
Total L2 
range 
(approx/ 
µm) 
L1 range 
(z slice 
number) 
L2 range 
(z slice 
number) 
L3 range 
(z slice 
number) 
Total 
time 
(hours) 
Time 
interval 
(mins) 
No. of 
Time 
points 
No. of 
Cells 
A P0 32 2 10 19-32 13-18 1-12 17.3 10 104 532 
B P1 99 1 15 1-45 46-61 62-99 18.7 22 51 347 
C P1 24 4 20 17-24 12-17 1-11/12 22.0 10 132 232 
D P2 82 1 15 1-38 39-54 55-82 15.2 10 91 224 
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2.2.1 
2.2.1.1Introduction 
 
In Part1 of this chapter I established that the cells in L1 and L3 can invade the 
frontal bone, and contribute a large number of cells to other layers (figure 2.10). 
What could not be discerned was how far individual cells could travel, if there 
was a significant lateral component to their movement and if they can move 
repeatedly up and down. 
I analysed the pathlength and displacements of the tracks of 1335 cells in the 
frontal bone between P0-P1. 
 
2.2.1.2 Results 
 
To access in a qualitative fashion the profiles if the cell paths, the cell tracks 
were initially visualized by inputting the cell co-ordinates into Blender software. 
This allowed a visualization of the cell paths from a sagittal view (looking onto 
the XZ plane) and dorsal view  (XY plane) of the tracks. (Blender images 
compiled by H. Flynn) 
 
 
2.2.1.2.1:Visualisation of XY dimension of cell tracks in cultured murine frontal 
bone reveals apparent prevailing direction of migration within a bone 
 
The cell path profiles of the migrating cells of the frontal bone show a large 
amount of variation, within and between frontal bone samples 
 
Some cells have long paths in the XY dimension, and the long axis of these cell 
paths often align in the same direction (figure 2.19 a, arrows).  
 
In Chapter 1 figure 1.4 it could be observed how the frontal bone expands 
radially from certain regions, often in ‘tongues’ of mineralization, which would 
result if osteoblasts moved in a net direction and deposited collagen matrix as 
they migrated. 
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There are also cells that appear to move in circles (2.19 white circles), and many 
cells tracks are visible only as dots (2.19b, yellow asterisks), with no lateral 
component to their movement. 
I next examined the cell movement upward and downward in the bone in the Z 
dimension. 
 
2.2.1.2.2In the Z plane cells ‘oscillate’ upwards and downward to achieve 
movement 
 
The cells in the z- plane take the form of a constant oscillation; cells appear to 
move constantly up and down in small increments to achieve a net migration. 
Figure 2.19: 
Visualisation of XY dimension of  cell tracks in cultured murine frontal bone 
reveals a prevailing direction of migration within a bone 
Panels A-D shows all cell tracks over total imaging time from frontal bone 
samples A-D respectively. Image created in Blender by H.Flynn from ImageJ 
track co-ordinates. The Z plane is effectively collapsed. White arrows 
indicate long axis of prevailing migration direction and white circles cells 
moving in circles. Yellow asterisk indicates cells that have not moved at all. 
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One striking difference to pathlength in the XY plane is that there are very few 
cells that do not produce a track in the z dimension; there are far fewer ‘dots’ as 
seen in figure 2.19. 
Most of the cells appear to oscillate constantly in the z-plane, producing a 
‘zigzag’ like pattern of movement (figure 2.20). 
A few show a large amount of displacement in the z- plane. These cells (blue 
asterisk) make large direct jumps through the layers, rather than moving in small 
increments like most cells. 
 
 
 
The cell tracks of Sample A when enlarged demonstrate this interleaving: 
upwards-migrating cells (red and pink) are found adjacent to downward 
migrating cells (blue and purple) throughout the sample (figure 2.21). 
 
I now quantify the distances travelled by cells to gain an insight into the invasive 
migratory process 
Figure 2.20:Visualisation of XZ plane cell tracks in cultured murine frontal bone reveals that 
some cells that move great distance in Z , and do so in large steps 
Panels A-D show cell tracks over total imaging time from frontal bone samples A-D 
respectively. Image created in Blender by H.Flynn from ImageJ track co-ordinates. 
Blue asterisk indicate cell make large ‘jumps’ in Z. Pink asterisk marks cells with oscillating 
paths 
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X 
Z 
Figure 2.21: Cells make large movements in both upward and downward 
direction 
Enlarged region of Sample A XZ plane from figure 2.20a. 
Image created by H.Flynn in Blender using ImageJ track coordinates 
Cells moving upwards in z are red and pink. Cells moving downward in z are 
blue and purple. Upwards and downwards paths are interleaved. 
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2.2.1.2.3The net displacement of a cell is a much shorter distance than its 
pathlength 
 
There is a wide variety of pathlengths amongst the cells of the frontal bone. 
In the four samples between 2.7-8.2% of cells had pathlengths of 0µm. 
 When plotted as histograms the pathlengths of cells in the frontal bone are right 
shifted, except for cells in sample D. The 25th and 75th percentile lies between 
6.3 µm and 42.1 µm (figure 2.22). The majority of the cells have pathlengths 
longer than half  a cell length (2.22). I used the distance of half a cell length to 
distinguish cells that may undergo extensive morphology change form those that 
are truly migrating. (See Tech appendix). 
The distribution of pathlengths shows variation between the four samples. 
Samples A and B have maximum pathlengths of 99.3 and 98.4 µm respectively, 
whilst in C and D cells maximum pathlengths are 65.1 and 63.6 µm respectively 
(Table 2.5). The tracking field was limited to a 243µm2; hence it is possible than 
cells travelled further than this. 
 
Table 2.5 Pathlength and displacement of cells in samples A-D 
Sample 
Mean 
pathlength 
and standard 
error (µm) 
Mean 
displacement 
and standard 
error (µm) 
Maximum 
pathlength 
(µm) 
Maximum 
displacement 
(µm) 
A 28.7±0.9 9.0 ±0.3 99.3 40.31 
B 24.7±1.0 8.4 ±0.4 98.41 58.67 
C 21.0±01.0 6.1 ± 0.3 65.1 48.84 
D 21.7±0.8 7.6 ± 0.3 63.6 26.13 
 
 
 The mean pathlength of cells was between 21.0 and 28.7 µm (Table 2.5). These 
median pathlengths are longer than the average cell length, and also comparable 
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and larger than the L2 thickness in these frontal bone regions (10-15 µm, Table 
2.2). The cells travel distances that would more than allow them to invade the L2 
of the frontal bone. Between 1.3% and 13% of cells in the samples travelled over 
50µm. 
 
 
 
 
 
 
 
Figure 2.22: The median pathlength of a cell is between 19-26 µm 
 
Frequency distributions of total pathlengths over imaging period in frontal bone 
explants A-D.  
Bins 5 µm in width. Dashed line in each sample indicates the mean length of half a 
cell in that sample (See Technical Appendix). 
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As noted in the figures 2.20 and 2.21 many of the cells ‘oscillate’ upwards and 
downwards in the Z-axis and move in circles in the XY axis, so the pathlength 
may not reflect the net displacement of a cell in the frontal bone. 
 
I plotted the distribution of the net displacement of cells in the frontal bone. 
 
The distribution of displacement of cells is less right shifted than the pathlength 
(figure 2.23). 
This measurement was considerably less than the pathlength of the cells, as 
expected from the cell traces in figure 3.5 and 3.6. The 25th and 75th percentile 
range is between 2.7-11.7 µm. Median displacement is between 5.3 and 7.6 µm, 
which is less than half a cells length. The maximum displacement was between 
26.1-58.7µm in the 4 samples.  
Figure 2.23 : Net displacement is shorter than pathlength 
Frequency distributions of the total net displacement of each cell over imaging 
period for frontal bone samples A-D. 
Bin width= 2.Black dashed line indicates mean length of half a cell in the 
sample 
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I conclude from this that many of the cells that appear to be ‘migrating’ may only 
be changing shape, as the cells were tracked by marking the centre of a cell.  
The median pathlength is 2.6 to 3.6 times greater than the median displacement, 
and this can be seen at the individual cell level (Table 2.4) 
 
 
2.2.1.2.4: The largest displacements in XY and Z plane when cells are moving 
into regions of low cell density 
 
I wanted to know what affect cell density in the local environment had upon the 
distance it moves. 
I found the higher the cell density in the bone the lower the displacement in 
either XY or Z. 
In all samples, cells moving into high-density areas make small displacements in 
both the XY and Z dimensions when movement at individual timepoints was 
plotted (figure 2.24). The largest displacements in XY and Z are achieved by 
cells moving in low-density areas (blue regions of heat map figure 2.24) and in 
regions of very high cell density the movements of individual cells are very 
small. 
 
The cells were then analysed for the distance they travelled in XY vs. the 
distance in Z, to discover in which direction cells move most (figure 2.25a). In 
this scatter graph the normalized Z distance of a cells was plotted against 
normalized XY distance. 
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2.2.1.2.5 Cells in bone with thinner L2 is skewed towards bigger movement in 
XY axis than Z 
 
Samples A, B and D are all XY dimension skewed, cells are more likely to travel 
further in the XY axis than the Z. The cells in Sample C however had no distinct 
skew; cells were equally likely to travel in as far in Z-axis as XY. 
 
The Z:XY distance ratio was plotted against the thickness of L2 (2.25b), to 
ascertain whether the maturity of the bone influences the direction of cell travel. 
The thicker the L2, the less XY skewed the distance a cell travelled becomes. 
 
 
Figure 2.24:Largest displacements in XY and Z plane when cells are moving into regions 
of low cell density 
Z displacement plotted against XY displacement for every cell at each timepoint in frontal 
bone Samples A-D.  
Relative density encoded as a heat map. 
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Figure 2.25 Cells in bone with thinner L2 is skewed towards bigger movement in XY axis 
than Z 
 
Red=Sample A, blue sample B, green=sample C and magenta sample D. 
A) Mean normalised Z displacement plotted against mean normalised XY 
displacement for each cells at every time point recorded. 
B) Z:XY normalised displacement ratio plotted against L2 thickness of the frontal 
bone. 
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2.2.1.3 Conclusions: 
 
There is little to no evidence of cell paths originating from the same point, hence 
I conclude cells are capable of true active migration in the bone. 
Very few cells travelled no distance in the time course observed in 4 frontal bone 
regions (2.7-8.25%). These could be used as reference points 
The majority of cells have pathlengths 6.3-42.1 µm. Comparatively few cells 
travelled a very long distance (greater than 50 µm), but many of the cells have 
displacement in z that would allow them to invade the frontal bone L2, and move 
across to the opposite layer, hence invading fully. 
Paths are not straight, many cells move in almost circular motions (figure 2.x), 
shown by median pathlength being 2.6-3.6 times greater than median total 
displacement. 
The largest movements of a cell is more likely to be in the XY axis rather than 
the Z axis, not an unexpected result in a regions where L2 is thin, between 10-20 
µm, and there is more room to move in the XY axis. 
I wished to know the speed of the cells moving in the bone, and if there is a 
difference between XY dimension and Z dimension cell velocity, investigated in 
the next section.  
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2.2.2 
2.2.2.1Introduction 
 
I have established that cells can move large distances in the XY and Z 
dimensions of the frontal bone, in direct and non-direct paths. 
I now examine the speeds that cells can move at within the bone, to understand 
how this compares to the rate of mineralization in the bone. 
 
2.2.2.2Results 
2.2.2.2.1: Cell velocities in XY and Z are comparable to the rates of 
mineralisation seen in the frontal bone 
 
Cells in the four samples travel at a mean velocity of between 1.1 and 2.2 
µm/hour over the tracking period (Table 2.6), but cells could move up to 83 
µm/hour between two timepoints. 
 
Table 2.6 Velocity of cells in Samples A-D 
Sample Mean 
velocity 
and 
standard 
error 
(µm/hr) 
Median 
Velocity 
(µm/hr) 
Maximum 
velocity in 
sample 
(µm/hr) 
Mean 
XY 
velocity 
(µm/hr) 
Median 
XY 
velocity 
(µm/hr) 
Mean z 
velocity 
(µm/hr) 
Median 
z 
velocity 
(µm/hr) 
A 2.2±0.12 1.7 30.7 33.7 6.23 0.146 0.004 
B 4.0±0.067 3.4 83.39 59.2 9.9 0.254 0.0479 
C 1.5±0.038 1.2 44.69 1.10 5.12 0.855 0.191 
D 1.1±0.099 1.0 51.32 23.7 7.37 0.0716 0.0770 
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When speed is split into the constituent XY and Z components it can be seen that 
cells travel much faster laterally through and along the bone compared to through 
the bone in z. 
The mean and median XY speed of cells is much faster that the median Z speeds, 
1.1- 59.2 µm/hour (mean) and 0.228-9.28 µm/hour (median) in the XY 
dimension compared to 0.004-0.855 µm/hour and 0.004-0.191µm/hour.  
 
Though the velocity of cell is z is many times lower than that of XY, the speed of 
cells in Z is in the range of the calculated rate of radial mineralisation in Z in 
figure 1.31 in Chapter 1. The rate of radial mineralisation ranged between 4.08 – 
25.86 µm in 48 hour, which corresponds to 0.085-0.589 µm/hour, comparable to 
the median Z cells velocities of 0.004-0.191µm/hour. 
 
The rate of longitudinal mineralisation was much faster than radial 
mineralisation, between 83-644 µm in 48hour. This equates to between 1.74 – 
13.4 µm/hour, again within median range of XY cell speeds of 0.228-9.28 
µm/hour (median). 
 
 
2.2.2.2.2: Max velocity correlates better with displacement than pathlength 
 
The top quartile of path lengths (28 µm and above), were achieved by cells 
moving between 1-6 µm per hour throughout their tracked lifetime.  
The mean velocities of a cell are therefore misleading, as at a speed of 1 µm/hour 
a cell in this study could move no further in than 22 µm. 
 
In figure 2.20 it could be seen that cells often moved in long straight lines (blue 
asterisk) to achieve a large displacement. Maximum velocity of cells was plotted 
against pathlength, to further understand the cell speed/distance travelled 
relationship. 
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Maximum velocity of a cell during its tracked lifetime shows a positive 
correlation with pathlength (figure 2.26), the fastest maximum velocities are 
amongst the longest pathlengths (red circles). This is evidence that suggest again 
that cells do not move at a consistent pace but put on sudden spurts of 
movement, which contributes the bulk of the total pathlength. Maximum velocity 
was defines as the largest distance a cell travelled between two consecutive 
timepoints. 
Figure 2.26: The max velocity of a cell does not correlate positively with its 
pathlength  
The max cell velocity over the time course  plotted against against the pathlength 
(Len) of the cell for frontal bone samples A-D. 
Red circles indicate outliers 
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This hypothesis is reinforced by the positive correlation between maximum 
velocity and net total displacement (figure 2.27).  
 
 
 
 
 
 
Figure 2.27: Max velocity and  total net displacement correlate positively, which 
suggests that the majority of a cells path is achieved in a short burst of fast movement 
 
Max velocity of a cell over the time course plotted against the total net displacement in 
the cell in the frontal bone Samples A-D 
Red dot indicates outliers 
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2.2.2.2.3 Speed change 
 
The preference for changes in speed in the Z or XY directions was investigated. 
Figure 2.28a shows the normalized speed change in the Z direction plotted 
against the normalised speed change in the XY direction. Samples A and C have 
a very strong preference for speed changes in the Z direction, whilst samples B 
and D show no preference for changes in speed in either the XY or Z direction. 
When the Z:XY ratio is plotted against the thickness of L2, there is no trend 
(2.28b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.28 Cells make bigger speed changes in the Z direction than the XY direction 
Red=Sample A, blue sample B, green=sample C and magenta sample D 
A) Mean normalised Z speed change plotted against mean normalised XY speed change 
for each cell at individual time points 
B) Z:XY normalised speed change ratio plotted against L2 thickness of the frontal bone. 
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2.2.2.3 Conclusion 
 
Though cells are actively moving in the z plane of the bone, the situation is more 
complex than that presented in section 1 of this, where cells cleanly divided into 
categories of half and full invasion of the bone. 
Cells take convoluted paths, sometimes ‘ping-ponging’ between layers or within 
a layer, and others making great leaps between them. 
Cells tend to make bigger changes in speed in the z direction as opposed to XY. 
The velocities in which they travel are comparable to the mineralisation rates 
seen in Chapter 1 of this thesis. 
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2.2.3: Part2 Summary of findings 
 
The cells of the frontal bone actively migrate upwards, downwards, laterally and 
longitudinally within the bone, at rates that allow them to move many cell 
lengths within 22 hours. 
There is no ‘grouping’ of cell paths at the same point of origin, suggesting 
against a system of cell divisions in L1 and L3 supplying a L2, but rather one of 
active migration. 
Very few cells travelled no distance in the time course observed in 4 frontal bone 
regions. The majority of cells moved and had pathlengths between 6.3-42.1 µm. 
Comparatively few cells travelled a very long distance (greater than 50 µm), but 
many of the cells have displacement in z that would allow them to invade the 
frontal bone L2, and move across to the opposite layer, hence invading fully. 
Paths are not straight, many cells move in almost circular motions (figure 2.19), 
shown by median pathlength being 2.6-3.6 times greater than median total 
displacement. Cells are oscillatory in the Z axis, their paths often moving up then 
down, and the movement of cells in z is often far less than the lateral movement 
in XY. 
The mean cells speeds in the Z dimension were comparable to the rate of radial 
mineralisation (increasing L2 thickness) in Chapter1 (figure 1.31b). The rate of 
radial mineralisation was between P0-P8 was found to be between 25 ± 2.6 µm 
per 48 hours (0.52 ± 0.05 µm per hour), for a single layer of biomineral. The 
mean cell speed in the Z dimension was between 0.0716-0.855 µm per hour in 
the four samples. The large amount of variation in Z velocity suggests 
heterogeneity in the population of invading cells. The different cell types 
contribute to this heterogeneity, as well as the stage of maturation of a cell type, 
the different roles of the same cell type and potentially the direction of invasion. 
It has been demonstrated in the calvaria of newborn rats that post proliferative 
osteoblasts express a different repertoire of genes depending which part of the 
frontal bone they are found in (e.g. near the suture vs. trabecular bone of orbital 
region) and whether they are found on the dorsal (ectocranial) surface or ventral 
(endocranial) surface of the bone (Candeliere et al., 2001). Variation is cell 
velocities and invasion patterns could be due to very local differences in 
biomineral type and topography. 
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The large variation in the population shows that not all cells are capable on 
invasion, though the majority have at least some movement in z in the time 
imaged. 
 
Cells are skewed to making large speed changes in Z rather than XY in the 
frontal bone.  A large change in Z speed could coincide with the large jumps 
made in Z, akin to ‘escape velocity’. Cells must move faster than the other 
migrating cells in the samples to invade another layer. 
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2.3:Summary of findings for Chapter 2 
 
In this chapter I have described a novel behaviour of cells in the frontal bone, 
cells of neural crest lineage can move both laterally across the layers of the 
frontal bone and crucially can move downward and upward into the bone. 
 
The traditional model of single continuous layer of osteoblasts depositing matrix 
in sheets across the frontal bone must be modified somewhat. A more complex 
mechanism exists: whereby cells that invade the L2 frontal bone from L1 and L3, 
depositing matrix as they move and therefore capable of mediating intercalary 
thickness growth and creating branched patterns of biomineral. 
 
I found that in the embryonic and early postnatal frontal bone there is a 
bidirectional system of upward and downward invasion of the frontal bone. This 
took the form of ‘partial invasion’ where invading cells are retained in L2; and 
‘full invasion’ where L1 labelled cells were found in L3, and L3 labelled cells 
were found in L2 after 24-48 hours of bone growth. 
 
Some factors affecting invading behavior were identified in this chapter though 
there are doubtless more, as will be discusses. 
 
Firstly, thickness of L2 was a factor that affected this invading behaviour, in thin 
immature regions cells were equally likely to fully or partially invade the frontal 
bone, whilst in thicker regions cells would be more likely to be L2 retained. This 
could be an effect of increased mineralization in thicker more mature regions 
slowing the progress of invading cells. This was not testable in Part2 of this 
chapter, as the samples time lapse imaged were in the thin range of bone 
(between 10-20 microns). The tracking of cell invasion in the thicker more 
mature bone of the orbital regions and comparison of cell paths and velocities 
would be a very interesting extension of this analysis. It presents the challenge of 
imaging through thick calcified tissue, and there are technical obstacles such as 
tissue penetration that would need to be overcome. 
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Secondly, the direction of invasion was a factor in determining invasive 
behaviour for some cells types. In both the RUNX2 single positive and 
RUNX2/HAND2 negative populations the upward and downward populations 
showed significant differences in L2 retention. This rule is not universal 
however, and it is unclear why the two HAND2 expressing invading cell 
populations didn’t also show this dichotomous behaviour. 
 
Thirdly, the expression of the cell markers investigated, and therefore cells type, 
in some instances had an affect on the invading behaviour of cells. The 
downward invading RUNX2+HAND2+ double positive, HAND2 single positive 
and RUNX2 single positive cells all showed significantly different L2 retention 
probabilities, becoming increasingly likely to be L2 retained. 
If there are differential signals from the dura mater and the dermis dictating 
invasion behaviour, cells must also be able to sense this signal, apparently not a 
universal feature of invading cells. 
 
It was striking in the cell populations as a whole how large the proportion of 
HAND2 positive cells were (between 32-70%). It is an interesting observation 
that HAND2 expression modulated the behaviour of RUNX2+ preosteoblasts; 
increasing the probability that downward invading cells to invade fully. 
HAND2 ablation in the NC lineage, from which the frontal bone is derived, 
severely compromised thickness growth and elaboration of the biomineral layer 
in the frontal bone. 
I propose that HAND2 has an essential role to play in cellular invasion and that 
this invasion is required for proper biomineral thickness growth in the frontal 
bone, including intercalary radial mineralization. 
 
I further confirmed the invasion capabilities of cells in the frontal bone by a 4D 
imaging experiment that tracked the movement of fluorescently labelled cells in 
the frontal bone. The distance moved by many cells would allow them to traverse 
L2 in the thinner regions of bone (20 µm). 
Some cells were found to move very considerable distances, up to 100 µm in 22 
hours, confirming the predictions of other authors that such distances were 
achievable by cells (Dallas and Bonewald, 2010). 
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The mean speed of cells observed of between 1.14-4 µm per hour is comparable 
to the 5.3 µm per hour reported by Veno et al. of DMP-1 (mature osteoblast 
marker) positive cells in the P5-P12 murine calvaria. In fact as this study only 
considered lateral movement in one plane, the cell velocities I observed in XY 
were of a higher range, between 1.1 and 59.2 µm per hour. The large variation 
and difference in cell velocity compared to these published findings likely reflect 
the numerous migratory cell types captured by the Wnt1CrexConfetti neural 
crest cell label. Not only would mature osteoblasts be labeled, but preosteoblasts, 
immature osteoblasts and osteocytes. Endothelial cells and osteoclasts are 
supposedly not of NC lineage and would be presumed not be labeled in the 
Wnt1CrexConfetti frontal bone, but I have evidence to believe for endothelial 
cells at least, this may be an error (see Chapter 3). 
 
An aim of the study was to find evidence is evidence that the invading cells, 
especially the preosteoblasts and osteoblasts, are capable of degrading 
mineralized collagenous matrix, hence truly ‘invading’ older matrix. Thus far the 
ability to destroy the inorganic crystals of hydroxyapatite is reported as a unique 
property of the osteoclast. 
Osteoblasts have been previously reported to display invasive behaviour of 
materials such as Matrigel, a reconstitution of basement membrane matrix rich in 
laminin and Col4 (Huang et al., 2016). 
A number of the invading cells in this study can certainly migrate at a 
comparable velocity to osteoclasts, which are reported to move across 
mammalian endochondral bone between 30-248 µm per hour across mammalian 
endochondral bone (Kanehisa and Heersche 1988). This high-speed migration 
comes between phases of resorption, where the osteoclasts are adhered to the 
collagenous matrix via the podosome (Saltel et al 2004). Cells moving in this 
study appear to move slowly for most of their tracked lifetime, and then in a 
‘spurt’ of speed achieve most of their displacement, demonstrated by the 
correlation if maximum speed and total displacement. Thus, there are cells 
present in the frontal bone that behave in the same manner as matrix degrading 
osteoclasts. 
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An intriguing candidate for a cell type that could invade the frontal bone are the 
Reversal cells observed in endochondral bones such as the femur and iliac crest. 
These are cells of osteoblastic lineage capable of the degradation and resorption 
of non-mineralised collagenous matrix through the expression of MMP 1 and 
MMP13(Abdelgawad et al., 2016). 
These cells have not been identified in dermal bone to date, but comparisons 
have been drawn between the remodeling surfaces of cortical bone and the 
cavities in cancellous bone, such as are found in the orbital region of the frontal 
(Lassen et al., 2017). 
 
Osteoclast presence in the frontal bone is reported to begin at low levels at e16, 
as judged by the onset on TRAP activity presence of gelatinase mRNA detection 
(Rice et al., 1997) . This is within the time window of intercalary mineral 
growth. 
  
Keeping within the limits of known mechanisms of bone resorption, to ascertain 
if there is there a population of mineral degrading osteoblasts hitherto unknown, 
cells of osteoblastic lineage would need demonstrate certain characteristics. 
Firstly, the ability to form podosomes, which allow migration and the formation 
of the resorping lacunae that are filled with collagenases. Reversal cells have 
been demonstrated to form podosomes and express MMP1 and 13, hence this 
cell type is not without precedent. Secondly and essential to degradation of 
mineral crystals, these cell would need to express ATP transferase proton pump 
that fills the resorptive lacunae with protons. Thirdly, these cells would need to 
be present within he same timeframe as observed intercalary biomineralisation, 
e14-e17. 
Though no multinucleated cells were observed in the DiI labeled sections it 
should not be excluded that there is a population of osteoclasts that are coupled 
to osteoblasts to produce the intercalary biomineral pattern observed. 
Another possibility is that mineral degradation is not needed, that the open and 
3D structure of biomineral leaves ‘pockets’ –empty cavities that osteoblasts are 
capable of migrating into subsequently and ‘filling’ in with newer matrix. A very 
high-resolution map of the progressive biomineralisation of trabeculae in the 
frontal bone would be needed to establish if this is a possibility. 
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3. Neural crest derived endothelial cells, their behaviour and functional role 
during dermal bone formation  
Introduction 
 
De novo blood vessel formation is termed ‘vasculogenesis’ and is achieved by 
angioblasts that derive exclusively from the mesodermal compartment.  
Vasculogenesis was once thought to only occur in the embryo to establish the 
initial vascular network, but has been shown to occur in adult humans (Asahara 
et al., 1997) . 
Angiogenesis describes the process of blood vessels developing as branches or 
networks extending from the existing vasculature, during growth or repair of 
tissues, including the bone.  
 
How the processes of angiogenesis and osteogenesis are coupled is an important 
area in bone research and there have been interesting recent developments in the 
field. (Kusumbe et al., 2014) found a small subset of endothelial cells in the 
metaphysis of long bones had a very significant influence on osteogenesis. These 
cells (expressing CD31 and Endomucin very highly) were a point of 
congregation for osteoprogenitors. Over 70% of RUNX2+ cells and over 60% of 
OSX+ osteoprogenitors in the bone were found adjacent to this subset of 
endothelial cells, which made up less that 2% of all endothelial cells in the 
endochondral bone studied. Increasing the numbers of these specialised 
endothelial cells increased the bone mass and number of osteoprogenitors, 
leading the authors to conclude that in the environment of the bone, these 
endothelial cells are necessary for optimal bone growth. As there is such an array 
of niche microenvironments in the bone, we speculated that the mechanisms of 
angiogenesis in dermal bone might be different to even endochondral bone. 
 
Broadly there are two types of angiogenesis, the traditional  ‘sprouting 
angiogenesis’ and the far more recently discovered ‘intussusceptive 
angiogenesis’ (Jain and Carmeliet, 2012, Djonov et al., 2003). 
 
Sprouting angiogenesis requires an angiogenic signal, the key one being vascular 
endothelial growth factor A (VEGF-A), to allow an endothelial cell to adopt’tip’ 
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cell morphology. These cells are very motile and have many extending filopodia, 
which move to seek out another tip cells elsewhere in the vascular network. 
Neighboring ‘stalk’ cells proliferate and form the vascular lumen of a new vessel 
hence extending the network. These ‘sprouts’ will join with a sprout from 
another vessel and form a single lumen (Adams and Alitalo, 2007, Eilken and 
Adams, 2010).  
 
Intussusceptive angiogenesis involves endothelial cells on opposite sides of a 
vessel ‘reaching’ out into the lumen to make contact. The cells then curve to 
either side, partitioning the single vessel into two discrete lumina. There is a 
space or channel left between to two new vessels that are invaded by pericytes 
and fibroblasts, which begin depositing collagen. This forms the ‘transcapillary 
tissue pillar’ which in SEM scans is indicative of this mode of angiogenesis 
(Burri et al., 2004). Interestingly, intussusceptive growth of vessels has more 
recently been found to be resulting from VEGFA signaling in another context 
(Baum et al., 2010) and also in grafted skeletal musculature (Gianni-Barrera et 
al., 2013) . 
 
This process however has never been observed in real time or in the bone and the 
involvement of VEGFA signaling in this process and in biomineral thickness 
growth has not been studied. To document my work on this is the aim of the 
present chapter.  
 
CD31 and Vascular endothelial growth factor receptor 2 (VEGFR2), (the latter 
for which VEGFA is the ligand), are both molecular markers of endothelial cells, 
and antibodies against both of these membrane bound proteins were used in this 
study to identify endothelial cells. 
VEGFR2 is a protein tyrosine kinase and the earliest known marker of the 
endothelial cell lineage (Millauer et al., 1993). A null deletion of VEGFR2 in 
mice is lethal and e8.5-9.5 due to the very severe embryological defects (Shalaby 
et al., 1995). 
CD31 is expressed throughout the whole vascular endothelium in adults (Muller 
et al., 1989), and plays an immune role, as it is a necessity for the movement of 
neutrophils and macrophages across the vascular endothelium (Bogen et al., 
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1994). It is able to upregulate the expression of adhesion molecules, and the 
existence of many different spliced isoforms means it can possibly expand the 
types of cells endothelial cells can bind to (Baldwin et al., 1994). 
VEGFA is the most important growth factor that stimulates angiogenesis, and 
does so by binding to VEGFR2 (Sun et al., 2009). 
The two molecules are known to be co-expressed in mammary tumours in the rat 
(Xie et al., 1999), and have also been reported co-expressed on the same cells in 
human squamous cell carcinoma (Kyzas et al., 2005). 
 
VEGFA also has a physiological role in concert with RUNX2. 
There is evidence that VEGFA is a chemo-attractant for RUNX2, and addition of 
VEGFA to an injured mouse skull decreases the time needed to heal the bone, 
increases RUNX2 and PECAM expression and increases vascularisation of the 
injured region (Behr et al., 2012). 
The Olsen lab has previously published that RUNX2 directly regulates VEGFA 
expression in long bones, but this has not been tested in dermal bones (Duan et 
al., 2015, Zelzer et al., 2004). A direct physical binding of RUNX2 on the Vegfa 
promoter has been demonstrated by Chromatin immunoprecipitation (ChIP) in 
several labs (Sun et al., 2009) and (Kwon et al., 2011).  
 
These findings suggest that osteoblastic cells/osteoprogenitors are providing the 
attractive cues for endothelial cells to grow towards them and could thus 
coordinate bone biomineralisation with the vascularisation and nutrient supply of 
adjacent osteoblasts/osteocytes necessary for their survival. A testable 
proposition by first tracing VEGFA positive cells from both sides of the growing 
bone, by verifying their RUNX2 positivity and by studying cell specific ablation 
of VEGFA.  
 
In this chapter I describe the presence of neural crest derived endothelial cells in 
the frontal bone. I demonstrate novel behaviour of these cells that is consistent 
with intussusceptive growth of vasculature inside Layer 2 by imaging these 
Wnt1xConfetti labeled cells ex vivo over time.  By DiI tracing I show that both 
Layer 1 and 3 give rise to endothelial cells as well as VEGFA-positive 
osteoblastic progenitors using VEGFA-LacZ+ mice. I then show that ablation of 
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VEGFA in these neural crest cells abrogates biomineral thickness growth beyond 
a very initial stage of appositional biomineralisation, thus implicating VEGFA 
signaling as integral part of the newly discovered process of intercalary 
biomineralisation.  
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3.1 Neural crest origin of endothelial cells in developing bone 
3.1.1Introduction 
 
In chapter 1 I demonstrated that from the earliest stages of biomineralisation the 
biomineral network of the frontal bone extends as a system of trabeculae. These 
spaces will be filled with bone marrow in the orbital region and with blood 
vessels throughout the rest of the frontal bone, and the endothelial cells that will 
form these vessels are present in the frontal bone associated with the biomineral 
deposits from e15 (figure 1.12). 
 
The endothelial cell lineage is considered entirely mesodermal in origin (Noden, 
1989). I observed in the Wnt1CrexConfetti mouse line a population of neural 
crest cells that expressed endothelial cell markers and displayed endothelial cell-
like morphology. 
 
3.1.2 Results 
3.1.2.1 VEGFR2 positivity of Wnt1CrexConfetti clone in the frontal bone 
 
Figure 3.1a shows a 3D projection of a sagittal section from an e18 
Wnt1xConfetti frontal bone, which labels cells of the NC lineage in four colours 
(green, yellow, red, cyan); here only the red clones are shown. Cells stained 
green are VEGFR2 positive (KDR epitope) and are identified as endothelial 
cells. L3 is particularly rich in endothelial cells, and these cells extend into L2. In 
figure 3.1b the process of a neural crest derived cell is magnified, and whilst the 
cytoplasm is red, this is surrounded by the green fluorescence of the VEGFR2 
antibody label, VEGFR2 being a membrane bound protein. In panel C, (rotated 
view of orange box in A), we see this time an entire neural crest cell, which has 
VEGFR2 positivity and is displaying an unusual cell morphology, apparently 
‘curving’ around itself to begin to form a doughnut shape. I went on to look at a 
number of sections to establish how common neural crest cells expressing 
endothelial cell markers were in the frontal bone. 
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3.1.2.2 Up to a third of NC cells in the layers of the frontal bone are CD31+ 
 
I quantified in 5 e18 Wnt1xConfetti sections the number of cells of neural crest 
lineage that were also positive for endothelial cell markers, the results are shown 
in figure 3.2. 
There is a significant contribution of non-neural crest (NC) derived cells in the 
e18 Wnt1CrexConfetti frontal bone. There was a fraction of non-NC cells in 
every layer of the bone, L1 containing 19.2% non-NC cells, L2 26.7% non-NC 
cells, and L3 14.2% non-NC cells (figure 3.2a). It would be expected that this 
non-neural crest component would constitute cells of endothelial and osteoclast 
lineage in the frontal bone. 
I analysed the NC cell fraction of the three layers for CD31 positivity.   
Figure 3.1 Neural crest derived endothelial cells in the frontal bone 
 
3D projection of e18 Wnt1CrexConfetti frontal bone with VEGFR2 antibody 
stain and DAPI nuclear counterstain. Red clone only shown 
A) View of L2 
B) Enlargement of box B showing VEGFR2 staining in membrane of NC clone 
cell process 
C) Neural crest derived cell in C (rotated view of orange box in A) is VEGFR2 
positive and is displaying unusual cell morphology, apparently ‘curving’ around 
itself. 
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The average CD31+ fraction of NC cells in L1 was 13.4%, in L2 23.6 %, and in 
L3 nearly a third, 31%, on NC cells were positive for the CD31 marker (figure 
3.2b). The variation between samples gave a standard error between 4.2% (L2) 
Figure 3.2: Neural crest cell population in the murine frontal bone includes NC 
derived endothelial cells whose proportion of total NC derived cells increases 
progressively through layers 1 to and 3 
A) There is a significant contribution of cells in the frontal bone that are not 
neural crest in origin, between 26-14% of total cells depending on the layer. This 
mesodermal compartment constitutes endothelial cell and some early osteoclasts 
of the neural crest component B) The percentage of CD31 positives cells varies 
from 13-30%.C) There is high sample to sample variation and small number of 
cells results in high standard error D) In L2 at this developmental stage there are 
a relatively small number of osteocytes (8%). Data collected from 5 CD31 
stained sections from 2 different Wnt1xConfetti frontal bones, n refers to number 
of cells. 
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and 9.2 % (L3), and as the absolute number of CD31+ cells is small, hence there 
is no significant difference between the layers (figure 3.2c) 
The NC fraction of L2 also contained osteocytes; approximately 8% of NC cells 
in L2 were osteocytes are e18 (figure 3.2d). 
It was noted but not quantified that there were CD31+ NC derived cells in the 
dermis overlying the frontal bone, suggesting that this cell population is not 
exclusive to cranial dermal bone. 
No blood vessels in the underlying brain tissue were seen to be CD31+ in any of 
the 5 sections. 
 
 
3.1.3 Conclusions 
 
There is a population of CD31+ neural crest derived cells in all three layers of 
the frontal bone at e18. The regional variation of the CD31+ fraction is high, but 
may be up to 1/3 of all NC derived cells in a layer of the bone. 
The presence of CD31 positive cells in the overlying dermis suggests that these 
cells are not an exclusive feature of the frontal bone. When searching the 
literature I found one instance of neural crest derived endothelial cells being 
described in the head by (Bell et al., 2012), in the dermal papilla of the whisker 
pad. Apart from this the only report I am aware of that presents the existence of 
endothelial cells of neural crest lineage is in the bone marrow derived cells of the 
tibia by (Nagoshi et al., 2008). 
These novel cells are therefore relatively rare, and represent a new lineage that 
NC stem cells can give rise to. 
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3.2: VEGFR2+ VEGFA+ progenitors invade from both sides of the nascent bone 
3.2.1: Introduction 
 
I have established there is a significant fraction of NC derived endothelial cells in 
the frontal bone. 
I wish to understand if these NC endothelial cells have the same invasive 
capabilities as the RUNX2+, HAND2+ cells of the frontal bone described in 
chapter 2.  
In chapter 2 figure 2.10, between 25-58% of invading cells were negative for 
RUNX2 and HAND2, expressing no molecular marker. I predicted that much of 
this population is made up of endothelial cells. 
 
The endothelial cell lineage is a good candidate for cells with invasive/migratory 
potential, as the vascular network is constantly remodeling itself and need to 
respond to injury quickly.  
 
VEGFR2 is the canonical marker for endothelial cells, and so this molecule was 
chosen as an identifier of the endothelial cell population in cultured frontal bone 
explants labeled with lipophilic cell label. 
The most prolific and one of the most important signaling molecules for the 
stimulation of angiogenesis is VEGFA. Amongst others, VEGFA is a substrate 
for VEGFR2 and a key regulator of bone formation. As well as identifying 
endothelial cells I wish to identify any part of the invasive population that can 
promote the growth of endothelial cells.  
 
VEGFA is hard to stain for in vivo, as it is a secreted molecule that is degraded 
very quickly after secretion and undergoes various modifications that renders 
antibodies difficult to use. For this reason we took advantage of a VEGFA-LacZ 
mouse (a gift from Dr. Christiana Ruhrberg, UCL) in which LacZ is inserted into 
the VEGFA locus as a monitor for cells expressing VEGFA in vivo (Miquerol et 
al., 1999). As LacZ is known to have a long half-life one needs to interpret 
results from tracing LacZ positive cells with caution: a LacZ positive progenitor 
cell might have been expressing VEGFA earlier than the time point when we 
were assaying for LacZ. Thus it is possible that VEGFA could have been 
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expressed by a cell prior to any invasion of the bone. However we have RNA 
ISH data from our collaborator (Dr. Quenten Schwartz, unpublished) showing 
positive cells inside growing layer 2 biomineral. In order to find out whether 
both layers 1 and 3 give rise to VEGFA positive cells within layer 2 I labeled 
both sides of a P5 VegfaLacZ frontal bone with DiI/DiO as described in detail in 
Chapter 2. After 2 days incubation the frontal bones were fixed and antibody 
stained for the receptor VEGFR2 and β-galactosidase. 
 
Results 
3.2.2:There is a novel invading population of FLK+VEGFA+ cells in the frontal 
bone 
3.2.2.1 Both L1 and L3 give rise to VEGFR2+VEGFA+ cells 
 
I find that both layers give rise to VEGFA expressing cells, as well as a 
population of VEGFR2+VEGFA+ double positive cells. 
 
Figure 3.3 shows a sagittal section through a frontal bone from A P5 VegfaLacZ 
explant that was labeled with lipophilic dye on L1 and incubated with culture for 
48 hours. It contains blood vessel that is lined with double positive VEGFA and 
VEGFR2 positive cells (yellow asterisk). These cells are also positive for the 
lipophilic label, indicating that they have invaded from L1. 
This implies that in the frontal bone endothelial cells can promote their own 
growth in auto and paracrine fashion, as well as potentially ‘attracting’ RUNX2+ 
osteoprogenitors. This is a potential mechanism of cell migration, cells moving 
into different layers when the VEGFA signal attracts.  
I quantified the invading population and its VEGFR2+/VEGFA+ fraction. 
I find differences and similarities in the downward and upward migrating 
populations. 
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3.2.2.2: The fraction of VEGFR2+VEGFA+ cells is enriched in the downward 
invading population compared to the upward 
 
The fraction of VEGFR2 single positive cells is very small in both downward 
and upward migrating populations (figure 3.4, a and b cyan segment), 4.6% and 
3.3% respectively. In both the invading populations approximately half of cells 
are unlabelled. The downwards migrating population however has a large 
proportion of VEGFR2+VEGFA+ double positive cells (31.9 %), and a bigger 
proportion than the upward moving population (18.4%).  
 
 
Figure 3.3 VEGFA+ VEGFR2+ double positive cells labelled with lipophilic dye can be 
observed in the murine frontal bone along the walls of a blood vessel 
Example of VEGFR2+VEGFA+ double positive cells carrying DiO lipophilic dye in 
cultured frontal bone explant.  
A-D) Sagittal section through cultured frontal bone explant of postnatal day 6 (P6) 
VegfaLacZ reporter mouse. L1/L2 boundary marked by yellow dashed line, L2/L3 
boundary by white dashed line. DiO was applied to L1 side of the sample. A) Superposition of nuclear counter stain DAPI (blue), DiO (green, VEGFA (cyan) 
and VEGFR2 (red). Cells carrying DiO and positive for both markers are 
denoted with a yellow asterisk.	B) Dapi and DiO 	C) Dapi and VEGFA	D) Dapi and VEGFR2 	
L1 
L2 
L3 
* 
*
*
* 
* * 
* 
* 
DAPIVEGFA DAPIVEGFR2 
DAPIDiO DAPIDiOVEGFAVEGFR2 
A B
C D
L2 L2 
L2 L2 
	 192	
 
 
The upward moving population is more likely to be VEGFA+ single positive 
than the downward moving population (25.1% vs. 11.6 % respectively). 
 
From this data I have established that there are differences in the cell population 
profiles of upwards and downwards migrating VEGFR2/VEGFA population. 
I now investigate if there is a difference in invasion pattern of these two invading 
populations. 
 
 
 
 
 
 
 
 
 
A) Downward B) Upward 
n=212 n=145 
51.9
% 
4.6% 3.3% 
31.9% 
11.6% 
25.1% 
18.4% 
53.3% 
VEGFR2-VEGFA- VEGFR2+VEGFA- VEGFR2+VEGFA+ VEGFR2-VEGFA+ 
Figure 3.4: Upward and downward invading cell populations have different 
abundances of VEGFR2+VEGFA+ double positive cells 
 
Pie charts showing percentage of each cell type making up the A) downward 
invading (L1 labelled) and B) Upward invading (L3 labelled) cell populations, 
in DiI labeled P5 VegfaLacZ frontal bone sections antibody stained for 
VEGFR2 and β-galactosidase 
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3.2.2.3: VEGFR2 expressing endothelial cells are most likely to be L2 retained 
independent of direction of migration 
 
To understand if the upward and downward invading population of a cell type is 
has different invasive qualities, or indeed a cell type has distinct invasive 
behaviour compared to other cell types, I plotted a beta distribution of the 
probability of L2 retention for invading cells antibodied stained for VEGFR2 and 
β-galactosidase. 
All cells carrying lipophilic DiI label were counted and assessed for VEGFR2 
and VEGFA positivity in populations moving upward and downward in the 
frontal bone.  
The four population categories were: VEGFR2 single positive, 
VEGFR2+VEGFA+ double positive, VEGFA single positive and 
VEGFR2/VEGFA negative. The cell populations were split into half invasion 
(L2) and full invasion (L1/L3 depending on DiI application) categories (Tables 
3. 1 and 3.2). 
 
Table 3.1: Layer distribution of invading cells DiI labelled in L1, assessed for 
VEGFR2 and VEGFA positivity 
 Sections are taken from the same P6 VegfaLacZ frontal bone explant, n=1. The 
L2 and L3 distribution of cells were used to construct beta distribution curves. 
 
Section Thickness/µm No. of 
DiO only 
(double 
negative) 
cells 
No. of 
VEGFR2 
single 
positive 
cells 
No. of 
VEGFR2VEGFA 
double positive 
cells 
No. of 
VEGFA 
single 
positive 
cells 
Total 
 L2 L3 L2 L3 L2 L3 L2 L3  
1 97.8 42 10 3 0 35 10 0 0 100 
2 50.8 42 16 7 0 15 6 20 6 112 
Total 84 26 10 0 50 16 20 6 212 
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Table 3.2: Layer distribution of invading cells DiI labelled in L3, assessed for 
VEGFR2 and VEGFA positivity 
 Sections are taken from the same P6 VegfaLacZ frontal bone explant, n=1. The 
L2 and L1 distribution of cells were used to construct beta distribution curves. 
 
Section Thickness/µm 
No. of Dio 
only 
(double 
negative) 
cells 
No. of 
VEGFR2 
single 
positive 
cells 
No. of 
VEGFR2VEGFA 
double positive 
cells 
No. of 
VEGFA 
single 
positive 
cells 
Total 
 
L2 L1 L2 L1 L2 L1 L2 L1 
 
1 24.5 13 25 0 0 0 2 7 21 68 
2 73.2 27 12 5 0 18 8 3 4 77 
Total 40 37 5 0 18 10 10 25 145 
 
 
 
As explained in Chapter 2, beta distributions are a continuous probability 
distributions, where there are only two possible outcomes, a positive event and a 
negative event. Crucially for this analysis they can be used when the underlying 
distribution of data is unknown. The beta distribution is initially uniform, but the 
distribution can be revised if there are observations for positive and negative 
events, hence taking account of observed outcomes. In this case a positive event 
(probability=1) would be L2 retention of a cell, whilst a negative event (p=0) 
would be full invasion i.e. the cell is not observed in L2. A conditional 
probability distribution of the outcomes of the binomial is then produced (see 
Appendix for formulas and positive negative inputs). If peaks overlap 
significantly (over 5%) than there is no real difference in the distributions. 
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Endothelial less are highly likely to be L2 retained independent of invasion 
direction 
 
The population of invading cells that was found to be VEGFR2 single positive 
was very small (10 cells moving in downward direction spread over two sections, 
5 cells moving upward found in 1 out of 2 sections), and they were all observed 
in L2 of the frontal bone (figure 3.5). Red solid lines represent downward 
invading replicates, and the dotted red line the pooled data distribution (i.e. all 
replicate events added together). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This means it can be concluded that endothelial cells are very likely to invade 
and be retained in L2. 
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Figure 3.5 Beta distributions of VEGFR2 single positive cells shows very high 
probability of L2 retention 
 
Downward invading cells shown by red curves (solid line- individual 
replicates, dotted line- pooled data). Upward invading cells VEGFR2 single 
positive cells were only found in one section, represented by green line. Both 
upward and downward moving populations were found retained in L2 
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A population of VEGFR2+VEGFA+ double positive cells was also observed in 
the frontal bone, and these cells were also very likely to be retained in L2, 
independant of the direction of invasion (figure 3.6). The downward (red) and 
upward (green) distributions are highly overlapping with the exception of one 
upward invading replicate with a very low number of cells. 
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Figure 3.6 Beta distributions of VEGFR2+VEGFA+ double positive cells 
shows high probability of L2 retention 
 
Beta distributions of probability of VEGFR2+VEGFA+ double positive cells 
being retained in L2. 
Downward invading double positive cells shown by red curves (solid line- 
individual replicates, dotted line- pooled data). Upward invading cells double  
positive cells shown by green curves (solid line-replicates, dotted line- pooled 
cell population). Both upward and downward moving populations show a high 
likelihood of L2 retention. 
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VEGFA+ single positive cells do show a difference in invasive behaviour 
between the upward and downward populations. The downward invading cells 
are most likely to be retained in L2 (figure 3.7, red dotted line), whilst the 
upward migrating cell are most likely to fully invade into L1 (figure 3.7, green 
dotted). These distributions overlap to a non-significant (0.475%), hence 
populations can be said to be significantly different, though with the caveat of a 
very low number of sections. 
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Figure 3.7 Beta distributions of VEGFA single  positive cells shows a potential 
difference in upward and downward migrating populations 
 
Beta distributions of probability of VEGFA+ single positive cells being 
retained in L2. 
Downward invading cells shown by red curves (solid line- individual 
replicates, dotted line- pooled data). Upward invading cells shown by green 
curves (solid line-replicates, dotted line- pooled cell population). Both upward 
and downward moving populations show a high likelihood of L2 retention. 
Downward invading VEGFA single positive cells show a much higher 
probability of L2 retention than do upward migrating cells. 
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Finally, the population of invading cells that expressed neither VEGFR2 or  
VEGFA were most likely to be L2 retained if moving downward, whilst upward 
invading cells had no marked preference for full or half invasion (figure 3.8). 
The downward replicates exhibited very consistent behaviour compared to the 
upward replicates, which had little overlap between beta distributions. 
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VEGFA single positive cells are significantly more likely to fully invade into L1 
that other cell types 
 
To understand if the expression of specific molecular markers alone alters a cells 
ability to invade the frontal bone, I plotted the beta distributions of all four cell 
type populations travelling in the same direction against each other (figure 3.9). 
In these distributions I use only the pooled data for clarity. 
For cells travelling in the L1>>L3 direction (downward), there is a very strong 
preference for L2 retention of all cells types (fig 3.9a). The VEGFR2 single 
positive cells have the highest likelihood of L2 retention (p=1), but the other 
three cells types also show a very high L2 retention probability (approximately 
p= 0.75), and nearly completely overlapping beta distributions. 
 
Figure 3.8 Beta distributions of VEGFR2VEGFA double negative cells show 
no significant difference between upward and downward migrating 
populations 
 
Beta distributions of probability of  VEGFR2/VEGFA double negative cells 
being retained in L2. 
Downward invading double negative cells shown by red curves (solid line- 
individual replicates, dotted line- pooled data). Upward invading cells shown 
by green curves (solid line-replicates, dotted line- pooled cell population).  
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In 
the upward migrating population (figure 3.9b), the VEGFA single positive cells 
Figure 3.9 VEGFA single positive cells invade upward fully into L2 unlike any 
other invading cell type 
Beta distributions of the probability of L2 retention of invading cell 
populations. Number above peaks indicate number of cells observed in 
distribution 
A) Downward invading cells all display a high probability of L2 retention 
and highly overlapping distributions 
B) Upward invading cells show less overlap of beta distributions, but only 
VEGFA single positive cells have a significantly different probability 
of L2 retention, being most likely to fully invade into L1 
 
0	
1	
2	
3	
4	
5	
6	
7	
8	
0	 0.1	 0.2	 0.3	 0.4	 0.5	 0.6	 0.7	 0.8	 0.9	 1	
De
ns
ity
	o
f	β
	
Probability	of	L2	reten3on	of	cells	
VEGFR2	single	
posi:ve	
VEGFR2VEGFA	
double	posi:ve	
VEGFA	single	
posi:ve	
Double	nega:ve	
0	
2	
4	
6	
8	
10	
12	
0	 0.1	 0.2	 0.3	 0.4	 0.5	 0.6	 0.7	 0.8	 0.9	 1	
De
ns
ity
	o
f	β
	
Probability	of	L2	reten3on	of	cells	
VEGFR2	single	
posi:ve	
VEGFR2VEGFA	
double	posi:ve	
VEGFA	single	
posi:ve	
Double	nega:ve	
A 
B 
5 
77 
22 
35 
10	110	
66	
26	
	 201	
show distinct behaviour, being most likely to fully invade (0.7), whilst the other 
cells types are all skewed toward L2 retention and have widely overlapping 
distributions. 
 
3.2.3 Conclusions 
 
The existence of VEGFR2+VEGFA+ double positive cells is very interesting, 
and a novel finding in the dermal bone. The only other report of a 
VEGFR2+VEGFA+ positive cell type I could find in the literature was in 
squamous cell carcinomas of the head (Kyzas et al., 2005). These cells were 
found in tumours of the lip, tongue and roof of the mouth. It is possible that these 
cells are more common, as co-overexpression of VEGFR2 and VEGFA is often 
reported in tumours, but this expression is not often examined on a cell level, but 
rather on a whole tumour level (Rydén et al., 2003, Nordby et al., 2015). As the 
high expression of these molecules is associated with poor prognosis, it could be 
of medical relevance to further investigate the presence and function of these 
cells.  
 
When investigating the potential invasion behaviour of the VEGFR2/VEGFA 
population, it was found that endothelial cells, as defined by VEGFR2 
expression, are highly likely to invade and be retained in L2 independent of the 
direction of invasion. This could be a system whereby the frontal bone 
vasculature is evenly supplied from both sides by new endothelial cells. 
 
The direction of invasion had little effect on the probability of L2 retention of the 
cells of the frontal bone, except in the case of VEGFA+ single positive cells. 
In cell types invading from the same layer of origin, probability of L2 retention 
was very similar, the exception being high probability of VEGFA single positive 
cells to fully invade in the upward invading population. 
Hence the VEGFA single positive cell is of potential interest as only cell type 
that showed a significantly different invasive behaviour based on layer of origin 
and compared to other cells invading upward. 
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For now, I wish to further characterise the VEGFA positive cells that displayed 
distinct behaviour. 
As discussed in the introduction of this chapter, there is evidence of RUNX2 and 
VEGFA co-expression and interaction in bone. 
By staining explants of DiI labeled P5 VegfaLacZ frontal bone explants for 
RUNX2, I was able to compare the invading dynamics of the this population to 
the VEGFR2/VEGFA invading population, with the view of discerning 
similarities that may imply a common precursor for both the endothelial and 
osteoblastic lineages. 
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3.3:RUNX2+ VEGFA+ progenitors invade from both sides of the nascent bone 
3.3.1Introduction 
 
From figure 3.4 it is clear that there is a significant VEGFA+ population in the 
invading cells of the frontal bone, and I wished to investigate the role of VEGA 
in relation to bone growth further. 
RUNX2 is able to bind to the promoter of Vegfa and promote the expression of 
Vegfa (Kwon et al., 2011, Sun et al., 2009). In many cancers these two 
molecules are found to be co-expressed and upregulated, potentially aiding the 
growth and metastasis of tumours (Xie et al., 1999, Niu et al., 2012). In has also 
been reported that VEGFA is expressed in preosteoblasts and immature 
osteoblasts and therefore could act as the principal angiogenic factor at this early 
stage of cell differentiation in the bone (Furumatsu et al., 2003). 
There is some evidence that VEGFA is a chemoattractant for RUNX2, and 
addition of VEGFA to an injured mouse skull decreases the time needed to heal 
the bone, increases RUNX2 and CD31 expression and increases vascularisation 
of the injured region (Behr et al., 2012). 
 
To investigate the expression of RUNX2 and VEGFA in the frontal bone, 
cultured frontal bones DiI labeled from P5 VegfaLacZ mice were stained for 
RUNX2 and β-galactosidase. 
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3.3.2 A RUNX2+VEGFA+ double positive cell type invades the frontal bone 
from both dorsal and ventral surfaces 
 
I identified invasive RUNX2+VEGFA+ cells in the frontal bone by antibody 
staining. 
Figure 3.10 shows a sagittal section of a frontal bone explant of a P5 VegfaLacZ 
reporter mouse, where lipophilic dye was applied to L1. It was then antibody 
stained for LacZ and RUNX2. I observed that there were cells carrying the 
lipophilic dye label that were also positive for LacZ and Runx2, marked with 
pink (3.10 a, b, c) and yellow (3.10d) asterisks. 
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Figure 3.10 Invading population of frontal bone includes RUNX2+VEGFA+ 
double positive cell type 
 
Sagittal section of a P5 VegfaLacZ frontal bone DiO labelled and cultured for 48 
hours, antibody stained for Runx2 and beta-galactosidase, and counterstained 
with DAPI 
A) Overlap of DAPI, RUNX2, VEGFA and DiO channels, pink asterisk 
indicates DiO positive cells double positive for RUNX2 and VEGFA 
B) DiO and DAPI 
C) VEGFA and DAPI 
D) RUNX2 and DAPI 
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When these cell populations were quantified, the downwards and upward 
invading populations of cells in the RUNX2/VEGFA assay show widely varying 
proportions of specific cell types (figure 3.11). 
The RUNX2+VEGFA- population in the downward migrating cell population is 
half the proportion of the upward-migrating population (figure 3.11a and b red 
segments respectively). 
There is a double positive RUNX2+VEGFA+ population, which is enriched in 
the upward population compared to the downward population (42.3% vs. 25.7% 
of invading cells). 
The RUNX2-VEGFA+ population is also enriched in the upward migrating 
population (21.2% vs. 14.2% in the downward population). 
I went on to investigate the invasive behaviour of these cells using beta 
distributions as described previously. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: The upward and downward invading cells have different population 
profiles in a RUNX2/VEGFA double stain 
Pie charts showing percentage of each cell type making up the A) downward 
invading (L1 labelled) and B) Upward invading (L3 labelled) cell populations, in 
a DiI labelled P6 VegfaLacZ frontal bone sections antibody stained for RUNX2 
and β-galactosidase  
 
RUNX2-VEGFA- RUNX2+VEGFA- RUNX2+VEGFA+ RUNX2-VEGFA+ 
n=281 n=132 
52.3% 
19.9% 
7.8% 
16.6% 
25.7% 
21.2% 
42.3% 
14.2% 
A) Downward B) Upward 
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3.3.3 A RUNX2+VEGFA + double positive cell type invades the frontal bone 
from both dorsal and ventral surfaces 
3.3.3.1:Introduction 
 
As with the other invading populations in this thesis I wished to understand if the 
expression different markers effects the pattern of invasion of a cell, and if any 
cell types displays different behaviour depending on the direction of invasion. 
In Chapter 2 part 1 I was able to demonstrate that RUNX2 single positive cells 
are more likely to be L2 retained in the downward invading population than the 
upward, which were only 50% likely to be retained in L2. RUNX2 single 
positive cells invading downward also showed a significant difference between 
the 
Downward invading RUNX2HAND2 double positive cells as well as HAND2 
single positive cells. 
I am interested to discover if expression of VEGFA with RUNX2 can alter cell 
behaviour. 
Cells were organised in a similar manner to RUNX2/HAND2 and 
VEGFR2/VEGFA invading populations into four categories: RUNX2 single 
positive, RUNX2VEGFA double positive, VEGFA single positive and 
RUNX2/VEGFA double negative. The number of each cell type in each layer 
was assessed and recorded (Tabled 3.3 and 3.4). As with the VEGFR2/VEGFA 
invasion study in section 2 of this chapter, P5 VegfaLacZ frontal bone explants 
were used to be able to stain for VEGFA expressing cells. Explants were all 
cultured for 48 hours with DiI applied to either L1 or L3, as detailed in Chapter 2 
and Materials and Methods. 
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Table 3.3: Layer distribution of invading cells DiI labelled in L1, assessed for 
VEGFR2 and VEGFA positivity 
 Sections are taken from the same P5 VegfaLacZ frontal bone explant, n=1. The 
L2 and L1 distribution of cells were used to construct beta distribution curves. 
 
 
Section Thickness/µm No. of DiO 
only 
(double 
negative) 
cells 
No. of 
RUNX2 
single 
positive 
cells 
No. of 
RUNX2VEGFA 
double positive 
cells 
No. of 
VEGFA 
single 
positive 
cells 
Total 
 L2 L3 L2 L3 L2 L3 L2 L3  
1 34.0 35 42 9 10 15 19 9 8 147 
2 30.6 30 39 6 4 15 32 5 3 134 
Total 65 81 15 14 30 51 14 11 281 
 
Table 3.4: Layer distribution of invading cells DiI labelled in L3, assessed for 
VEGFR2 and VEGFA positivity 
 Sections are taken from the same P5 VegfaLacZ frontal bone explant, n=1. The 
L2 and L1 distribution of cells were used to construct beta distribution curves. 
 
Section Thickness/µm No. of DiO 
only 
(double 
negative) 
cells 
No. of 
RUNX2 
single 
positive 
cells 
No. of 
RUNX2VEGFA 
double positive 
cells 
No. of 
VEGFA 
single 
positive 
cells 
Total 
 L2 L1 L2 L1 L2 L1 L2 L1  
1 28.9 19 12 6 0 2 7 8 5 59 
2 36.1 19 21 4 3 9 15 2 0 73 
Total 38 33 10 3 11 22 10 5 132 
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3.3.3.2:Results 
3.3.3.2.1: VEGFA single positive cells display different behaviour dependant on 
the direction of invasion 
 
 
RUNX2 single positive cells are very likely to be L2 retained whether upward or 
downward migrating (figure 3.12). The distributions of the replicates are all 
highly overlapping. 
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Figure 3.12: Beta distributions of RUNX2 single positive cells show strong 
probability of L2 retention 
Beta distributions of probability of RUNX2 single positive cells being retained 
in L2. 
Downward invading RUNX2 positive cells shown by dotted red curve, only 
one section examined contained RUNX2 single positive cells. Upward 
invading cells shown by green curves (solid line-replicates, dotted line- pooled 
cell population). There is no significant difference between the upward and 
downward invading populations. 
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The expression of VEGFA with RUNX2 on double positive cells has the effect 
of increasing the likelihood of full invasion (figure 3.13). The pooled data peaks 
are between 0.35 and 0.55 probability of L2 retention, but all peaks (replicates 
and pooled data) also overlap considerably, thereby showing no significant 
difference based on the layer of origin. 
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Figure 3.13: Beta distributions of RUNX2VEGFA double positive cells show 
even probability of half or full invasion of the frontal bone 
Beta distributions of probability of  RUNX2VEGFA double positive cells 
being retained in L2. 
Downward invading double positive cells shown by red curves (solid line- 
individual replicates, dotted line – pooled cell population). Upward invading 
cells shown by green curves (solid line-replicates, dotted line- pooled cell 
population). There is no significant difference between the upward and 
downward invading populations. 
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The VEGFA single positive cells show a potential difference in invasive ability 
(figure 3.14). Upward migrating cells are consistently L2 retained, whilst 
downward migrating cells are more likely to fully invade. The pooled data curves 
overlap by less than 5%(3.12%), but I feel the spread of data in the downward 
replicates suggest that this may not be a good representation of the population, 
and that it is not a true difference. 
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Figure 3.14:Beta distributions of VEGFA single positive cells show a potential 
difference in migration behavior depending on the layer of origin 
 
Beta distributions of probability of VEGFA single positive cells being retained 
in L2. 
Downward invading double positive cells shown by red curves (solid line- 
individual replicates, dotted line – pooled cell population). Upward invading 
cells shown by green curves (solid line-replicates, dotted line- pooled cell 
population). There is overlap between the replicates, though the pooled cell 
population curves do not significantly overlap, suggesting there may be some 
behavioural difference between upward and downward populations. 
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Double negative cells (figure 3.15) are evenly distributed between full and half 
invasion. The beta distributions for upward and downward invasion are highly 
overlapping , showing no significant difference in behaviour. 
 
 
 
3.3.3.2.2:RUNX2 single positive cells are more likely than other downward 
invading cells to be L2 retained 
The expression of different molecular markers does not appear to make a 
significant difference to the pattern of invasion of cells, with one exception. 
RUNX2 single positive cells invading from L1 are significantly more likely to be 
L2 retained than any other cell type (figure 3.16a). 
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Figure 3.15: Beta distributions of  RUNX2/VEGFA double negative cell 
populations are equally likely to half and fully invade the frontal bone 
independent of layer of origin 
 
Beta distributions of probability of RUNX2/VEGFA double negative cells 
being retained in L2. 
Downward invading double positive cells shown by red curves (solid line- 
individual replicates, dotted line – pooled cell population). Upward invading 
cells shown by green curves (solid line-replicates, dotted line- pooled cell 
population). There is considerable overlap between all replicated and pooled 
data curves, suggesting distributions have no significant difference. 
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In the upward invading cells there is more overlap between the beta distributions, 
but the least overlap is between RUNX2 single positive and RUNX2VEGFA 
double positive cells (figure 3.16b). 
This data suggests that the expression of VEGFA by RUNX2 expressing pre-
osteoblasts increases the likelihood of full invasion of a cell. 
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Figure 3.16 Downward invading RUNX2 positive cells show increased 
likelihood of L2 retention compared to the other downward invading cell types 
Beta distributions of the probability of L2 retention of invading cell 
populations. Number above peaks indicate number of cells observed in 
distribution 
A) RUNX2 positive cell types is significantly more likely than others to be 
L2 retained 
B) RUNX2 single and RUNX2VEGFA double positive populations show 
significantly different distributions. 
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It is conceivable that migrating from one surface of a bone to another could 
increase the stimulation of endothelial cell proliferation over a wider area and 
hasten the development of the vascular network in the bone. 
It also suggests that either there is a subset of RUNX2 positive preosteoblasts 
that express no other marker that are destined for L2 retention. It is also possible 
that these preosteoblasts are a specific subset for which other markers that define 
them have not been identified within the scope of this study. 
 
 
3.3.3 Conclusions 
 
In this section I confirm the existence of VEGFA expressing preosteoblastic cells 
(as defined by RUNX2 expression) in the frontal bone. 
These cells are capable of both full and half invasion of the bone, and can invade 
upward and downward. There is no significant difference in invading behaviour 
observed between the upward and downward travelling populations. 
 
The invasion of cells in all three layers allows a signal for proliferation of 
endothelial cells to be swiftly distributed throughout the bone, potentially very 
important in a developing structure. 
 
It is interesting to speculate if the VEGFR2+VEGFA+ and RUNX2+VEGFA+ 
double positive populations overlap, to properly resolve this a triple stain or 
insitu hybridisation would need to be carried out of all three markers, in a DiI 
cell tracing bone explant. 
 
One notable difference between the downward invading population of the 
VEGFR2/VEGFA and RUNX2/VEGFA data sets is that the latter population as 
a whole (i.e. all four cells types) are much more likely to fully invade than the 
former (compare 3.9a with 3.16a).  
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It is possible that the position in the mediolateral and posterior axis may be 
crucial in the understanding of dynamics of cell invasion due to the differential 
signals that can be received. 
Also, maturity of the bone (which varies with position in the frontal bone) could 
be a significant factor in cell behaviour. The frontal samples in the 
VEGFA/RUNX2 analysis indeed had indeed significantly thicker L2 
measurements than those in the VEGFR2/VEGFA analysis (97 and 50 µm vs. 34 
and 30 µm), and the cells showed increased ability to fully invade. 
This study was limited by a low number of sections that were taken from the 
same frontal bone explant,. 
To extend this study, replicates of the experiment would need to be conducted at 
different thicknesses of bone. The bone could be categorized into thin (20-40 
µm), medium (40-60 µm) and thick (60 µm +), as 20-100 µm was the range of 
bone thickness where invasion was observed (see Appendix). A suitable number 
of replicates conducted to allow proper analysis of any differences. 
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3.4: VEGFA KO in NC lineage causes aberrant cell invasion in the frontal bone 
3.4.1 Introduction 
 
Given that cells from both layers 1 and 3 give rise to VEGFA+ positive 
progenitors invading into the biomineral layer 2 I wanted to test whether VEGFA 
is directly involved in this process. To this end the Wnt1-Cre transgene was 
crossed with both a conditional floxed VEGFA mutant as well as with a 
recombinase dependent GFP reporter (Wiszniak et al., 2015). This allowed us to 
monitor the behavior of neural crest cells that have lost VEGFA in relation to 
layer 2 growth. I wished to answer if: 
1) The distribution of  NC derived cells was affected in the bone 
2)  Does layer 2 elaborate in the same way in the mutant bone as wild type 
bone? 
3)  Can we discern any defect? 
 
VEGFA+ positivity of immature osteoblasts changes the invasive behaviour of 
the cells in the frontal bone (figure 3.16b), as did HAND2 (See figure 2.12). 
To further investigate the role of VEGFA in the frontal bone I analysed dermal 
bone where VEGFA had been ablated. 
 
 
3.4.2 Results 
 
The Wnt1-Cre;Vegfafl/fl	mouse was created by Wizsniak et al. The KO mice do 
not survive beyond P0, and display a cleft palate, small and misshapen mandible 
and Meckel’s cartilage and a generally smaller head than WT littermates. 
This ablation also severely limits the development of the frontal bone and all but 
removed the parietal bone (figure 3.17). 
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I then examined the frontal bone of a Wnt1-Cre;Vegfafl/fl	 mouse at e17.5 to 
observe any differences in cell distribution (figure 3.18). 
In figure 3.18 I compared sagittal sections from e18 frontal bones of a mouse 
with VEGFA expression ablated in the NC lineage (figure 3.18a), and a WT 
mouse (figure 3.18b). 
In the KO mouse NC cells have not invaded layer 2 at all, whilst in the WT 
mouse L2 is extensively invaded by NC labelled cells. There are some cells in 
the frontal bone, which are now exclusively mesodermal. 
 
 
pb pb 
A B 
 Figure 3.17 Hypoplasia of the frontal bone in the Wnt1-Cre;Vegfafl/fl  mouse 
 
Alizarin red and alcian blue stain of e17.5 skulls from WT mouse (A) and Wnt1-
Cre;Vegfafl/fl mutant mouse (B). Adapted from (Wiszniak et al., 2015) 
Pb=parietal, fb=frontal,nc=nasal cartilage, pmx=premaxilla, mx=maxilla, 
mk=meckel’s cartilage, md=mandible, eo=exoccipital. 
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Figure 3.18: Wnt1Cre:Vegfafl/fl KO mouse frontal bone lacks NC derived 
cells in L2 in contrast to the WT specimen 
 
A) Sagittal section of frontal bone in an e17.5 Wnt1Cre: VEGFA fl/fl: GFPfl/fl 
mouse, green labels NC derived cells. There are virtually no GFP labelled cells 
within L2.  
B) Sagittal section of an e17.5 Wnt1CrexGFP frontal, green labels NC derived 
cells. L2 is extensively filled with GFP labelled cells. 
Nuclei labelled with DAPI (blue), scale bar 50µm 	
L2	
L1	
L3	
L2	
L1	
L3	
A 
B 
DAPI Wnt1Cre:GFP 
DAPI Wnt1Cre: VEGFA fl/fl: GFPfl/fl  
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3.4.3 Conclusion 
 
This evidence leads me to the conclusion that the development of the vasculature 
of the frontal bone is intimately linked to the development of the thickness and 
mediolateral growth of the frontal bone. The ablation of expression of VEGFA in 
the NC cells of the frontal bone prevents the NC invasion of the frontal bone and 
the development of it.  
 
The mesodermal cells in replacement of the NC lineage is also echoed in the 
Hand2fl/fl KO described by (Jordan, 2011).The frontal bone there is also invaded 
by a few mesodermal cells in place of the usual NC lineage, partly rescuing the 
ablation of the frontal bone. 
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3.5 Endothelial cell behaviour and blood vessel growth in the frontal bone by 
vivo imaging 
3.5.1 Introduction 
 
Given that there is a significant proportion of neural crest cell derived endothelial 
cells found in the growing bone and that VEGFA plays a major role in the 
biomineral growth of layer 2 I wished to examine the way how this vasculature 
actually forms within this layer. Does it form by sprouting morphogenesis or can 
we see evidence for intussusceptive growth – septation of vessels by endothelial 
cells leading to de novo vessel bifurcation? 
 
To this end I performed live imaging of Wnt1xConfetti frontal bone specimens 
in 3D over 17hrs. 
I then examined the stacks in ImageJ to identify endothelial cells, which have 
extended morphology and are found lining blood vessel lumina. 
In the 4D stacks obtained it was easily possible to distinguish vascular lumina 
from areas of collagen matrix by the lack of background signal; collagen is 
known to weakly autofluoresce in the green-yellow spectrum after uv/green laser 
exposure (Banerjee et al., 1999) . Thus it was possible to identify flattened NC 
derived cells lining these lumina directly as endothelial cells. 
I then tracked the cells through the time lapsed stack (1 image taken every 10 
minutes) and observe some unique behavioural features consistent with the 
concept of intussusceptive growth. 
 
Figure 3.19 is an XY view of a collapsed z-stack of L3 only in a P1 
Wnt1xConfetti mouse. This plane of view makes it much easier to see any cells 
with extended morphology than in the sagittal plane. The white arrows indicate 
cell with very long thin morphologies, which are ‘crisscrossing’ the frontal bone. 
These are the same long structures seen CD31 labelled in the section in figure 
3.2. 
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Presented below are cells identified that I believe are taking part in angiogenesis 
in a number of ways, and within a timeframe consistent with published works. 
 
 
3.5.2 Results 
 
3.5.2.1 NC derived endothelial cells can form lumen by a change in cell 
morphology by ‘curving’ around themselves 
 
Within 12 hours of tracking a NC derived endothelial cells was observed to form 
a pore by the end of the cell ‘curling’ inwards towards one another. 
 
Figure 3.20A shows a rounded red clone blue asterisk in Sample A at time point 
1 in the XY plane (time interval = 10 minutes, see table 3.1). By t=57(9.3 hours 
Figure 3.19: Neural crest derived cells with endothelial 
morphology in the frontal bone in timelapse imaging  
Dorsal view of collapsed  L3 z-stack of a P1 Wnt1xConfetti 
frontal bone cultured explant.  White arrows indicate cells of very 
extended morphology in the frontal bone of a P1 mouse, dorsal 
view of frontal bone. 
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of imaging) the cell morphology has altered dramatically, and with a partner 
yellow clone (pink asterisk) has enclosed a small lumen, indicated in the YZ 
(4.5h) and XZ (3.20e) planes by a white arrow. The morphology is reminiscent 
of the red clone in figure 3.2c. By t=74(12.2 hours of imaging), the red clone has 
formed a ‘donut’ shape, enclosing its own lumen, as has and adjacent yellow cell 
(black asterisk). 
Within 12 hours cells are capable of a morphology change that results in the 
formation of a smaller lumina, and the extension of the capillary network. 
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Figure 3.20: NC derived endothelial cells can form lumen by a change in cell 
morphology  
A-C shows XY dimension view of a red clone (blue asterisk), which within 12 
hours of tracking changes from rounded morphology to curved (B), and eventually 
forms a donut (C). In the orthogonal views (D-F = XZ and G-I=YZ planes) a 
patent lumen forms from this change in morphology (white arrows). Yellow cross 
in A-C indicates where cross section of  orthogonal view was taken. (t)= 
timepoint, interval between  time points was 10 minutes. 
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3.5.2.2 Lumen space can be increased by cells at the lumen margin forming a 
‘doughnut’ before dividing into two separate cells  
 
Figure 3.21 shows yellow clone (blue asterisk) that develops a hole within itself 
(3.21A-B, 3.21D-E, and 3.21G-H change), before eventually splitting into 2 
cells. This strategy increases the size of the vessel lumen by increases the 
number of cells lining it, alternatively this divide could be the beginning of 
sprouting angiogenesis. 
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Figure 3.21 Lumen space can be  increased by cells at the lumen margin 
forming a ‘doughnut’ before  dividing into two separate cells  
A-C shows XY dimension view of a yellow clone (blue asterisk), which 
forms a hole within itself (white arrows in  XZ and YZ views E and H 
respectively), eventually splitting into two. Magenta cross indicates points 
where orthogonal views were taken. White arrow indicated forming pore. 
(t)= timepoint, interval between time points was 10 minutes. 
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3.5.2.3 Endothelial cells change morphology and work as a pair to enclose and 
line a lumen, creating three enclosed compartments from two 
 
In figure 3.22 two red clones (blue and yellow asterisk panel A) were observed to 
move close together over time with a concomitant change to more elongated 
morphology (3.22b). They begin to form a small enclosed lumen (3.22c), but by 
t=93 they have flattened out and lie close together to enclose and line a separate 
two previously linked lumina (3.22d), as well as helping to form the wall of third 
lumen (3.22d bottom right). 
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Figure 3.22: Endothelial cells change morphology and work as a pair to 
enclose and line a lumen, creating three enclosed compartments from two 
A-D shows XY dimension view of two  red clones (blue and yellow 
asterisk), that change from initial rounded morphology to curved (C), and 
finally adopt a flattened morphology (D). In the XZ orthogonal views (E-H= 
XZ) the gap between the cells disappear over time as they align. White cross 
indicates points where orthogonal views were taken. (t)= timepoint, interval 
between time points was 10 minutes. 
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3.5.2.4: The lumen of vessels can be enlarged by simple elongation of an 
endothelial cell 
 
Finally in figure 3.23 a yellow clone is seen to elongate and increasingly align 
with another clone to extend the length of a lumen, and join two separate spaces 
to create a larger one. 
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Figure 3.23:The  lumen of vessels can be  enlarged by the  elongation of an 
endothelial cell 
A yellow cloned (magenta asterisk) aligns with a red clone(yellow asterisk) to 
increase the length of the lumen. (t)= timepoint, interval between time points 
was 10 minutes. 
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3.5.3 Conclusions 
 
In this section I have described and demonstrated previously unknown behaviour  
of NC derived endothelial cells in the frontal bone. 
 
Cells changed shape to enclose new spaces, and the formation of ‘doughnut’ like 
structures is especially reminiscent of intussusceptive angiogenesis. 
Some existing vessels became septated, whilst in other cases separate vessel 
lumens became joined and enlarged. 
The cells in this system are able to remodel the microvasculature , and I propose 
that this is achieved by intussusceptive angiogenesis. 
 
I did not identify behaviour associated with sprouting angiogenesis, for example 
I did not observe any evidence of ‘tip’ cells reaching out. This could be due to 
the cytoplasmic localisation of the fluorescent proteins. Use of  membrane-
localised proteins may have been able to visualize this process, and allow an 
assessment of which types of angiogenesis occur in the frontal bone. 
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3.6:Chapter Summary 
 
In this chapter I have described the existence of a novel population of neural 
crest cells derived endothelial cells in the frontal bone, which can contribute to 
the formation of vasculature in addition to smooth muscle cells. 
Previous work by LeDouarin (Etchevers et al., 2001) in quail-chick chimeras has 
shown that neural crest cells give rise to pericytes in the head vasculature, but not 
to QH1+ endothelial cells. Whilst a wider set of markers in the chick might 
reveal a similar origination such fate is hitherto unreported in vertebrates. 
I am aware of two studies that have shown neural crest cells to give rise to 
endothelial cells, both in postnatal mice (Nagoshi et al., 2008, Bell et al., 2012). 
 Bell et al. observed CD31 positive cells expressing the Wnt1Cre-YFP neural 
crest lineage label in the dermal papilla of the vibrissae follicle. Nagoshi et al. 
quantified that 3.85% of neural crest cells in the bone marrow were CD31 
positive. CD31 positive NC derived cells in the tibia were also observed and 
thought to be derived from the bone marrow CD31 positive NC stem cells. 
I quantified a higher percentage of CD31 positive cells in the frontal bone than 
reported in the tibia bone marrow (between 13-30%), which points to a 
difference of enrichment in different tissues. Enrichment in the frontal bone 
could be a result of the proximity of the head to the neural crest and hence 
closest to cell migration. To reach the bone marrow of the tibia NC derived cells 
must travel in the circulation, demonstrated by Nagoshi et al. 
 
To further explore this NC derived endothelial cell lineage, the phenotype of an 
endothelial cell KO in the NC lineage could be examined. This could be 
achieved by crossing a Wnt1Cre line with the VEGFR2flox mouse line (Hooper et 
al., 2009). If there is a significant contribution of these cells to specific organs, a 
reduction in the number of endothelial cells would be expected, especially in the 
frontal bone if up to 30% of NC cells are also of the endothelial lineage. 
 
I also identify an essential role of VEGFA in L2 formation of L2 in the frontal 
bone. 
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Recent work by (Duan et al., 2015) has  shown in endochondral ossification that 
VEGFA is necessary for the vascularisation of the perichondrium. This can now 
be extended to the dermal bone.  
 
I have traced a VEGFR2+ VEGFA+  population invading the frontal bone from 
both dorsal and ventral surfaces, and furthermore that neural crest specific 
VEGFA ablation arrests the invasion process in the frontal bone.  
Thus, VEGFA expressing endothelial cells are potentially capable of promoting 
endothelial cell growth in an autocrine and paracrine fashion in the frontal bone. 
As we had a fluorescent reporter contained in our transgenic system we can 
clearly see that green (neural crest) cells are present in L1 and L3, but do not 
invade the early e17.5 biomineral layer of L2.  
The presence VEGFR2+ VEGFA+  double positive cells have been reported 
previously in squamous cell carcinoma in the head. I can report that I observe 
this cells type in the P5 frontal bone. 
 
There is also a population of RUNX2+ VEGFA+ cells. This co-expression would 
confer the ability to osteoblasts of promoting the growth of vasculature in its 
local environment, which would be one mechanism whereby the process of 
biomineralisation in the frontal bone could be interlinked with that of 
vascularisation. These double positive cells are capable of full or half invasion 
whether in the L1-L3 or L3-L1 direction. This is in contrast to the RUNX2 single 
positive cells, which have a high probability of half invasion only. 
 
How exactly the interaction between endothelial and osteoblastic cells takes 
place that forms the branched network inside the emerging layer 2 remains to be 
seen. Interestingly a recent study has shown that MMP9 and VEGFA are in a 
mutually regulatory relationship (Hollborn et al., 2007) (Ortega et al., 2003) . 
Previous work in our lab (Jordan, 2011) found RUNX2+ osteoblasts to express 
MMP9 in our the frontal bone.  
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Live imaging revealed novel behaviour of NC derived endothelial cells in the 
dermal bone vasculature. 
These NC derived endothelial cells can change their morphology, which could 
contribute to the extension and formation of the vascular network in a number of 
ways: 
-NC derived endothelial cells can form lumen by a change in cell 
morphology  
-Lumen space can be increased by cells at the lumen margin forming a 
‘doughnut’ before dividing into two separate cells  
-Endothelial cells change morphology and work as a pair to enclose and 
line a lumen, creating three enclosed compartments from two 
-The elongation of an endothelial cell can enlarge the lumen of vessels 
 
Further work 
To resolve the role of the NC derived endothelial cells in the developing frontal 
bone, in vivo imaging must be applied to the genetically labelled components 
key signalling components and cell markers, to establish their contribution to the 
development of L2 in the frontal bone 
For example, whether VEGFA positive RUNX2 cells directly interact with 
endothelial cells in the frontal bone would be important to discern. This is 
possible to antibody label in fixed sections, but a live system presents a 
challenge. A first step of investigating these cell types in cultures may provide 
the information desired. In an invasion chamber experiment, where a Matrigel 
matrix is provided for cells to invade, invasion of a line of immortalized mouse 
calvarial osteoblasts was improved 15 fold by the inclusion of VEGFA (Huang et 
al 2016). 
It had less of an effect on ‘migration’ of these osteoblasts laterally through a 
membrane (3 fold improvement). 
Vegfa expressed by preosteoblasts is a potential supply of invading stimulus to 
osteoclasts and endothelial cell proliferation where it is needed in the bone to 
support mature osteoblasts and future remodeling activity. 
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Chapter 4: Relating cell lineage topology to biomineralisation patterns in the 
frontal bone 
Introduction 
 
In Chapter 1 I described novel patterns of mineralisation in the frontal bone, 
including ‘intercalary’ patterns of biomineralisation seen particularly in the 
orbital region of the frontal bone. 
In Chapter 2 I investigated the behaviour of cells within the frontal bone 
associated with its growth.  I extended the current understanding that cells in the 
frontal bone can not only move across the surface of the bone (Dallas and 
Bonewald, 2010, Veno et al., 2007), but can also move upward and downward 
into the frontal bone. Many of these invading cells are RUNX2 positive, a pre-
osteoblastic marker, and it was found that a subset of these migrating cells move 
exceptional distances (50 µm+). 
In chapter 3 endothelial cells were also identified as an invading cell type and 
displayed complex morphology changes and coordination to extend the vascular 
network in the bone. 
What I could not ascertain from this data is how the cells are arranged in relation 
to the biomineral, and how they may help to form it and shape it. 
 
Disrupting the organisation (alignment and polarity) of cells in the bone has been 
shown to adversely affect normal bone growth.  In the Col12a1-/- mutant mouse 
the collagen fibres of the femur (largely made up of Col1) are misaligned and 
shorter compared to the wildtype bone (Izu et al., 2011). This results in 
osteoblasts losing their even distribution and alignment in the endochondral 
bone, as well as their strict cell polarity in relation to the collagen fibres. The 
bones are weakened and shortened by this disorder of osteoblasts. The spatial 
relationship between different cell lineages has been investigated in the 
cancellous spaces of bones (Hauge et al., 2001), where the biomineral borders 
the bone marrow, but not throughout a single dermal bone. 
 
The current knowledge of how these three cells are distributed in the frontal bone 
is rather generalised. Osteoblasts migrate out of the initial condensations in the 
mouse skull, and are thought to lie above the developing bone. Osteocytes are 
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embedded within mineralised material, connected to surface osteoblasts via their 
dendritic processes (Bonewald, 2011, Palumbo et al., 1990). The precise 
distribution in relation to the normal biomineralisation patterns in the bone are 
not described, though there are some descriptions of the association of 
osteoprogenitors and more differentiated bone cells with the vasculature of 
(long) bone (Qing et al., 2012, Kusumbe et al., 2014). 
 
An area of research where knowledge of the exact cell distribution in a bone is 
highly useful is in the creation of synthetic bone grafts. In this field it is 
acknowledged that as well as the correct molecular environment for growth, the 
correct surface topography is necessary for optimal bone formation in biological 
grafts, as it influences the adhesion, proliferation and differentiation of 
osteoblasts (Rosales-Leal et al., 2010, Oh et al., 2006). Interestingly 
heterogeneity of the biomineral in bone has recently been demonstrated to dictate 
cell behaviour and distribution, in a study where cultured endochondral bone 
slices were homogenously seeded with osteoclasts. After incubation the 
osteoclasts were found to have arranged themselves and targeted resorption to 
areas initially of the lowest mineral quality (Pernelle et al., 2017). 
 
In this chapter, I consider the frontal bone in 3 dimensions to gain an idea of the 
spatial association of the mineralised matrix at different ages and the cell 
lineages associated with frontal bone growth and development. I investigate three 
major cell types that influence the biomineralisation pattern of the frontal bone: 
osteoblasts, endothelial cells and osteocytes.  
 
These cell types are readily identified from a nuclear counterstain and the 
collagen visible in the brightfield channel of a flat mount frontal bone. This is an 
important consideration, as it is very difficult for an antibody stain to penetrate a 
non-sectioned bone successfully, usually only the most superficial layers can be 
antibody labelled, so cells for this analysis had to be able to be unambiguously 
identified without a molecular marker (see figure 4.2 in Section 1 of this 
chapter). 
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Osteoblasts are found in high-density groups visible in the dorsal plane, are often 
arranged in ‘rosette’ like clusters. They have a rounded/cuboidal blast-like 
appearance (Moursi et al., 2002). As discussed in detail in previous chapters, 
osteoblasts primary role is deposition of the collagenous matrix that becomes 
mineralised to form the bone. It has additional roles in regulation of osteoclasts 
through the expression of RANKL (Udagawa et al., 1999, Yasuda et al., 1998) 
and in angiogenesis (Deckers et al., 2002). 
 
Endothelial cells line blood vessel lumen, and have a long and elongated 
morphology, their nuclei appearing long and flat. These cells have a very 
important role in angiogenesis, as discussed in detail chapter 3 of this thesis. 
It is also a somewhat contentious point as to when the blood vessels of the 
frontal bone form in relation to the ossification of this bone, hence any 
information on this would be highly interesting. 
 
Osteocytes are another major cell type that is readily identifiable from a nuclear 
counter stain and brightfield alone. These cells are terminally differentiated 
osteoblasts that become incorporated into the calcified matrix over time, and can 
be identified by distinctive pits in the collagen channel, the ‘lacunae’ in which 
they sit (Franz‐Odendaal et al., 2006, Bonewald, 2011). Osteocytes have an 
important regulatory role to play in bone maintenance and repair, as was 
discussed briefly in the general introduction. They can sense and respond to 
changes in mechanical load on bone, and detect microcracks in the bone in need 
of repair (Hazenberg et al., 2006, Hazenberg et al., 2009). After sensing this 
stress, they can adjust the activity of other bone cells to respond appropriately to 
the stimulus. They are capable of both negative and positive regulation of 
osteoblasts, being able to suppress the proliferation of osteoblasts through 
secretion of sclerostin (Van Bezooijen et al., 2004), and also stimulate 
osteoblastic activity in response to mechanical stress (Taylor et al., 2007) . 
Osteocyte are also capable of inhibiting osteoclast activity (Heino et al., 2002) 
and stimulating recruitment of osteoclasts to sites of remodeling when in an 
apoptotic state (Kogianni et al., 2008), and also as healthy mature osteocytes, 
again through the action of sclerostin (Wijenayaka et al., 2011).  
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To understand the relationship between cell type and biomineral, a large portion 
of a frontal bone with the biomineral dye labelled at e14-15 and e16-17 was tile-
scanned as a z-stack on a confocal microscope. The specimen had been DAPI 
stained and the brightfield channel collected to allow identification of 
osteoblasts, endothelial cells and osteocytes. 
 
In section 1 I demonstrate that there are complex patterns of biomineralisation 
and cell topology. I describe how I produced the cell lineage map from the 
original confocal scan. I then describe the different architectural features of the 
biomineral, which is the basis for the subdivision of the scanned region. I set this 
out in a time line, which is how I organise the analysis of the relationship of the 
organisation of cell lineages and biomineralisation. I describe and compare the 
global distribution of the three different cell lineages throughout the entire scan. 
 
In section 2 I compare the organisation of the different cell lineages to the 
regions of intercalary biomineralisation, a novel type of mineralisation fully 
described in Chapter 1. I find differences in the spatial organisation of different 
cell lineages. 
 
In section 3 I compare the spatial organisation of the three different cell lineages 
to the mediolaterally oriented ridges of matrix. I find that cells of all types are 
associated with the ridges, but there is a difference in their mediolateral 
distribution. 
 
In section 4, I describe the complex cell lineage distribution in the midposterior 
frontal bone. This region is centred around non-trabeculated blocks of red matrix, 
which is surrounded by unlabelled matrix. In this region more than any other 
there is a striking difference in the cell distribution in the centre of the region 
compared to the margins. Coalesced blocks of osteoblasts and osteocytes 
dominate the centre of the region, with a few endothelial cells organised into 
large blood vessels. At the margins, there is an ‘osteoblast fringe’, where 
osteoblasts surround the mineralised region and extend out radially in lines in all 
directions. 
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That specific biomineral patterns show distinct distributions of cells around and 
within the mineralised matrix suggests that the cell lineage distribution has an 
important role to play in the development of ossified bone. 
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4.1:Introduction 
4.1.1:The NC clone lineages of the frontal bone produce more than once cell type 
 
As discussed in chapter 2 and 3, the cells of the frontal bone are nearly all neural 
crest in origin. 
In the Wnt1xConfetti frontal bone in Chapter 2 it was demonstrated that the 
frontal bone is a mixture of many clonal colours, hence many different cell 
lineages. These lineages can produce cells of different types, demonstrated in 
figure 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CD31 is a marker for endothelial cells, and as noted in chapter 3, there is a 
population of CD31+ cells seen in the Wnt1CrexConfetti clone lineages (yellow, 
red and cyan). Figure 4.1 shows the fraction of CD31 positivity for each clonal 
colour in five separate frontal bones. 
The fraction of CD31+ cells in an individual clone varied from 0-0.71, and in no 
region were CD31+ neural crest cells found to be of only one clonal colour.   
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Figure 4.1: The Neural Crest (NC) derived clone lineages of the frontal 
bone produce more than one cell type 
A breakdown of the CD31+ positive fraction of individual NC clones in the 
three layers of the frontal bone. Data was collected from 5 e18 
Wnt1CrexConfetti frontal bone sagittal sections antibody stained for CD31. 
In the five samples no one clonal colour gives rise to all CD31+ cells, and 
no clonal colour constitutes only CD31+ cells. This suggests that different 
NC derived cell lineages give rise to different cells types 
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This suggests that the different clonal lineages (i.e. different colours of 
Wnt1Crex Confetti cells) can give rise to more than one cell type. 
Though the different cell types arise from different lineages, they must distribute 
throughout the frontal bone to allow proper function, i.e. proper 
biomineralisation of vascularisation of the bone. 
I defined regions of the frontal bone based on the pattern and age of 
biomineralisation observed, and sought to describe the patterns of cell 
distribution for osteoblasts, endothelial cells and osteocytes. 
 
4.1.2 Results 
4.1.2.1: Architectural structure of biomineralisation defines different regions in 
the frontal bone 
 
To analyse the relationship between the distribution of the three cell lineages and 
the architectural features of the biomineralised matrix, a flat mount of the mouse 
frontal bone culled at P1, exposed to matrix labelling agent at e14 (calcein) and 
e16 (xylenol orange) (See Chapter 2 Table 1.1 Experiment 1), was 
counterstained with DAPI and tile-scanned of confocal microscope to produce a 
z-stack of the region. This scan contained distinct architectural features in the 
mineralised matrix. 
 
This scan is shown in figure 4.2a and b. The biomineralisation pattern and 
structure varies both with age and spatial distribution. For example the e14/15 
(green) biomineralisation is limited to the supraorbital ridge region and shows 
complex trabeculation and intercalary growth.  
The red biomineral is not confined to regions of intercalary growth; and is found 
in both trabeculated and non- trabeculated deposits. In one region the e16/17 
biomineral appears to be forming ridges. 
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From the DAPI and brightfield channels it was possible to categorise the cells. 
Using the morphological properties outlined in figure 4.3, DAPI stained cells 
were assigned a number based on cell type using the ImageJ Cell Counter plugin. 
In figure 4.3a a rosette of osteoblasts is shown, identified from a DAPI 
counterstain of a P1 frontal bone, demonstrating typical rounded morphology and 
clustering into rosettes. In figure 4.3b the elongated shape of endothelial cells are 
illustrated, as it shows a number of endothelial cells lining a blood vessel lumen, 
a feature that can itself be recognised as it lacks background DAPI staining that 
is seen in the adjacent collagen matrix (white arrows). Finally in figure 4.3c, 
osteocytes are found in the P1 frontal bone flat mount, resting in the distinct pit 
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Figure 4.2:Architectural structure of biomineralisation defines different regions in the frontal 
bone 
Max project of 6 z-planes of flatmount confocal scan of a P1 WT frontal bone. Specimen was 
injected with calcein mineral matrix dye (green) at e14, and with XO (red) at e16 . 
A) View onto dorsal surface of the flat mount fontal bone stained with DAPI (blue), calcein 
(green) and XO (red)  
B) View onto dorsal frontal bone with brightfield channel included. Any biomineral formed 
between e18-P1 will not be labelled with any matrix dye  
Scale bar 500µm, orientation of sample indicated A=anterior, p=posterior, m=medial, 
l=lateral. 
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in the collagen matrix, which is readily identified by the brightfield channel 
(white arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This information was then turned into a cell type map using the MorphoLibJ 
plugin developed by Dr. John Lapage. Using this map, the spatial patterns of 
different cell lineages were compared to each other and to the pattern of 
biomineral in the region. 
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Figure 4.3: Distinct cell morphology allows identification of three 
cell lineages in the frontal bone from the DAPI and brightfield 
channels 
A) Cell type 1: osteoblasts, Rounded/cuboidal cells, often found in 
clusters or ‘rosettes’ 
B) Cell type 2: Endothelial cells, flat elongated cells 
enclosing/surrounding a lumen, which can be identified by lack of 
background staining of DAPI (blue). 
C) Cell Type 3: Osteocytes, oval shaped cells in lacunae- small pits 
in the collagen, visible in the brightfield (grey) channel.  
Scale bar 20µm 
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4.1.2.2  
The relationship of the architectural structure of biomineralisation and cell 
lineage distribution is complex 
 
The distribution of the different cell lineages was not uniform over the imaged 
region of the frontal bone, and distribution and population size differed between 
the lineages. Osteoblasts were the most numerous cells, followed by osteocytes 
and endothelial cells that were the most rare. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
e14calce16XOOBECOC 
P
2 
3 
Figure 4.4: The relationship of the architectural structure of biomineralisation and cell lineage 
distribution is complex 
A collapsed z-stack of age labelled biomineral and cell type distribution in the P1 frontal bone. The 
scan was segregated into a number of different regions for analysis. 
Bright green outlines highlight areas of ‘yellow’ matrix that have formed via appositional and 
intercalary biomineralisation.  
The blue line defines an area of ‘ridges’, blocks of e16/17 matrix arranged in parallel lines that are 
mediolaterally orientated. 
The orange outline defines a newer region of bone, with e16/17 and unlabelled matrix which is very 
cell dense, and untrabeculated 
e14= matrix labelling agent injected at 14, e16=matrix labelling agent injected at 
e16,OB=Osteoblasts, EC= endothelial cells, OC= Osteocytes. 
Scale bar 500µm 
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Figure 4.4 shows a max project of the Z-stack with biomineral labeled at e14 and 
e16 (green and red respectively), as well as the three identified cell lineages 
labeled with different colours: cyan osteoblasts, magenta endothelial cells and 
white osteocytes. 
 
There were 4051 cells counted in total, of which 66% were osteoblasts, 14% 
were endothelial cells and 20% were osteocytes. 
The pattern is clearly complex, so to analyse the relationship between cell 
lineage and biomineral distribution, the scan was is divided into four major 
categories that took note of certain features in the biomineral and the cell lineage 
distribution: 
 
1) Intercalary biomineral. At the centre of this region is the region of yellow 
matrix that is the result of the overlap of older green and younger red 
matrix. This region is the product of intercalary growth (see chapter 1 
section 1.3). 
2)  Biomineral ridges. These are made up of blocks of e16/17 (red) matrix 
that are arranged in parallel lines that are orientated with the mediolateral 
plane. 
3) Non-trabeculated matrix. At the centre of this region are blocks of e16/17 
(red) matrix that are non-trabeculated. These blocks are surrounded by 
unlabeled matrix, which I consider mineralised because of the high 
percentage of osteocytes within in. 
4) Osteoblast fringe. Surrounding the non-trabeculated region is a distinctive 
margin of osteoblasts. The region is either unmineralised and/or 
composed of only unlabeled matrix formed between e18-P1. 
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4.1.2.3: Different architectural features of biomineralisation and cell topology 
emerge at different times 
 
The different architectural features represent differences in the form of 
mineralisation with time. 
Figure 4.5 shows the timing of formation of the 4 categories defined above. 
The intercalary region is the first to form, between e14-17, and the biomineral 
ridges. The non-trabeculated region forms between e16-P1 and the osteoblast 
fringe approximately around P0-P1 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.2.4: Endothelial cells are constrained to the centre of the mineralised region 
of the frontal bone compared to osteoblasts and osteocytes. 
 
The distribution and arrangement of cells differs between the three lineages. 
Figure 4.6 shows the spatial distribution throughout the scanned region of 
osteoblasts (4.6a,cyan), endothelial cells (4.6b, magenta), osteocytes (4.6c,white) 
and an overlay of all cell types (4.6d). 
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Osteoblast fringe	
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Birth 
Region 
Figure 4.5: Different architectural features of biomineralisation and cell topology 
emerge at different times 
Timeline of emergence of different features of biomineral growth and cell topology in 
the prenatal and perinatal mouse frontal bone. 
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Figure 4.6: The global distribution of osteoblast, endothelial and osteocyte 
cell lineages varies in different regions of the frontal bone 
Max project of cells maps for individual cell types (A-C) and combined cell 
type map (D) 
A) Distribution of osteoblasts(OB). Red outline indicate areas where 
osteoblasts have coalesced, green outlines indicate large areas of no 
osteoblasts. Most osteoblasts are found in the newer area of matrix as defined 
in Figure 4.2. 
B) Distribution of endothelial cells (EC). These cells are found at the centre 
of the bone, often arranged in columns outlining a blood vessel. This is the 
only cell type which is more prolific in the older region of bone than the 
newer region. 
C) Osteocytes (OC) are widely distributed within the bone, and are most 
dense in the ‘newer’ areas in much the same places as osteoblasts (red 
outlines). 
D) All three cell maps overlayed, emphasising centralisation of endothelial 
cells compared to the other two cell types. 
Scale bar 500 µm 
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Osteoblasts (4.6a) though widely distributed, are absent from large parts of the 
central regions of the biomineralised area (green outlines). They are often found 
in clusters, and coalesce into very high dense groups (red outlines). Osteoblasts 
are the cells most often found on the outermost periphery of the mineralised 
regions. 
Osteocytes (4.6c) are also found widely distributed throughout this region of the 
frontal bone. They are often found as single isolated cells but also as coalesced 
clusters like the osteoblasts (red arrows). 
Endothelial cells (4.6b) are most often found in column shaped groups, denoting 
the vessels they are surrounding, and in the centre of the mineralised region, not 
at the periphery. 
When the three cell lineage maps are combined (4.6d) the difference in spatial 
distribution between the three different lineages becomes more obvious. 
The coalesced clusters are composed of both osteoblasts and osteocytes, and the 
osteoblasts surround all other cell types as a ‘fringe’. The endothelial cells are 
centralised compared to the other two cell types. 
 
 
4.1.3 Conclusion: 
 
The three cell lineages do not share the same spatial distribution throughout the 
frontal bone. Endothelial cells are centralised compared to osteoblast and 
osteocyte cell distributions.  
Both osteocyte and osteoblasts can be found in large coalesced clusters. 
The osteoblasts are found in a fringe that surrounds the other cell types. The cells 
in this fringe extend out radially in all directions. 
This implies that the formation of the blood vessel network ‘trails’ that of the 
formation of the mineralised trabecular network, with osteoblasts being the first 
cells to enter/colonise a non-ossified region. 
 
I will analyse these regions separately in respect to cell type arrangement 
compared to matrix, and also describe the pattern of cell distribution for each 
lineage. 
I first look at the cell distribution of the three lineages compared to each other. 
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4.2: The intercalary biomineral is cell poor but the different cell lineages 
surround it in distinct patterns 
4.2.1: Introduction 
 
The intercalary biomineral is formed by the deposition within old biomineral of 
newer matrix.  
In the flat mount sample of this analysis it shows as yellow biomineral, where 
younger red matrix has been deposited within older green matrix. The resolution 
of the flat mount scan does not allow delineation of the dye colour boundaries 
and hence the region appears yellow. 
Due to the novel nature of intercalary mineralisation, I was particularly interested 
in the cell lineages associated with the regions of yellow matrix. 
In chapter 1 it appeared that the intercalary growth was limited to between e14-
e17. I am interested to see in there is a difference in cell type distribution 
compared to other areas in the frontal bone. 
The cell map was separated into the three lineages and each cell type compared 
to the intercalary biomineral. 
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4.2.2 Results 
4.2.2.1: Osteoblasts are associated with termini of branches of biomineral formed 
by intercalary matrix  
 
Osteoblasts are not widespread in regions of intercalary biomineral (yellow). 
They are found in groups at the termini of branches of intercalary biomineral. 
From the termini the osteoblasts form rectangular blocks that extend in the 
direction of the branch growth. This can be seen in figures 4.7b, a max projection 
of the osteoblast cell map and the e14/15 and e16/17 aged matrix of the frontal 
bone. 
At the termini two branched of yellow matrix groups of osteoblasts can be found 
(blue arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A B 
e14calce16XOOB 
Figure 4.7 Groups of osteoblasts can be found at the termini of branches of intercalary 
biomineral A) Indicates position of region of intercalary growth expanded in B.	B)  Age labelled mineralised matrix  (red and green) overlaid with osteoblast cell map 
(cyan). Blue arrows indicate groups of osteoblasts at the termini of biomineral branches 
formed by intercalary growth. Arrow heads indicate osteoblasts potentially within the 
biomineral matrix. Max project of all 6 z-planes.	
Scale bar 200µm 
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There also appear to be osteoblasts within the intercalary biomineral (arrow 
heads). I examined the individual z-slices of the stack to discover if these 
osteoblasts lie within the matrix or above and/or below it. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Osteoblasts are found largely ventral to intercalary biomineral  
Single optical slices (slice interval 4 µm) of age labelled biomineral and osteoblast cell 
map. 
A) Most dorsal slice (z=1) shows only a single osteoblast associated with the 
intercalary biomineral (blue arrow). 
B)  A handful of osteoblasts are associated with the intercalary biomineral in the 
z=3 plane 
C)  Groups of osteoblasts that were associated with the termini of intercalary 
branches in figure 4.7 lie ventral to the branches in z=6. Red arrow indicates 
large group of osteoblasts lying ventral to the corresponding yellow biomineral 
in a. 
Scale bar 200µm 
A
B C
e14calce16XOOB 
Dorsal	
surface	 z=1 (A) 
z=3 
(B) 
z=6 
(C) 
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I find that the osteoblasts most closely associated with the intercalary biomineral 
lie ventral to it. Figure 4.8 shows three optical slices from the z-stack of the 
intercalary biomineral and osteoblast map. They range from the most dorsal z-
slice (4.8a) to the most ventral section (4.8c). The large group of osteoblasts (red 
arrow) is in the ventral most slice, and lie below the yellow biomineral.  
I now examine the pattern of endothelial cells in this intercalary region. 
 
4.2.2.2:Endothelial cells are found most commonly in trabeculae in the 
intercalary region 
 
The most prolific cell type in this region is the endothelial cell, and their 
distribution is concentrated in the trabeculae of the intercalary biomineral. 
Figure 4.9 is a max projection of the endothelial cell map and the e14/15 and 
e16/17 aged matrix of the frontal bone. The endothelial cells most closely 
associated with the yellow biomineral are found lining and filling the trabeculae 
of the bone. 
I examined the distribution of endothelial cell further by examining the 
individual z slices of the stack. 
Almost all the endothelial cells associated with the intercalary biomineral lie on 
the L3 side of L2, beneath the intercalary biomineral. 
 
Figure 4.10 shows three optical slices from the z-stack of the intercalary 
biomineral and endothelial cell map. The vast majority of the endothelial cells 
are found in the most ventral z= 6 slice (figure 4.10c). They are arranged around 
blood vessels and align with the branches of biomineral that overlay them. This 
is a similar distribution to the osteoblasts in this region. 
Finally I examine the osteocyte cell lineage in this region of intercalary 
biomineral. 
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e14calce16XOEC 
Figure 4.9 Endothelial cells 
are found most commonly 
in trabeculae in the 
intercalary region  
Age labelled mineralised 
matrix  (red and green) 
overlaid with endothelial 
cell map (pink). Blue arrow 
indicates a group of 
endothelial cells at the 
termini of  a biomineral 
branch formed by 
intercalary growth. Arrow 
heads indicate endothelial 
cells potentially within the 
biomineral matrix. 
There appear to be more 
endothelial cells associated 
with the intercalary matrix 
itself than osteoblasts. 
Max project of all 6 z-
planes. 
Scale bar 200µm 
A
B C
e14calce16XOEC 
Dorsal	
surface	 z=1 (A) 
z=4 
(B) 
z=6 
(C) 
Figure 4.10 Endothelial cells like 
osteoblasts, are found most 
commonly ventral to deposits of 
intercalary biomineral 
Selected single optical slices (slice 
interval 4 µm) of age labelled 
biomineral and endothelial cell 
map. A) Most dorsal slice (z=1) 
shows very few endothelial 
cells, though a few are 
within the intercalary 
biomineral itself (blue 
arrows)	B) In the z=4 plane there is a 
greater number of 
endothelial cells, though 
only a small proportion are 
within the intercalary 
biomineral (blue arrow)	C) Most of the endothelial cells 
in this region are evident in 
z=6, the most ventral z-
plane, and ventral to the 
intercalary biomineral seen 
in A).	
Scale bar 200µm 
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The intercalary biomineral of the frontal bone contains only a handful of 
osteocytes. The biomineral surrounding the intercalary region in an appositional 
manner is osteocyte rich. 
Figure 4.11 is a max projection of the osteocyte cell map and the e14/15 and 
e16/17 aged matrix of the intercalary region. 
There are a very small number of osteocytes in the yellow biomineral (blue 
arrowheads, 4.11).  
The yellow matrix is surrounded by a margin of trabeculated red matrix, laid 
down at e16-17. This matrix had many osteocytes within it (white arrows). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I examined the individual z-sliced to understand the distribution of the osteocytes 
in the thickness of the bone. 
The osteocytes of the appositional biomineral are arranged in lines that align 
with the branches of e16/17-mineralised matrix. 
e14calce16XOOC 
Figure 4.11 Osteocytes are 
common in the appositional 
biomineral surrounding the 
intercalary biomineral 
Age labelled mineralised 
matrix (red and green) 
overlaid with osteocyte cell 
map (white). Blue arrow 
heads indicate osteocytes 
apparently within the 
intercalary biomineral. There 
are very few osteocytes in the 
region, most are within the 
biomineral laid down between 
e16-e17 (red matrix- white 
arrows).Max project of all 6 
z-planes. 
Scale bar 200µm 
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The yellow biomineral has few osteocytes embedded (figure 4.12b). The red 
matrix with osteocytes embedded is found in the most ventral z-slice, indicating 
this red matrix was added in an appositional fashion to the older matrix. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The osteocytes align with the direction of the red matrix branching, on a cell 
level, and as a group of cells. 
These cells retained the orientation and arrangement of the osteoblasts that 
deposited the red matrix. The osteoblasts that currently populate the region have 
the same orientation and alignment. 
 
A
B C
e14calce16XOOC 
Dorsal	
surface	 z=1 (A) 
z=3 
(B) 
z=6 
(C) 
Figure 4.12 Osteocytes are rare within intercalary biomineral, but 
common in appositionally deposited e16-e17 biomineral 
Selected single optical slices (slice interval 4 µm) of age labelled 
biomineral and osteocyte cell map. A) Most dorsal slice (z=1) shows very few osteocytes.	B) In the z=3 plane there are very few osteocytes, some of these are 
within the yellow intercalary biomineral (blue arrows)	C) The majority of osteocytes in this region are found ventral to the 
yellow intercalary biomineral (z=6), embedded within the e16-17 
(red) appositionally deposited biomineral.	
Scale bar 200µm 
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4.2.2.3: Osteoblasts and endothelial cells are at the centre of system of e16 
trabeculae at P1, hence still have potential in this region to growth in an 
intercalary fashion.  
 
One area of the appositional biomineral surrounding the intercalary region still 
has the potential to grow in an intercalary fashion at P1. 
Figure 4.13 shows a small system of red trabeculae, formed at e16/17. At the 
centre of this is a rosette of osteoblasts and endothelial cells (cyan and magenta 
cells, green asterisks). This means this area of matrix still has the potential to 
grow from the ‘inside out’ in an intercalary fashion, whilst osteoblasts at the 
edge of the region (top right of figure) allows it to expand laterally in an 
appositional manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This is evidence that two types of mineralisation are possible simultaneously in 
the frontal bone in the mediolateral and anterior-posterior axis. 
 
 
e14e16OBOCEC 
* 
* 
Figure 4.13 :Endothelial 
cells and osteoblasts are at 
the  centre of system of e16-
e17 trabeculae at P1 
 
Single optical slice (z=6) of 
ventral frontal bone. 
The red matrix at this time 
is also very osteocyte rich 
(white cells), and the 
trabeculae filled with 
rosettes of osteoblasts and 
endothelial cells (green 
asterisks). There is therefore 
potential for new deposition 
on the inside of the 
trabeculae in this region. 
Scale bar 100µm 
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4.2.3 Conclusions 
 
Osteoblasts are not widespread in regions of intercalary biomineral. They are 
found in groups at the termini of branches of intercalary biomineral, and lie 
ventral to the intercalary matrix. From the termini of these biomineral branches 
the osteoblasts form rectangular blocks that extend in the direction of the branch 
growth. 
Endothelial cells show a similar pattern to osteoblasts in this intercalary region. 
They are found ventral to the intercalary biomineral in groups surrounding blood 
vessels, but also aligned to the direction of biomineral branching. They are more 
likely to be associated with trabecular than the osteoblasts. 
Osteocytes in the intercalary biomineral itself are very rare. In the appositionally 
deposited mineral ventral to the intercalary matrix, osteocytes are more common. 
They retained the cell alignment and directionality of the biomineral branches 
which the osteoblasts and endothelial cells have.  
The implication of these results is that this region does not have the potential to 
grow in an intercalary manner any more; there is a lack of osteoblasts and also of 
osteocytes. The ‘inside out’ stage of growth is apparently short lived, and may be 
associated with a particular developmental stage, as it is observed in three mice 
in this thesis study in the same e14-e17 time window and not afterwards 
It also suggests that at e14-16 very few osteoblasts become embedded and make 
the differentiation into osteocytes. The osteoblasts with the capability to degrade 
and invade the previously laid down biomineral could be a subset of the 60-70% 
of osteoblasts that undergo apoptosis (Karsdal et al., 2002). 
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4.3: Many cells types are associated with biomineral ridges 
4.3.1:Introduction 
 
The second architectural element of biomineralisation identified were ridges of 
e16 matrix; arranged in discrete blocks that aligned into parallel columns. They 
begin in the margin of e16/17 matrix surrounding the intercalary region centred 
around the supraorbital ridge, and extend out towards the midline. 
Figure 4.14 shows these ridges in a dorsal view of the frontal bone. Extending 
and spreading medially from the older yellow matrix is an area where the e16/17 
matrix takes the form of small blocks arranged in parallel lines.  
I wish to understand the cell lineages associated with this novel arrangement of 
biomineral, and their spatial distribution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
P 
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e14calce16XO 
4.14: e16/17  ridges of biomineral extend mediolaterally from the 
supraorbital ridge to the midline in the frontal bone 
 
Dorsal view onto flatmount of P1 frontal bone taken on epifluorescent 
dissection scope. e14/e15 biomineral labelled with calcein (green) and  
e16/e17 forming biomineral labelled wih Xylenol orange (red). The 
e16/17 biomineral deposits in this region are in blocks that align to form 
‘ridges’ that extend from the orbtial region (lateral side)to the midline. 
Scale bar 500µm, orientation indicated by arrow. 
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4.3.2 Results 
4.3.2.1:  OB, EC, and OC cell lineages are prolific in the region of bio mineral 
ridges 
 
All three cell lineages are prolific in the region of biomineral ridges. The groups 
of cell are aligned with the ridges. 
This distribution can be seen in figure 4.15. This is a max projection of the cell 
map of all three lineages and e16/17 aged matrix of the biomineral ridges. The 
orientation of the ridges is mediolateral. The cells surround the blocks of 
biomineral. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I split the cell lineage map into constituent cell types to examine the spatial 
distribution. 
A B e16XOOBECOC 
M 
L 
A 
P 
Figure 4.15 All three cell lineages are found associated with e16/e17 
biomineral ‘ridges’ 
A) Ridges of mediolaterally orietntated biomineral in confocal z stack 
B) Map of osteblast (cyan), endothelial (pink) and osteocyte (white) 
cell lineages overlaid with e16/17 XO labelled biomineral ridges 
(red). 
Orientation of these ridges is with the mediolateral axis. 
Scale bar 200µm 
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4.3.2.2 Osteoblasts and osteocytes are found at the most medial point of the 
biomineral ridges, and endothelial cells confined to lateral levels 
 
Osteoblasts are found at the medial tip of the biomineral ridges and form a ‘cap’ 
on the region. In figure 4.16 the three separate cell types are shown with the 
biomineral ridges  (4.16a-osteoblasts, b-endothelial cells and c-osteocytes). 
 
 
In 4.16a osteoblasts are found in the medial half of the biomineral ridges, not the 
lateral half (green line marks boundary). The osteoblasts appear to lie in gaps 
between the red blocks of matrix (lack of white overlay). This suggests that this 
region is potentially still growing by intercalary biomineralisation.  The 
osteoblasts are also found on all lateral edges of the ridges, surrounding them. 
The endothelial cells in this region are found mostly in the lateral half of the 
biomineral ridges. The endothelial cells in the lateral half of the ridges form 
blood vessels, which is not seen in the ECs in the medial half. Their distribution 
e16XOOB e16XOEC e16XOOC A B C
Medial 
Lateral Lateral Lateral 
Medial Medial 
Figure 4.16:Osteoblasts and osteocytes are found at the most medial point of  the biomineral ridges, 
whilst endothelial cells are found at medial and lateral levels. 
Bright green line marks the boundary between an area of osteoblasts and no osteoblasts within this 
system of biomineral ridges  A) e16 to e17  aged biomineral (red) and osteoblast (cyan) cell map, dark green line delineating 
two parallel groups of osteoblasts	B)  e16 to e17  aged biomineral  and endothelial (pink) cell map, note endothelial cells do not 
extend as far as the ridges 	C)  e16/ e16 to e17  aged biomineral and osteocyte (white)  cell map, blue outlines delineating 
groups of osteocytes.	
 Scale bar 200µm 
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‘trails’ the progress of the osteoblasts, not extending to the medial most point tip 
of the ridges (figure 4.16b). 
 Osteocytes associated with the biomineral ridges are found mostly in the medial 
half, with very few in the lateral half. 
All of the cell types are found in blocks that align themselves with the biomineral 
ridges, i.e. with the mediolateral axis.  
This is illustrated with the doted outlines in figure 4.16. 
 
4.3.3 Conclusions 
 
The cell lineages of the biomineral ridge region all form groups that align with 
the axis of mineralisation, and hence show similarity to the cell distribution of 
the intercalary region. 
The osteoblasts and endothelial cells of the biomineral ridge region show 
overlapping but complementary distributions. The osteoblasts ‘cap’ the medial 
extent of the biomineral ridges but are not found in the lateral half of the ridges. 
Endothelial cells are found in the lateral half of the ridges but do not extend to 
the medial edge of the ridges. 
Osteocytes are not confined to the lateral or medial half, but are mostly found in 
the medial half of the ridges. 
The osteoblasts created a border around the ridges and every other cell lineage. 
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4.4 The non-trabeculated region of matrix in the mid frontal bone at P1 is 
surrounded by a fringe of osteoblasts 
4.4.1: Introduction 
There is a region of bone that is mineralised but not trabeculated posterior to the 
supraorbital ridge. 
 
The region of the frontal bone posterior of the intercalary growth of the 
supraorbital ridge has blocks of non-trabeculated matrix at its centre. 
 
 
 
 
 
 
 
 
In figure 4.17c the blocks of red matrix (laid down between e16-17) are 
surrounded by unlabeled (grey) matrix laid down between e18-P1. None of the 
biomineral shows signs of trabeculation. 
The cell density is very high in the region, and so I analysed the cell lineage map 
to understand if differences in cell topology could explain the different 
architectural style of mineralisation to other regions of the frontal bone 
Figure 4.17 There is a region of bone that is mineralised but not trabeculated 
posterior to the supraorbital ridge. 
A) Most posterior part if frontal bone scan contains untrabeculated biomineral. 
B )Single z plane (z=3) of P1 frontal bone with e14/15 biomineral labelled with 
calcein (green) and e16/e17 biomineral labelled with xylenol orange (red). 
Biomineral formed between e18 and P1 is unlabelled , but presence ofnuelcei 
indicated by  DAPI (blue)show  stained osteocytes in lacunae (visible as pits in 
brighfield channel in (C)) can indicate regions that have mineralised. 
 Scale bar 500µm 
A 
B C 
e14calce16XODAPI e14calce16XOBrightfield 
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4.4.2 Results 
4.4.2.1:Osteoblasts surround osteocytes and non-trabeculated biomineral in a 
‘fringe’ 
 
The non-trabeculated region has many osteocytes, which are found both as 
isolated cells and in large coalesced groups. A fringe of osteoblasts borders the 
entire region. The non-trabeculated region does not contain many endothelial 
cells, and the cells present are found in the centre of the bone. 
 
This arrangement of cells can be seen in figure 4.18, cell lineages maps overlaid 
with the red e16/17 deposited matrix. 
 
 
 
 
 
Endothelial cells are also found in the center of the region, but they are 
concentrated in large vessels in the centre (magenta cells figure 4.18a). 
This region is very rich in osteocytes; many individual ones are visible in the 
centre of the non-trabeculated region (white cells figure 4.18a) 
At the periphery of the non-trabeculated region the osteocytes are coalesced into 
three large groups (red asterisk). These are regions of high cell density where 
segmentation was poor.  
A B 
e16XOECOC e16XOOBECOC 
* * 
* 
* * 
* 
Dorsal	
surface	 z=2 (A 
and B) 
Figure 4.18 Osteoblasts surround osteocytes and biomineral in a ‘fringe’ 
Single z plane (z=2) from confocal scan of untrabeculated biomineral in the P1 frontal bone A) Osteocyte (white) and endothelial cell (pink) cell map shown with e16/17 (red) labelled 
matrix. Red asterisk indicate regions with very high density of osteocytes	B) Osteoblast (cyan) cell map shows that this cell type surrounds the region of untrabeculated 
biomineral, especially areas of high osteocyte density. 	
Scale bar 500µm 
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The osteoblasts in this region are found in groups at the centre, and as a fringe of 
cells that border the non-trabeculated bone and the other cell lineages (figure 
4.18b) 
There is a lot of overlap between the three large coalesced areas containing 
osteocytes and osteoblasts, but the border of these groups is always margin of 
osteoblasts (4.18b, red arrows).  
 
The implication of the border of osteoblasts is that the non-trabeculated area is 
growing concentrically in an appositional fashion, the ring of osteoblasts forming 
in a growth front.  
 
4.4.2.2 At the ventral level of the frontal bone matrix, groups of osteocytes and 
osteoblasts expand and coalesce 
 
I looked at more ventral levels of the frontal bone to observe if the pattern of 
cells changes, as it does in intercalary regions. 
The regions of coalesced osteocytes and osteoblasts have expanded, so much so 
that they begin to join up into one large region. 
 
This can be seen in figure 4.19, cell lineages maps overlaid with the red e16/17 
deposited matrix. 
The osteoblasts still form a border around this region, and the endothelial cells 
are still confined to the centre. 
The osteoblasts in this region grow out radially, whether they are in the centre of 
the bone or at the periphery. These means areas of osteoblasts and osteocytes can 
enlarge and coalesce over time. 
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4.4.3 Conclusions 
 
The non-trabeculated region has many osteocytes, which are found both as 
isolated cells and in large coalesced groups. These coalesced groups also contain 
many osteoblasts. In more ventral layers of the frontal bone these groups of 
osteoblasts expand and merge into large groups. 
Osteoblasts are the cell lineage also found at the margin of these coalesced 
groups. They also border the entire non-trabeculated region in an ‘osteoblast 
fringe’. The osteoblasts grow out radially, whether they are in the centre of the 
bone or at the periphery. This way the bone grows from the centre and the 
periphery. 
The non-trabeculated region does not contain many endothelial cells, and the 
ones present are found in the centre of the bone. 
 
 
 
 
Dorsal	
surface	
e16XOECOC e16XOOBECOC 
A B 
z=6 (A 
and B) 
Figure 4.19 At the ventral level of the frontal bone matrix, groups of osteocytes and osteoblasts expand 
and coalesce 
Single z plane (z=6) from confocal scan of untrabeculated biomineral in the P1 frontal bone A) Osteocyte (white) and endothelial cell (pink) cell map shown with e16/17 (red) labelled matrix. 
Osteocytes very more common and widely distributed.	B) Osteoblast (cyan) cell map shows that this cell type surrounds osteocytes as at more dorsal 
levels.	
Scale bar 500µm 
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4.5: Summary of findings 
Distribution of cells in not homogenous throughout different ages and 
architectures of biomineral 
 
This distribution of cell lineages in relation to specific biomineral structures has 
never before been described, and has provided some insight into how the shapes 
of these ossified structured may be achieved. 
Correct positioning, alignment and distribution of cells is likely to be very 
important for the formation of biomineral in the frontal bone, as has been shown 
in the endochondral femur with disorganised osteoblasts (Izu et al., 2011). I find 
are similarities and differences in the distribution of osteoblasts in relation to 
different architectural biomineral structures of the frontal bone, as well as 
differences in osteocyte and endothelial cells distribution. 
 
By analysing the spatial arrangement of different cell lineages in relation to the 
spatial and temporal patterns of matrix, it was possible to identify key differences 
between the orbital region, which is the thickest part of the frontal bone, and the 
newer more posterior regions, as well as having some insight to how the bone 
expands mediolaterally. These conclusions are summarised in figure 4.20. 
 
Region 1:Intercalary region 
Within the earliest deposited biomineral in the frontal bone, formed in an 
intercalary fashion between e14-17, there were very few cells of any lineage 
observed at P1.The lack of cells would mean that there is no further potential for 
this region to expand from the ‘inside out’ any more. The implication is that the 
period of intercalary expansion of biomineral is restricted in time as well as 
space, limited to the earliest stages of biomineralisation in the orbital region. 
The lack of osteocytes in this intercalary region is particularly interesting. 
Osteocytes are present in the matrix deposited appositionally between e16 to e17 
ventral to the intercalary biomineral, meaning that osteoblasts in this time 
window can indeed terminally differentiate. Perhaps the osteoblasts that are 
capable of intercalary mineral deposition are excluded from the population that 
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can differentiate into osteocytes, and undergo apoptosis as 50-70% of osteoblasts 
do (Karsdal et al., 2002).  
Whilst osteoblasts are not widespread in regions of intercalary biomineral, they 
are found in groups at the termini of branches of intercalary biomineral, and lie 
largely ventral to the mineralised matrix. This coordinated arrangement may be 
the mechanism that allows the branches to extend quickly beyond the rest of the 
‘biomineralisation front’. 
This implies that the alignment of the long axis of cell migratory paths seen in 
chapter 2 part 2 figure were not artefactual. The explants where this was 
observed may have been forming a directional biomineral structure such as ridge 
or branch.  
 
Endothelial cells show a similar pattern to osteoblasts in this intercalary region. 
They are found ventral to the intercalary biomineral in groups surrounding blood 
vessels, but also aligned to the direction of biomineral branching. They are more 
likely to be associated with the trabeculae in this intercalary region than the 
osteoblasts. 
 
Region 2: Biomineral Ridges 
 
In the regions of mediolaterally aligned biomineral ridges there appeared to be a 
concentration of osteoblasts and to a lesser extent osteocytes in the medial 
portion of the ridges. 
Endothelial cells were found in both the medial and lateral half portions of the 
biomineral ridges but do not extend to the medial edge of the ridges. 
There could be some biological relevance to this. In co-cultures of osteoblasts 
and endothelial cells the presence of mature osteoblasts supports proliferation 
and vessel forming abilities of endothelial cells (Hofmann et al., 2008). Also of 
great relevance in this thesis is the observation that the inclusion of endothelial 
cells in cultures of osteoblasts on mineralised scaffolds improves the migratory 
ability of osteoblasts but inhibits the migratory ability of endothelial cells (Shah 
et al., 2011).As was highlighted in chapter 2.2 there is a need to discover that 
migratory properties of cells in relation to biomineral. Ridges of biomineral 
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could be one way of very quickly extending the trabecular network without 
‘consolidating’. 
 
 
 
 
 
 
 
Region 3 and 4: Non-trabeculated region 
 
The non-trabeculated region does not contain many endothelial cells, and the 
ones present are found in the centre of the region, and centralised compared to 
the groups of osteoblasts and osteocytes. 
There is no clear directionality to biomineralisation in this region, and the cells 
are organised in a concentric and radial manner, such as in the non-trabeculated 
region with its osteoblast fringe, where cells extend out in all directions (figure 
4.20). The non-trabeculated region has many osteocytes, which are found both as 
isolated cells and in large coalesced groups. These coalesced groups also contain 
many osteoblasts. In more ventral layers of the frontal bone these groups of 
osteoblasts and osteocytes expand and merge into large groups. 
Osteoblasts are the cell lineage also found at the margin of these coalesced 
groups. The presence of osteoblasts at the centre and the periphery of this region 
means it can continue to expand the biomineral from the centre and the margin of 
the mineralised zone. 
1) Intercalary biomineral:  
Formed between e14 and e17 by intercalary  
incorporation of new matrix into old. Very cell sparse, with most OBs, ECs 
and OCs found ventral to the yellow mineralised matrix 
 
2) Biomineral ridges: 
Blocks of matrix arranged in parallel lines and interspersed with cells, 
especially OBs and OCs.Th region is ‘capped’ by osteoblasts, and 
endothelial cells do not extend to the end of the region but are confined to 
the base  of the ridges, trailing the mineral growth. 
 
3) Non-trabeculated region: 
Characterised by blocks of e16 to e17 aged mineral matrix and unlabelled 
new matrix, but no trabeculation or branching morphogenesis. A few large 
blood vessels are found at the centre. The e16 matrix is surrounded by 
osteoblasts and both e16 to e17 and e18 to P1aged  matrix containing  many 
osteocytes. 
4) Osteoblast fringe 
A border of osteoblasts surrounds the region 3, suggesting is is actively 
expanding by concentric apposition at this age. 
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Figure 4.20: Characteristic cell distributions in relation to 
biomineral architecture 
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I have demonstrated that the different patterns of biomineral deposition have 
different spatial distributions of the three cell lineages investigated. 
 
As mentioned previously, this information could be of great use is in the 
development of synthetic bone grafts. A great deal of research is focused on 
creating the optimal material for use in the clinic, with appropriate surface 
chemistry to ‘biofunctionalise’ the material and hence encourage the adhesion, 
proliferation and function of osteoblasts. There have been advances in the 
development of 3D cultures and co-cultured of osteoblasts with endothelial cells 
to better mimic the conditions required for ossification (Unger et al., 2007, Shah 
et al., 2011). The suggestion from this analysis is that the distribution of 
endothelial cells and osteoblasts does not always overlap in the developing bone, 
and careful distribution of the different cell types in culture could be designed to 
mimic exact biological conditions. 
 
A realistic scaffold could be constructed from an appropriate biopolymer that 
encourages the relevant cells to adopt the distribution seen in the wildtype frontal 
bone as described in this chapter. It may not even be necessary to place cells at 
specific locations as bone cells distributed homogenously have been shown to 
quickly adopt of heterogeneous distribution on the surfaces of bone (Pernelle et 
al., 2017). 
 
Further work 
This analysis could be extended or improved in a number of ways. 
One limitation was the lack of molecular markers, which may have lead to a over 
or underestimate of cells, particularly of osteoblasts, which did not have such 
distinct morphology as endothelial cells and osteocytes, and may not have been 
correctly distinguished from pre-osteoblasts. This could be overcome by use of a 
reporter line labelling a desired cell type, overcoming the problems of antibody 
labelling a 3D tissue sample. An example is the Osx-Cherry reporter mouse 
which allows the fluorescent labelling of osteoblasts (Strecker et al., 2013). For 
the lineage labelling of osteocytes there is available the DMP1-Cre mouse line 
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(Lu et al., 2007). The vasculature of the bone could be visualised in great detail 
by a DiI injection into the organism, as DiI incorporates into the cell membrane. 
(Li et al., 2008). 
 
A greater number of frontal bones samples would also improve the study, and 
allow an assessment of how ‘typical’ cell arrangements are, for example, is the 
intercalary region always devoid of osteocytes? 
 
To extend this analysis, I would be interested in investigating the cell 
arrangement around the suture in relation to biomineralisation. This would be 
most useful if the cell and biomineral topology were investigated in both an early 
(e14-P1) and later time window (P7-P14), to compare times when the suture is 
not thought to be a major source of osteoprogenitors, with a time when it is 
considered the source of all new bone cells. It may also be interesting to examine 
the cell and biomineral topology in specimens where craniosynostosis has fused 
either the coronal or interfrontal suture e.g. the Apert mouse model (Lomri et al., 
1998, Nagata et al., 2011). 
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5. Cryptic modularity of growth and intercalary mechanism of mineralisation in 
the cranial base 
Introduction 
 
The mammalian cranial base is an important ossified structure in the vertebrate 
skull and the proper development of the overall shape and size of the cranial base 
is developmentally and clinically significant. It extends from the atlas to the 
nasal region hence several anatomical and developmental structures have their 
growth linked to the cranial base, including the notochord, pituitary and many 
regions of the brain. 
 
In primates, especially humans, an important feature of the cranial base is the 
development of the cranial base flexion, the steep angle of the structure which 
correlates with the size of the posterior cranial fossa (Lieberman et al., 2008, Nw, 
1999). In cases where cranial base growth is aberrant, there is an impact upon the 
brain. One example is Arnold-Chiari syndrome where premature and over 
ossification creates a shortened cranial base, leading to herniation of the 
cerebellum (Milhorat et al., 1999). The symptoms and anatomical changes 
associated with Chiari are most likely to be diagnosed in one of two age 
brackets: firstly in young children, and a second emergence later in an 
individuals later twenties and early thirties. An individual in the older age 
bracket often have symptoms for many years before the syndrome is properly 
diagnosed (Labuda, 2012). The two different emergences of the syndrome 
suggest that there are at least two important phases of growth that the occipital 
region is subject to. 
 
The work in this chapter was enabled by the Column of Hope, Syringomyelia 
and Chiari malformation Research Foundation, for whose support I am indebted. 
 
The sequence of growth of the individual elements of the cranial base has 
remained elusive, partly because its multipartite nature and of the multiple tissue 
origins of the endochondral bones that form it. 
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Components of the cranial base 
The mammalian cranial base is completely cartilaginous in the embryo. As the 
cranial base matured through development the bones emerge as endochondral 
ossification between the so-called ‘synchondroses’ of the cranial base. The 
synchondroses are cartilaginous regions that lie between the ossified bones and 
are considered ‘double ended’ equivalents of the growth zones found in long 
endochondral bones such as the femur (Lieberman et al., 2000). 
 The synchondroses have a central zone of resting chondrocytes, flanked either 
side by proliferative chondrocytes stacked into columns with distinctive colloidal 
morphology. This is then flanked on both sides by regions of hypertrophic 
cartilage. These synchondroses become ossified in humans when the cranial base 
is fully mature. In most mouse strains the synchondroses remain patent even at 
maturity, though an exception is reported (Adams et al., 2013). 
 
 
 
 
 
 
 
 
 
Figure 5.1 Anatomy and tissue origins of the cranial base 
The anterior half of the spheno-occipital synchondrosis is the boundary between 
neural crest and mesodermal tissue in the embryonic cranial base. Red circle 
indicates the position of the pituitary dorsal to the cranial base. 
Dark green= neural crest derived bone, light green= neural crest derived 
cartilage, dark grey= mesoderm derived bone, dark grey=mesoderm derived 
cartilage. B.occ=basisocciput, B.sph=basisphenoid Eth=ethmoid, MSS= 
midsphenoidal synchrondrosis, bs=basisphenoid,P.sph=presphenoid, SOS= 
spheno-occipital synchondrosis, IOS=intra occipital synchondroses 
Eth P.Sph MSS B.Sph 
SOS 
B.Occ 
Ex.Occ 
IOS 
Ex.Occ 
IOS 
A	P	
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The anterior most bone in the mammalian cranial base is the ethmoid, which is 
composed in the embryo of completely neural crest derived cartilage (figure 5.1). 
In the human the ethmoid becomes ossified in the adult. In the mouse the 
ethmoid remains cartilaginous even at maturity and does not ossify. 
Posterior to the ethmoid is the spheno-ethmoid synchondrosis (SES), the most 
anterior synchondrosis of the cranial base, which is also neural crest derived. The 
SES is general ossified at birth in humans though can remain patent with no 
adverse affects into the teens (Lingawi, 2012). 
Because the ethmoid remains cartilaginous at maturity in the mouse, some 
authors consider the mouse to lack an SES (McBratney-Owen et al., 2008), 
though others acknowledge its existence as a growth zone (Laurita et al., 2011). 
Posterior to the SES is the sphenoid bone. In human adults the sphenoid is a 
complete ossified structure, but in development exists in three parts: 
the presphenoid bone most anteriorly, the midsphenoidal synchondrosis (MSS) 
directly posterior to it, and the basisphenoid bone (figure 5.1). The MSS is the 
last part of the sphenoid to ossify and remain a patent cartilage until 2-3 years of 
age in the human (Laurita et al., 2011, Madeline and Elster, 1995). The three 
elements of the sphenoid lie ventral to the diencephalon and third ventricle of the 
brain in the embryo. 
The spheno-occipital synchondrosis (SOS) is the most posterior synchondrosis, 
and lies ventrally offset to the posterior of the pituitary. In humans it is the last 
synchondrosis to remain cartilaginous and does not close until the mid to late 
teens (Bassed et al., 2010, Okamoto et al., 1996, Cendekiawan et al., 2010). 
The basisocciput is the most posterior bone of the cranial base, and lies ventral to 
the posterior cranial fossa, and articulates with the atlas. 
 
Many studies on the metrics of the cranial base in humans have been carried out 
largely focused on the position of certain radiological landmarks and consider the 
cranial base growth as a whole. The literature of the field rarely considers the 
coordination of growth between and within the separate elements in the cranial 
base. 
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Embryological tissue origin of the cranial base 
The cranial base is derived from two different tissue lineages, somitic mesoderm 
and neural crest. The boundary of mesodermal and neural crest has been long 
disputed. (Couly et al., 1993) demonstrated in the chick that the boundary is 
found between the basipresphenoid (neural crest) and basipostsphenoid 
(mesoderm). In the mouse it has been demonstrated by (McBratney-Owen et al., 
2008) that neural crest/mesoderm tissue boundary moves anteriorly with age  
(figure 5.2). At e17.5 all tissue anterior to the anterior boundary of the SOS is 
neural crest labeled, but by P10 the boundary has shifted to midway in the 
basisphenoid. A limitation of this study was the use of a sagittal view of  
 
 
 
 
 
 
Figure 5.2: Studies on tissue growth of the cranial base are limited by the 
genetic approach  
 
Midsagittal view of whole mount cranial base at three different ages 
(Adapted from McBratneyOwen et al. 2008).   
A) Mesodermal lineage reporter mouse at P0. Dark blue shows areas 
derived from the mesoderm. 
B) Neural crest lineage reporter mouse at P0. Dark blue shows the 
territories that are neural crest derived.  
C) Neural crest lineage reporter mouse at P10. The neural crest (dark 
blue)/non neural crest boundary has moved anteriorly from P0 (B). 
A 
B 
C 
A	P	
D	
V	
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wholemounts, so there is no information on mediolateral pattern of the 
NC:mesoderm boundary (figure 5.2). 
 
Signalling in cranial base and surrounding structures 
 
As briefly mentioned in the introduction to this thesis the cranial base is in a 
region subject to many different signaling sources. The posterior basisphenoid 
and SOS are of especial interest, as they lie ventral to the pituitary gland. 
The pituitary forms from an invagination of ectoderm known as Rathke’s pouch 
at the anterior most extent of the notochord. This ectoderm is in contact with the 
ventral diencephalon, and is subject to signaling from both the diencephalon and 
notochord.  
The notochord is known to secrete many signaling molecules, including Sonic 
hedgehog (Shh), which is expressed in the mouse anterior notochord between 
e10-e12, at the same time the cells of the basisoccipital anlage are condensing in 
cartilage (Nie et al., 2005). It is also expressed in the oral ectoderm ventral to the 
anterior cranial base at e13.5 (Young et al., 2006). Inhibition of Shh signaling 
directly prior to cranial base development prevents its proper formation in the 
chick (Balczerski et al., 2012).  
The ventral diencephalon expresses BMP4, FGF8 and 10 and Wnt4 among other 
signaling molecules, and this contact induces pituitary formation. This is so 
conserved in vertebrate that mouse ventral diencephalon can induce pituitary 
formation in the chick (Gleiberman et al., 1999). The loss of either BMP4 and 
FGF8 prevents Rathke’s pouch developing into the anterior pituitary (Takuma et 
al., 1998). In the Pitx1HS-HIP mutant, where hedgehog signalling in Rathke’s 
pouch and the oral ectoderm is ablated, mice lack a pituitary but also appear to 
have no SOS or ossified tissue as in an age matched WT, evidence that the same 
signaling affects their development (Treier et al., 2001). 
Most anteriorly the ethmoid shares a suture with the frontal bone (frontoethmoid 
suture) and is directly posterior and ventral to the nasal capsule and nasal bone, 
hence its growth would be expected to be more dictated by these structures than 
that of the sphenoid and basisoccipital. The nasal capsule has been shown in the 
chick to be subject to another source of Shh signaling from the foregut endoderm 
(Benouaiche et al., 2008). 
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Within the cranial base itself Indian hedgehog (Ihh) signalling is very important 
to its development. Ihh acts with parathyroid hormone related protein (PTHRrP) 
as two opposing gradients which control the proliferation of cells within the 
synchondrosis (Young et al., 2006, St-Jacques et al., 1999). Ihh is expressed by 
prehypertrophic chondrocytes and induces the proliferation and differentiation of 
chondrocytes, and PTHrP expressed in the resting and proliferative zones 
prevents premature differentiation of chondrocytes by inhibiting Ihh. Ihh can 
induce the expression of PTHrP, hence the PTHrP-/- mouse has a shortened 
prematurely ossifying cranial base just like in the Ihh KO mice, the latter of 
whom entirely lack PTHrP expression in the cranial base (Karaplis et al., 1994, 
Young et al., 2006). Chondrocyte proliferation is reduced in the Ihh -/- mice but 
expression of Col X, the marker of hypertrophic chondrocytes, is much more 
widespread than in the WT (Young et al., 2006).  
 
Downstream of hedgehog signaling it has been demonstrated that primary cilium 
mutations also result in cranial base phenotypes. 
Polaris is a key structural component of the primary cilium, and Kif3a a motor 
protein essential for cilium function. The Kifa3-/- KO mice and Polaris fl/fl 
Wnt1Cre mice at e18.5 present a ‘clefting’ of the basisphenoid (Khonsari et al., 
2013). 
In contrast both Polaris fl/fl:Col2α1-Cre and Kif3afl/fl: Col2α1-Cre mice 
(cartilage specific conditional ablation) both the SOS and MSS display 
premature closure and ossification and the chondrocytes present in the 
synchondroses are disorganized. The characteristic columns of chondrocytes fail 
to form and the distinct pattern of signaling domains of Ihh and ColX are 
deranged (Koyama et al., 2007, Ochiai et al., 2009).  
It has been demonstrated in another mutant phenotype that failure of 
chondrocytes to form columns disrupts cartilage growth. In chick Vangl2 
mutants (component of planar cell polarity pathway) limbs are shortened and 
thickened due to failure of chondrocytes to align correctly into columns (Li and 
Dudley, 2009). 
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The multipartite anatomical nature, complex sequential development and 
multiple tissue origins of the cranial base necessitates that I examine the different 
elements separately in my analysis of growth. 
 
Ossification and mineralisation of the cranial base cartilage 
The pattern of ossification of the cranial base is also poorly understood. One of 
the tenants of the current model of cranial base growth is that the cartilaginous 
synchondroses are the source of all new growth in the cranial base. By this logic, 
if a synchondrosis becomes ossified too early, the cranial base will not be able to 
expand. Also, the effect upon an organism depends on which synchondrosis is 
closed. 
This is seen in Crouzon syndrome, where with cranial synostosis midface 
hypoplasia is found due to an activating mutation in the FGFR2. The hypoplasia 
is caused by shortening of the cranial base due to premature over ossification in 
MSS, which can be seen in patients and in the Crouzon mouse mutant (Liu et al., 
2013).  
In Apert syndrome the cranial base is shortened and thickened cranial base due to 
a premature ossification of the SOS. This impacts the angle of the cranial base 
and effects the development of the overlying brain (Nagata et al., 2011). 
The independent aberrant ossification of the different synchondrosis suggests 
they are subject to different programs of growth, and as such their growth and 
ossification should be considered separately as well as a whole. 
 
In one study in the literature the sequence of ossification in relation to the cranial 
base synchondroses is studied but is limited by the analysis and experimental 
design (figure 5.3)(Wealthall and Herring, 2006).  
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In this study a mouse at P5 was injected with one mineral matrix-labelling agent 
(calcein), and injected again at P10 with a spectrally distinct labelling agent 
(xylenol orange), then culled two hours later. It shows both symmetrical and 
appositional growth of the cranial base with the last mineral label (red) bordering 
the synchondrosis. 
The cranial base is examined as a whole mount, hence the resulting 
mineralisation pattern is only viewed from the perichondrium, and as seen in 
Chapter 1, this can give a potentially misleading impression of a complex pattern 
of biomineralisation. Also, 2 hours is not long enough for the matrix-labelling 
agent to consolidate. Much of it is still in the calcium rich extracellular fluid, 
seen in figure 5.3 by the nonspecific and ubiquitous red labelling near the 
synchondrosis. 
 
Chapter organisation 
In this chapter I address the question of whether there is co-ordination of growth 
and mineralisation between the different bones and synchondroses of the cranial 
base. I wish to answer whether there is a common principle to the growth 
Figure 5.3 Whole mount analysis shows appositional and symmetrical growth of 
bone either side of the SOS and MSS 
Adapted from Weathall and Herring 2006 
Image of whole mount cranial base from P10 mouse injected with calcein at P5 
and xylenol orange at P10, culled 2 hours after last injection. 
A) SOS with part of bassiocciput (occ) and part of basisphenoid (sph) 
B) MSS with part of basisphenoid and presphenoid (pre). 
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trajectory of the constituent elements of the cranial base, or if growth of the 
different bones and synchondroses is modular and independent of other elements. 
 
As so many cranial base mutants describe misalignment and disordered column 
formation of the chondrocytes in the synchondroses, I wished to analyse how 
groups of dividing chondrocytes arrange themselves and how they contribute to 
the cranial base. I have used the Wnt1CrexConfetti mouse to do this. In these 
mice the Wnt1Cre promoter drives expression of one of four fluorescent proteins 
with distinct spectra, hence cells of the neural crest lineage are permanently 
labeled with a stochastically chosen colour (Snippert et al., 2010). A detailed 
description of how the labelling strategy is achieved can be found in Chapter 3. 
In this chapter the pattern of neural crest derived chondrocytes is described in 
detail. 
 
Using this novel genetic technique I re-examine the cranial base to relate the 
macroscopic anatomical growth of the cranial base to the cell proliferation of the 
chondrocytic tissue during different stages of growth. This study encompasses 
cranial base growth from e14 to 4 weeks of age in the mouse, when it is near 
maturation. 
 
In Part 1 of this chapter I examine the gross anatomical changes in the 
dimensions of the cranial base, and utilise the Wnt1CrexConfetti mouse to 
dissect the clonal structure of the cartilaginous synchondroses.  
This reveals a cryptic modularity in the growth sequence of the individual cranial 
base elements, which has relevance for the interpretation of the phenotypes of 
many cranial base syndromes. 
 
In section 1 of Part 1 I examine the cranial base at e18 in both the Wnt1crexLacZ 
mouse and Wnt1CrexConfetti mouse. I confirm the existence of the SES in the 
mouse cranial base at this age. The analysis of the Wnt1CrexConfetti cranial 
base reveals an isotropic and anisotropic pattern of clonal expansion in the 
cartilage. It also indicates that the growth of the SES and MSS are differently 
controlled. 
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To understand when this anisotropy/isotropy emerges, I then undertook a time 
course analysis of the cranial base of the Wnt1CrexConfetti line at ages e14.5, P1 
and P26. 
This analysis shows that anisotropy of clones establishes in dorsal-ventral plane 
the MSS before the SES, and by P26 anisotropy is established in both 
synchondroses. 
 
In the Section 2 of Part1, I quantify the anatomical growth of the elements of the 
cranial base in the anterior-posterior (A-P) axis, hence the length of the cranial 
base. I find that the growth of separate elements is not coordinated, with different 
phases of growth and contraction for different bones and cartilages. 
 
I then examined length growth in the chondrocyte clones of the cranial base. 
I find that clone length growth is continuous in the cranial base SES and MSS, 
but cellular expansion in the A-P axis within clones in not. Finally I related the 
effect of the length growth of chondrocyte clones on the length growth of the 
cranial base synchondroses. 
I find that the length growth of the SES can be explained by the increase in both 
clone length and cellular numerosity of the clone. 
The length of the MSS is controlled by an ontogenetic expansion and then 
contraction of the number of clones in the A-P axis. 
This is evidence of a differential control of growth in the cranial base depending 
on the anterior-posterior position of that element. 
 
In section 3 I quantify the anatomical growth in the dorsal ventral axis, the 
thickness growth of the cranial base. 
This revealed that the thickness growth of the cranial base synchondroses is 
continuous between e14.5-P26. The SOS is the synchondrosis with the fastest 
rate of growth and by P26 is the thickest synchondrosis in the cranial base .The 
SOS has a biphasic growth trajectory; unlike the MSS and SES with grow at a 
steady rate. I then related the contribution of clone growth in the dorsal ventral 
axis to the thickness growth of the cranial base synchondroses. 
From this analysis, the shape and orientation of cells within the chondrocyte 
clones of the cranial base emerge as a factor in thickness growth. 
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In section 4, I compare the growth of length and thickness of the cranial base 
synchondroses to understand how these are related. 
Between e14.5-P1, length growth of the synchondroses dominates growth though 
length and thickness growth are coordinated. Between P1 and P26 however there 
is a disconnect between the growth trajectories of the two dimensions, the 
synchondroses contract in length whilst increasing in thickness. This disconnect 
can be explained by the growth trajectory of clones between P1-P26. 
 
In Part 2 of this chapter I examine another aspect of cranial base development, 
the biomineralisation of the endochondral bones. 
 
In section 1 of Part 2 I demonstrate that the sequence of biomineralisation in the 
bones of the cranial base depends on both mediolateral and anterior-posterior 
position. In section 2 I demonstrate that the cranial base ossified in an intercalary 
manner reminiscent of that seen in the dermal frontal bone in Chapter 1. 
Finally in section 3, I find that the synchondroses of the cranial base are bordered 
by the oldest mineralised matrix of the cranial base, contrary to previous findings 
in the literature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 276	
5.1 Cryptic polyclonal modularity of growth in the cranial base  
5.1.1 Anisotropic and isotropic expansion of chondrocyte clones in the cranial 
base 
 
The cranial base anterior to the pituitary is nearly exclusively NC derived at e18, 
as reported previously (Couly et al., 1993, McBratney-Owen et al., 2008).  
Figure 5.4 shows an e18 Wnt1CrexLacZ cranial base stained with X-gal. There 
are NC derived cells present in the anterior margin of the SOS, but anterior to 
this much of the posterior basisphenoid is unlabelled and hence mesodermal in 
origin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: The e18 Wnt1xLacZ cranial base shows cells anterior to the 
pituitary are NC derived 
A) X-gal (dark blue), hematoxylin and eosin (HE) stain of sagittal section 
of an e18 Wnt1CrexLacZ cranial base, X-gal stain labels the neural crest 
derived anterior portion of the cranial base. The posterior boundary is the 
anterior margin of the SOS. 
B) SES as defined by a region of proliferative chondrocytes at the 
anterior presphenoid (yellow outline) 
Scale bar 500µm 
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5.1.1.2 
5.1.1.2.1 The SES is patent in the mouse as a one directional growth zone 
 
The SES is a recognised feature of the human and primate cranial base as a block 
of cartilage that lies between the ossified presphenoid bone and ossified ethmoid 
bone. In the mouse the ethmoid remains unossified, and because of this many 
authors do not acknowledge the presence of the SES in the mouse cranial base 
(McBratney-Owen et al., 2008).  
I examined to the cranial base for evidence of a growth zone between the 
presphenoid bone and the ethmoid cartilage, to decide whether I could include 
the SES in my analysis of chondrocyte clones. 
When examining the Wnt1CrexLacZ cranial base at e18, anterior to the future 
presphenoid there is a region chondrocytes that assume the stacked colloidal 
morphology of proliferative chondrocytes. Anterior to this region is the ethmoid 
where cells have a resting chondrocyte morphology (figure 5.4b, yellow dotted 
outline). 
I then examined the e18 Wnt1xConfetti cranial base. By using the 
Wnt1CrexConfetti reporter, a pattern of clonality becomes visible in the 
chondrocytes of the synchondroses. From this clonal pattern, the direction of 
clonal expansion also becomes visible in a region with an ossified presphenoid, 
anterior to the region of hypertrophic chondrocytes posterior to the proliferative 
chondrocytes. This can be seen in figure 5.5a, where in an e18 Wnt1Crexconfetti 
cranial base, directly anterior to the trabeculated bone is a narrow region of 
hypertrophic cartilage, and anterior to this a region of stack colloidal 
chondrocytes. 
This indicates that this region is an active zone of cellular expansion, though not 
double-sided like the MSS and SOS. As it is a region of cell proliferation and in 
the equivalent position, I consider this feature to be the murine SES in the 
anatomical and clonal analyses of this chapter. 
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5.1.1.2.2 Chondrocyte clonal expansion in the SES and MSS appear to be 
aligned to the dorsal ventral axis, unlike chondrocyte clones of the ethmoid 
 
In the Wnt1CrexConfetti cranial base, the individual NC derived clones in the 
ethmoid show very little to no directionality of growth. This is evident in figure 
5.5a, which shows an e18 Wnt1xConfetti SES and ethmoid. The multi-coloured 
chondrocyte clones do not align in any one direction in the ethmoid. In the SES 
there is some alignment in the DV axis of clones made up of small numbers of 
cells. 
Figure 5.5: Confetti labeling reveals directionality of growth in SES and 
ethmoid chondrocytes clones 
A) Sagittal section of SES in an e18 Wnt1xConfetti cranial base and nuclei 
counterstained with DAPI. As well as the colours of the confetti 
construct, many of the cells are unlabelled. 
B) Sagittal section of  SES in an e18 Wnt1xLacZ  specimen stained with 
Xgal and a HE stain. Note there is no unlabelled material in the cells of 
the cartilage in the lower image. 
Scale bar 500µm 
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This novel information is not visible in the e18 Wnt1xLacZ cranial base figure. 
From the comparison it is clear that there is much unproductive recombination in 
the Wnt1CrexConfetti line, yet it also gives useful clonal information that is not 
available in the Wnt1CrexLacZ specimen. There are many clones in the SES and 
ethmoid cartilage at this age, all in small groups of 2-5 cells of a single colour. 
The unlabelled cells can be of use, and treated like another colour when 
considering images subjectively. It was not used in any calculations due to the 
impossibility of discriminating whether an unlabelled region is made up of one 
or many clones. 
 
I examined the pattern of clones in the more posterior MSS to understand if the 
other synchondroses of the cranial base display any anisotropy of clones. 
 
Unlike the cartilage of the ethmoid, the NC derived chondrocytes clones of the 
MSS display clear anisotropic expansion. The clones expand in the DV axis, 
forming parallel columns of cells.  
In figure 5.6b shows the MSS in an e18 Wnt1CrexConfetti specimen, and the 
parallel columns of clones. Many of these clones have contact with the 
perichondrium and appear to extend into the bone (red arrows). Rarely, these 
clones extend from the ventral perichondrium to the dorsal perichondrium (white 
arrow). This information is invisible in the Wnt1CrexLacZ MSS. 
 
The clones of the MSS and SES and ethmoid appear to have display different 
types of clonal expansion. I investigated the clones of the NC:mesodermal 
boundary, to establish the pattern of clonality at this important and mobile 
landmark in the cranial base. 
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5.1.1.2.4.The chondrocyte clones at the neural crest/mesodermal boundary 
expand anisotropically in the manner of the MSS clones 
 
The confetti clones of the NC:mesodermal cranial base expand anisotropically. 
The cells of the separate clones are stacked in columns that align with the DV 
axis. This can be seen in figure 5.7a (white arrows), where three NC clones are in 
contact with the ventral perichondrium and extend upwards into the SOS. 
These findings hint at a modularity of growth of the cartilage of the cranial base, 
depending on the anterior-posterior position of the synchondrosis. 
Figure 5.6:Confetti labeling reveals anisotropic  growth in the MSS in the dorsal-ventral 
axis 
A) Sagittal section of MSS in an e18 Wnt1CrexConfetti cranial base nuclei 
counterstained with DAPI. As in the SES there are many cells unlabelled interleaved 
with the labelled clones. The coloured clones form parallel columns that are aligned 
with the dorsal-ventral axis. 
B) Sagittal section of MSS in an e18 Wnt1CrexLacZ specimen stained with Xgal and a 
HE stain. All cells in the cartilage are labelled, but gives no information about the 
direction of expansion of chondrocytes. 
Scale bar 500µm 
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5.1.1.3 Conclusion 
 
From sections of e18 Wnt1Cre x LacZ and confetti mice I can identify a growth 
zone anterior to the presphenoid, due to the presence of cells with the 
morphology of proliferative chondrocytes. On this basis I consider the mouse to 
possess an SES and will include this region in future analyses and measurements. 
It appears that at e18 the NC derived chondrocytes that divide in clonal groups 
have directionality to their growth. These clonal groups can not be seen in a 
Wnt1CrexLacZ specimen of the same age, and are potentially useful as they 
indicate in which direction cells are dividing, and hence which dimension of the 
cranial base that they are contributing to. They are also helpful in defining the 
region of proliferative chondrocytes in the SES region. 
Figure 5.7: The neural crest chondrocyte clones at the neural crest: mesoderm 
boundary expand anisotropically like the clones of the MSS 
Hypertrophic region in both samples is largely unlabelled 
A) Sagittal section of anterior SOS in e18 Wnt1CrexConfetti specimen nuclei 
counterstained with DAPI. 
B) Sagittal section of anterior SOS in e18 Wnt1CrexLacZ specimen with Xgal 
and HE stain. 
Scale bar 100 µm 
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To establish whether the appearance of clonal alignment is true anisotropy and 
when it emerges in the synchondroses of the cranial base I undertook a time 
course study examining the Wnt1CrexConfetti cranial base at e14.5, P1 and P26, 
and quantifying the direction that the long axis of individual clonal groups was 
aligned to in comparison to the cranial base longitudinal axis (the anterior-
posterior axis of the skull). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 283	
5.1.2: Time course of the Wnt1CrexConfetti cranial base reveals differences in 
the chondrocyte clonal anisotropy in SES and MSS 
 
 
At e14.5 I observe that the cranial base in completely cartilaginous, with no 
ossification centres. The NC:mesodermal boundary is of the cranial base is at the 
level of the anterior margin of the pituitary. The precursors to the SOS, MSS and 
SES are establishing. I wish to examine the pattern of neural clones in more 
detail, and how their expansion influences the growth of the cranial base 
cartilage. 
 
5.1.2.2 
5.1.2.2.1 NC derived cells in the e14.5 cranial base consist of a very large 
number of small clones 
 
At e14.5 the NC derived clones of the cranial base are prolific, but individual 
clones are made up of very small numbers of cells. 
This can be seen in figure 5.8, which shows an e14.5 Wnt1xConfetti mouse 
sagitally sectioned at the midline. The nasal septum and the cartilage in the 
position of the sphenoid is full of labeled cells, but the ‘confetti’ like appearance 
of the clones indicates that individual clones constitute a small number of cells. 
 
There are NC derived cells aligned with the A-P axis forming a proto-
perichondrium, which can be seen in figure 5.8. There is a margin of cells that 
are perpendicular to the cells in the interior of the cartilage that lies ventral to the 
thirds ventricle. 
This suggests that a growth signal for cell proliferation is already established at 
this age in this axis. 
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Figure 5.8: NC derived cells in the e14.5 cranial base consist of a very large 
number of small clones 
Midsagittal section of an e14.5 Wnt1CrexConfetti  specimen nuclei 
counterstained with DAPI. B.occ=basisocciput, Pit=pituitary, 
SOS=sphenoccipital synchondrosis 
Pit
. 
Tongue 
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5.1.2.2.2 SES and ethmoid chondrocyte clonal expansion changes from isotropic 
habit at the early stage of development to anisotropic at a later stage  
 
The SES and ethmoid appear to have very little anisotropy in the e14.5 cranial 
base. By P1 the SES confetti clones have begun to align with the dorsal ventral 
(DV) axis, though most ethmoid clones are isotropic. By P26, when the cranial 
base in mouse nears maturation the chondrocytic clones of the SES and ethmoid 
have established strong anisotropy, and are aligned with the DV axis. 
This finding is illustrated by figure 5.9. Figures 5.9a shows there is a little 
organisation of the clone number of small clones in the SES the e14.5 
Wnt1CrexConfetti cranial base. In 5.9b, a P1 Wnt1CrexConfetti specimen, the 
number of cells within individual clones has increased, and the clones are 
aligning with the DV axis in the SES. In figure 5.9c, clones in the SES and 
ethmoid have increased in cellular numerosity, and all align with the DV axis. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9: SES clonal expansion appears relatively chaotic at early stage to but becomes 
anisotropic at a later stage of development 
Sagittal sections of Wnt1CrexConfetti cranial base at e14.5, P1 and P26 
A) Wnt1Cre x Confetti SES at e14.5.Cells appear disorganised, individual clones have 
very small number of cells. 
B) Wnt1Cre x Confetti SES at P1. The neural crest derived clones have expanded and 
appears more orientated in the dorsal ventral axis. 
C) Wnt1Cre x Confetti SES at P26. Clones appear to have dorsal-ventral directionality. 
All sections DAPI counterstained to show nuclei (blue). 
200µm 
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5.1.2.2.3Anisotropic clonal expansion is established early stages of development 
of the MSS 
 
I went on to examine the arrangement of clones in the MSS and how they change 
through time 
The chondrocyte clones found in the mid-sphenoid at e14.5 have already 
established a dorsal-ventral alignment. This anisotropy is very pronounced at P1, 
with individual clones aligned in tall columns of cells. This anisotropy persists in 
the P26 MSS. 
 
 
 
This can be seen in the series of images in figure 5.10, a sequence of sagittal 
sections from the Wnt1xConfetti cranial base showing the MSS. At e14.5 the 
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Figure 5.10: Anisotropic clonal expansion is established early in the MSS 
Sagittal sections of Wnt1Cre xConfetti cranial base at e14.5, P1 and P26 
A) Wnt1Cre x Confetti MSS at e14.5. Cells of the neural crest derived 
clones have some dorsal ventral alignment. Scale bar 100µm. 
B) Wnt1Cre x Confetti MSS at P1. The neural crest derived clones 
have clear dorsal-ventral directionality. Scale bar 200µm. 
C) Wnt1Cre x Confetti MSS at P26. Clones appear to have dorsal-
ventral directionality. Scale bar 200µm. 
All sections DAPI counterstained to show nuclei (blue). 
 
 
	 287	
small chondrocyte clones are aligned in the DV axis (5.10a), the largest columns 
only being 2-3 cells in height. By P1 the chondrocyte clones are highly 
anisotropic with clones many cells tall in the DV axis (5.10b). At P26 the cells 
within individual chondrocyte clones are still aligned with the DV axis, but the 
number of clones in the MSS is greatly reduced compared to P1. The MSS itself 
has also appears narrowed compare to P1 (figure 5.10c). 
 
 This sequence is unlike that seen in SES. I wished to understand the sequence of 
clonal expansion at the NC:mesodermal boundary, and I hence I examined the 
NC clonal contribution in the SOS over time. 
 
5.1.2.2.4: At e14.5 the NC clones contribute to the SOS in an anisotropic 
fashion, and by P1 the NC:mesodermal border has moved anteriorly into the 
basisphenoid 
 
At e14.5 there are NC clones contributing to the anterior SOS, and these cells 
align in the DV axis. From figure 5.7a we know that this anisotropic contribution 
is still present at e18, but by P1 the NC:mesodermal boundary has moved 
anteriorly out of the SOS. 
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Figure 5.11 shows this process. At e14.5 in the Wnt1CrexConfetti SOS (5.11a) 
the clones are mostly made up of small number of cells aligned in the DV axis. 
By P1 in the Wnt1CrexConfetti cranial base (5.11b) there is no NC contribution 
to the cartilage of the SOS, the most posterior NC labelling is seen in the 
basisphenoid bone. In figure 5.11c, at P26, the SOS cartilage has narrowed, and 
though there is NC labelling in the basisphenoid bone, it is far less extensive than 
at P1. 
A 
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Figure 5.11: NC clone contribution to the SOS is lost after birth 
Sagittal sections of Wnt1Cre xConfetti cranial base at e14.5, P1 and P26 
A) Wnt1Cre x Confetti SOS at e14.5. Neural crest contribution is to 
anterior margin only 
B) Wnt1Cre x Confetti SOS at P1. There is no contribution to the 
neural crest cartilage at this stage 
C) Wnt1Cre x Confetti SOS at P26. As at P1, there is no neural crest 
contribution 
All sections DAPI counterstained to show nuclei (blue). 
Scale bar 200µm. 
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This shows that at the early stages of development there is a similarity in clonal 
expansion in the MSS and SOS. There is also a similarity is the contraction 
(narrowing of the cartilage) between P1 and P26 that was not evident in the SES 
between these ages. This can be seen in the time courses of the MSS and SOS in 
figures 5.10 and 5.11 respectively.  
The similarity in growth pattern could indicate that MSS and SOS are coordinate 
in growth to some extent. 
To be able to compare the directionality of clones in the MSS and SES I analysed 
the alignment of the long axis of the clones compared to the longitudinal axis of 
the cranial base (i.e. the anterior posterior axis). 
 
 
5.1.2.2.5:Quantifying the anisotropic growth of clones in the cranial base 
synchondroses 
MSS clone show less varied directionality than SES 
 
To quantify the direction that clones were aligned to, an outline was drawn 
around the clones, defined as a discrete group of chondrocytes adjacent to each 
other all of the same colour. This was done using ImageJ, where the dimensions 
of the clone outlines can be measured, as well as the angle of the long axis of the 
clone from the horizontal. Images were corrected before measurement of clones 
to ensure the cranial base was at the horizontal and not at an angle. 
The clone outlines were used to understand which way the clones aligned 
compared to the direction of longitudinal growth (i.e. anterior posterior axis) of 
the cranial base. The alignment of the long axis of clones was arranged into a 
frequency distribution into bins 20o wide (figure 5.12). 0o would be a clone 
aligned perfectly with the anterior posterior axis of the cranial base, whilst a 
clone at 90o would be aligned with the dorsal ventral axis of the head (5.12a). 
The e14.5 SES has clone that align between 80o and 160o from the cranial base 
anterior posterior axis (figure 5.12b). This alignment shifts somewhat with age to 
between 60o and 140o (5.12c). By P26 the alignment of clones has split into two 
categories, one peak between 0o and 40o hence alignment reasonably well with 
the direction of anterior posterior growth, and another at 100o to 120o, better 
aligned to the dorsal ventral axis. 
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At e14.5 the clones of the MSS are aligned predominately between 20o-40o from 
the cranial base anterior posterior axis (figure 5.12e). This changes by P1, where 
clones are aligned predominately between 70 o and 110o from the cranial base 
(figure 5.12f), meaning the growth is aligned with the dorsal ventral axis of the 
skull increasing the height of the synchondrosis cartilage in preference to width. 
This dorsal ventral alignment is maintained at P26, becoming even more 
narrowly centred around 90o (figure 5.12g).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0	
5	
10	
15	
20	
10°	
30°	
50°	
70°	
90°	110°	
130°	
150°	
170°	
B C D 
e14.5 
SES 
MSS 
0	
2	
4	
6	
8	
10	
12	
14	
10°	
30°	
50°	
70°	
90°	110°	
130°	
150°	
170°	
0	
5	
10	
15	
20	
25	
30	
35	
10°	
30°	
50°	
70°	
90°	110°	
130°	
150°	
170°	
0	
2	
4	
6	
8	
10	
10°	
30°	
50°	
70°	
90°	110°	
130°	
150°	
170°	
0	
1	
2	
3	
4	
5	
6	
7	
10°	
30°	
50°	
70°	
90°	110°	
130°	
150°	
170°	
0	
5	
10	
15	
20	
10°	
30°	
50°	
70°	
90°	110°	
130°	
150°	
170°	
E F G 
P26 
0o 
90
o 
180o 
A 
P1 
A	P	
D	
V	
Figure 5.12: MSS chondrocyte clones show more defined anisotropy of growth than SES 
Vertical axis shows number of clones, circular axis degrees from the horizontal. Green 
line total of clones in a single specimen, orange line represent individual sections from 
that specimen. 
A) Direction of measurements. Yellow box represents clone outline, black outline cranial 
base 
B-D) Frequency plots of alignment of SES clone direction with cranial base at the ages 
of e14.5, P1 and P26. Most SES clones are at an angle of 100-120 degrees to the cranial 
base between the ages of e14.5 and P1. By P26 there is and even distribution between 
120 and 20 degrees, which would contribute to longitudinal growth. E-G) Frequency plot 
of alignment of SES clone direction with cranial base at the ages of e14.5, P1 and  P26. 
The predominate angle of the clones changes from 20-40 degrees at e14.5 to between 80 
and 100 degrees at P1 and P26. Growth between P1 and P26 is therefore directed at 
approximately 90 degrees to the cranial base.  
Clones were measured across three sagittal sections in a single mouse for each timepoint. 
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The clones of the MSS show a clearer anisotropy compared to the SES clones. 
(5.12b-d compared to 5.12 e-g). The two synchondroses also have somewhat 
different predominate directions of their clones. This is especially noticeable at 
e14.5 where SES clones and aligned at 90-130o from the cranial base whilst MSS 
clones are aligned at 30o (5.12 b and 5.12e). Also at P26, where SES clones 
appear to align in two major directions, 0-40o and 90-130o, whilst the MSS 
clones align very well to 90o from the cranial base long axis (5.12d and g). 
 
 
5.1.2.2.6 Number of clones in the SES and MSS rises from e14.5 to P1 and 
declines after P1to P26 
 
In the SES and MSS the number of clones appeared to vary with age. 
I quantified the number of clones in the SES and MSS at e14.5, P1 and P26. 
Clonal population follows different trajectories in the SES and MSS. 
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Figure 5.13: Number of clones in the synchondroses rises from e14.5 to 
P1 and declines after birth 
 
Mean number of clones per synchondrosis. Dark green line SES, light 
green MSS. Clones counted across three sagittal sections from a single 
specimen for each timepoint. 
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Figure 5.13 shows that the SES begins at e14.5 with a relatively high number of 
clones, 27.7, which slightly increases at P1 to 31. By P26 the number of clones 
has greatly decreased to 10.7(dark green line). 
The MSS shows a different pattern of clone population variation. 
Figure 5.13 (bright green line) shows at e14.5 there are very few clones in the 
MSS, 10.7, and this increases nearly fourfold to 40.3 by P1. But by P26 the 
number of clones reduces to 9, near the e14.5 number. 
 
A difference in the contribution of numbers of clones in the SES and MSS is 
more evidence that these two cartilaginous structured experience differential 
control of growth. 
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5.1.2.3: Conclusion 
 
From a qualitative analysis of the clonal structure of the MSS and SES, it appears 
that these two structures are dis-coordinated in their clonal growth patterns. This 
was confirmed when the alignment of chondrocyte clones was quantified 
 
It was found that the number of clones changes with age in both synchondroses, 
rising at P1 and declining at P26 in both, but the SES at e14.5 has a higher 
number of clones than the MSS. The direction of these clones as compared to the 
cranial base long axis varied between the synchondroses, and with age within a 
single synchondrosis. In the MSS this is particularly clear, with e14.5 clonal 
chondrocyte groups having long axis aligned at 30o from the cranial base, whilst 
at P1 and P26 these cloned are aligned at 90o to the cranial base. These later 
clones are dividing in a direction that contributes to thickness growth of the 
cranial base synchondroses, whilst at an earlier age the alignment would 
contribute more to length growth. The clones of the SES never align 
predominately at right angles to the cranial base, but and angles of 120o and 30o. 
I am interested to see if these clonal changes translate into directionality of 
growth in the cranial base. From this I would predict the MSS grows more in 
thickness than the SES. 
 
To relate this alignment of clones to the gross anatomical growth of the MSS and 
SES at different points of development, I went on to measure the growth of the 
individual bone and cartilage elements of the cranial base as well as the growth 
of individual clones. 
I wish to discover if the growth of chondrocytic neural crest clones in a cranial 
base synchondrosis is related to the anatomical trajectory of growth within a 
synchondrosis. I also wish to ascertain whether the sequence of growth of the 
synchondroses differs between the three synchondroses. 
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5.1.3: Disjunction of anatomical and clonal length growth in the cranial base 
bones and synchondroses 
5.1.3.1 Introduction 
 
The rate of growth of the cranial base is known to differ along the A-P axis, 
especially the timing of the closure of the cranial base synchondroses in humans, 
the closure of which varies by decades (Madeline and Elster, 1995). Though the 
timing of the closure of these synchondrosis has been well studied in relation to 
malformation of the skull (especially the very late closure of the SOS), it has 
been pointed out that 60% of the final length of the cranial base has been 
achieved by birth in humans (Wei et al., 2016), and reaches full size before the 
skull vault or facial region (Bastir et al., 2006). 
The growth before the closure of the sutures should not be ignored when trying 
to understand its growth. 
In the mouse line used in this study (C57BL/6J) the synchondroses of the cranial 
base are thought to never ossify and therefore never close. 
To understand the coordination of the growth of the cranial base as a whole and 
between the separate elements in the mouse, I measured the A-P length of each 
of the bones and synchondroses of the cranial base at e14.5, P1 and P26 (see 
Technical Appendix for landmarks used). This was done using 3 sections from 1 
specimen for each age. 
This gives detailed information on the changing contribution to length of the 
constituent elements of the cranial base. 
 
5.1.3.2 Results 
5.1.3.2.1: The total length of the cranial base length is dominated by different 
elements at different ages  
 
 At different stages of development the constituent elements of the cranial base 
are contributing in different proportions to its total length. 
 
At e14.5 the average cranial base length is 2449µm. At e14.5 the mesodermal 
basisocciput is overwhelmingly the largest single element of the cranial base, 
comprising half its total length. The other elements are comparatively small, all  
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being between 4-13% of the total length of the cranial base (Figure 5.14, first bar 
stacked column).  
By P1 the cranial base has lengthened considerably, to 6484 µm in length (figure 
5.14, stacked column 2). As a whole, the neural crest components of the cranial 
base have now increased in their contribution to the cranial base, but this is due 
to differential expansion of the separate NC derived bones. 
The ethmoid is now contributing 17% to the cranial base, a 6% increase on 
e14.5. 
Figure 5.14: Cranial base length is dominated by different regions at different ages  
Stacked column chart showing the anterior posterior length in microns of the 
separate cartilage and bone elements of the cranial base at e14.5, P1 and P26. 
Numbers represent the percentage that each element makes of the total cranial base 
at that age. Green coloured elements are NC derived, grey are mesodermally 
derived. Measurements taken are the mean of three sagittal sections from a single 
specimen at each age. 
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The presphenoid nearly doubles its contribution to the cranial base, from 8-14%, 
whilst the basisphenoid does not make a gain from 13% of the cranial base at 
e14.5 to 14% at P1. 
 
The basisocciput at P1 makes up only 30% of the cranial base, a sharp decrease 
from 50% at e14.5 
The synchondroses all make small increases in contribution to cranial base length 
between e14.5 and P0, the SES, MSS and SOS going from 4-5%, 8-9% and 7-
10% of the cranial base length respectively. 
 
By P26 the cranial base is 10571 µm in length, the three synchondroses have all 
decreased in absolute size and in relative contribution to the cranial base, the 
SES from 5-3%, the MSS 9- 3% and the SOS from 10-3% of cranial base length 
(figure 5.14, columns 3). 
 
The basisocciput (30-28%), presphenoid (14-17%) and ethmoid cartilage (17-
19%) do not make big changes in their contribution to the total length of the 
cranial base. 
 
The basisphenoid makes a large increase in contribution to the cranial base the 
biggest gain in length, from 14 -21% of the cranial base. The sphenoid as a 
whole is now the longest bone in the cranial base, making up 41% of its length. 
 
It is clear from these results that the different constituent elements of the cranial 
base differ in their timing of length growth. 
 
To compare this more directly, I calculated the rate of increase in length of each 
of the cranial base elements, from e14.5-P1, and P1-P26, to identify the phases of 
substantial growth of each element. 
 
 
 
 
	 297	
5.1.3.2.2: The rate of longitudinal growth in the cranial base constituents changes 
between the prenatal and postnatal stages 
 
In the e14.5-P1 time window all elements of the cranial base increase, though not 
at the same rate. The rate of increase of the cranial base between P1-P26 is 
slower for the total cranial base compared to e14.5-P1. Also, in this P1-P26 time 
window whilst the ossified structures of the cranial base increase in length, the 
cartilaginous MSS and SOS halve in length. 
The embryonic stage of the cranial base growth is extremely fast, from e14.5 to 
P1 the cranial base increases in length 2.5. Between P1 and P26 the cranial base 
increases in length 1.6 fold, the rate of increase has nearly halved (far right bars, 
figure 5.15). 
 
 
 
 
 
 
 
 
 
In the e14.5-P1 (blue columns, figure 5.15) time window, the basisocciput is the 
slowest growing bone in the cranial base, increasing in length by 1.7 fold. 
Figure 5.15: The rate of longitudinal growth in the cranial base constituents changes 
between the prenatal and postnatal stages 
Bar chart showing the percentage change in length of individual cranial base elements 
between e14.5 and P1 (blue bars) and P1 and P26 (red bars). Eth=ethmoid, 
P.Sph=prespehnoid, B.Sph=basisphenoid and B.Occ=basisocciput 
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The presphenoid is the fastest growing element, increasing in length 4.6 fold 
between e14.5 to P1. 
Between P1 and P26 the rate of length growth is slower than the e14.5-P1 time 
window for every element (red bars figure 5.15). 
The MSS and SOS are especially notable, as these synchondroses have both 
halved in length compared to the P1 size. The SES has not significantly changed 
in length from P1. 
The basisocciput is still the slowest growing, but the fastest growing bone is now 
the basisphenoid, which increases in length 2.5 fold in the P1-P26 time window. 
 
The maximum growth rate of the constituent bones and cartilage of the cranial 
base is not coordinated within the cranial base. At different time points different 
elements are dominating the length growth of this anatomical structure. 
The ethmoid and presphenoid are the fastest lengthening bones in the cranial 
base between e14.5-P1, but their growth slows comparatively between P1-P26. 
The basisphenoid is the fastest lengthening element at P1-P26. 
The basisocciput has the most consistent growth of all the elements in the time 
course examined. 
The synchondroses of the cranial base have widely varying growth trajectories. 
The SES, MSS and SOS all increase at a similar rate between e14.5 and P1, all 
between a 2.9-3.2 fold increase in length. 
There is a disjunction of length growth of the synchondroses between P1 and 
P26. The anterior most synchondrosis, the SES, does not significantly change in 
length between P1-P26, but the MSS and SOS contract by half the P1 length in 
this time. 
 
These results indicate that there may be different sequence of growth signaling 
depending upon the anterior-posterior position of an element in the cranial base. 
 
I will now analyse the pattern of growth of the NC derived chondrocytic clones 
of the MSS and SES to understand if the different anatomical growth trajectories 
have a relationship to the clonal growth pattern. 
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Clonal contribution to longitudinal growth in the cranial base 
 
To understand the contribution to length of chondrocyte clones to the cranial 
base, I considered two properties: the absolute length of the clones, and the 
number of cells in the A-P axis of a clone. The clones were counted across three 
sections of a single mouse for each timepoint, the clone numbers are detailed in 
Table 5.1. 
 
Table 5.1 Total numbers of neural crest derived chondrocyte clones 
 
Age No. of 
Wnt1Crex 
Confetti  
specimens 
No. of sections No. of Clones 
SES 
No. of clones 
MSS 
e14.5 1 3 83 32 
P1 1 3 93 121 
P26 1 3 32 27 
 
 
 
5.1.3.2.3:The length of NC derived clones increases in the SES and MSS with 
age  
 
Between e14.5 - P1 and P1-P26 the average absolute length of the clones in in 
the SES and MSS increases with age. In the SES and MSS clones size doubles 
between e14.5 and P1. In the SES clone size doubles again between P1 and P26. 
Clones size also increases in the MSS in the later time period, but only by 50%. 
There is no significant difference between the size of clones in the age-matched 
SES and MSS (figure 5.16). 
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5.1.3.2.4: The length increase of clones is not due to proliferation of 
chondrocytes in the AP axis. 
 
 
The number of clones contributing to height synchondrosis does not correlate 
with the increases size of the clone (5.16b). This figure shows that there is no 
difference in the number of cells between e14.5- P1 in either the SES or MSS.  
The number of cells in the clones increases between P1-P26 in both the SES and 
MSS. 
As with clone length, there is no significant difference in the number of cells 
contributing to clone length in the MSS and SES at the same age. 
 
I then compared the clone length and clone cell count to the length of the 
synchondrosis at 14.5, P1 and P26, to understand if the growth of clones and the 
synchondroses are linked. 
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Figure 5.16: Clone length continuously increases with age in the MSS and SES 
A) Mean length of individual clones in the SES and MSS at e14.5 (yellow), 
P1(purple) and P26(orange), as measured in Wnt1xConfetti specimens.  
B) Mean number of cells in the anterior posterior axis in the SES and MSS at 
e14.5 (yellow), P1(purple) and P26(orange), as measured in Wnt1xConfetti 
specimens.  
Error bars show standard error of the mean. Clones were measured across three 
sections in a single specimen for each timepoint . 	
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5.1.3.2.5 SES length growth can be explained by clonal expansion 
 
The average length of a clone in the SES correlates with the length of the SES as 
it increases with time. The number of cells in the clones also increases with time, 
and positively correlates with the length growth of the SES. 
 
Figure 5.17 shows two scatter plots: 5.18a is the length of the SES against the 
length of an average clone in; 5.18 b shows the length of the SES against the 
number of cells in the AP axis of a clone. 
Both variables of clone size correlate well with the length of the SES; the longer 
the clone or the more cells in the A-P axis, the bigger the synchondrosis. The 
length of the SES and clone length correlates positively with age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.17: Expansion of the SES at clonal resolution 
A) Length of SES vs. the mean absolute length of the clone at e14.5 (yellow), 
P1(purple) and P26(orange). 
B) Length of SES vs. mean number of cells per clone contributing to length (i.e. in 
longitudinal plane) at e14.5 (yellow), P1(purple) and P26(orange). 
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5.1.3.2.6 Ontogenetic expansion and contraction of the MSS at clonal resolution 
 
The length of the clones in the MSS is related to cellular numerosity of the clone. 
However this does not correlate with MSS length. 
 
Between e14.5 and P1, the length of the MSS increases, and is accompanied by a 
small increase in clone length, and number of cells in a clone (figure 5.18a and 
b). 
Between P1-P26 the length of the MSS decreases, and both the length of clones 
and the cellular numerosity of the clones increases. 
 
This relationship of MSS length and clone length and cellular numerosity is 
different from the relationship seen in the SES. 
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Figure 5.18: Ontogenetic expansion and contraction of the MSS at clonal resolution 
A) Length of MSS vs. the mean absolute length of the clone at e14.5 (yellow), P1 
(purple) and P26 (orange). 
B) Length of MSS vs. mean number of cells contributing to the length of the clone at 
e14.5 (yellow), P1 (purple) and P26(orange). 
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5.1.3.3 Conclusion 
 
The SES and MSS do not achieve changes in their length via the same 
mechanisms. 
The clones of the SES increase in length due to an increase in cellular 
numerosity of the clones in the A-P axis between e14.5 and P26. 
In the MSS there is a disconnect between the growth trajectory of the 
synchondrosis and the constituent clones.  
The growth trajectory of the MSS is biphasic, with a considerable increase in 
length between e14.5-P1. This increase in can be explained by the length of the 
constituent chondrocyte clones, and is accompanied by an increase in cellular 
numerosity. 
However, the second phase of MSS development in a contraction of the cartilage 
size by half between P1-P26. Instead of a decrease in clone length, the clone 
length increases between P1 - P26, as does the number of cells per clones. 
This is different to the linear relationship between SES length and SES clone 
length. 
The mechanism for decreasing the length of the MSS between P1-P26 does not 
involve a decrease in clone size, but likely involves a decrease in the number of 
clones which I have demonstrated takes place between P1-P26 (section 1,figure 
5.13). 
 
This difference could be explained by a difference in the source of growth 
signaling due to the position of the two synchondroses. The SES is most likely 
influenced by the factors that dictate the growth of the ethmoid, which will be 
influenced by the growth trajectory of the frontal and nasal bones, as well as the 
nasal capsule. The MSS is more anterior, and more likely influenced by 
signalling from the overlying brain, specifically the diencephalon. As explained 
in the introduction the ventral diencephalon is known to be a source of Shh, 
BMP4 and FGF signaling in the early stages of cranial base development. 
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As well as examining the length growth of the synchondroses, it was also 
possible to consider the thickness growth of the synchodroses, and the 
relationship of clonal height and cellular expansion to the thickness growth of the 
cranial base. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 305	
 
5.1.4 There is a disconnect in thickness growth between the three synchondroses 
of the cranial base 
5.1.4.1 Introduction 
As well as growing in the A-P axis, I analysed the thickness growth of the 
synchondroses, the measurements in the D/V axis. From this I gained 
information of the variation in thickness in the AP axis of the cranial base with 
time. 
5.1.4.2 
5.1.4.2.1: There is continuous growth in synchondrotic thickness between e14 
and P26 
 
All three synchondroses of the cranial base (SES, MSS and SOS) increase in 
thickness between e14.5-P1 and P1- P26. The SOS makes the largest increase in 
thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19: Continuous growth in synchondrotic thickness between e14 and P26 
Column chart showing the mean thickness in microns of the three synchondroses 
in the cranial base at e14.5, P1 and P26. 
Green tones represent neural crest derived elements and grey denotes the 
mesodermal derived elements. Measurements are an average from three sagittal 
section from a single specimen. Error bars show standard error of the mean. 
0	
100	
200	
300	
400	
500	
600	
700	
e14.5	 P1	 P26	
Sy
nc
ho
nd
ro
si
s	h
ei
gh
t/
μm
		
	
SES	
MSS	
SOS	
	 306	
 
At e14.5 the SOS and MSS are both 97µm in thickness and the SES is the 
thickest synchondrosis at 150 µm (figure 5.19, first column cluster). 
 
By P1, the SOS has become the thickest synchondrosis at 333 µm. The SES is 
the second thickest synchondrosis and the MSS the thinnest, though they have 
both increases in thickness from e14.5 (figure 5.19 second bar cluster). 
 
All three synchondroses increase in thickness between P1-P26. The SOS remains 
the thickest synchondrosis at P26, and is on average 653 µm thick. It is 
considerably thicker than the MSS (387 µm) and the SES (359 µm) (figure 5.19, 
3rd column cluster). 
 
I calculated the fold change of thickness of the synchondroses between e14.5-P1 
and P1-P26 to discover if there are phases to the increase in synchondrotic 
thickness. 
 
5.1.4.2.2 Thickness growth in the SOS is biphasic 
 
The SES and MSS grow consistently between the three ages sampled. The SOS 
has an early phase of accelerated growth, and then a slower phase of thickness 
growth later in development. 
The SES increases in height 1.7 fold between e14.5-P1, and 1.5 fold between P1-
P26. The increases in thickness are very consistent in the two time windows 
sampled (figure 5.20, 1st column cluster). 
The MSS also shows a consistent thickness growth trajectory, but the rate of 
increase is faster than in the SES. The MSS doubles in thickness between e14.5-
P1 and between P1-P26 (figure 5.20 2nd column cluster). 
The most posterior synchondrosis, the SOS, unlike the anterior synchondroses 
has a biphasic growth trajectory. 
The SOS increases in thickness 3.4 fold between e14.5-P1, and slows down 
between P1-P26, the SOS doubles in thickness in this time window (figure 5.20, 
thirds column cluster).  
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At e14.5 the SES is the thickest synchondrosis in the cranial base. However it 
has the slowest rate of thickness increase throughout the timecourse, and by P26  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
is the thinnest synchondrosis. Both the SES and MSS grow consistently 
throughout development, and do not display phasic thickness growth. 
In contrast the SOS displays biphasic thickness growth, a very fast phase of 
increase between e14.5-P1, and a slower one between P1-P26. The SOS has the 
fastest rate of thickness growth of the three synchondroses of the cranial base, 
and at P26 is considerably thicker than the SES and MSS. 
I quantified the clone height and cellular numerosity of the clones in the DV axis 
in the SES and MSS, to understand the relationship, if any, between thickness 
growth of the synchondroses and thickness growth of clones. 
 
 
 
Figure 5.20 Thickness growth in the SOS is biphasic 
Blue bars indicate factor increase in thickness of cartilage between e14-
P1 Red bars indicate factor increase in thickness of cartilage between P1-
P26. Most notable increase in thickness is by the SOS that between e14.5 
and P1 increases in thickness by 3.5 fold. This rate is not sustained in 
postnatal stage 
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5.1.4.2.3 Dorsal- ventral clonal expansion and dorsal ventral cellular expansion 
of clones are not coordinated 
 
5.1.4.2.4. Clone height does not continually increase with age 
 
Between e14.5-P1 clone height in the SES and MSS increases, but between P1-
P26 there is no significant increase in the height of the clone. Between P1 and 
P26 there is no significant increase in the height of the clones in the SES and 
MSS (figure 5.21). 
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Figure 5.21: Clone height and cellular numerosity does not continuously increase 
with age 
A) Mean height of individual clones in the SES and MSS at e14.5 (yellow), 
P1 (purple) and P26 (orange), as measured in Wnt1CrexConfetti 
specimens. Between P1 to P26 there is no significant change in clone 
height. 
B) Mean number of cells contributing to height in individual clones in the 
SES and MSS at e14.5 (yellow), P1(purple) and P26(orange), as 
measured in Wnt1CrexConfetti specimens. Between e14.5 and P1 there is 
no significant change in the number of cells making up the height of a 
clone.  
Clones were counted and measured across three sagittal sections of a 
single specimen for each age. Error bars show standard error of the mean. 
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5.1.14.2.5 Cellular numerosity of a clone does not increase continuously with age 
 
The number of cells contributing to the height of a clone does not change in the 
SES and MSS between e14.5-P1, despite the absolute height of the clones 
increasing in this time period. 
Conversely, the number of cells contributing to the height of the clone does 
increase in the SES and MSS between P1-P26. This is in spite of an increase in 
the height of the clones in this time period (figure 5.21b). 
If the number of cells is not connected to the size of the clone, then another 
factor is influencing clonal size. 
 
Between e14.5-P1, when clone height increases but is not explained by cellular 
expansion, the most likely factors driving the height increase is orientation of 
cells becoming more strictly DV aligned, which would effectively increase 
height without a need for increased cell number in a clone. Another possibility 
would be an increase in collagen deposition between the cells, spacing them 
further apart. 
 
Between P1-P26 the there is an increase in cell numbers in the DV axis, without 
a concomitant increase in clone height. This indicates a change in cell shape 
and/or orientation, which results in the chondrocytes within a clone being more 
condensed at P26 than at P1. 
 
I next compared the clonal thickness growth patterns to the synchondrosis 
growth trajectory. 
 
 
 
5.1.4.2.6 SES thickness growth is explained by both cell proliferation in clones 
and cell shape change 
 
The thickness growth of the SES between e14.5 and P26 can be explained by an 
increase in the height of the constituent neural crest clones. 
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Figure 5.22 plots the height of the SES plotted against the absolute height of the 
clones (5.22a), shows a positive correlation. 
This growth is achieved in two phases by two different mechanisms. 
The growth of the SES e14.5-P1 must be achieved by a change of orientation and 
shape of cells within the clones, as cell number does not change (red arrow). 
Between P1-P26 the increases in thickness of the SES is explained by cellular 
expansion within the clones (figure 5.24b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.22: Thickness growth of the SES is explained by both cell shape and cell 
proliferation 
A) SES height against mean absolute clone height at e14.5 (yellow),P1 (purple) and 
P26 (orange). 
B) SES height against mean number of cells contributing to the height of a clone at 
e14.5 (yellow),P1 (purple) and P26 (orange). Red arrow indicates a region where 
the height of the synchondrosis increases, without a concomitant increase in the 
number of cells. Hence cell proliferation cannot be the only mechanism of clone 
size increase. 
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5.1.4.2.7 MSS thickness growth cam be accounted for by cell proliferation  
 
The thickness growth of the MSS between e14.5 and P26 can be explained by an 
increase in the height of the constituent neural crest clones, comparable to the 
SES. 
However, the sequence of the mechanisms governing clone height it reversed. 
 
Between e14.5-P1, the increase in MSS thickness is explained by cellular 
numerosity (figure 5.23b). 
Between P1-P26 there is no concomitant increase in cellular numerosity with 
increase in synchondrosis thickness (red arrow). In this time period, the 
orientation and shape of cells change to increase the height of the clone and 
hence the synchondrosis thickness. 
 
 
 
 
 
 
 
 
 
 
From this analysis comparing synchondrosis thickness with clone height, shape 
and orientation of the cells in a clone emerges as a novel factor in the growth of 
the cranial base. 
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Figure 5.23: Thickness growth of the MSS is explained by cell proliferation alone 
 
A) MSS height against mean clone height at e14.5 (yellow),P1 (purple) and 
P26 (orange). 
B) MSS height against mean number of cells contributing to clone height at 
e14.5 (yellow),P1 (purple) and P26 (orange). 
As clone height increases in absolute terms and number of cells, synchondrosis 
height increases. 
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5.1.4.3 Conclusions 
 
At e14.5 the SES is the thickest synchodrosis in the cranial base, by P26 the SOS 
in the thickest. 
The thickness growth of the SES and MSS is consistent between e14.5 and P26, 
whilst the thickness growth of the SOS is biphasic. 
 
Cell shape and orientation within a clone as well as cell proliferation emerges as 
a factor in clone height and therefore synchondrosis height. 
Both cell proliferation and cell shape are a factor in SES and MSS growth, but 
the timing of the contribution of these mechanisms differs. 
In the SES, the shape and orientation of cells is a factor of thickness growth 
between e14.5-P1, whilst between P1-P26 cell proliferation explains the increase 
in clone height. 
This is reversed in the MSS, where cell proliferation governs height of the MSS 
and constituent clones between e14.5-P1, whilst between P1-P26 cell shape and 
orientation have a more significant influence on MSS height. 
I have established that there is modularity in the growth trajectories of the 
individual bones and synchondroses of the cranial base. 
As well as different rates and phases of growth, there is evidence that different 
mechanisms are responsible for the clone dimension increase that drives length 
and thickness growth. 
 
Finally, I compare the length growth of the cranial base elements with the 
thickness growth, to establish if the phases of growth in the different axes are 
coordinated or disconnected. 
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5.1.5 Correlation and disjunction of AP and DV growth of cranial base elements 
depends on stage of development 
5.1.5.1Introduction 
I have demonstrated that when both length and thickness growth are quantified 
separately, the different bones and synchondroses show a modularity in their 
anatomical growth trajectories, as well as the patterns of clonal growth. 
I now analyse how the length growth and thickness growth of the synchondroses 
are related. 
 
5.1.5.2.1: There is correlation and disjunction of growth in length and thickness 
within the cranial base synchondroses 
 
Between e14.5 and P1, there is a preference for growth in the AP axis rather than 
in the DV direction in the MSS and SES. In the SOS however the expansion in 
both axes is similar. 
Between P1 and P26 growth is skewed towards thickness growth in all the 
synchondroses of the cranial base. This skew is particularly pronounced in the 
SOS. 
 
This is illustrated in figure 5.24 (circle markers). Between e14.5-P26 the SOS 
expands 3.6 fold in length and 3.4 fold in thickness. The  
 
MSS and SES increase in length preferentially to thickness; expanding 3.0 and 
3.4 fold in length whilst only 1.7 and 2 fold in thickness respectively. Whatever 
the rate of increase however, the synchondroses increase in both length at 
thickness at this earlier stage. 
This coordination of growth is lost at the later stage.  
The thickness of the SOS and MSS doubles between P1-P26, but these 
synchondroses halve in length in this time (5.24 triangle markers). 
The SES is more coordinated, increasing very slightly in length and increasing in 
thickness by a factor of 1.5 fold. 
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5.1.5.2.2: Prenatal synchondrotic growth is length skewed, whilst postnatal 
synchondrotic growth is thickness skewed 
 
To better compare the phases of growth between the e14.5-P1 and P1-P26 time 
windows, I divided the fold change in length by the fold change in thickness for 
each of the synchondroses. 
The result was that in the earlier time window, the synchondroses preferentially 
expand in length. In the later time window the synchondroses all preferentially 
expand in thickness over length. 
This is illustrated in figure 5.25. The e14.5-P1 of growth has an AP:DV ratio of 
above 1 for all the synchondroses (blue columns). 
Figure 5.24:There is correlation and disjunction of growth in length and 
thickness within the cranial base synchondroses 
The factor change in thickness plotted against the factor change in length for the 
three synchondroses of the cranial base between e14.5-P1 (circles) and P1-P26 
(triangles). Red outline highlights SOS prenatal growth that shows greatest 
increase in length and height growth. 
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The AP:DV growth ratio is below 1 for the postnatal stage in all synchondroses 
(figure 5.25, red columns). 
 
Finally I examined the coordination of clone growth in the AP and DV directions 
within and between the synchondroses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.25 Prenatal synchondrotic  growth is length skewed, whilst postnatal 
synchondrotic growth is thickness skewed 
Column graph plotting the ratio of length increase of synchondroses to the 
thickness increase of synchondroses ( AP:DV) for two time periods. 
 e14-P1 (blue) and P1-P26 (red). Line indicates co-ordinated growth (a 1:1 
ratio) 
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5.1.5.2.4: The coordination of synchondrotic clone growth in the AP and DV 
axes is different in the MSS and SES 
 
There is also a disconnect in the phases of clonal growth within and between the 
synchondroses of the cranial base. 
In the e14.5-P1 time window the SES and MSS clones show very similar co-
ordination of length and thickness growth. In the later P1-P26 stage this change, 
the SES clones showing a pronounced preference for length growth, and the 
MSS clones a preference for thickness growth over length. 
 
In the SES between e14.5-P1 the clone expands evenly in the AP and DV 
directions, the AP:DV ratio of growth being 0.95. Between P1-P26, the clones in 
the SES are heavily skewed towards expanding in the AP direction by a factor of 
2.7(figure 5.26 1st column cluster).  
 
In the MSS clones between e14.5-P1 are slightly skewed to expansion in the DV 
dimension rather than AP, with an AP:DV ratio of 0.9. This preference becomes 
more pronounced between P1-P26 and the AP:DV ratio of growth decreases to 
0.77(figure 5.26). 
 
This shows that clone growth in the cartilage, whether through cell proliferation 
or shape change, is coordinated in the early stage of development between the 
synchondroses. At a later stage however, the clones in separate synchondroses 
follow their own trajectory, and the correlation of length and thickness of clones 
is lost. 
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5.1.4.3 Conclusions 
 
There is a disconnect between the phases of longitudinal and thickness growth 
within each of the three synchondroses of the cranial base. 
In the e14.5-P1 stage the synchondroses of the cranial base grow in the length 
preferentially to the thickness. 
Later, between P1-P26 this reverses, and synchondroses growth in thickness in 
preference to length. 
The preference is not equal in all synchondroses. The SES is only slightly skews 
towards thickness growth at P1-P26, whilst the MSS and SOS are very heavily 
skewed towards thickness over length growth. 
 
There is also a disconnect in the phases of clonal growth within and between the 
synchondroses of the cranial base. 
In the e14.5-P1 time window the SES and MSS clones show very similar co-
ordination of length and thickness growth. In the later P1-P26 stage this change, 
Figure 5.26: The coordination of synchondrotic clone growth in the AP and DV axes 
is different in the MSS and SES 
Column graph plotting the ratio of length increase of clones in the anterior posterior 
axis, to the growth of clones in the dorsal ventral axis ( AP:DV) for two time periods. 
 e14-P1 (blue) and P1-P26 (red). Line indicates co-ordinated growth (a 1:1 ratio) 
0	
0.5	
1	
1.5	
2	
2.5	
3	
SES	Chondrocyte	clones	 MSS	Chondrocyte	clones	
AP
:D
V	
cl
on
e	
gr
ow
th
	ra
2o
	
e14.P1	
P1-P26	
	 318	
the SES clones showing a pronounced preference for length growth, and the 
MSS clones a preference for thickness growth over length. 
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5.1.5 Summary of Part I findings 
 
My data has revealed a complex modularity in the sequence of growth of the 
constituent elements of the cranial base. 
This cryptic modularity was only accessible by use of the confetti reporter to 
reveal the clonal structure of the chondrocytes of the cranial base cartilage. 
 
The different boney and cartilaginous elements of the cranial base have different 
growth trajectories for growth in the longitudinal axes and for thickness growth. 
 
Thickness growth of the three synchondroses in continuous, and can be 
explained by cell proliferation of chondrocyte clones and by change in cell shape 
and orientation within the clone. 
The influence of shape change as a factor in the growth of chondrocytes clones 
was elucidated by quantative analysis of clonal dimensions as well as cellular 
proliferation of the clone.  
 
The differences in the anatomical growth trajectories and patterns and 
mechanism of clonal growth are most likely explained by the anterior position of 
the elements in the cranial base. The anterior posterior position dictates where 
the growth signal will come from in the skull. 
 
Shh signaling is important to all positions in the cranial base, but there are 
various sources depending on position. 
 In the posterior cranial base, particularly the basisoccipital will be influenced by 
Shh signalling from the notochord, remnants of which can persist embedded in 
the basisocciput until a late embryonic stage (Barteczko and Jacob, 1999). Shh 
mRNA can be detected in the notochord up to e12 (Nie et al., 2005). The SOS 
will be subject to Shh signalling not only from anterior notochord but also by the 
pituitary which expresses Shh until e14 (Nie et al., 2005). 
The sphenoid (both portions) and MSS in the midcranial base i.e.ventral to the 
diencephalon which provides Shh signaling until e13 –e14 (Nie et al., 2005)and 
in the ventral diencephalon  BMP4 and FGF8 and 10 signalling. 
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The SES and ethmoid will also be influenced by hedgehog signalling from the 
diencephalon but also by signalling from the nasal capsule. 
As well as signaling factors, intrinsic gene expression in different regions of the 
cranial base provide a basis for differences in control of growth, and in many 
mouse mutants one cartilage can be effected whilst the others are normal. 
Examples include the ethmoid cartilage (including nasal septum) being the only 
structure affected in the cranial base of Alx3-/-/Alx4-/- mice (Beverdam et al., 
2001), the MSS alone ossifies prematurely in the FGFRP344R  mutant (Laurita 
et al., 2011). The FGFR2P253R mutant exemplifies the importance issues of both 
time and space, at birth it appears than only the SOS is effected by premature 
closure, but by 4 weeks of age there are signs of closure of the MSS as well 
(Nagata et al., 2011). 
 
Hence, even though they form one structure, the bones of the cranial base have 
some independence of growth. 
 
This work links for the first time the genetics of clonal shape change with 
anatomical shape changes, and is of great clinical relevance. It also emphasizes 
the importance of timing when considering the effects of mutations on the 
growth of the cranial base. 
 
In the Muenke syndrome mouse model (caused by activating FGFR3P244R -/-
mutation) though patent at birth, the MSS begins to prematurely ossify at 1 week 
of age and is premature closed by 5 weeks of age, leading to a shortened cranial 
base. There appeared to no shortening of the basisoccipital and no affect on the 
height of the cranial base (Laurita et al., 2011). 
From my analysis of cranial base growth I found that the most important time for 
length expansion of the MSS is between e14.5 and P1, but the sequence major 
growth phases of the adjacent bones differs, the presphenoid develops in length 
most significantly between e14.5-P1, whilst the basisphenoid has a significant 
growth phase later between P1-P26 (i.e. between birth an 4 weeks of age). In the 
Muenke mouse model the shortening of the cranial base would therefore be due 
mainly because of the adverse effect of MSS closure has on the growth of the 
basisphenoid, at a time it grows so rapidly in length in the WT mouse.  
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In the human Muenke condition midface hypoplasia and cranial base shortening 
is observed (Ridgway et al., 2011, Nah et al., 2012), and midfacial advancement 
surgery is used to correct this (Collmann et al., 2011). As humans are normally 
heterozygous for the FGFR3 mutation the cranial base phenotype is variable and 
not all patients require this surgery (Honnebier et al., 2008). The normal time of 
MSS closure in humans is between birth and 3 years of age (Madeline and Elster, 
1995), which suggests any intervention should be very early in life. A proper 
analysis of the timing of the synchondrosis closure in Muenke patients would be 
helpful in information the most effective time and region in which surgery would 
provide improvement to the shortening of the cranial base. Advances in medicine 
in the future could potentiate the targeted application of FGFR3 antagonists at an 
appropriate time to the cranial base. 
 
Thus armed with information of the sequential and modular mode of cranial base 
growth, the pathophysiology of syndromes can be dissected and better 
understood. 
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5.2 Intercalary mineralisation strategy in endochondral ossification 
5.2.1 Introduction 
The evolutionary emergence of boney tissues 
 
Endochondral bone emerged later in phylogeny than dermal bone (figure 5.27), 
yet is by far the better studied of the two bone types. As such the mechanisms of 
ossification of endochondral ossification are presumed to apply to dermal 
ossification. However the reverse is more likely true. 
Mechanisms that are used in dermal bone formation, such as those discussed in 
Chapters 1-4 could potentially be co-opted in the younger endochondral bone. 
The initial stage of formation of endochondral and dermal bone differ. 
Endochondral bone is preceded by a cartilaginous template, which over time is 
replaced by bone. This allows large 3D shapes to be achieved by long bones such 
as the femur. 
 Dermal bone has no precursor; collagen is laid down in layers by osteoblasts 
that differentiate directly from mesenchymal cells. As such, dermal ossification 
forms flat bones such as the frontal, parietal and maxilla. 
 
 
Figure 5.27: The evolutionary emergence of bone 
 
 
 
	 323	
5.2.1: The sequence of biomineralisation varies along the anterior-posterior and 
mediolateral axis in the murine cranial base 
5.2.1.1 Introduction 
 
In the frontal bone in chapter 1 in both wholemounts and in sections it was 
apparent that there were differences in the timing of the onset of mineralization, 
continuity and extent of mineralization depending on both the anterior posterior 
and mediolateral axis of the frontal bone. It was discussed that this could be the 
result of different signals, different local anatomy and functions that the bone has 
in different regions, as well as the source of the initial cells. 
It was also observed that there were hitherto unreported ‘intercalary’ patterns of 
biomineralisation, with younger biomineral on the inside of older biomineral. I 
am interested to see if this pattern is also apparent in the cranial endochondral 
bone, or if is unique to dermal bone. 
In Part 1of this chapter it was shown the anlage of the mouse basisoccipital was 
the first to achieve defined morphology. The ossification centres of the cranial 
base are reported to first emerge at the midline and in the basisoccipital first, then 
basisphenoid and last presphenoid in mice and humans (Jeffery and Spoor, 2004, 
Kjaer, 1989, Shum et al., 2004). As such it would also be expected that the more 
medial and posterior levels of the cranial base would show evidence of the 
earliest ossification. 
I investigated if these predictions for the sequence of mineralisation were true in 
the cranial base. 
 
 
5.2.1.2  
5.2.1.2.1: There is preferential biomineralisation in the basisphenoid at the 
midline in the cranial base 
 
There is widespread biomineralisation at e14/15 in the presphenoid, basisphenoid 
and basisocciput. However, there is biomineralisation only in the basisphenoid at 
e16/17 in the medial cranial base. 
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This can be seen in Figure 5.28, a sagittal section of the cranial base showing the 
presphenoid, basisphenoid and the basisoccipital bones. The specimen was 
injected at e14 with calcein, e16 with XO, e18 doxycycline and culled at P1 
(Experiment 3, Table1.1). There is extensive labelling in all three bones between 
Figure 5.28: There is preferential biomineralisation on the basisphenoid at 
the midline in the cranial base 
Sagittal section of P1 culled specimen from Experiment 3 (Table1), showing 
the presphenoid (P.Sph), MSS ,basisphenoid (B.Sph), SOS and basisocciput 
(B.Occ)in a medial plane. Specimen exposed to calcein at e14 (green) , XO 
at e16 and doxycycline and e18 (yellow) 
A) e14 calcein and DAPI, there is extensive staining in the entire cranial 
base 
B) e16 XO and DAPI, mineralisation only in the basisphenoid not in the 
Basisocciput or Presphenoid. 
C)  e18 doxycycline and DAPI, less extensive than e14 staining but 
there is evidence of mineralisation in all three bones 
D)  e14, 16 and e18 mineralisation with brightfield channel  
Scale Bar 500µm 
A	P	
D	
V	
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e14/15 at the dorsal and ventral margins and in the centre of the bones (green 
biomineral 5.28.a). 
At e16/17(figure 5.28 b-red labelling) biomineralisation is confined to the 
basisphenoid; there is no evidence of biomineralisation in either the basisocciput 
or presphenoid. 
The e18/19 biomineralisation is evident (figure 5.28 c-yellow labelling) in all 
three bones, but the basisphenoid is more extensively mineralized than in the 
other two bones. 
 
The mineralization sequence of the cranial base varies along the anterior 
posterior axis, as seen in the mineralization of the frontal bone (chapter 1). 
 
In the frontal bone it was also observed that there is variation in the sequence of 
mineralization in the mediolateral axis. 
I examined sections of the cranial base at different mediolateral levels to evaluate 
if the pattern of biomineralisation varied across this axis. 
 
5.2.1.2.2.At lateral planes there is preferential mineralization of the basisocciput 
and not the basisphenoid 
 
 
The basisocciput and the basisphenoid are extensively biomineralised at e14/15, 
and at e16/17 the basisocciput is preferentially mineralized at lateral planes. 
 
Figure 5.29 is sagittal section from a P1 mouse showing the basisocciput, SOS 
and basisphenoid at a more lateral plane than in figure 5.28. This specimen was 
exposed at e14/15 to calcein (green) and e16/17 to XO (red) (Experiment 1, 
Table 1.1) At this mediolateral level, whilst there is extensive e14/15 
biomineralisation in the basisocciput and basisphenoid, there is no evidence of 
any e16/17 biomineralisation in the basisphenoid at all (yellow box 5.29b). This 
is reminiscent of areas in the frontal bone whether mineralization commenced at 
e14 but did not continue at e16/17. 
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In a more medial plane to 5.29 (approx. 100 µm closer to the midline), the 
sequence of biomineralisation changes again (figure 5.30). Both the basisocciput 
and basisphenoid both show extensive mineralization at e14/15 and e16/17. 
 
 
Figure 5.29: Mineralisation is not continuous in anterior posterior axis 
Sagittal section of P1 culled specimen from Experiment 3 (Table1), showing 
the presphenoid, MSS ,basisphenoid, SOS and basisocciput in a lateral 
plane. Specimen exposed to calcein at e14 (green) , XO at e16 and 
doxycycline and e18 (yellow) 
A) e14 calcein and DAPI, there is extensive staining in The basisocciput 
and basiphenoid 
B) e16 XO and DAPI, mineralisation only in thebasisoccput 
C) e14 and e16 mineralisation  
SOS 
B.Sph 
B.Occ 
e14DAPI 
e16DAPI 
e14e16DAPI 
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Figure 5.30: Both the basisphenoid and basisocciput are extensively mineralised between 
e14 and e17 at certain mediolaeral levels  
Sagittal section of P1 cranial base from specimen injected with calcein at e14 and xylenol 
orange at e16 to visualize mineralization at these times. More lateral plane to 5.28 
A) DAPI (blue) and calcein (green) 
B) DAPI and xylenol orange (red) 
C) DAPI, calcein and xylenol orange 
B.occ=basisocciput, B.Sph= basisphenoid Pit=pituitary. 
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5.2.1.3:Intercalary biomineral growth in the endochondral bone of the cranial 
base 
 
After the examination of biomineralisation throughout the A-P and mediolateral 
levels of the cranial base, I closely examined the pattern of mineralization at a 
more local level. I wished to know if the so –called intercalary mineralization of 
the dermally ossifying frontal bone can be found in the cranial base, and if so 
where and at what time of embryonic development. 
I find that there is a pattern of intercalary biomineralisation found in the 
basisphenoid and basisocciput and it occurs in the same e14-e17 time window as 
observed for the frontal bone. 
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Figure 5.31: Intercalary patterns of mineralisation found in the frontal bone 
can also be observed in the endochondral bone of the skull, 
A) Sagittal section of P1 culled specimen from Experiment 1 (Table1), 
showing basisphenoid, SOS and basisocciput in a lateral plane. Specimen 
exposed to calcein at e14 (green) and XO at e16. 
B) Enlargement of region in basisocciput displaying intercalary growth 
pattern. Deposits of younger red biomineral within older green biomineral 
highlighted by white asterisk. 
C) Enlargement of a region of a basisphenoid displaying intercalary 
mineralisation pattern. Deposits highlighted by white asterisk. 
Scale bars 200µm 
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The pattern of biomineralisation in the cranial base is reminiscent of that in the 
trabeculated regions frontal bone, with two layers of mineralization as ‘struts’ of 
mineralized material joining the two layers (chapter 1 figure 1.8). 
This is apparent in figure 5.31a, a sagittal section through the basisocciput and 
basisphenoid. This specimen was exposed to calcein at e14 (green), XO and e16 
(red) and culled at P1. 
The younger red biomineralised matrix is found almost exclusively surrounded 
by older green biomineral in the basisphenoid and basisocciput (white asterisks, 
figure 5.31 b and c). 
 
 
5.2.3: The synchondroses of the cranial base do not provide growth fronts for 
biomineralisation 
5.2.3.1 Introduction 
The synchondroses of the cranial base are considered growth zones, where the 
hypertrophic cartilage at the margins of the synchondroses is converted to 
ossified bone. 
It logically follows from this model that the newest biomineralised bone would 
also expected to be adjacent to the hypertrophic regions and the oldest 
biomineral in the centre of the bones. 
I examined the biomineralisation pattern in relation to the synchondroses to 
determine the validity of the role of the synchondroses as ossification fronts. 
 
5.2.3.2: The oldest biomineral is found closest to the margins of the cranial base 
synchondroses 
 
I find that the oldest biomineralised matrix in the bones of the cranial base is 
found adjacent to the synchondroses, and newer mineralized matrix is found in 
the centre of the bone.  
This is demonstrated in figure 5.32 a. This sagittal section of the basisocciput, 
SOS and basisphenoid from a specimen labeled at e14 with calcein, e16 with XO 
and culled at P1. The calcein labeled e14/15 biomineral (green) is found closest 
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to the hypertrophic cartilage of the synchondrosis at the posterior and anterior 
margins. The nearest e16/17 biomineral is found over 200µm posterior of the 
synchondrosis in the basisocciput. 
 
 
 
5.2.3.3 Conclusion 
 
The margins of the hypertrophic zones synchondrosis might be expected to 
border the newest bone, as this is the point of invasion for osteoprogenitors and 
the point of supply of osteoblasts transdifferentiated into osteoblasts. That the 
SOS at least in the cranial base does not show this pattern is noteworthy and 
curious.  
 
Figure 5.32 The oldest biomineral is found closest to the margins of the cranial base 
synchondroses 
Sagittal section of the SOS from cranial base of Experiment 1 specimen (e14 calcein, e16 
XO, culled P10) DAPI counterstain, and diagrammatic representation of the expected and 
observed mineralisation pattern. 
Red arrow indicates the e16/17 staining closest to the SOS (approx 230 µm) from the 
hypertrophic cartilage of the SOS. 
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One possibility is that whilst the new cartilage is established in the synchondrosis 
the first bone marrow is in the centre of the initially ossifying region. This would 
supply osteoprogenitors first to regions other than the synchondrosis. 
Osteoblasts derived from hypertrophic chondrocytes would be expected to be 
intimately linked with the hypertrophic region. However, one logical though 
would be that if this region is attracting osteoclasts to secrete MMP-9 (which will 
degrade any non-native collagen, not being Col2 specific) in maybe inefficient to 
concentrate new mineralization in this environment. Osteoblasts could migrate 
along previous mineral struts/trabeculae and deposit here, consolidating previous 
mineralization. 
The synchondrosis may be a centre of growth in the cranial base, but this does 
not translate into a centre of ossification. 
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5.2.4: Mineralisation Summary: 
 
There is a complex mediolateral pattern to mineralization in the cranial base. The 
medial planes of the basisphenoid show evidence of continuous 
biomineralisation from e14-e19, whilst at more lateral levels in the basisphenoid; 
there is no evidence of biomineralisation between e16-17. 
At medial planes the basisocciput shows no evidence of biomineralisation 
between e16-17, but at lateral levels biomineralisation is continuous between e14 
and e17. It is somewhat surprising that e14 to e15 labelled biomineral was 
present to the same extent at the midline in all three structures of the 
synchondrosis, as the first ossification centre reported to appear is that in the 
basisocciput (Shum et al., 2004). My observations could stem simply from the 
possibility that the two-day window of labelling is not narrow enough to capture 
the biomineralisation in the basisocciput before the onset of bimineralisation of 
the basis- and presphenoid. 
 
An intercalary pattern of mineralization growth is observed in the cranial base as 
in the frontal bone, and the first time this observation has been made in cranial 
endochondral bone. 
I have been able to find no specific mention of this phenomenon in the literature, 
but I believe I can observe it in one study. In the vertebral bodies of the medaka 
(Oryzias latipes), a teleost fish, there is evidence of an intercalary process of 
biomineralisation (Yu et al., 2016). The vertebral bodies of the spine are labeled 
with alizarin at 12dpc, and then again with calcein at 16dpc, when the specimens 
were imaged as wholemounts using confocal microscopy (figure 5. 33). It is 
evident in some of the vertebrae that the second (calcein) mineral label is 
deposited within the first mineral label (alizarin). It is very interesting to see this 
in the bone of medaka, which is considered acellular as unlike mammalian bone 
or even zebrafish bone it contains no osteocytes (Ekanayake and Hall, 1987). 
In labelling studies of endochondral long bone in mammals I can see no evidence 
of this intercalary mineralization pattern whether in embryonic stages (Stern et 
al., 2015) or postnatal studies (Sugiyama et al., 2011, Tomlinson and Silva, 
2015, Pineault et al., 2015). 
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It 
was noted in the frontal bone that intercalary biomineralisation occurred in the 
orbital region, which is the thickest part of the frontal bone. The intercalary 
deposits are in the basisocciput and basisphenoid are more widespread and more 
extensive than in the frontal bone, and both these bones are much thicker than the 
frontal. Intercalary biomineralisation could be a novel way of increasing the 
thickness of ossifying structures. 
This is evidence that there is a similarity of mineralisation mechanism in the 
more ancient dermal bone and phylogenetically younger endochondral 
ossification (figure 5.34). It would be interesting to investigate whether this is a 
case of co-option or convergent evolution due to so many genes and cell types 
being in common with the two types of bone. 
 
A B 
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Figure 5.33 Evidence of  intercalary mineralisation in medaka vertebral 
bodies 
Adapted from Yu et al. 2016. 
Confocal stack of wholemount live scan of vertebral bodies, with 
biomineral labelled at 12dpc (A) and 16dpc (B). When the two stains are 
merged it can be seen cavities in the older biomineral (red) are filled with 
younger biomineral (green) (C-pink arrows). Specimen was imaged at 
16dpc. APC= alizarin complexeone (red), calcein green 
Scale bar 50µm 
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The synchondroses of the cranial base do not provide growth fronts for 
biomineralisation as maybe expected in the prenatal mouse, with the oldest 
biomineral lying closest to the SOS and MSS in both medial and lateral regions. 
The centre of the basisphenoid and occiput often contain the youngest 
biomineral.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.34 Intercalary biomineral growth a mechanism of mineral growth 
shared by endochondral ossification and dermal ossification, which emerge at 
separate points of phylogeny 
Heterostracans 
Placoderms 
Mammals (mouse) 
Dermal bone 
intercalary 
biomineralisation 
Ossified jaws and 
endochondral 
ossification 
Co-option of intercalary 
biomineralisation? 
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5.3 Summary of findings 
 
My data has revealed a complex modularity in the sequence of growth of the 
constituent elements of the cranial base. It also reveals that there is a mechanism 
of intercalary growth in the cranial base, as was observed in the frontal bone, 
which is formed by the more ancient dermal ossification mechanism. 
 
Prenatal growth of cartilage and bone in the cranial base 
 
This cryptic modularity was only accessible by use of the confetti reporter to 
revealed the pattern of expansion of chondrocytes clones in the cranial base 
cartilage and I was able to correlate this with the growth of the anatomy of the 
cranial base. 
 
 
The prenatal (e14.5-P1) stage of cranial base growth is characterised by a focus 
on length growth in preference to height in the synchondroses. This is at a time 
where the long axis of the clones within the SES and MSS begin aligned more to 
the anterior posterior axis then the dorsal ventral axis. 
Between P1-P26 the synchondroses of the cranial base are skewed towards a 
faster rate of thickness growth rather than length growth. Between these two 
times the long axis of chondrocyte clones is aligned at right angles to the cranial 
base, especially in the MSS. As the clone height increases at this time, it is no 
surprise that there is a change in the emphasis on dorsal-ventral growth. 
Also between P26 the length of the synchondroses decreases, even though clone 
length and the number of cells within a clone continue to increase. 
 
 
The number of clones in SES and MSS rises from e14.5 to P1 and then sharply 
decreases by P26. When examining the images it appears that clones are being 
removed in discrete clonal groups. This could be a strategy for the controlled 
decrease in synchondrosis length, whilst the height of the synchondrosis can 
continue to be enlarged. 
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The thickness and length growth of some elements of the cranial base is 
correlated, but there is a disconnect in other elements, most notably the MSS and 
SOS. 
The thickness growth of the SOS in the prenatal stage is far faster than the other 
two synchondroses. It could be argued that as the SOS is much close to the 
pituitary and notochord it is exposed to more Shh signaling than the MSS and 
SES dorsal to it, stimulating faster growth. In postnatal stages the effects of 
hedgehog signaling are voided, and the SOS grows at a similar rate to the other 
synchondroses. 
 
MSS in the midcranial base will be influence by the overlying diencephalon. The 
SES is most likely influenced by signals from the adjacent developing brain 
regions, and by the factors affecting ethmoid and nasal capsule signalling. 
 
 
These differences between bones have clinically relevance, as the cranial base is 
in contact with so many different anatomical landmarks along its length. Studies 
in humans show the anterior cranial base to grow faster (up to double the rate) of 
the posterior cranial base (Jeffery, 2002, Burdi, 1969, Ford, 1956). However, the 
landmarks used mean this is measuring the growth rate of the basisocciput 
(posterior cranial base) with the basisphenoid, presphenoid and part or most of 
the ethmoid (anterior cranial base). There is some justification for this based on 
the origin of the flexion of the skull base in humans, but these measurements will 
obscure differences in contribution of the bones to the length of the cranial base, 
and differenced in individual growth trajectories. Thus studied that include the 
distinct of the ‘mid cranial base’ in addition to and anterior and posterior 
measurement will have more realistic and discriminating information on growth 
rates (Singh et al., 1997). In prenatal monitoring and to inform surgery, it is vital 
to understand what the normal growth of the individual bones is to be able to 
understand the impact of aberrant growth and where intervention would be best 
directed. Based on my results, it would seem essential to the understanding of 
cranial base development. 
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Mechanism of mineralisation in the cranial base 
 
The intercalary pattern of mineralization growth is observed in the cranial base 
as in the frontal bone, but more extensively. It was found throughout the 
basisphenoid and basisocciput of specimens labeled at e14 with one matrix 
labelling agent, and at e16 with another.  
As in the frontal bone, I found no evidence of intercalary growth at e18 or later. 
In the two specimens which had a matrix-labelling agent injected at e18, this 
birthdated biomineral to only found as an appositional layer to previously formed 
biomineral. 
This is the first report of this mechanism of mineralisation in a mammalian 
endochondral bone. As previously stated, the only other instance in the literature 
I can find of this intercalary mineralization is the vertebral bodies of the teleost 
medaka (Yu et al., 2016), with no evidence in the long bones of mammals. 
This study could be extended by the examination of the endochondral bone of the 
limbs and vertebrae in the mouse, in animals where biomineral is birthdated 
multiple times in the seemingly critical e14-e17 time window. 
It has been established that the mechanisms of ossification in the skull show 
differences to those of the body, even in bone of the same type (i.e. dermal and 
endochondral bone). It would be interesting to ascertain if this intercalary 
mineralization applies only to the skull in mammals. A narrower time period 
between injections may also give an insight into the mechanism, as if he exact 
time window is know, as a critical analysis of the signals and genes and cell 
types involved could be undertaken. 
My result that the synchondroses of the cranial base do not provide growth fronts 
for new biomineralised material is in direct opposition to previous findings 
(Wealthall and Herring, 2006). I explained in the introduction that I believed 
certain aspects of this study, namely analysing wholemounts only and the short 
consolidation time for the last matrix labelling dye, could have obscured and 
confounded the results. My own analysis of sections of the cranial base shows 
this to be true, and highlights an important distinction between the growth of 
cartilage in endochondral structures and their ossification. The synchondroses are 
undoubtedly the source of new chondrocytes and expansion of the cartilage 
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itself, as seen by the increase of clone size throughout the timecourse of 
development. The margins of the synchondroses might then expected to be the 
source of the youngest bone, but I have shown this to be untrue. The ossification 
centres of bone are separate entities to the synchondrosis and though they 
coordinate the growth of the same structure, they do not function as a continuous 
unit. 
 
In phylogeny cartilage and endochondral bone arise at very different points. The 
bones of the cranial base were the first chondral structures to ossify, 
intermittently in the Devonian placoderms.  
 
This work links for the first time the genetics of clonal shape change with 
anatomical shape changes, and is of great clinical relevance. 
It also emphasizes the importance of timing when considering the effects of 
mutations on the growth of the cranial base. 
 
Thus armed with information of the sequential and modular mode of cranial base 
growth, the pathophysiology of syndromes can be dissected and better 
understood. 
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6: Thesis Summary   
6.1: Introduction 
 
In this thesis I have sought to build upon previous findings made in our lab 
on the nature of biomineralisation in the intramembranously 
ossifying frontal bone, and growth of the cranial base. 
After describing the existence of unique and novel mineralisation patterns in the 
frontal bone that exhibit temporal and spatial variation I investigated the role of 
different cell types associated with this complex biomineralised architecture as 
well as their behaviour through time. 
In the cranial base as well as observing the novel biomineralisation mechanism 
also found in the frontal bone, I was able for the first time to measure and 
quantify the expansion and orientation of neural crest derived chondrocyte clones 
within the synchondroses and relate that to the growth of the gross anatomy of 
the cranial base. 
 
6.2: A novel intercalary biomineralisation mechanism in the prenatal frontal bone 
and cranial base 
 
In this thesis I furthered the work of Jordan et al, who discovered a process of 
‘intercalary’ mineralisation in the frontal bone, a process whereby younger 
mineralised matrix is found within older matrix, a reversal of the traditional 
model of appositional deposition. 
I can report intercalary mineralisation in both the dermal frontal bone and 
endochondral cranial base in the prenatal mouse, to my knowledge the first 
report of such a mechanism in the embryo. In both types of bone the intercalary 
stage was between e14 to e17, with biomineral forming at e16 to e17 deposited 
within and sometimes mixed with biomineral deposited between e14 and e15, the 
very initial mineralisation stage of the frontal bone. 
In the literature I am aware of two other studies where this intercalary pattern is 
apparent, though not acknowledged. The first is in the frontal bone of the 
postnatal rat, where between approximately 6 and 9 weeks of age there is 
evidence of ‘inside out’ growth on the endocranial side of the anterior frontal 
bone (Cleall et al., 1968). In the same study the authors report the mineralisation 
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pattern of the cranial base at the same stage, but I can observe no evidence of 
intercalary growth from this data. 
The second study in which I can discern intercalary biomineralisation is in 
endochondral bone in the vertebral bodies of a teleost fish, medaka. In all 
vertebral bodies shown at high resolution younger green matrix (16 dpc) is found 
within older red matrix (12 dpc). The endochondral bone of medaka is unlike 
that of mammals as it contains no osteocytes (hence is called ‘acellular’). 
However, medaka have both osteoblasts and multinucleate osteoclasts (Nemoto 
et al., 2007), and due to the conservation with mammals of many genes and gene 
networks involved in ossification such as Runx2, osteonectin and Col1(Renn et 
al., 2006a, Renn et al., 2006b), they are gaining popularity along with zebrafish 
as model organisms for bone formation (Renn and Winkler, 2009, Iida et al., 
2014).  
That intercalary mineralisation is apparent in teleost fish may indicate that this is 
an ancient mechanism of ossification. Alternatively, it could be a mechanism that 
arises independently in different classes due to similarities in the genes and cells 
involved. 
Indeed, in the anterior orbital region of the frontal bone in which I observe this 
novel biomineralisation there is much variation within mammals, and even 
within species. The frontal sinus is an epithelium lined cavity in the anterior 
region of the frontal bone, and is thought to arise from remodelling and 
resorption of the frontal bone by cells migrating out of the nasal capsule (Smith 
et al., 2008, Wang et al., 1994). Many carnivorous mammals have highly 
developed frontal sinuses (notably bears, cats and dogs). Insectivores (such as 
bats) and rodents have either very small or no frontal sinuses (Curtis and Van 
Valkenburgh, 2014, Hall, 1993). In the Bovidae the frontal sinuses have been 
gained and lost in phylogeny six times (Farke, 2010). In humans the sinus 
generally develops between 2 to 6 years of age (Brown et al., 1984) and its 
presence varies between different populations and individuals, ranging from 
absent to well developed (Aydinlioglu et al., 2003, Brothwell et al., 1968). 
Interestingly in patients with CCD, which has been mapped to the Runx2 locus 
in humans, the frontal sinus is almost always absent, persisting at a far lower rate 
than control populations (Jensen and Kreiborg, 1994). 
This indicates that this region of the frontal bone is highly plastic in onotogeny 
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and phylogeny. It is possible that intercalary biomineralisation is also a highly 
plastic phenotype and has been overlooked because of the high amount of 
variation in timing of onset and due to inter-species and inter-individual 
variation. 
 
It has been shown in cortical long bone that the quality of biomineral can dictate 
its remodelling potential by cells with osteoclast resorption activity (Pernelle et 
al., 2017). It could be envisaged that intercalary biomineralisation creates 
heterogeneity in bone quality (this would need to be tested) and thus mark out 
bone for future remodelling.  
The presence of intercalary mineralisation in the endochondral cranial base could 
also have a role in remodeling, as the cranial base in later stages of development 
becomes cancellous to accommodate bone marrow. 
I would be interested to investigate the pattern of mineralisation that takes place 
in the region of the frontal sinus in species where it is highly developed. It would 
also improve the completeness of this study by investigating later postnatal time 
point and see if in the mouse, as in the rat, there is a late stage of intercalary 
deposition. 
 
6.3: Cell behaviour compatible with intercalary biomineralisation 
 
After observing a novel intercalary pattern of invasion, I speculated that this is 
incongruous with the current knowledge of the arrangement of osteoblasts and 
other bone cells within the frontal bone. Osteoblasts must be able to move into 
the middle layer 2 of the bone and deposit new matrix to achieve this pattern. 
It is known that osteoblasts, osteoclasts and even certain populations of 
osteocytes have the ability to migrate across bone (Veno et al., 2007, Dallas et 
al., 2008, Novack and Faccio, 2011).  I have extended this to show by DiI/DiO 
labelled cell tracing and live imaging that cells of osteoblastic and endothelial 
cell lineage can invade the dermal frontal bone from the ectocranial layer 1 and 
endocranial layer 3. 
The cell velocities are lower for invasion into the bone compared to lateral 
migration along it. The velocities of cells were in the range of previously 
reported osteoblasts and osteoclast velocities (Veno et al., 2007, Dallas and 
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Bonewald, 2010), and showed wide variation in the invading population. 
Osteoclasts go through phases of resorption and then rapid migration, indeed 
they are mutually exclusive activities in time, as the cell must adhere to the 
mineralised matrix to create the resorption lacunae (Lomaga et al., 1999). 
Heterogeneity in the velocity of migrating osteoblast populations has been 
previously noted (Veno et al., 2007), and to further this study the differences 
between cells that move very little and those that travel great distances should be 
considered, but extended to consider the function of these cells. This should be 
done by identifying the markers expressed by the invading cells and by their 
lineage, to be able to link cell function and behaviour.  
 
I have gone some way to identifying cell lineages of potential interest by the 
antibody labelling of cells invading bone whose invasion was traced by lipophilic 
dye.  
I found differences in behaviour and composition of upward and downward 
invading cell populations, and differences in behaviour depending on cell type. 
RUNX2 single positive cells moving downward into the frontal bone are 
significantly more likely to be retained than their upward invading counterparts. 
This downward invading RUNX2 single positive population was also more 
likely to be L2 retained than either the HAND2 single positive or 
RUNX2+HAND2+ double positive populations invading in the same direction. 
The downward-invading population is enriched for both HAND2 and RUNX2 
positive cells compared to the upward-invading population. 
 These RUNX2 single positive cells could be those committed to osteoblast and 
osteocyte differentiation, whilst HAND2 expressing preosteoblasts could have a 
role in communicating between the L1 and L3 layers of bone, whose growth rate 
needs be coordinated. The inner endocranial L3 must expand more slowly then 
the ectocranial L1, which covers a greater surface area. 
 
HAND2 ablation in the neural crest lineage, from which the frontal bone is 
almost exclusively derived, severely impacts and compromises thickness growth 
and elaborate trabeculation of layer 2. HAND2 therefore is of great significance 
in the formation of the frontal bone. Its role controlling the cycling of biological 
events may effect the timing of the invasive process and thus the potential of the 
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bone to grow by intercalary biomineralisation (Shindoh et al., 2014). 
 
This invasive behaviour can be compared to osteoblasts of endochondral bone, 
which are shown to ‘invade’ the cartilage to deposit new matrix, though after the 
collagenous Col2 based ECM of cartilage has been degraded by osteoclasts. An 
important point to consider is that only immature osteoblasts invade the cartilage 
in endochondral ossification (Maes et al., 2010), and it is pre-osteoblasts and 
immature osteoblasts that are traced in my experiments in dermal bone. 
To extend my findings and be able to draw a proper comparison with 
endochondral bone the potential invasive behaviour of both immature and mature 
osteoblasts in the frontal bone should be investigated.  
There is no true lineage marker  available for osteoclasts in the same way as the 
Runx2 committed preosteoblasts; TRAP positivity and multinucleation is used to 
identify osteoclasts. However the reversal cells of the long bone (cells of 
osteoblastic lineage) have been shown to take up TRAP from other cells, hence 
were long thought to be a type of mononucleated osteoclast (Everts et al., 2002, 
Abdelgawad et al., 2016). Our lab has identified TRAF6 expressing 
presosteoblasts. TRAF6 is essential in the differentiation of osteoclasts and their 
function, as TRAP+ osteoclasts are found in Traf6-/- mice but are unable to 
adhere to the bone surface (Lomaga et al., 1999, Kobayashi et al., 2001). Cells of 
osteoblastic lineage in endochondral bone have been demonstrated to express 
proteins conferring the ability to degrade collagenous matrix (Abdelgawad et al., 
2016) .The function of osteoclasts therefore may not be limited to cells of 
monocyte lineage. 
 
To further this work in the future, the presence of certain molecules and 
structures should be investigated in RUNX2 positive cells in the frontal bone, to 
understand if cells of osteoblast lineage are truly capable of degradation of 
mineralised tissue. Namely: the ATP transferase pump that fills the resorption 
lacunae with protons and confers the ability to degrade hydroxyapatite (Blair et 
al., 1989) and the presence of intergrin and actin restructuring that forms the 
podosome (Destaing et al., 2003). Whatever the lineage, there must be cells 
present capable of degrading inorganic matrix to result in the ‘mixed’ matrix 
pattern seen. Though live imaging is the best way to understand cell motility, the 
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use of antibodies in whole bone explants is fraught with difficulty, as penetration 
of this tissue is very poor. The use of a genetic reporter line is needed to be able 
to track preosteoblasts in realtime, such as the Osx:Cherry line (Strecker et al., 
2013), but also to track more mature cells expressing mature osteoblast markers 
and their eventual fate, for which the DMP1Cre mouse has been described (Lu et 
al., 2007). 
 
 
6.4: Behaviour and role of endothelial cells in development of frontal bone  
 
Endothelial cell invasion into the cartilage of endochondral bones is crucial for 
its subsequent ossification (Engsig et al., 2000). I find that endothelial cells 
invade the frontal bone, and ablation of the endothelial proliferative factor 
VEGFA in the NC lineage nearly completely inhibits the invasion of NC cells 
into the frontal bone. (Wiszniak et al., 2015) suggest that the hypoplasia of the 
bones of the calvaria in the Wnt1Cre:Vegfafl/fl mice was related to a wider 
defect due to the failure of major blood vessels forming in the head. After my 
examination of the frontal bone histology in sagittal sections, I suggest that the 
lack of NC cells in layer 2 is also a contributing factor in this phenotype. 
VEGFA is a chemoattractant for endothelial cells (Eilken and Adams, 2010) and 
RUNX2 positive preosteoblasts and osteoblasts (Behr et al., 2012, Huang et al., 
2016) so perhaps failure to express this leaves no signal to attract either 
endothelial cells or presosteoblasts into the layer 2 of the bone. 
 
VEGFA was shown in this thesis to be co-expressed with RUNX2 in the 
invasive preosteoblasts of the frontal bone, and whilst no change in behaviour 
was seen in the VEGFA expressing preosteoblasts compared to non-VEGFA 
expressing preosteoblasts, this could be simply due to low sample size. 
In the invading populations, a unique VEGFR2+ VEGFA+ double positive 
population was identified that originates from both layer 1 and layer 3. These 
cells showed very similar invasive behaviour to the VEGFR2 single positive 
cells but increased L2 retention compared to VEGFA single positive cells. This 
double positive cell type has been observed previously in squamous cell 
carcinomas of the head and neck (Kyzas et al., 2005), but this is the first report in 
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the dermal bone. 
 
By live imaging of genetically lineage labelled NC cells and antibody staining, I 
identified a new NC derived endothelial cell population for the first time in 
dermal bone. These cells were observed through time and displayed behaviour 
consistent with a mechanism of intusussceptive angiogenesis based on changes 
in morphology that created new lumen in the dermal bone vascular network. 
 
Thus, I have identified unique cell types that are involved in the invasion of the 
dermal bone and in the radial thickness growth the L2 biomineral layer. 
Future studies would need to utilise genetically labelled specimens to track these 
cell types in real time and thoroughly understand their role and interactions. 
 
 
6.5: Cell arrangement for manipulation in future biosynthetic implants 
 
The complexity of the biomineral architecture necessitated a review of the 
arrangement of cells within the frontal bone. The spatial distribution of cell 
lineages was often found to be characteristic of the biomineralised architecture 
they were adjacent to. Groups of osteoblasts are found at the termini of branches 
of intercalary biomineral, and a ‘fringe’ of osteoblasts borders newly forming 
region. The development of the vascular network of the frontal bone appears to 
lag that of the biomineral branching and trabeculation, vessels were always 
found centralised compared to the osteoblasts and osteocytes when examining 
the dorsal surface of the bone. 
The use of 3D culture medias has shown to be effective and changing the shape 
of the cultures and surfaces has been shown to alter and improve osteoblast 
proliferation and differentiation. This information on the specific spatial 
distribution of cells could aid development of bone organ cultures and synthetic 
bone development for the clinic, and be specific to the bone requiring repair. 
This is especially needed for large defects in the calvaria which to not ossify well 
in patients over the age of two years (Cowan et al., 2004). 
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6.6:Frontal bone growth 
6: The suture is not asynchronous or symmetrical growth front 
 
The frontoparietal suture of the calvaria does not provide a uniform growth front. 
I observe asynchronous mineralisation along its length, as well as differential 
mineralisation in the frontal and parietal margins either side of the suture in some 
mediolateral planes. In the embryo at least the suture is not a key source of new 
ossification. 
This reflects several aspects of the development of these bones in phylogeny and 
development. The frontal bone develops prior to the parietal in evolutionary 
history (Koyabu et al., 2014), expresses the markers of bone cells earlier (Rice et 
al., 1997, Iseki et al., 1997) and as I have shown begins to mineralise prior to the 
parietal. The frontal and parietal are derived from two different embryological 
tissues, the frontal being neural crest derived, and the parietal being derived from 
the mesoderm (Jiang et al., 2002). In FGFR2IIIc -/- mice by e18.5 the 
frontoparietal suture demonstrates craniosynotosis (as in activating mutations of 
this receptor in Apert patients and mouse mutants), the interfrontal suture does 
not form and there is a large space between the two frontal bones (Eswarakumar 
et al., 2002). Mutations of FGFR3 in the mesodermal vs. the neural crest lineage 
elicits craniosynostosis of the frontoparietal suture only in the mesodermal 
transgenic mouse, showing that cell may indeed be a basis for difference in 
growth (Holmes and Basilico, 2012). Another study has shown that the level of 
response to FGF treatment is far greater in the parietal than the frontal, and hence 
the regeneration of the parietal is improved (Behr et al., 2010). Conversely the 
frontal bone was demonstrated to heal better than the parietal in another study 
(Quarto et al., 2010).  
Thus I add to the collection of data showing that there are differences in growth 
and osteogenic potential of the frontal and parietal, potentially based on their 
different embryological origins. 
This study could be extended by the measurement of mineralisation rate in the 
parietal compared to the frontal, and the examination of the mineralisation 
pattern of the interfrontal suture, which would be expected to be symmetrical. 
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6.7:Cranial base growth 
6.7.1:Cryptic modularity of growth in the cranial base 
 
Using polyclonal genetic lineage labelling of the neural crest derived cranial base 
I found that there is a cryptic modularity in the growth of its multiple 
cartilaginous and ossified elements. 
The height, width and orientation of individual neural crest clones in the cranial 
base changes with age in the synchondroses, as do their number. These changes 
can often be correlated to the growth of the gross morphology of the cranial base, 
for a change in orientation of clones from with the cranial base to 90o from it, 
marks changes in phases that emphasise length growth and then height growth of 
the cartilage. 
I would be interested in the future in combining the clonal labelling with known 
mutants in which the chondrocytes cannot align, such as those in the PCP 
pathway (Li and Dudley, 2009) and the inhibition of cadherins (Romereim et al., 
2014), in order to better understand the role that cartilage expansion has to play 
in the growth of the cranial base. 
 
6.7.2: The cranial synchondroses do not represent mineralisation fronts in the 
mouse embryo 
 
The cranial base synchondroses are not a source of new mineralised tissue as has 
been reported previously in postnatal mice (Wealthall and Herring, 2006). I find 
the oldest biomineral is adjacent to the synchondroses in the P1 mouse, and the 
newest biomineral in the centre of the bones, not the margins as is reported in 
postnatal animals (Sips et al., 2008). This emphasizes the importance of 
considering the initial embryonic stages of ossification separately to the postnatal 
patterns. 
Future work should investigate the formation of biomineral in the postnatal 
cranial base until maturation in conjunction with polyclonal neural crest lineage 
analysis, to dissect out all the growth phases of this endochondral structure, and 
directly compare cartilage expansion with changes in mineralisation. 
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6.8: Syndromes of craniosynostosis with synchondrosis closure 
 
In Apert, Crouzon and Muenke syndromes, a phenotype of craniosynostosis is 
exhibited with premature ossification of one or more cranial base synchondroses. 
It has been demonstrated that this is due to the effect of increased FGF signalling 
on the differentiation of osteoprogenitors and in cartilage. 
FGFR2 activating mutations found in Apert syndrome cause craniosynostosis 
(most often of the frontoparietal suture (Cohen and Kreiborg, 1996)) and 
premature ossification in the midline of the SOS initially and later in the MSS 
(Nagata et al., 2011). In the frontoparietal and interfrontal sutures FGFR2 is 
widely expressed and involved in the differentiation of osteoprogenitors (Iseki et 
al., 1999), and increased numbers of osteoblasts and bone matrix deposition has 
been demonstrated at the sutures of mouse models of Apert syndrome (Lomri et 
al., 1998). However, the effects of the mutation also include ectopic cartilage 
formation in the cranial sutures (Wang et al., 2005), and the cranial base 
phenotype is observed in mice where the FGFR2 mutation is targeted only to 
chondrocytes, resulting in an accelerated hypertrophy of chondrocytes. This is 
considered to be the result of elevated expression of Runx2 in the cranial base 
chondrocytes that induces the expression of Ihh, which is a differentiation signal 
for chondrocytes (Nagata et al., 2011, Yoshida et al., 2004).  
 
The aberrant growth of one element in the skull can have a ‘knock-on’ effect on 
the whole skull morphology, especially the cranial base and cranial vault that 
both contact and encompass large regions of the skull. 
It would be interesting in the future to apply clonal analysis to mouse mutants 
with aberrant growth in both the cranial sutures and synchondroses, to see how 
the growth and alignment of cells compares to the results in WT animals. 
 
 
6.9: Concluding remarks 
 
The findings in this thesis raise some interesting questions about the mechanisms 
of endochondral and dermal ossification and their variation in space and time 
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that merit investigation in the future. Significantly intercalary mineralisation was 
demonstrated it both types of bone. 
If the process of intercalary growth could be defined genetically, maybe reliant 
on a subset of osteoblastic cells that can resorb bone, then perhaps its emergence 
in phylogeny could be traced and dissected out. This would require the study of 
biomineralisation throughout embryonic and postnatal life in a variety of species. 
 
In any case, the process of dermal ossification has been demonstrated in this 
thesis to involve a number of novel cells types, sometimes described for the first 
time in dermal bone. Any future work should concentrate in elucidating their 
specific function in the ossification and biomineralisation of the skull. 
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Chapter 7 
Materials and Methods 
 
7.1WT and transgenic organisms 
 
7.1.1 Animal Husbandry 
Wnt1Cre (Jiang et al., 2000),Confetti reporter (Snippert et al., 2010) and WT 
(SV129/B6 background) lines were maintained and bred by the University of 
Warwick BSU. 
 
The Wnt1 GFP Vegfr2 KO and VegfaLacZ   mice were a kind gift from Dr 
Christiana Ruhrberg, UCL Institute of Ophthalmology, Bath Street, London, who 
genotyped specimens in advance. 
 
7.1.2: Confetti Reporter transgenic mice 
Reporter mice were purchased as breeding pairs from Jackson lab with the 
B6.129P2-Gt (ROSA)26Sortm1(CAG-Brainbow2.1)Cle/J transgene.  Mice were 
then bred at the University of Warwick BSU with SV129/B6 background stock. 
Reporter allowed the permanent labeling of a cell lineage whilst giving clonal as 
well as cellular resolution. To generate transgenics required for 
experiment/analysis the confetti mice were bred with Wnt1Cre, Hand2cre and 
Hoxb1Cre transgenics. (Snippert et al., 2010) (Livet et al., 2007) 
 
7.2 Molecular Biology 
7.2.1 Genotyping 
7.2.1.1 DNA extraction 
Genomic DNA from tail or earsnips was extracted using the HotShot method 
(Truett et al., 2000). Animal tissue in 1.5ml eppendorf tube was incubated with 
75 µl HotShot solution  (25 mM NaOH, 0.2 mM disodium EDTA ,pH12 ) at 
95°C for 1 hour, then 75µl of neutralising buffer (40 mM Tris-HCl, pH5  ) was 
added and the DNA incubated overnight at 4°C. Concentration of DNA was determined 
by NanoDrop ND-1000 Spectrophotometer, operated by ND- 1000 V3.6.0 software, and diluted 
to 50-100ng/ µl for PCR. 
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7.2.1.2 PCR 
Reaction master mix composition, PCR programs, and PCR fragment sizes are 
detailed in Tables 1-3 below.  
All PCRs were run in a Mastercycler Gradient PCR machine (Eppendorf), in 
Thin-walled 0.2 mL tube trips (Helena Biosciences). 
 
Table7.1 : PCR Master Mix component concentrations 
Reaction mixes were made up to full volume with DNAse free water 
 
Reagent  Cre Master Mix 
component final 
concentration 
Confetti Master Mix 
component final 
concentration 
Buffer A 1x 1x 
MgCl2 16.7mM 2mM 
dNTP 16.7mM 0.2mM 
Forward primer 20 µM 1 µM(transgenic and WT 
allele) 
Reverse Primer 20 µM 1 µM  
Kapa Taq 0.03u/ µl 0.03u/ µl 
Genomic DNA 1-10 ng/µl 1-10 ng/µl 
Final Reaction volume 20 µl 15 µl 
 
 
Table 7.2: PCR primer sequence and fragment size 
 
 
Strain Forward primer  
(5’-3’) 
Reverse primer  
(5’-3’) 
WT 
fragmen
t size 
(bp) 
Transgene 
fragment 
size (bp) 
All Cre 
lines 
GCTGGTTAGCACC
GCAGGTGTAGAG 
CGCCATCTTCCAG
CAGGCGCACC 
X 500 
Confetti GAATTAATTCCGG CCAGTTGCTACCT 300 386 
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TATAACTTCG 
(transgenic allele) 
ATCCTC (common) 
AAAGTCGCTCTGA
GTTGTTAT 
(wildtype allele) 
 
 
 
 
Table 7.3: PCR programs for genotyping 
PCR program Step Cre  Confetti 
Temp(°C) Time(s) Temp(°C) Time(s) 
1 94 180 94 180 
2 94 30 94 40 
3 68 30 64 30 
4 72 20 72 30 
5 72 600 72 600 
6 4 HOLD 4 HOLD 
Repeat steps 2-4 x25 x35 
 
 
7.2.1.3 Imaging DNA 
 
PCR products were run with 2-4ul loading buffer (NEB) onto a 1.5% agarose gel 
(SeaKem) in1x TAE buffer with 0.01ul/ml ethidium bromide (Sigma). Samples 
were run alongside NEB 1kb ladder (figx) in a horizontal gel electrophoresis 
system (VWR International) . Gel was run at 140V for 30-40 mins, or until 
adequate seperation of bands was achieved then imaged in a G:Box UV 
transluminator (Syngene). 
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7.3 Histology 
7.3.1 Specimen preparation 
 
All Embryos and postnatal mice were culled according to a Schedule 1 method 
as set out by UK Home Office legislation.  
Specimens not used for live imaging or incubation were left whole or parts of the 
skull dissected and then placed in 4% PFA solution, 4 hours with shaking for 
embryos and o/n at 4 °C for postnatal samples.  Postnatal animals older than P8 
that were to be sectioned then required incubation in 0.5M EDTA until the bones 
were translucent and soft enough to be sectioned (between 1 and 4 weeks); this 
did not appear to affect the fluorescence of reporter proteins. Samples to be 
sectioned were then placed in 20%-30% sucrose in a 50ml falcon tube until they 
sunk. specimens would be frozen on dry ice in Tissue-Tek™ in the desired 
orientation. Specimens were then stored at -80°C until sectioning or further 
dissection.  
 
7.3.2 Sectioning 
Sectioning was performed on a Bright 5040 Cryostat, slices mounted on 
Superfrost Plus ground edge microscope slides (VWR). Sections were cut 
Figure 1: DNA Ladders used for 
running Cre and Confetti samples on 
2 % agarose gel 
 
A) NEB 1kb DNA ladder 
B) Generuler 1kb DNA ladder 
A	 B	
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between 10-25 mm thick. Sections were air dried on slides for at least 2 hours, 
then stored at -80°C. 
 
7.3.3 Staining  
7.3.3.1Immunohistochemistry  
 
Frozen sections were defrosted for 3-5 mins then post fixed for 10 mins in 4% 
PFA at room temperature. Samples were then rinsed 3 timed in PBS and blocked 
for 1 hour with 20% FCS and 0.2% Triton in PBS a room temperature. Note for 
goat derived primary antibodies DAKO serum free block was used. Slides were 
then incubated overnight at 4°C with the primary antibody in PBS. The 
following day sections were washed with PBS for 1 hour changing washes every 
5-10 minutes at room temperature. The secondary antibody in PBS was them 
added to the slides for 1 hour at room temperature. The sections were washed a 
second time for 1 hour with DAPI changing washes every 5-10 minutes. The 
sections were then counterstained with DAPI if desired for 3-4 minutes at 1:1000 
dilution in PBS, embedded in 50µl mouwiol plus DABCO, covered with a No.0 
coverslip  and sealed with nail varnish. Stained and mounted slides were stored 
at 4°C. 
Concentrations for primary and secondary antibodies are displayed in table 4 and 
5 below. 
Table 7.4- Primary antibodies 
Antigen Host Working 
dilution 
Company Reference 
β-
galactosidase 
Chicken IgY 1:1500 Abcam ab9361 
CD31 
(PECAM) 
Rabbit IgG 1:50 Abcam ab28364 
FLK/KDR Goat 
Polyclonal 
1:50 R&D systems AF644 
GFP IgGY 1:400 Abcam ab13970 
HAND2 Goat, 1:50 + AMP R & D AF3876 
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Table 7.5- Secondary Antibodies 
 
Secondary Antibody Working 
dilution 
Company Reference 
Donkey anti Rabbit AlexaFluor® 488 1:200 ThermoFisher A-21206 
Donkey anti Rabbit AlexaFluor® 647 1:200 ThermoFisher A-31573 
Donkey anti Goat AlexaFluor® 488 1:200 ThermoFisher A-11155 
Donkey anti Goat AlexaFluor® 555 1:200 ThermoFisher A-21432 
Donkey anti Goat AlexaFluor® 647 1:200 ThermoFisher A-21447 
Goat anti Chicken IgY AlexaFluor® 488 1:200 ThermoFisher A-11039 
Goat anti Chicken IgY AlexaFluor® 647 1:200 ThermoFisher A-21449 
Goat anti Mouse IgG2a AlexaFluor® 488 1:200 ThermoFisher A-21131 
Goat anti Mouse IgG2a AlexaFluor® 555 1:200 ThermoFisher A-21137 
 
 
 
7.4 Frontal bone explants 
7.4.1 Flat-Mount Bone Preparation 
 The murine ethmoid, frontal and parietal from mineralisation experiment 3 stage 
P0  was flat-mounted onto a slide as follows. The specimen was culled via 
cervical dislocation (Schedule 1) and fixed in 4% PFA at 4°C for one week, then 
stored at  
-80°C. 
The specimen was thawed at room temperature and rinsed with PBS. The dermis 
was removed and the frontal bone was isolated with the parietal and part of the 
nasal bones to ensure the frontal bone was undisturbed. The brain and meninges 
were dissected out and the sample was treated with permabilisation (0.1% 
polyclonal 1:500 systems 
Osteopontin Rabbit IgG 1:50 Abcam ab 
RUNX2 Mouse, IgGa 1:200 Abcam ab76956 
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Triton) and counterstaining (1:5,000 DAPI) overnight at 4°C. The following 
morning sample was rinsed 3 times with PBS. The whole explant was flattened 
onto a  Superfrost Plus ground edge slide , mounted in 150 µl mouwiol and the 
slide was sealed with vacuum grease. 
 
7.4.2 Lipophilic Dye Labelling  
 
Mice between e15 and P8 were culled according to a Schedule 1 Method. The 
calvaria of the animal dissected out as one piece, including the ethmoid, frontal, 
parietal and parts of the occiput. The dermis and meninx were removed carefully 
under the dissection scope, if necessary fluorescence was checked under 
epiflourescent dissection scope blue/green filter for transgenic specimens . The 
lipophilic dye(Life technologies NeuroTrace® DiI Tissue-Labeling Paste, DiO 
labeling paste) was then applied either dissolved in ethanol or as a suspension in 
petroleum jelly on either the dermis or brain side of the calavria in a spot like 
fashion with a bent fine guage needle  tip avoiding the sutures. The calvaria was 
then put on a polycarbonate membrane in a 6-well dish (6 Well transwell, 
polycarbonate membrane, 24mm, 8.0mm, Corning). A coverslip was laid over 
the calvaria and gently pressed down, and then the well filled with 1 ml of tissue 
culture media (DMEM supplemented with 10% FCS, 100µg/ml ascorbic acid 
and 20u/ml penicillin/streptavidin). The 6 well dish was then left in a tissue 
culture incubator at 37°C, 5% CO2 and 100% humidity for 24-48 hours. 
The calvaria were then removed from the incubator, rinsed with PBS, fixed in 
4% PFA and embedded in TissueTek (VWR) then stored at -80°C. Labelling 
regimes are detailed in Table 6 below. 
 
Table 7.6: Lipophilic dye labeling experiments 
 
Genotype Age No. of 
explants 
Side of 
frontal 
bone 
labelled 
Lipophilic Dye 
used 
Supplier Supplier 
Reference 
WT e17 2 Dermis Neurotrace®CM- Thermofisher N-22883 
	 357	
DiI  
WT e17 2 Brain Neurotrace®CM-
DiI 
WT P6 5 Dermis Neurotrace®DiO Thermofisher N-22881 
WT P6 5 Brain Neurotrace®DiO 
VegfaLacZ P8 2 Dermis Neurotrace®DiO 
VegfaLacZ P8 2 Brain Neurotrace®DiO 
 
 
 
7.5 Mineralisation experiments 
 
Experiments for labelling mineralised bone matrix in vivo were undertaken under 
a new project licence (Home Office reference PPL70/7118) held by K. Jordan. 
The title of this Project Licence, was Analysis of the kinetics of dermal bone 
Mineralization. The licence contains one protocol, “Injectionof labelling agents.” 
(K.Jordan 2012) 
Labelling agents were administered via intraparitoneal injection to mouse dams. 
Dosages were based on previously published values that were sufficient to confer 
the agents to the foetuses to achieve embryonic labelling.(K.Jordan 2012). 
Dosage for individual agents are listed in Table 7 below. 
 
 
 
Table 7.7- Matrix labeling Agent Dosage 
 
Agent Dose mg/kg 
Calcein 10 
Doxycycline 50 
Xylenol Orange 90 
 
Mineralised bone was permanently labelled at 2-3 time-points between e14 and 
e19 in WT embryos with nonharmful dyes listed in table 8. Labelling agents 
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were chosen that could be visualised without any treatment to enhance signal in 
emission areas with non-overlapping spectra such that they could be 
concomitantly analysed. 
Labelling agents were prepared in Phosphate Buffered Saline (PBS, 137 mM 
NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.4) and sterilised 
prior to injection. 
 
 
Table 7.8-Labelling Regimes 
Experiment e14 e16 e18 Cull Age 
1 calcein xylenol 
orange 
X P1 
2 xylenol 
orange 
X calcein P8 
3 calcein xylenol 
orange 
doxycycline P1 
 
 
Specimens were collected as per method in section X, and either sectioned or flat 
mounted (section Y). 
 
Labelling for mineralized matrix was also performed on fixed samples. Dissected 
bones were incubated in labelling agent for 15 mins and then washed for three 
hours in PBS. Slides were matrix labeled by incubation with labelling agent for 
45 seconds then rinsed 8 times in PBS. All  matrix labelling agents used for fixed 
sample matrix staining where used at a concentration of 0.1mg/ml. Specimens 
were then counterstained for DAPI as outlined previously. 
 
 
 
 
 
 
	 359	
 
 
 
7.6 Imaging 
 
Imaging of samples was carried out the MZ-FL Stereofluorescence dissection 
scope (University of Warwick Imaging suite) or on the following confocal 
microsopes; Leica SP2 and SP5, Zeiss LSM 710 and 880 (University of 
Warwick Imaging suite), and the Zeiss LSM 780 at the Institute of Molecular 
Imaging, John Radcliffe Hospital, Oxford.  
 
7.6.1 Sectioned samples 
 
7.6.2 Live frontal bone explant imaging 
 
Wnt1CrexConfetti mice were culled by anaesthetic overdose (Schedule 1). The 
frontal bone from one hemisphere was dissected out with a minima border of the 
nasal bone and parietal, to ensure the capture of the entire frontal bone, but also a 
sample that was small enough to be well flattened. The explant was cleared of 
meninges , and then placed in cultured media (as described in section) for 15 
mins at 37°C. The explant was then placed dermis or brain side down in the 
centre of a No.0 coverslip bottomed collagen coated petri dish (Mat Tek). The 
sample was then flattened by lightly pressing down a carbonate member well, 
kept in placee by the petri dish lid. The well was filled with approx. 1ml of 
culture media. A suitable region was then found by eye under the epifluorescent 
microscope, where z-stack could be imaged that included both L1 and L3 of the 
bone. Imaging was carried out on the Leica SP5 with a x40 objective, chosen for 
being the objective with the greatest working distance. The interval between the 
slices was between 1-4 µm. A time course over 15-22 hours was then imaged. 
Settings for imaging were optimized from settings used for fixed 
Wnt1CrexConfetti sections.  
Details of imaging protocol for frontal bone samples A-D are in Table 9 below. 
 
Table 7.9: Live Imaging of Wnt1CrexConfetti frontal bone explants 
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Sample Age Interval 
between 
slices (µm) 
Thickness of 
bone L2(µm) 
Time 
Interval 
between 
each stack 
(mins) 
Total Time 
Imaged 
(hrs) 
A P1 4 10 10 22 
B P0 2 15 10 17 
C P1 1 20 22 18.7 
D P2 1 15 10 15 
 
7.7 Image analysis  
7.7.1General analysis 
All image analysis utilised the Fiji open access software (Schindelin et al., 2012). 
Additional plugins were developed by Dr JLapage. 
 
Images from the confocal microscopes were either optical sections from a z-
stack, collapsed maximal projections of z-stacks or stitched z-stack maximal 
projections. Adjustments for brightness and contrast were made, in a linear 
fashion to the entire image as required. 
Images from the epifluorescent microscopes are true photographs, which were 
also adjusted for brightness and contrast as required using Fiji. 
 
7.7.2 Mineralised matrix analysis 
Multi channel confocal z stacks were manually examined to identify three cell 
types based on morphology (osteoblast, endothelial and osteocyte), see table x 
for recognition criteria. The image file  was annotated to record these cell types 
and their position using the cell counter plugin in Fiji-2, and the annotation file 
saved separately. 
The Fiji-2 MorphoLibJ plugin was created for Image J, which segmented each 
cell type from the annotation file and created a watershed image in which each 
annotated cell was outlined discretely, and colour coded according to cell type. 
This new image could then be overlayed with the channels showing mineralized 
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matrix for analysis of spatial patterns. 
3D Viewer (Schmid et al., 2010) and reslice were used to analyse the pattern of 
mineralization. 
Cell type Criteria for 
identification 
Shape Colour code 
Osteoblast Blast like form, 
rounded, many 
timed found in 
groups, near but not 
lining blood vessel 
lumens 
 Cyan  
Endothelial cell Long extended 
morphology, lining 
a lumen 
 
Magenta 
Osteocyte Isolated cell 
Embedded in 
labelled matrix, 
 
White 
 
7.7.3 Lipophilic dye labelling 
 
Labelled cells  (DiI/DiO and antibody labeled) were recorded manually using the 
Fiji-2 Cell counter plugin. Data was recorded in annotation files opened in excel 
for further analysis. 
 
7.7.4 Live cell tracking 
 
Manual cell tracking was performed as a collaborative exercise using the 
MTrackJ plugin in Fiji (Meijering et al., 2012), with some modifications made 
by Dr JML Lapage as part of undergraduate module BS373 School of 
LifeSciences, University of Warwick. 
		 	
	 362	
 The centre of the cell at each timepoint was marked and defined using the 
original .tif timelapsed z-stack for each of the samples A-D (Table 7). From this 
traces of the cell path in 3D were constructed.  
The tracks were saved as .mtj files. When loaded into MtrackJ the tracks could 
be used to produce tables of measurements in .mdf format. The .mdf files could 
be produced to include all cells or only a certain subset e.g. cells traced for the 
first hour, or only within a certain range of z-slices.  
Local cell density was calculated by centring a cylinder on each cell centre of 
dimensions xyz. This made the test sensitive to z and xy density. 
 
7.8 Statistical Analysis and Data presentation 
All statistical analysis was performed and graphs produced on either Microsoft 
Excel or Prism 7.0 software, some further details are provided below. 
7.8: Beta distributions 
 
The beta distributions were produced in Microsoft Excel. The beta probability 
density function (f) is given by: 
f (x) = 1B(a,b) x
a−1(1− x)b−1, 0 < x <1
 
Where B is the beta function, a ∈ 0,∞ is the right (positive) parameter and 
b ∈ 0,∞  is the left (negative) parameter. 
 
7.8.2: Live imaging data 
 
Distribution of cell tracking data from the four samples was non-Gaussian in 
distribution, so for analysis of cells properties such as velocity, pathlength, 
displacement etc. it was deemed inappropriate to pool data as a mean value with 
standard deviation. 
 
Histograms of the data distributions were produced for each property, and where 
appropriate the median value quoted with the 95% confidence intervals. 
When analysing trends in the data non-parametric tests were used with 
confidence that the large number of data points (between 232 and 532) gave the 
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tests good statistical power. If the data was non-paired a Mann-Whitney U-test 
was performed (Mann and Whitney, 1947). If the data points were paired a 
Wilcoxon matched pairs signed-rank test was used (Wilcoxon and Wilcox, 
1964). 
 
7.8.3 Clone alignment analysis 
Clone alignment was assessed by sorting clone angles into bins 20o wide from 0o-
20o to 160o-170o. 
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8. Technical appendix 
 
8.1.1 Fluorescent labelling of mineralized matrix 
 
A time-course of dye retention was performed by K.Jordan to ensure any 
individual labelling agent would cleared from the bloodstream before the 
addition of the next labelling agent. A two-day gap was chosen as desirable 
minimum injection period and it was found that the dye was not retained in the 
circulatory system more than two days. 
A dye swap was also performed to test that one matrix labelling agent was not 
binding to mineral preferentially over the other. It was found that swapping the 
order of matrix labelling agents did not effect the resulting mineralization 
pattern. 
The optimal confocal imaging wavelengths for the matrix labelling agents were 
also optimised by K.Jordan. 
 
8.1.2 Measuring thickness of the dye labelled biomineral 
 
Biomineral layers were measured at 10 points or more along the anterior 
posterior axis of sections. All measurements were used to calculate the p value 
between samples using a two-tailed unpaired parametric t-test using Prism 7.0 
software. 
P values are given below in tables 8.1 and 8.2 for absolute layer thickness and 
rate of mineralisation respectively. The p values were assigned significance 
according to conventional limits: where p ≤0.05> 0.01 = *, where p≤0.01>0.001 
=**, where p≤0.001>0.0001=*** and where p≤0.0001=****. 
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Table 8.1 P values for differences in the absolute thickness of labelled biomineral 
layers 
 
 e14 e16 e18 e18-P1 P0-P1 P0-P8 
e14  0.0246 0.1130 0.0149 0.0061 <0.0001 
e16   0.5121 0.2005 0.3406 0.0002 
e18    0.2005 0.1090 <0.0001 
e18-P1     0.6973 0.0003 
P0-P1      0.0035 
P0-P8       
 
Table 8.2 P values for differences in the rate of radial biomineralisation 
 
 e14 e16 e18 e18-P1 P0-P1 P0-P8 
e14  0.1227 0.2312 0.0156 0.1308 <0.0001 
e16   0.6094 0.6957 0.0915 0.0002 
e18    0.2926 0.0142 0.0001 
e18-P1     0.0408 0.0408 
P0-P1      0.1498 
P0-P8       
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8.2 Analysis of DiI/DiO labelled cell tracking in the frontal bone 
8.2 .1Sample thickness 
 
Table 8.3RUNX2 / HAND2 antibody labeled bone sections 
 
Sample Downward (L1 DiI 
application) sample 
thickness (microns) 
Upward (L3 DiI 
application) 
sample 
thickness (microns) 
1 19.1 22.7 
2 29.9 22.7 
3 57.2 29.7 
4 60.2 31.3 
5 68.9 82.6 
 
 
Table 8.4VEGFR2 / VEGFA antibody labeled bone sections 
 
Sample Downward (L1 DiI 
application) sample 
thickness (microns) 
Upward (L3 DiI 
application) 
sample 
thickness (microns) 
1 97.8 24.5 
2 50.8 73.2 
 
Table 8.5 RUNX2 / VEGFA antibody labeled bone sections 
 
 
Sample Downward (L1 DiI 
application) 
thickness (microns) 
Upward (L3 DiI 
application) 
thickness (microns) 
1 34.0 28.9 
2 30.6 36.1 
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8.2.2Beta distribution inputs 
 
The following tables contain the input data for the bets distribution as described 
above. Alpha value are the number of positive events (i.e. cells in L2) plus 1, 
whilst beta values are the corresponding negative events (cells in L1 or L3) plus 
1. 
 
Table 8.6 Alpha and beta values used for beta distribution input for downward 
(L1 labelled) invading RUNX2 /HAND2 stained cells 
 
Cell type Value Sample
1 
Sample 
2 
Sample 
3 
Sample 
4 
Sample 
5 
Total 
RUNX2+ 
HAND- 
α 2 3 1 7 29 38 
β 2 1 1 1 3 4 
RUNX2+ 
HAND+ 
α 6 7 11 27 84 131 
β 16 9 6 29 38 94 
RUNX2- 
HAND+ 
α 15 27 38 5 3 84 
β 36 69 58 30 79 268 
RUNX2- 
HAND- 
α 13 43 49 13 74 188 
β 2 2 7 1 4 13 
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Table 8.7:Alpha and beta values used for beta distribution input for upward (L3 
labelled) invading RUNX2 /HAND2 stained cells 
 
Cell type Value Sample
1 
Sample 
2 
Sample 
3 
Sample 
4 
Sample 
5 
Total 
RUNX2+ 
HAND- 
α 5 1 4 7 6 19 
β 12 2 2 10 1 23 
RUNX2+ 
HAND+ 
α 2 3 6 3 16 26 
β 3 2 5 9 9 24 
RUNX2- 
HAND+ 
α 1 7 6 14 25 49 
β 2 11 4 6 6 25 
RUNX2- 
HAND- 
α 2 1 1 1 17 18 
β 4 15 8 11 1 35 
 
Table 8.8:Alpha and beta values used for beta distribution input for downward 
(L1 labelled) invading VEGFR2 /VEGFA stained cells 
 
Cell type Value Sample 1 Sample 2 Total 
VEGFR2+ 
VEGFA- 
α 4 8 11 
β 1 1 1 
VEGFR2+ 
VEGFA+ 
α 36 16 51 
β 11 7 17 
VEGFR2- 
VEGFA+ 
α n/a 21 21 
β n/a 7 7 
VEGFR2- 
VEGFA- 
α 43 43 85 
β 11 17 27 
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Table 8.9: Alpha and beta values used for beta distribution input for upward (L3 
labelled) invading VEGFR2 /VEGFA stained cells 
 
Cell type Value Sample 1 Sample 2 Total 
VEGFR2+ 
VEGFA- 
α n/a 6 6 
β n/a 1 1 
VEGFR2+ 
VEGFA+ 
α 1 19 19 
β 3 3 5 
VEGFR2- 
VEGFA+ 
α 8 4 11 
β 22 5 26 
VEGFR2- 
VEGFA- 
α 14 28 41 
β 26 13 38 
 
Table 8.10 Alpha and beta values used for beta distribution input for downward 
(L1 labelled) invading RUNX2/VEGFA stained cells 
 
Cell type Value Sample 1 Sample 2 Total 
RUNX2+ 
VEGFA- 
α 7 5 11 
β 1 4 4 
RUNX2+ 
VEGFA+ 
α 3 10 12 
β 8 16 23 
RUNX2- 
VEGFA+ 
α 9 3 11 
β 6 1 6 
RUNX2- 
VEGFA- 
α 20 20 39 
β 13 22 34 
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Table 8.11:Alpha and beta values used for beta distribution input for upward (L3 
labelled) invading RUNX2 /VEGFA stained cells 
 
Cell type Value Sample 1 Sample 2 Total 
RUNX2+ 
VEGFA- 
α n/a 10 10 
β n/a 2 2 
RUNX2+ 
VEGFA+ 
α 10 16 25 
β 7 20 26 
RUNX2- 
VEGFA+ 
α 4 10 13 
β 26 9 34 
RUNX2- 
VEGFA- 
α 19 36 54 
β 32 43 74 
 
8.2.3:Beta distribution overlaps 
 
Differences between cells populations could be found by calculating the overlap 
between beta distribution curves. If the curve overlap is below 5% then the 
populations could be claimed to be significantly different. The percentage 
overlap between curves is shown in the following tables for all invading 
populations in this thesis. Tables 8.12-8.16 are the overlap percentages for 
different cells travelling in the same direction. Tables 8.17-8.18 show the overlap 
between the same cell type invading in different directions. Populations with less 
than 5% overlap are highlighted in pink. All downward invading populations in 
VEGFR2/VEGFA labeled data set had beta distributions that overlapped by 
more then 5%, so no table is shown. 
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Table 8.12: Percentage overlap between beta distributions of downward invading 
cell populations assessed for RUNX2/HAND2 expression 
 
 
 
Table 8.13: Percentage overlap between beta distributions of upward invading 
cell populations assessed for RUNX2/HAND2 expression 
 
 
Cell 
populations  
RUNX2  
single 
positive 
RUNX2+HAND2+ 
double positive 
HAND2 
single 
positive 
RUNX2HAND2 
Double 
negative 
RUNX2 single 
positive 
 >5% >5% >5% 
RUNX2HAND2 
Double positive 
  >5% 0.716% 
RUNX2 single 
positive 
   >5% 
 
Table 8.14: Percentage overlap between beta distributions of upward invading 
cell populations assessed for VEGFR2/VEGFA expression 
 
Cell populations  VEGFR
2 
single 
positive 
VEGFR2/VEGF
A 
Double positive 
VEGF
A 
single 
VEGFR2/VEGF
A 
Double negative 
VEGFR2 single 
positive 
 >5% 1.65% >5% 
VEGFR2/VEGF
A 
Double positive 
  0.362% 4.99% 
VEGFA single    0.152% 
 
 
 
 
Cell 
populations  
RUNX2  
single 
positive 
RUNX2+HAND2+ 
double positive 
HAND2 
single 
positive 
RUNX2HAND2 
Double 
negative 
RUNX2 single 
positive 
 0.0558% 4.02% >5% 
RUNX2HAND2 
Double positive 
  0.0679% 1.15x10-7 % 
Runx2 single 
positive 
   0.00286% 
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Table 8.15 Percentage overlap between beta distributions of downward invading 
cell populations assessed for RUNX2/VEGFA expression 
 
 
 
Cell populations  RUNX2 
single 
positive 
RUNX2/VEGFA 
Double positive 
VEGFA 
single 
RUNX2/VEGFA 
Double negative 
RUNX2 single 
positive 
 >5% 0.534% 1.28% 
RUNX2/VEGFA 
Double positive 
  >5% >5% 
VEGFA single    >5% 
 
 
 
 
Table 8.16 Percentage overlap between beta distributions of upward invading 
cell populations assessed for RUNX2/VEGFA expression 
 
Cell populations  RUNX2 
single 
positive 
RUNX2/VEGFA 
Double positive 
VEGFA 
single 
RUNX2/VEGFA 
Double negative 
RUNX2 single 
positive 
 3.68% >5% >5% 
RUNX2/VEGFA 
Double positive 
  >5% >5% 
VEGFA single    >5% 
 
 
 
Tables 8.17-8.19 Percentage overlap between beta distributions of upward and 
downward invading populations of the same cell type 
A) 8.17 RUNX2/HAND2 populations 
B) 8.18 VEGFR2/VEGFA population 
C) 8.19 RUNX2/VEGFA  population 
 
Table8.17 
Cell type Beta distribution overlap of total cell 
population 
RUNX2 single positive 0.086% 
RUNX2HAND2 
Double positive 
>5% 
RUNX2 single positive >5% 
RUNX2HAND2 
Double negative 
1.74x10-8 % 
 
	 373	
Table 8.18 
Cell type Beta distribution overlap of total cell 
population 
VEGFR2 single positive >5% 
VEGFR2VEGFA 
Double positive 
>5% 
VEGFA single positive 0.475% 
RUNX2/VEGFA 
Double negative 
1.38% 
 
Table 8.19 
Cell type Beta distribution overlap of total cell 
population 
RUNX2 single positive >5% 
RUNX2VEGFA 
Double positive 
>5% 
VEGFA single positive 3.12 % 
RUNX2/VEGFA 
Double negative 
>5% 
 
 
 
8.3 Cranial base analysis 
 
For the measurements of longitudinal growth of the cranial base in Chapter 5.1, 
set landmarks were used for comparing growth in different ages. 
From posterior to anterior: 
1) Posterior point of basisocciput 
2) Posterior SOS 
3) Anterior SOS 
4) Posterior MSS 
5) Anterior MSS 
6) Posterior SES (transition between bone and hypertrophic cartilage at 
anterior point of presphenoid bone) 
7) Anterior SES 
8) Anterior point of nasal capsule (palnes with full nasal septum measurements 
were not included) 
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Table 8.20 Cranial base length measurements in Wnt1CrexConfetti specimens 
Mean length in microns of cranial base bones and cartilage. Mean form three 
sagittal sections of a single specimen for each age 
 
Age  No. 
of 
mice 
No. of 
sections 
Basisocciput 
length/ 
µm  
SOS 
length/ 
µm 
Basisphenoid 
length/ 
µm 
MSS 
length/ 
µm 
Presphenoid 
length/ 
µm 
SES 
length/ 
µm 
Ethmoid 
length/ 
µm 
e14.5 1 3 1193 174 329 184 203 97 269 
P1 1 3 1973 626 939 597 933 295 1119 
P26 1 3 3179 300 2346 282 1969 323 2171 
 
 
 
 
Figure 8.1 Landmarks for measurements of cranial base length dimension 
Measurements were taken at the positions of the red crosses. Bone represented as grey, 
cartilage as pink. 
B.Sph=basisphenoid, P.Sph= presphenoid. 
Pituitary 
SOS 
Ethmoid 
BSph. 
MSS 
PSph. 
SES 
1 
X 
X 
X 
X 
X 
X X X 
2 
3 
4 
5 
6 
7 
8 
Basisocciput 
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Table 8.21 Height measurements of cranial base synchondroses in 
Wnt1CrexConfetti specimens 
 
Age  No. of 
mice 
No. of 
sections 
SOS 
height/ 
µm 
MSS 
height/ 
µm 
SES 
height/ 
µm 
e14.5 1 3 98 98 146 
P1 1 3 333 193 246 
P26 1 3 653 387 358 
 
 
 
Table 8.22: Number of clones used in analysis of clone height, length and 
orientation in in Wnt1CrexConfetti specimens 
Total number of clones counted and measured in the cranial base synchondroses 
in three sections of a single specimen for each age. 
 
Age No. of mice No. of sections No. of SES 
clones 
No. of MSS 
clones 
e14.5 1 3 83 32 
P1 1 3 93 121 
P26 1 3 32 27 
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